10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________________________________________

FORM 10-Q

(Mark One) 

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2018

or

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                              to                             

Commission File Number: 1-13991

MFA FINANCIAL, INC.

(Exact name of registrant as specified in its charter)

_____________________________________________ 

Maryland	13-3974868
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
350 Park Avenue, 20th Floor, New York, New York	10022
(Address of principal executive offices)	(Zip Code)

(212) 207-6400

(Registrant’s telephone number, including area code)

Not Applicable 

(Former name, former address and former fiscal year, if changed since last period)

_____________________________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x  No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer x	Accelerated filer o
Non-accelerated filer o	Smaller reporting company o
	Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o

No x

449,546,435 shares of the registrant’s common stock, $0.01 par value, were outstanding as of October 31, 2018.

MFA FINANCIAL, INC.

TABLE OF CONTENTS

		Page
PART I
FINANCIAL INFORMATION
Item 1.	Financial Statements
	Consolidated Balance Sheets as of September 30, 2018 (Unaudited) and December 31, 2017	1
	Consolidated Statements of Operations (Unaudited) for the Three and Nine Months Ended September 30, 2018 and September 30, 2017	2
	Consolidated Statements of Comprehensive Income/(Loss) (Unaudited) for the Three and Nine Months Ended September 30, 2018 and September 30, 2017	3
	Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) for the Nine Months Ended September 30, 2018 and September 30, 2017	4
	Consolidated Statements of Cash Flows (Unaudited) for the Nine Months Ended September 30, 2018 and September 30, 2017	5
	Notes to the Unaudited Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	55
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	87
Item 4.	Controls and Procedures	94
PART II
OTHER INFORMATION
Item 1.	Legal Proceedings	95
Item 1A.	Risk Factors	95
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	95
Item 3.	Defaults Upon Senior Securities	95
Item 4.	Mine Safety Disclosures	95
Item 5.	Other Information	95
Item 6.	Exhibits	95
Signatures		96

MFA FINANCIAL, INC. CONSOLIDATED BALANCE SHEETS
(In Thousands Except Per Share Amounts)	September 30, 2018			December 31, 2017
	(Unaudited)
Assets:
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities:
Agency MBS, at fair value ($2,795,273 and $2,727,510 pledged as collateral, respectively)	$	2,905,490		$	2,824,681
Non-Agency MBS, at fair value ($3,237,108 and $2,379,523 pledged as collateral, respectively)	3,334,610			3,533,966
CRT securities, at fair value ($504,931 and $595,900 pledged as collateral, respectively)	538,945			664,403
Mortgage servicing rights (“MSR”) related assets ($565,272 and $482,158 pledged as collateral, respectively)	565,272			492,080
Residential whole loans, at carrying value ($1,149,293 and $448,689 pledged as collateral, respectively) (1)	2,471,567			908,516
Residential whole loans, at fair value ($685,095 and $996,226 pledged as collateral, respectively) (1)	1,449,365			1,325,115
Cash and cash equivalents	104,186			449,757
Restricted cash	6,489			13,307
Other assets	406,069			742,909
Total Assets	$	11,781,993		$	10,954,734
Liabilities:
Repurchase agreements	$	7,278,270		$	6,614,701
Other liabilities	951,483			1,078,397
Total Liabilities	$	8,229,753		$	7,693,098
Commitments and contingencies (See Note 10)
Stockholders’ Equity:
Preferred stock, $.01 par value; 7.50% Series B cumulative redeemable; 8,050 shares authorized; 8,000 shares issued and outstanding ($200,000 aggregate liquidation preference)	$	80		$	80
Common stock, $.01 par value; 886,950 shares authorized; 449,472 and 397,831 shares issued and outstanding, respectively	4,495			3,978
Additional paid-in capital, in excess of par	3,620,268			3,227,304
Accumulated deficit	(598,971		)	(578,950		)
Accumulated other comprehensive income	526,368			609,224
Total Stockholders’ Equity	$	3,552,240		$	3,261,636
Total Liabilities and Stockholders’ Equity	$	11,781,993		$	10,954,734

(1) Includes approximately $215.1 million and $183.2 million of Residential whole loans, at carrying value and $723.8 million and $289.3 million of Residential whole loans, at fair value transferred to consolidated variable interest entities (“VIEs”) at September 30, 2018 and December 31, 2017, respectively. Such assets can be used only to settle the obligations of the VIEs.

The accompanying notes are an integral part of the consolidated financial statements.

1

MFA FINANCIAL, INC. CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
	Three Months Ended   September 30,						Nine Months Ended   September 30,
(In Thousands, Except Per Share Amounts)	2018			2017			2018			2017
Interest Income:
Agency MBS	$	14,332		$	15,533		$	42,795		$	50,014
Non-Agency MBS	58,667			63,252			169,812			212,728
CRT securities	7,748			8,676			25,939			22,898
MSR related assets	6,407			7,194			20,249			17,833
Residential whole loans held at carrying value	29,524			9,026			61,788			26,219
Cash and cash equivalent investments	754			1,452			2,348			2,854
Interest Income	$	117,432		$	105,133		$	322,931		$	332,546
Interest Expense:
Repurchase agreements and other advances	$	50,881		$	46,303		$	142,832		$	141,444
Other interest expense	7,997			2,972			18,410			7,202
Interest Expense	$	58,878		$	49,275		$	161,242		$	148,646
Net Interest Income	$	58,554		$	55,858		$	161,689		$	183,900
Other Income, net:
Net gain on residential whole loans held at fair value	$	34,942		$	18,679		$	105,883		$	48,660
Net gain on sales of investment securities	16,415			14,933			32,661			30,530
Other, net	(2,998		)	(4,515		)	(1,519		)	13,812
Other Income, net	$	48,359		$	29,097		$	137,025		$	93,002
Operating and Other Expense:
Compensation and benefits	$	6,868		$	10,892		$	20,654		$	26,258
Other general and administrative expense	4,155			4,081			13,569			14,060
Loan servicing and other related operating expenses	8,758			6,177			23,569			14,785
Operating and Other Expense	$	19,781		$	21,150		$	57,792		$	55,103
Net Income	$	87,132		$	63,805		$	240,922		$	221,799
Less Preferred Stock Dividends	3,750			3,750			11,250			11,250
Net Income Available to Common Stock and Participating Securities	$	83,382		$	60,055		$	229,672		$	210,549
Earnings per Common Share - Basic and Diluted	$	0.19		$	0.15		$	0.56		$	0.54
Dividends Declared per Share of Common Stock	$	0.20		$	0.20		$	0.60		$	0.60

The accompanying notes are an integral part of the consolidated financial statements.

2

MFA FINANCIAL, INC. CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS) (UNAUDITED)
	Three Months Ended   September 30,						Nine Months Ended   September 30,
(In Thousands)	2018			2017			2018			2017
Net income	$	87,132		$	63,805		$	240,922		$	221,799
Other Comprehensive Income/(Loss):
Unrealized loss on Agency MBS, net	(9,177		)	(3,032		)	(27,507		)	(22,241		)
Unrealized (loss)/gain on Non-Agency MBS, net	(25,101		)	10,020			(62,743		)	93,429
Reclassification adjustment for MBS sales included in net income	(9,455		)	(14,935		)	(25,580		)	(30,283		)
Reclassification adjustment for other-than-temporary impairments included in net income	—			—			—			(1,032		)
Derivative hedging instrument fair value changes, net	5,390			5,791			32,974			16,671
Other Comprehensive (Loss)/Income	(38,343		)	(2,156		)	(82,856		)	56,544
Comprehensive income before preferred stock dividends	$	48,789		$	61,649		$	158,066		$	278,343
Dividends declared on preferred stock	(3,750		)	(3,750		)	(11,250		)	(11,250		)
Comprehensive Income Available to Common Stock and Participating Securities	$	45,039		$	57,899		$	146,816		$	267,093

The accompanying notes are an integral part of the consolidated financial statements.

3

MFA FINANCIAL, INC. CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED)
	Nine Months Ended September 30, 2018
(In Thousands,  Except Per Share Amounts)	Preferred Stock 7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share			Common Stock				Additional Paid-in Capital			Accumulated Deficit			Accumulated Other Comprehensive Income			Total
	Shares	Amount		Shares		Amount
Balance at December 31, 2017	8,000	$	80	397,831		$	3,978	$	3,227,304		$	(578,950	)	$	609,224		$	3,261,636
Cumulative effect adjustment on adoption of new accounting standard for revenue recognition	—	—		—		—		—			295			—			295
Net income	—	—		—		—		—			240,922			—			240,922
Issuance of common stock, net of expenses (1)	—	—		51,892		517		391,065			—			—			391,582
Repurchase of shares of common stock (1)	—	—		(251	)	—		(1,957		)	—			—			(1,957		)
Equity based compensation expense	—	—		—		—		3,887			—			—			3,887
Accrued dividends attributable to stock-based awards	—	—		—		—		(31		)	—			—			(31		)
Dividends declared on common stock	—	—		—		—		—			(249,287		)	—			(249,287		)
Dividends declared on preferred stock	—	—		—		—		—			(11,250		)	—			(11,250		)
Dividends attributable to dividend equivalents	—	—		—		—		—			(701		)	—			(701		)
Change in unrealized gains on MBS, net	—	—		—		—		—			—			(115,830		)	(115,830		)
Derivative hedging instrument fair value changes, net	—	—		—		—		—			—			32,974			32,974
Balance at September 30, 2018	8,000	$	80	449,472		$	4,495	$	3,620,268		$	(598,971	)	$	526,368		$	3,552,240

	Nine Months Ended September 30, 2017
(In Thousands,  Except Per Share Amounts)	Preferred Stock 7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share			Common Stock				Additional Paid-in Capital			Accumulated Deficit			Accumulated Other Comprehensive Income		Total
	Shares	Amount		Shares		Amount
Balance at December 31, 2016	8,000	$	80	371,854		$	3,719	$	3,029,062		$	(572,641	)	$	573,682	$	3,033,902
Net income	—	—		—		—		—			221,799			—		221,799
Issuance of common stock, net of expenses (1)	—	—		25,726		250		190,265			—			—		190,515
Repurchase of shares of common stock (1)	—	—		(641	)	—		(5,158		)	—			—		(5,158		)
Equity based compensation expense	—	—		—		—		5,209			—			—		5,209
Accrued dividends attributable to stock-based awards	—	—		—		—		20			—			—		20
Dividends declared on common stock	—	—		—		—		—			(233,244		)	—		(233,244		)
Dividends declared on preferred stock	—	—		—		—		—			(11,250		)	—		(11,250		)
Dividends attributable to dividend equivalents	—	—		—		—		—			(686		)	—		(686		)
Change in unrealized gains on MBS, net	—	—		—		—		—			—			39,873		39,873
Derivative hedging instruments fair value changes, net	—	—		—		—		—			—			16,671		16,671
Balance at September 30, 2017	8,000	$	80	396,939		$	3,969	$	3,219,398		$	(596,022	)	$	630,226	$	3,257,651

(1)  For the nine months ended September 30, 2018 and 2017, includes approximately $2.0 million (250,946 shares) and $5.2 million (640,748 shares), respectively surrendered for tax purposes related to equity-based compensation awards.

4

MFA FINANCIAL, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
	Nine Months Ended   September 30,
(In Thousands)	2018			2017
Cash Flows From Operating Activities:
Net income	$	240,922		$	221,799
Adjustments to reconcile net income to net cash provided by operating activities:
Gain on sales of MBS, CRT securities and U.S. Treasury securities	(32,661		)	(30,530		)
Gain on sales of real estate owned	(6,582		)	(2,844		)
Gain on liquidation of residential whole loans	(18,598		)	(7,178		)
Other-than-temporary impairment charges	—			1,032
Accretion of purchase discounts on MBS and CRT securities, residential whole loans and MSR related assets	(64,211		)	(67,065		)
Amortization of purchase premiums on MBS, CRT securities, and residential whole loans	21,141			23,766
Depreciation and amortization on real estate, fixed assets and other assets	1,354			1,199
Equity-based compensation expense	3,891			5,369
Unrealized gain on residential whole loans at fair value	(26,788		)	(12,499		)
Unrealized losses/(gains) on MBS, CRT securities and Swaps	2,767			(11,932		)
(Increase)/decrease in other assets and other	(31,018		)	10,538
Increase/(decrease) in other liabilities	33			(10,248		)
Net cash provided by operating activities	$	90,250		$	121,407
Cash Flows From Investing Activities:
Principal payments on MBS, CRT securities and MSR related assets	$	1,797,012		$	3,387,673
Proceeds from sales of MBS, CRT securities and U.S. Treasury securities	341,589			222,143
Purchases of MBS, CRT securities, MSR related assets and U.S. Treasury securities	(2,021,914		)	(1,425,717		)
Purchases of residential whole loans and capitalized advances	(2,158,105		)	(391,613		)
Principal payments on residential whole loans	345,917			105,549
Proceeds from sales of real estate owned	93,635			51,834
Purchases of real estate owned and capital improvements	(10,179		)	(17,224		)
Redemption of Federal Home Loan Bank stock	—			10,422
Additions to leasehold improvements, furniture and fixtures	(1,009		)	(596		)
Net cash (used in)/provided by investing activities	$	(1,613,054	)	$	1,942,471
Cash Flows From Financing Activities:
Principal payments on repurchase agreements and other advances	$	(48,988,034	)	$	(57,118,263	)
Proceeds from borrowings under repurchase agreements	49,651,416			55,302,002
Proceeds from issuance of securitized debt	419,970			147,847
Principal payments on securitized debt	(67,945		)	(9,140		)
Payments made for securitization related costs	(2,472		)	(1,520		)
Payments made for settlements on interest rate swap agreements (“Swaps”)	(40,885		)	(30,050		)
Proceeds from settlements on Swaps	57,656			—
Proceeds from issuances of common stock	391,932			190,928
Payments made for costs related to common stock issuances	(350		)	(412		)
Dividends paid on preferred stock	(11,250		)	(11,250		)
Dividends paid on common stock and dividend equivalents	(239,623		)	(228,982		)
Net cash provided by/(used in) financing activities	$	1,170,415		$	(1,758,840	)
Net (decrease)/increase in cash, cash equivalents and restricted cash	$	(352,389	)	$	305,038
Cash, cash equivalents and restricted cash at beginning of period	$	463,064		$	318,575
Cash, cash equivalents and restricted cash at end of period	$	110,675		$	623,613
Non-cash Investing and Financing Activities:
Net (decrease)/increase in securities obtained as collateral/obligation to return securities obtained as collateral	$	(505,850	)	$	131,930
Transfer from residential whole loans to real estate owned	$	161,572		$	97,388
Dividends and dividend equivalents declared and unpaid	$	90,136		$	79,605
Payable for unsettled MBS and residential whole loans purchases	$	10,888		$	124,006

The accompanying notes are an integral part of the consolidated financial statements.

5

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

1.   Organization

MFA Financial, Inc. (the “Company”) was incorporated in Maryland on July 24, 1997 and began operations on April 10, 1998.  The Company has elected to be treated as a real estate investment trust (“REIT”) for U.S. federal income tax purposes.  In order to maintain its qualification as a REIT, the Company must comply with a number of requirements under federal tax law, including that it must distribute at least 90% of its annual REIT taxable income to its stockholders.  The Company has elected to treat certain of its subsidiaries as a taxable REIT subsidiary (“TRS”). In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate related business. (See Note 2(o))

2.   Summary of Significant Accounting Policies

(a)  Basis of Presentation and Consolidation

The interim unaudited consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”).  Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been condensed or omitted according to these SEC rules and regulations.  Management believes that the disclosures included in these interim unaudited consolidated financial statements are adequate to make the information presented not misleading.  The accompanying unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.  In the opinion of management, all normal and recurring adjustments necessary to present fairly the financial condition of the Company at September 30, 2018 and results of operations for all periods presented have been made.  The results of operations for the three and nine months ended September 30, 2018 should not be construed as indicative of the results to be expected for the full year.

The accompanying consolidated financial statements of the Company have been prepared on the accrual basis of accounting in accordance with GAAP.  The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Although the Company’s estimates contemplate current conditions and how it expects them to change in the future, it is reasonably possible that actual conditions could differ from those estimates, which could materially impact the Company’s results of operations and its financial condition.  Management has made significant estimates in several areas, including other-than-temporary impairment (“OTTI”) on MBS (See Note 3), valuation of MBS, CRT securities and MSR related assets (See Notes 3 and 14), income recognition and valuation of residential whole loans (See Notes 4 and 14), valuation of derivative instruments (See Notes 5(c) and 14) and income recognition on certain Non-Agency MBS (defined below) purchased at a discount. (See Note 3)  In addition, estimates are used in the determination of taxable income used in the assessment of REIT compliance and contingent liabilities for related taxes, penalties and interest. (See Note 2(o))  Actual results could differ from those estimates.

The Company has one reportable segment as it manages its business and analyzes and reports its results of operations on the basis of one operating segment; investing, on a leveraged basis, in residential mortgage assets.

The consolidated financial statements of the Company include the accounts of all subsidiaries; all intercompany accounts and transactions have been eliminated. In addition, the Company consolidates entities established to facilitate transactions related to the acquisition and securitization of residential whole loans as well as MBS resecuritization transactions completed in prior years. Certain prior period amounts have been reclassified to conform to the current period presentation.

6

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

(b)  MBS and CRT Securities

The Company has investments in residential MBS that are issued or guaranteed as to principal and/or interest by a federally chartered corporation, such as the Federal National Mortgage Association (“Fannie Mae”) or the Federal Home Loan Mortgage Corporation (“Freddie Mac”), or an agency of the U.S. Government, such as the Government National Mortgage Association (“Ginnie Mae”) (collectively, “Agency MBS”), and residential MBS that are not guaranteed by any agency of the U.S. Government or any federally chartered corporation (“Non-Agency MBS”). In addition, the Company has investments in CRT securities that are issued by Fannie Mae and Freddie Mac. The coupon payments on CRT securities are paid by Fannie Mae and Freddie Mac and the principal payments received are based on the performance of loans in a reference pool of previously securitized MBS. As the loans in the underlying reference pool are paid, the principal balance of the CRT securities is paid. As an investor in a CRT security, the Company may incur a loss if certain defined credit events occur, including, for certain CRT securities, if the loans in the reference pool experience delinquencies exceeding specified thresholds.

Designation

MBS that the Company generally intends to hold until maturity, but that it may sell from time to time as part of the overall management of its business, are designated as “available-for-sale” (“AFS”). Such MBS are carried at their fair value with unrealized gains and losses excluded from earnings (except when an OTTI is recognized, as discussed below) and reported in Accumulated other comprehensive income/(loss) (“AOCI”), a component of Stockholders’ Equity.

Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of AOCI to earnings as a realized gain or loss using the specific identification method.

The Company has elected the fair value option for certain of its Agency MBS that it does not intend to hold to maturity. These securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statements of operations.

The Company has elected the fair value option for its CRT securities as it considers this method of accounting to more appropriately reflect the risk sharing structure of these securities. Such securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statements of operations.

Revenue Recognition, Premium Amortization and Discount Accretion

Interest income on securities is accrued based on the outstanding principal balance and their contractual terms. Premiums and discounts associated with Agency MBS and Non-Agency MBS assessed as high credit quality at the time of purchase are amortized into interest income over the life of such securities using the effective yield method. Adjustments to premium amortization are made for actual prepayment activity.

Interest income on the Non-Agency MBS that were purchased at a discount to par value and/or are considered to be of less than high credit quality is recognized based on the security’s effective interest rate which is the security’s internal rate of return (“IRR”). The IRR is determined using management’s estimate of the projected cash flows for each security, which are based on the Company’s observation of current information and events and include assumptions related to fluctuations in interest rates, prepayment speeds and the timing and amount of credit losses. On at least a quarterly basis, the Company reviews and, if appropriate, makes adjustments to its cash flow projections based on input and analysis received from external sources, internal models, and its judgment about interest rates, prepayment rates, the timing and amount of credit losses, and other factors. Changes in cash flows from those originally projected, or from those estimated at the last evaluation, may result in a prospective change in the IRR/ interest income recognized on these securities or in the recognition of OTTIs.  (See Note 3)

Based on the projected cash flows from the Company’s Non-Agency MBS purchased at a discount to par value, a portion of the purchase discount may be designated as non-accretable purchase discount (“Credit Reserve”), which effectively mitigates the Company’s risk of loss on the mortgages collateralizing such MBS and is not expected to be accreted into interest income.  The amount designated as Credit Reserve may be adjusted over time, based on the actual performance of the security, its underlying collateral, actual and projected cash flow from such collateral, economic conditions and other factors.  If the performance of a security with a Credit Reserve is more favorable than forecasted, a portion of the amount designated as Credit Reserve may be reallocated to accretable discount and recognized into interest income over time.  Conversely, if the performance of a security with

7

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

a Credit Reserve is less favorable than forecasted, the amount designated as Credit Reserve may be increased, or impairment charges and write-downs of such securities to a new cost basis could result.

Determination of Fair Value for MBS and CRT Securities

In determining the fair value of the Company’s MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity.  (See Note 14)

Impairments/OTTI

When the fair value of an AFS security is less than its amortized cost at the balance sheet date, the security is considered impaired.  The Company assesses its impaired securities on at least a quarterly basis and designates such impairments as either “temporary” or “other-than-temporary.”  If the Company intends to sell an impaired security, or it is more likely than not that it will be required to sell the impaired security before its anticipated recovery, then the Company must recognize an OTTI through charges to earnings equal to the entire difference between the investment’s amortized cost and its fair value at the balance sheet date.  If the Company does not expect to sell an other-than-temporarily impaired security, only the portion of the impairment related to credit losses is recognized through charges to earnings with the remainder recognized through AOCI on the consolidated balance sheets.  Impairments recognized through other comprehensive income/(loss) (“OCI”) do not impact earnings.  Following the recognition of an OTTI through earnings, a new cost basis is established for the security and may not be adjusted for subsequent recoveries in fair value through earnings.  However, OTTIs recognized through charges to earnings may be accreted back to the amortized cost basis of the security on a prospective basis through interest income.  The determination as to whether an OTTI exists and, if so, the amount of credit impairment recognized in earnings is subjective, as such determinations are based on factual information available at the time of assessment as well as the Company’s estimates of the future performance and cash flow projections.  As a result, the timing and amount of OTTIs constitute material estimates that are susceptible to significant change.  (See Note 3)

Non-Agency MBS that are assessed to be of less than high credit quality and on which impairments are recognized have experienced, or are expected to experience, credit-related adverse cash flow changes.  The Company’s estimate of cash flows for its Non-Agency MBS is based on its review of the underlying mortgage loans securing the MBS.  The Company considers information available about the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, year of origination, loan-to-value ratios (“LTVs”), geographic concentrations and dialogue with market participants.  As a result, significant judgment is used in the Company’s analysis to determine the expected cash flows for its Non-Agency MBS.  In determining the OTTI related to credit losses for securities that were purchased at significant discounts to par and/or are considered to be of less than high credit quality, the Company compares the present value of the remaining cash flows expected to be collected at the purchase date (or last date previously revised) against the present value of the cash flows expected to be collected at the current financial reporting date.  The discount rate used to calculate the present value of expected future cash flows is the current yield used for income recognition purposes.  Impairment assessment for Non-Agency MBS that were purchased at prices close to par and/or are otherwise considered to be of high credit quality involves comparing the present value of the remaining cash flows expected to be collected against the amortized cost of the security at the assessment date.  The discount rate used to calculate the present value of the expected future cash flows is based on the instrument’s IRR.

Balance Sheet Presentation

The Company’s MBS and CRT Securities pledged as collateral against repurchase agreements and Swaps are included on the consolidated balance sheets with the fair value of the securities pledged disclosed parenthetically.  Purchases and sales of securities are recorded on the trade date. 

(c) MSR Related Assets

The Company has investments in financial instruments whose cash flows are considered to be largely dependent on underlying MSRs that either directly or indirectly act as collateral for the investment. These financial instruments, which are referred to as MSR related assets, are discussed in more detail below. The Company’s MSR related assets pledged as collateral against repurchase agreements are included in the consolidated balance sheets with the amounts pledged disclosed parenthetically. Purchases and sales of MSR related assets are recorded on the trade date. (See Notes 3, 6, 7 and 14)

8

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

Term Notes Backed by MSR Related Collateral

The Company has invested in term notes that are issued by special purpose vehicles (“SPV”) that have acquired rights to receive cash flows representing the servicing fees and/or excess servicing spread associated with certain MSRs. The Company considers payment of principal and interest on these term notes to be largely dependent on the cash flows generated by the underlying MSRs as this impacts the cash flows available to the SPV that issued the term notes. Credit risk borne by the holders of the term notes is also mitigated by structural credit support in the form of over-collateralization. Credit support is also provided by a corporate guarantee from the ultimate parent or sponsor of the SPV that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the underlying MSRs be insufficient.

The Company’s term notes backed by MSR related collateral are reported at fair value on the Company’s consolidated balance sheets with unrealized gains and losses excluded from earnings and reported in AOCI. Interest income is recognized on an accrual basis on the Company’s consolidated statements of operations. The Company’s valuation process for such notes considers a number of factors, including a comparable bond analysis performed by a third-party pricing service which involves determining a pricing spread at issuance of the term note. The pricing spread is used at each subsequent valuation date to determine an implied yield to maturity of the term note, which is then used to derive an indicative market value for the security. This indicative market value is further reviewed by the Company and may be adjusted to ensure it reflects a realistic exit price at the valuation date given the structural features of these securities. Other factors taken into consideration include indicative values provided by repurchase agreement counterparties, estimated changes in fair value of the related underlying MSR collateral and the financial performance of the ultimate parent or sponsoring entity of the issuer, which has provided a guarantee that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the related underlying MSR collateral be insufficient.

Corporate Loans

The Company has made or participated in loans to provide financing to entities that originate residential mortgage loans and own the related MSRs. These corporate loans are generally secured by certain MSRs, as well as certain other unencumbered assets owned by the borrower.

Corporate loans are recorded on the Company’s consolidated balance sheets at the drawn amount, on which interest income is recognized on an accrual basis on the Company’s consolidated statements of operations. Commitment fees received on the undrawn amount are deferred and recognized as interest income over the remaining loan term at the time of draw. At the end of the commitment period, any remaining deferred commitment fees are recorded as Other Income on the Company’s consolidated statements of operations. The Company evaluates the recoverability of its corporate loans on a quarterly basis considering various factors, including the current status of the loan, changes in the fair value of the MSRs that secure the loan and the recent financial performance of the borrower.

(d)  Residential Whole Loans (including Residential Whole Loans transferred to consolidated VIEs)

Residential whole loans included in the Company’s consolidated balance sheets are primarily comprised of pools of fixed and adjustable rate residential mortgage loans acquired through consolidated trusts in secondary market transactions, with the majority at discounted purchase prices. The accounting model utilized by the Company is determined at the time each loan package is initially acquired and is generally based on the delinquency status of the majority of the underlying borrowers in the package at acquisition. The accounting model described below for purchased credit impaired loans that are held at carrying value is typically utilized by the Company for purchased credit impaired loans where the underlying borrower has a delinquency status of less than 60 days at the acquisition date. The Company may also purchase newly or recently originated loans that are performing as of the purchase date. Such loans are typically held at carrying value, but the accounting methods for income recognition and determination and measurement of any required loan loss reserves differ to those used for purchased credit impaired loans held at carrying value. The accounting model described below for residential whole loans held at fair value is typically utilized by the Company for loans where the underlying borrower has a delinquency status of 60 days or more at the acquisition date. The accounting model initially applied is not subsequently changed.

The Company’s residential whole loans pledged as collateral against repurchase agreements are included in the consolidated balance sheets with amounts pledged disclosed parenthetically.  Purchases and sales of residential whole loans are recorded on the trade date, with amounts recorded reflecting management’s current estimate of assets that will be acquired or disposed at the closing

9

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

of the transaction. This estimate is subject to revision at the closing of the transaction, pending the outcome of due diligence performed prior to closing. Recorded amounts of residential whole loans for which the closing of the purchase transaction is yet to occur are not eligible to be pledged as collateral against any repurchase agreement financing until the closing of the purchase transaction. (See Notes 4, 6, 7, 14 and 15)

Residential Whole Loans at Carrying Value

Purchased Credit Impaired Loans

The Company has elected to account for these loans as credit impaired as they were acquired at discounted prices that reflect, in part, the impaired credit history of the borrower. Substantially all of these loans have previously experienced payment delinquencies and the amount owed may exceed the value of the property pledged as collateral. Consequently, these loans generally have a higher likelihood of default than newly originated mortgage loans with LTVs of 80% or less to creditworthy borrowers. The Company believes that amounts paid to acquire these loans represent fair market value at the date of acquisition. Loans considered credit impaired are initially recorded at the purchase price with no allowance for loan losses. Subsequent to acquisition, the recorded amount for these loans reflects the original investment amount, plus accretion of interest income, less principal and interest cash flows received. These loans are presented on the Company’s consolidated balance sheets at carrying value, which reflects the recorded amount reduced by any allowance for loan losses established subsequent to acquisition.

Under the application of the accounting model for purchased credit impaired loans, the Company may aggregate into pools loans acquired in the same fiscal quarter that are assessed as having similar risk characteristics. For each pool established, or on an individual loans basis for loans not aggregated into pools, the Company estimates at acquisition, and periodically on at least a quarterly basis, the principal and interest cash flows expected to be collected. The difference between the cash flows expected to be collected and the carrying amount of the loans is referred to as the “accretable yield.” This amount is accreted as interest income over the life of the loans using an effective interest rate (level yield) methodology. Interest income recorded each period reflects the amount of accretable yield recognized and not the coupon interest payments received on the underlying loans. The difference between contractually required principal and interest payments and the cash flows expected to be collected is referred to as the “non-accretable difference,” and includes estimates of both the effect of prepayments and expected credit losses over the life of the underlying loans.

A decrease in expected cash flows in subsequent periods may indicate impairment at the pool and/or individual loan level, thus requiring the establishment of an allowance for loan losses by a charge to the provision for loan losses. The allowance for loan losses generally represents the present value of cash flows expected at acquisition, adjusted for any increases due to changes in estimated cash flows, that are subsequently no longer expected to be received at the relevant measurement date. Under the accounting model applied to credit impaired loans, a significant increase in expected cash flows in subsequent periods first reduces any previously recognized allowance for loan losses and then will result in a recalculation in the amount of accretable yield. The adjustment of accretable yield due to a significant increase in expected cash flows is accounted for prospectively as a change in estimate and results in reclassification from nonaccretable difference to accretable yield.

Other Loans at Carrying Value

The Company also has investments in loans that are not considered to be credit impaired at purchase. To date such loans have included newly or previously originated performing loans that are primarily comprised of: (i) loans to finance (or refinance) one-to-four family residential properties and are not considered to meet the definition of a “Qualified Mortgage” in accordance with guidelines adopted by the Consumer Financial Protection Bureau (“Non-QM loans”), (ii) short-term business purpose loans collateralized by residential properties made to non-occupant borrowers who intend to rehabilitate and sell the property for a profit (“Rehabilitation loans” or “Fix and Flip loans”), (iii) loans to finance (or refinance) non-owner occupied one-to-four family residential properties that are rented to one or more tenants (“Single-family rental loans”), and (iv) previously originated loans secured by residential real estate that is generally owner occupied (“Seasoned performing loans”), (collectively “Other Loans at Carrying Value”). The Company’s Other Loans at Carrying Value are initially recorded at their purchase price. Interest income on Other Loans at Carrying Value purchased at par is accrued based on each loan’s current interest bearing balance and current interest rate, net of related servicing costs. Interest income on such loans purchased at a premium/discount to par is recorded each period based on the contractual coupon net of any premium or discount and related servicing costs, and adjusted for actual prepayment activity.

10

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

An allowance for loan losses is recorded when, based on current information and events, it is probable that the Company will be unable to collect all amounts due according to the existing contractual terms of the loan agreement. Any required loan loss allowance would typically be measured based on fair value of the collateral securing the loan and would reduce the carrying value of the loan with a corresponding charge to earnings. Significant judgments are required in determining any allowance for loan loss, including assumptions regarding the loan cash flows expected to be collected, the value of the underlying collateral and the ability of the Company to collect on any other forms of security, such as a personal guaranty provided either by the borrower or an affiliate of the borrower. Income recognition is suspended for loans at the earlier of the date at which payments become 90 days past due or when, in the opinion of management, a full recovery of income and principal becomes doubtful. When the ultimate collectability of the principal of an impaired loan is in doubt, all payments are applied to principal under the cost recovery method. When the ultimate collectability of the principal of an impaired loan is not in doubt, interest income is recorded under the cash basis method as interest payments are received. Interest accruals are resumed when the loan becomes contractually current and performance is demonstrated to be resumed. A loan is written off when it is no longer realizable and/or it is legally discharged.

Residential Whole Loans at Fair Value

Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at time of acquisition. For the majority of these loans, there is significant uncertainty associated with estimating the timing of and amount of cash flows that will be collected. Further, the cash flows ultimately collected may be dependent on the value of the property securing the loan. Consequently, the Company considers that accounting for these loans at fair value should result in a better reflection over time of the economic returns for the majority of these loans. The Company determines the fair value of its residential whole loans held at fair value after considering portfolio valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans and trading activity observed in the market place. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations.

Cash received reflecting coupon payments on residential whole loans held at fair value is not included in Interest Income, but rather is presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations. Cash outflows associated with loan-related advances made by the Company on behalf of the borrower are included in the basis of the loan and are reflected in Net gain on residential whole loans held at fair value.

(e)  Cash and Cash Equivalents

Cash and cash equivalents include cash on deposit with financial institutions and investments in money market funds, all of which have original maturities of three months or less.  Cash and cash equivalents may also include cash pledged as collateral to the Company by its repurchase agreement counterparties as a result of reverse margin calls (i.e., margin calls made by the Company).  At September 30, 2018 and December 31, 2017, the Company had cash and cash equivalents of $104.2 million and $449.8 million, respectively. The Company’s investments in overnight money market funds, which are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency, were $71.1 million and $354.0 million at September 30, 2018 and December 31, 2017, respectively.  (See Notes 7 and 14)

(f) Restricted Cash

Restricted cash represents the Company’s cash held by its counterparties in connection with certain of the Company’s repurchase agreements that is not available to the Company for general corporate purposes. Restricted cash may be applied against amounts due to repurchase agreement counterparties, or may be returned to the Company when the related collateral requirements are exceeded or at the maturity of the repurchase agreement.  The Company had aggregate restricted cash held as collateral or otherwise in connection with its repurchase agreements of $6.5 million and $13.3 million at September 30, 2018 and December 31, 2017, respectively.  (See Notes 5(c), 6, 7 and 14)

(g)  Goodwill

At September 30, 2018 and December 31, 2017, the Company had goodwill of $7.2 million, which represents the unamortized portion of the excess of the fair value of its common stock issued over the fair value of net assets acquired in connection with its formation in 1998.  Goodwill is tested for impairment at least annually, or more frequently under certain circumstances, at the entity level.  Through September 30, 2018, the Company had not recognized any impairment against its goodwill. Goodwill is included in Other assets on the Company’s consolidated balance sheets.

11

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

(h) Real Estate Owned (“REO”)

REO represents real estate acquired by the Company, including through foreclosure, deed in lieu of foreclosure, or purchased in connection with the acquisition of residential whole loans. REO acquired through foreclosure or deed in lieu of foreclosure is initially recorded at fair value less estimated selling costs. REO acquired in connection with the acquisition of residential whole loans is initially recorded at its purchase price. Subsequent to acquisition, REO is reported, at each reporting date, at the lower of the current carrying amount or fair value less estimated selling costs and for presentation purposes is included in Other assets on the Company’s consolidated balance sheets. Changes in fair value that result in an adjustment to the reported amount of an REO property that has a fair value at or below its carrying amount are reported in Other Income, net on the Company’s consolidated statements of operations. (See Note 5(b))

(i)  Depreciation

Leasehold Improvements and Other Depreciable Assets

Depreciation is computed on the straight-line method over the estimated useful life of the related assets or, in the case of leasehold improvements, over the shorter of the useful life or the lease term.  Furniture, fixtures, computers and related hardware have estimated useful lives ranging from five to eight years at the time of purchase.

(j)  Loan Securitization and Other Debt Issuance Costs

Loan securitization related costs are costs associated with the issuance of beneficial interests by consolidated VIEs and incurred by the Company in connection with various financing transactions completed by the Company.  Other debt issuance and related costs include costs incurred by the Company in connection with issuing 8% Senior Notes due 2042 (“Senior Notes”) and certain other repurchase agreement financings. These costs may include underwriting, rating agency, legal, accounting and other fees.  Such costs, which reflect deferred charges, are included on the Company’s consolidated balance sheets as a direct deduction from the corresponding debt liability. These deferred charges are amortized as an adjustment to interest expense using the effective interest method. For Senior Notes and other repurchase agreement financings, such costs are amortized over the shorter of the period to the expected or stated legal maturity of the debt instruments. The Company periodically reviews the recoverability of these deferred costs and in the event an impairment charge is required, such amount will be included in Operating and Other Expense on the Company’s consolidated statements of operations.

(k)  Repurchase Agreements

The Company finances the holdings of a significant portion of its residential mortgage assets with repurchase agreements.  Under repurchase agreements, the Company sells securities to a lender and agrees to repurchase the same securities in the future for a price that is higher than the original sale price.  The difference between the sale price that the Company receives and the repurchase price that the Company pays represents interest paid to the lender.  Although legally structured as sale and repurchase transactions, the Company accounts for repurchase agreements as secured borrowings. Under its repurchase agreements, the Company pledges its securities as collateral to secure the borrowing, which is equal in value to a specified percentage of the fair value of the pledged collateral, while the Company retains beneficial ownership of the pledged collateral.  At the maturity of a repurchase financing, unless the repurchase financing is renewed with the same counterparty, the Company is required to repay the loan including any accrued interest and concurrently receives back its pledged collateral from the lender.  With the consent of the lender, the Company may renew a repurchase financing at the then prevailing financing terms.  Margin calls, whereby a lender requires that the Company pledge additional securities or cash as collateral to secure borrowings under its repurchase financing with such lender, are routinely experienced by the Company when the value of the MBS pledged as collateral declines as a result of principal amortization and prepayments or due to changes in market interest rates, spreads or other market conditions.  The Company also may make margin calls on counterparties when collateral values increase.

The Company’s repurchase financings typically have terms ranging from one month to six months at inception, but may also have longer or shorter terms.  Should a counterparty decide not to renew a repurchase financing at maturity, the Company must either refinance elsewhere or be in a position to satisfy the obligation.  If, during the term of a repurchase financing, a lender should default on its obligation, the Company might experience difficulty recovering its pledged assets which could result in an unsecured claim against the lender for the difference between the amount loaned to the Company plus interest due to the counterparty and

12

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

the fair value of the collateral pledged by the Company to such lender, including accrued interest receivable or such collateral.  (See Notes 6, 7 and 14)

In addition to the repurchase agreement financing arrangements discussed above, as part of its financing strategy for Non-Agency MBS, the Company in prior periods entered into contemporaneous repurchase and reverse repurchase agreements with a single counterparty.  Under a typical reverse repurchase agreement, the Company buys securities from a borrower for cash and agrees to sell the same securities in the future for a price that is higher than the original purchase price.  The difference between the purchase price the Company originally paid and the sale price represents interest received from the borrower.  In contrast, the contemporaneous repurchase and reverse repurchase transactions effectively resulted in the Company pledging Non-Agency MBS as collateral to the counterparty in connection with the repurchase agreement financing and obtaining U.S. Treasury securities as collateral from the same counterparty in connection with the reverse repurchase agreement.  No net cash was exchanged between the Company and counterparty at the inception of the transactions.  Securities obtained and pledged as collateral are recorded in Other assets on the Company’s consolidated balance sheets.  Interest income is recorded on the reverse repurchase agreement and interest expense is recorded on the repurchase agreement on an accrual basis.   The Company’s liability to the counterparty in prior periods in connection with this financing arrangement is recorded in Other liabilities on the Company’s consolidated balance sheets and disclosed as “Obligation to return securities obtained as collateral, at fair value.”  (See Note 5(a))

(l)  Equity-Based Compensation

Compensation expense for equity-based awards that are subject to vesting conditions, is recognized ratably over the vesting period of such awards, based upon the fair value of such awards at the grant date.  For certain awards granted prior to January 1, 2017, compensation expense recognized included the impact of estimated forfeitures, with any changes in estimated forfeiture rates accounted for as a change in estimate. Upon adoption of new accounting guidance that was effective for the Company on January 1, 2017, the Company made a policy election to account for forfeitures as they occur.

Beginning in 2014, the Company has made annual grants of restricted stock units (“RSUs”) certain of which cliff vest after a three-year period and others of which cliff vest after a three-year period, subject to the achievement of certain performance criteria based on a formula tied to the Company’s achievement of average total stockholder return during that three-year period, as well as the total shareholder return (“TSR”) of the Company relative to the TSR of a group of peer companies (over the three-year period) selected by the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) at the date of grant. The features in these awards related to the attainment of total stockholder return over a specified period constitute a “market condition” which impacts the amount of compensation expense recognized for these awards.  Specifically, the uncertainty regarding the achievement of the market condition was reflected in the grant date fair valuation of the RSUs, which is recognized as compensation expense over the relevant vesting period.  The amount of compensation expense recognized is not dependent on whether the market condition was or will be achieved.

The Company makes dividend equivalent payments in connection with certain of its equity-based awards.   A dividend equivalent is a right to receive a distribution equal to the dividend distributions that would be paid on a share of the Company’s common stock.  Dividend equivalents may be granted as a separate instrument or may be a right associated with the grant of another award (e.g., an RSU) under the Company’s Equity Compensation Plan (the “Equity Plan”), and they are paid in cash or other consideration at such times and in accordance with such rules, terms and conditions, as the Compensation Committee may determine in its discretion.  Payments pursuant to dividend equivalents are generally charged to Stockholders’ Equity to the extent that the attached equity awards are expected to vest.  Compensation expense is recognized for payments made for dividend equivalents to the extent that the attached equity awards (i) do not or are not expected to vest and (ii) grantees are not required to return payments of dividends or dividend equivalents to the Company.  (See Notes 2(m) and 13)

(m)  Earnings per Common Share (“EPS”)

Basic EPS is computed using the two-class method, which includes the weighted-average number of shares of common stock outstanding during the period and an estimate of other securities that participate in dividends, such as the Company’s unvested restricted stock and RSUs that have non-forfeitable rights to dividends and dividend equivalents attached to/associated with RSUs and vested stock options to arrive at total common equivalent shares.  In applying the two-class method, earnings are allocated to both shares of common stock and estimated securities that participate in dividends based on their respective weighted-average shares outstanding for the period.  For the diluted EPS calculation, common equivalent shares are further adjusted for the effect of dilutive unexercised stock options and RSUs outstanding that are unvested and have dividends that are subject to forfeiture using the treasury stock method.  Under the treasury stock method, common equivalent shares are calculated assuming that all

13

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

dilutive common stock equivalents are exercised and the proceeds, along with future compensation expenses associated with such instruments, are used to repurchase shares of the Company’s outstanding common stock at the average market price during the reported period.  (See Note 12)

(n)  Comprehensive Income/(Loss)

The Company’s comprehensive income/(loss) available to common stock and participating securities includes net income, the change in net unrealized gains/(losses) on its AFS securities and derivative hedging instruments, (to the extent that such changes are not recorded in earnings), adjusted by realized net gains/(losses) reclassified out of AOCI for sold AFS securities and is reduced by dividends declared on the Company’s preferred stock and issuance costs of redeemed preferred stock.

(o)  U.S. Federal Income Taxes

The Company has elected to be taxed as a REIT under the provisions of the Internal Revenue Code of 1986, as amended, (the “Code”) and the corresponding provisions of state law.  The Company expects to operate in a manner that will enable it to satisfy the various requirements to maintain its status as a REIT for federal income tax purposes. In order to maintain its status as a REIT, the Company must, among other things, distribute at least 90% of its REIT taxable income (excluding net long-term capital gains) to stockholders in the timeframe permitted by the Code.  As long as the Company maintains its status as a REIT, the Company will not be subject to regular federal income tax to the extent that it distributes 100% of its REIT taxable income (including net long-term capital gains) to its stockholders within the permitted timeframe.  Should this not occur, the Company would be subject to federal taxes at prevailing corporate tax rates on the difference between its REIT taxable income and the amounts deemed to be distributed for that tax year.  As the Company’s objective is to distribute 100% of its REIT taxable income to its stockholders within the permitted timeframe, no provision for current or deferred income taxes has been made in the accompanying consolidated financial statements.  Should the Company incur a liability for corporate income tax, such amounts would be recorded as REIT income tax expense on the Company’s consolidated statements of operations. Furthermore, if the Company fails to distribute during each calendar year, or by the end of January following the calendar year in the case of distributions with declaration and record dates falling in the last three months of the calendar year, at least the sum of (i) 85% its REIT ordinary income for such year, (ii) 95% of its REIT capital gain income for such year, and (iii) any undistributed taxable income from prior periods, the Company would be subject to a 4% nondeductible excise tax on the excess of the required distribution over the amounts actually distributed. To the extent that the Company incurs interest, penalties or related excise taxes in connection with its tax obligations, including as a result of its assessment of uncertain tax positions, such amounts will be included in Operating and Other Expense on the Company’s consolidated statements of operations.

In addition, the Company has elected to treat certain of its subsidiaries as a TRS. In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. Generally, a domestic TRS is subject to U.S. federal, state and local corporate income taxes. Since a portion of the Company’s business may be conducted through one or more TRS, its income earned by TRS may be subject to corporate income taxation. To maintain the Company’s REIT election, no more than 20% of the value of a REIT’s assets at the end of each calendar quarter may consist of stock or securities in TRS. For purposes of the determination of U.S. federal and state income taxes, the Company’s subsidiaries that elected to be treated as a TRS record current or deferred income taxes based on differences (both permanent and timing) between the determination of their taxable income and net income under GAAP. No deferred tax benefit was recorded by the Company for the nine months endedSeptember 30, 2018 and 2017, as a valuation allowance for the full amount of the associated deferred tax asset was recognized as its recovery is not considered more likely than not.

 Based on its analysis of any potential uncertain tax positions, the Company concluded that it does not have any material uncertain tax positions that meet the relevant recognition or measurement criteria as of September 30, 2018, December 31, 2017, or September 30, 2017. The Company filed its 2017 tax return prior to October 15, 2018. The Company’s tax returns for tax years 2015 through 2017 are open to examination.

14

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

(p)  Derivative Financial Instruments

The Company may use a variety of derivative instruments to economically hedge a portion of its exposure to market risks, including interest rate risk and prepayment risk. The objective of the Company’s risk management strategy is to reduce fluctuations in net book value over a range of interest rate scenarios. In particular, the Company attempts to mitigate the risk of the cost of its variable rate liabilities increasing during a period of rising interest rates. The Company’s derivative instruments are currently comprised of Swaps, the majority of which are designated as cash flow hedges against the interest rate risk associated with its borrowings.

Swaps

The Company documents its risk-management policies, including objectives and strategies, as they relate to its hedging activities and the relationship between the hedging instrument and the hedged liability for all Swaps designated as hedging transactions.  The Company assesses, both at inception of a hedge and on a quarterly basis thereafter, whether or not the hedge is “highly effective.”

Swaps are carried on the Company’s consolidated balance sheets at fair value, in Other assets, if their fair value is positive, or in Other liabilities, if their fair value is negative.  Beginning in January 2017, variation margin payments on the Company’s Swaps that have been novated to a clearing house are treated as a legal settlement of the exposure under the Swap contract. Previously such payments were treated as collateral pledged against the exposure under the Swap contract. The effect of this change is to reduce what would have otherwise been reported as fair value of the Swap. All of the Company’s Swaps have been novated to a central clearing house. Changes in the fair value of the Company’s Swaps designated in hedging transactions are recorded in OCI provided that the hedge remains effective.  Changes in fair value for any ineffective amount of a Swap are recognized in earnings.  The Company has not recognized any change in the value of its existing Swaps designated as hedges through earnings as a result of hedge ineffectiveness. Periodic payments accrued in connection with Swaps designated as hedges are included in interest expense, and are treated as an operating cash flow.

The Company discontinues hedge accounting on a prospective basis and recognizes changes in fair value through earnings when: (i) it is determined that the derivative is no longer effective in offsetting cash flows of a hedged item (including forecasted transactions); (ii) it is no longer probable that the forecasted transaction will occur; or (iii) it is determined that designating the derivative as a hedge is no longer appropriate. (See Notes 5(c), 7 and 14)

Changes in the fair value of the Company’s Swaps not designated in hedging transactions are recorded in Other income, net on the Company’s consolidated statement of operations.

(q)  Fair Value Measurements and the Fair Value Option for Financial Assets and Financial Liabilities

The Company’s presentation of fair value for its financial assets and liabilities is determined within a framework that stipulates that the fair value of a financial asset or liability is an exchange price in an orderly transaction between market participants to sell the asset or transfer the liability in the market in which the reporting entity would transact for the asset or liability, that is, the principal or most advantageous market for the asset or liability.  The transaction to sell the asset or transfer the liability is a hypothetical transaction at the measurement date, considered from the perspective of a market participant that holds the asset or owes the liability.  This definition of fair value focuses on exit price and prioritizes the use of market-based inputs over entity-specific inputs when determining fair value.  In addition, the framework for measuring fair value establishes a three-level hierarchy for fair value measurements based upon the observability of inputs to the valuation of an asset or liability as of the measurement date. 

In addition to the financial instruments that it is required to report at fair value, the Company has elected the fair value option for certain of its residential whole loans, Agency MBS and CRT securities at time of acquisition. Subsequent changes in the fair value of these financial instruments are reported in Other income, net, in the Company’s consolidated statements of operations. A decision to elect the fair value option for an eligible financial instrument, which may be made on an instrument by instrument basis, is irrevocable. (See Notes 2(b), 2(d), 3, 4 and 14)

15

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

(r)  Variable Interest Entities

An entity is referred to as a VIE if it meets at least one of the following criteria:  (i) the entity has equity that is insufficient to permit the entity to finance its activities without additional subordinated financial support of other parties; or (ii) as a group, the holders of the equity investment at risk lack (a) the power to direct the activities of an entity that most significantly impact the entity’s economic performance; (b) the obligation to absorb the expected losses; or (c) the right to receive the expected residual returns; or (iii) have disproportional voting rights and the entity’s activities are conducted on behalf of the investor that has disproportionately few voting rights.

The Company consolidates a VIE when it has both the power to direct the activities that most significantly impact the economic performance of the VIE and a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE.   The Company is required to reconsider its evaluation of whether to consolidate a VIE each reporting period, based upon changes in the facts and circumstances pertaining to the VIE.

The Company has entered into several financing transactions which resulted in the Company consolidating the VIEs that were created to facilitate these transactions.  In determining the accounting treatment to be applied to these transactions, the Company concluded that the entities used to facilitate these transactions were VIEs and that they should be consolidated.  If the Company had determined that consolidation was not required, it would have then assessed whether the transfers of the underlying assets would qualify as sale or should be accounted for as secured financings under GAAP. (See Note 15)

The Company also includes on its consolidated balance sheets certain financial assets and liabilities that are acquired/issued by trusts and/or other special purpose entities that have been evaluated as being required to be consolidated by the Company under the applicable accounting guidance.

(s)  Offering Costs Related to Issuance and Redemption of Preferred Stock

Offering costs related to issuance of preferred stock are recorded as a reduction in Additional paid-in capital, a component of Stockholders’ Equity, at the time such preferred stock is issued. On redemption of preferred stock, any excess of the fair value of the consideration transferred to the holders of the preferred stock over the carrying amount of the preferred stock in the Company’s consolidated balance sheets is included in the determination of Net Income Available to Common Stock and Participating Securities in the calculation of EPS.

(t)  New Accounting Standards and Interpretations

Accounting Standards Adopted in 2018

Compensation - Stock Compensation - Scope of Modification Accounting

In May 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-09, Scope of Modification Accounting (“ASU 2017-09”). The amendments in ASU 2017-09 provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. Pursuant to this ASU, an entity should account for the effects of a modification unless all of the following are met: (1) the fair value (or calculated value or intrinsic value, if such an alternative measurement method is used) of the modified award is the same as the fair value (or calculated value or intrinsic value, if such an alternative measurement method is used) of the original award immediately before the original award is modified; (2) the vesting conditions of the modified award are the same as the vesting conditions of the original award immediately before the original award is modified; and (3) the classification of the modified award as an equity instrument or a liability instrument is the same as the classification of the original award immediately before the original award date is modified. The Company adopted ASU 2017-09 on January 1, 2018 and its adoption did not have an impact on its financial position or financial statement disclosures.

16

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

Statement of Cash Flows - Restricted Cash

In November 2016, the FASB issued ASU 2016-18, Restricted Cash (“ASU 2016-18”). ASU 2016-18 clarifies how entities should present restricted cash and restricted cash equivalents in the statement of cash flows with the objective of reducing the existing diversity in practice. The amendments in ASU 2016-18 require restricted cash and restricted cash equivalents to be included with cash and cash equivalents when reconciling the beginning-of-period and end-of period total amounts shown on the statement of cash flows. The Company adopted ASU 2016-18 on January 1, 2018 and its adoption did not have a significant impact on its financial position or financial statement disclosures.

Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments

In August 2016, the FASB issued ASU 2016-15, Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”). The amendments in ASU 2016-15 provide guidance for eight specific cash flow classification issues, certain cash receipts and cash payments on the statement of cash flows with the objective of reducing the existing diversity in practice. The Company adopted ASU 2016-15 on January 1, 2018 and its adoption did not have a significant impact on its financial position or financial statement disclosures.

Financial Instruments - Overall - Recognition and Measurement of Financial Assets and Financial Liabilities

In January 2016, the FASB issued ASU 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”). The amendments in this ASU affect all entities that hold financial assets or owe financial liabilities, and address certain aspects of recognition, measurement, presentation, and disclosure of financial instruments.  The classification and measurement guidance of investments in debt securities and loans are not affected by the amendments in this ASU. ASU 2016-01 was effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017.  The Company’s adoption of this ASU on January 1, 2018 did not have a significant impact on the Company’s financial position or financial statement disclosures as the classification and measurement of its investments in debt securities and loans were not affected by the amendments in this ASU.

Revenue from Contracts with Customers

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”).  The ASU requires an entity to recognize revenue in an amount that reflects the consideration to which it expects to be entitled for the transfer of promised goods or services to customers.  ASU 2014-09 replaced most existing revenue recognition guidance in GAAP when it became effective. The Company adopted this ASU on January 1, 2018 and its adoption did not have a material impact on the Company’s financial position or financial statement disclosures as the majority of the Company’s revenues are generated by financial instruments that are explicitly scoped out of this ASU. On adoption of the new standard on January 1, 2018, the Company recorded a transition adjustment, under the modified retrospective approach, of approximately $295,000 to the opening balance of retained earnings in order to reflect the recognition of a gain on sale of REO that was previously deferred under the prior accounting guidance.

17

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

3.MBS, CRT Securities and MSR Related Assets

Agency and Non-Agency MBS

The Company’s MBS are comprised of Agency MBS and Non-Agency MBS which include MBS issued prior to 2008 (“Legacy Non-Agency MBS”). These MBS are secured by:  (i) hybrid mortgages (“Hybrids”), which have interest rates that are fixed for a specified period of time and, thereafter, generally adjust annually to an increment over a specified interest rate index; (ii) adjustable-rate mortgages (“ARMs”), which have interest rates that reset annually or more frequently (collectively, “ARM-MBS”); and (iii) 15 and 30 year fixed-rate mortgages for Agency MBS and, for Non-Agency MBS, 30-year and longer-term fixed rate mortgages. In addition, the Company’s MBS are also comprised of MBS backed by securitized re-performing/non-performing loans (“RPL/NPL MBS”), where the cash flows of the bond may not reflect the contractual cash flows of the underlying collateral. The Company’s RPL/NPL MBS are primarily structured with a contractual coupon step-up feature where the coupon increases from 300 - 400 basis points at 36 - 48 months from issuance or sooner. The Company pledges a significant portion of its MBS as collateral against its borrowings under repurchase agreements and Swaps.  (See Note 7)

Agency MBS: Agency MBS are guaranteed as to principal and/or interest by a federally chartered corporation, such as Fannie Mae or Freddie Mac, or an agency of the U.S. Government, such as Ginnie Mae.  The payment of principal and/or interest on Ginnie Mae MBS is explicitly backed by the full faith and credit of the U.S. Government.  Since the third quarter of 2008, Fannie Mae and Freddie Mac have been under the conservatorship of the Federal Housing Finance Agency, which significantly strengthened the backing for these government-sponsored entities.

Non-Agency MBS:  The Company’s Non-Agency MBS are primarily secured by pools of residential mortgages, which are not guaranteed by an agency of the U.S. Government or any federally chartered corporation.  Credit risk associated with Non-Agency MBS is regularly assessed as new information regarding the underlying collateral becomes available and based on updated estimates of cash flows generated by the underlying collateral.

CRT Securities

CRT securities are debt obligations issued by Fannie Mae and Freddie Mac. The payments of principal and interest on the CRT securities are paid by Fannie Mae or Freddie Mac, as the case may be, on a monthly basis, and are dependent on the performance of loans in a reference pool of Agency MBS securitized by the issuing entity. As an investor in a CRT security, the Company may incur a loss if losses on the mortgage loans in the reference pool exceed the credit enhancement on the underlying CRT security owned by the Company. The Company assesses the credit risk associated with CRT securities by assessing the current and expected future performance of the associated reference pool. The Company pledges a portion of its CRT securities as collateral against its borrowings under repurchase agreements.  (See Note 7)

18

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

The following tables present certain information about the Company’s MBS and CRT securities at September 30, 2018 and December 31, 2017:

September 30, 2018

(In Thousands)	Principal/ Current Face		Purchase Premiums		Accretable Purchase Discounts			Discount Designated as Credit Reserve and  OTTI (1)			Amortized Cost (2)		Fair Value		Gross Unrealized Gains		Gross Unrealized Losses			Net Unrealized Gain/(Loss)
Agency MBS: (3)
Fannie Mae	$	1,851,447	$	70,882	$	(29	)	$	—		$	1,922,300	$	1,896,739	$	14,650	$	(40,211	)	$	(25,561	)
Freddie Mac	987,833		40,183		—			—			1,028,453		1,003,583		1,027		(25,897		)	(24,870		)
Ginnie Mae	5,028		92		—			—			5,120		5,168		48		—			48
Total Agency MBS	2,844,308		111,157		(29		)	—			2,955,873		2,905,490		15,725		(66,108		)	(50,383		)
Non-Agency MBS:
Expected to Recover Par (4)(5)	1,343,835		41		(23,835		)	—			1,320,041		1,343,272		25,146		(1,915		)	23,231
Expected to Recover Less than Par (4)	2,165,454		—		(167,910		)	(531,757		)	1,465,787		1,991,338		525,770		(219		)	525,551
Total Non-Agency MBS (6)	3,509,289		41		(191,745		)	(531,757		)	2,785,828		3,334,610		550,916		(2,134		)	548,782
Total MBS	6,353,597		111,198		(191,774		)	(531,757		)	5,741,701		6,240,100		566,641		(68,242		)	498,399
CRT securities (7)	495,018		9,936		(178		)	—			504,776		538,945		34,173		(4		)	34,169
Total MBS and CRT securities	$	6,848,615	$	121,134	$	(191,952	)	$	(531,757	)	$	6,246,477	$	6,779,045	$	600,814	$	(68,246	)	$	532,568

December 31, 2017

(In Thousands)	Principal/ Current Face		Purchase Premiums		Accretable Purchase Discounts			Discount Designated as Credit Reserve and  OTTI (1)			Amortized Cost (2)		Fair Value		Gross Unrealized Gains		Gross Unrealized Losses			Net Unrealized Gain/(Loss)
Agency MBS: (3)
Fannie Mae	$	2,170,974	$	82,271	$	(40	)	$	—		$	2,253,205	$	2,246,600	$	21,736	$	(28,341	)	$	(6,605	)
Freddie Mac	561,346		21,683		—			—			584,920		571,748		1,624		(14,796		)	(13,172		)
Ginnie Mae	6,142		112		—			—			6,254		6,333		79		—			79
Total Agency MBS	2,738,462		104,066		(40		)	—			2,844,379		2,824,681		23,439		(43,137		)	(19,698		)
Non-Agency MBS:
Expected to Recover Par (4)(5)	1,128,808		50		(22,737		)	—			1,106,121		1,132,205		26,518		(434		)	26,084
Expected to Recover Less than Par (4)	2,589,935		—		(192,588		)	(593,227		)	1,804,120		2,401,761		597,660		(19		)	597,641
Total Non-Agency MBS (6)	3,718,743		50		(215,325		)	(593,227		)	2,910,241		3,533,966		624,178		(453		)	623,725
Total MBS	6,457,205		104,116		(215,365		)	(593,227		)	5,754,620		6,358,647		647,617		(43,590		)	604,027
CRT securities (7)	602,799		8,887		(3,550		)	—			608,136		664,403		56,290		(23		)	56,267
Total MBS and CRT securities	$	7,060,004	$	113,003	$	(218,915	)	$	(593,227	)	$	6,362,756	$	7,023,050	$	703,907	$	(43,613	)	$	660,294

(1) Discount designated as Credit Reserve and amounts related to OTTI are generally not expected to be accreted into interest income.  Amounts disclosed at September 30, 2018 reflect Credit Reserve of $519.6 million and OTTI of $12.2 million.  Amounts disclosed at December 31, 2017 reflect Credit Reserve of $579.0 million and OTTI of $14.2 million.

(2) Includes principal payments receivable of $438,000 and $1.9 million at September 30, 2018 and December 31, 2017, respectively, which are not included in the Principal/Current Face.

(3) Amounts disclosed at September 30, 2018 include Agency MBS with a fair value of $746.7 million for which the fair value option has been elected. Such securities had no unrealized gains and gross unrealized losses of approximately $5.5 million at September 30, 2018. The Company did not have any Agency MBS for which the fair value option had been elected at December 31, 2017.

(4) Based on management’s current estimates of future principal cash flows expected to be received.

(5) Includes RPL/NPL MBS, which at September 30, 2018 had a $1.2 billion Principal/Current face, $1.2 billion amortized cost and $1.2 billion fair value. At December 31, 2017, RPL/NPL MBS had a $922.0 million Principal/Current face, $920.1 million amortized cost and $923.1 millionfair value.

(6) At September 30, 2018 and December 31, 2017, the Company expected to recover approximately 85% and 84% of the then-current face amount of Non-Agency MBS, respectively.

(7) Amounts disclosed at September 30, 2018 includes CRT securities with a fair value of $538.9 million for which the fair value option has been elected. Such securities had gross unrealized gains of approximately $34.2 million and gross unrealized losses of approximately $4,000 at September 30, 2018. Amounts disclosed at December 31, 2017 includes CRT securities with a fair value of $528.9 million for which the fair value option has been elected. Such securities had gross unrealized gains of approximately $40.5 million and gross unrealized losses of approximately $23,000 at December 31, 2017.

19

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

Sales of MBS and CRT Securities

During the nine months ended September 30, 2018, the Company sold certain Agency MBS for $75.3 million realizing losses of $3.8 million. The Company also sold certain CRT securities during the three and nine months ended September 30, 2018 for $118.9 million and $222.9 million, realizing gains of $13.0 million and $24.2 million, respectively. In addition, during the three and nine months ended September 30, 2018, the Company sold certain Non-Agency MBS for $24.3 million and $43.7 million, realizing gains of $3.4 million and $12.2 million, respectively. During the three and nine months ended September 30, 2017, the Company sold certain Non-Agency MBS for $44.5 million and $83.1 million, realizing gains of $14.9 million and $30.8 million, respectively. The Company has no continuing involvement with any of the sold MBS.

Unrealized Losses on MBS and CRT Securities

The following table presents information about the Company’s MBS and CRT securities that were in an unrealized loss position at September 30, 2018:

Unrealized Loss Position For:

	Less than 12 Months					12 Months or more					Total
	Fair Value		Unrealized Losses		Number of Securities	Fair Value		Unrealized Losses		Number of Securities	Fair Value		Unrealized Losses
(Dollars in Thousands)
Agency MBS: (1)
Fannie Mae	$	438,980	$	4,293	105	$	838,566	$	35,918	251	$	1,277,546	$	40,211
Freddie Mac	668,566		6,020		37	298,083		19,877		103	966,649		25,897
Total Agency MBS	1,107,546		10,313		142	1,136,649		55,795		354	2,244,195		66,108
Non-Agency MBS:
Expected to Recover Par (2)	435,011		1,849		15	3,877		66		7	438,888		1,915
Expected to Recover Less than Par (2)	44,630		219		6	—		—		—	44,630		219
Total Non-Agency MBS	479,641		2,068		21	3,877		66		7	483,518		2,134
Total MBS	1,587,187		12,381		163	1,140,526		55,861		361	2,727,713		68,242
CRT securities (3)	15,754		4		4	—		—		—	15,754		4
Total MBS and CRT securities	$	1,602,941	$	12,385	167	$	1,140,526	$	55,861	361	$	2,743,467	$	68,246

(1) Amounts disclosed at September 30, 2018 include Agency MBS with a fair value of $746.7 million on which the fair value option has been elected. Such securities had unrealized losses of $5.5 million at September 30, 2018. 

(2) Based on management’s current estimates of future principal cash flows expected to be received.

(3) Amounts disclosed at September 30, 2018 represent CRT securities on which the fair value option has been elected.

At September 30, 2018, the Company did not intend to sell any of its investments that were in an unrealized loss position, and it is “more likely than not” that the Company will not be required to sell these securities before recovery of their amortized cost basis, which may be at their maturity. 

Gross unrealized losses on the Company’s Agency MBS were $66.1 million at September 30, 2018.  Agency MBS are issued by Government Sponsored Entities (“GSEs”) and enjoy either the implicit or explicit backing of the full faith and credit of the U.S. Government. While the Company’s Agency MBS are not rated by any rating agency, they are currently perceived by market participants to be of high credit quality, with risk of default limited to the unlikely event that the U.S. Government would not continue to support the GSEs. Given the credit quality inherent in Agency MBS, the Company does not consider any of the current impairments on its Agency MBS to be credit related. In assessing whether it is more likely than not that it will be required to sell any impaired security before its anticipated recovery, which may be at its maturity, the Company considers for each impaired security, the significance of each investment, the amount of impairment, the projected future performance of such impaired securities, as well as the Company’s current and anticipated leverage capacity and liquidity position. Based on these analyses, the Company determined that at September 30, 2018 any unrealized losses on its Agency MBS were temporary.

Gross unrealized losses on the Company’s Non-Agency MBS were $2.1 million at September 30, 2018. Based upon the most recent evaluation, the Company does not consider these unrealized losses to be indicative of OTTI and does not believe that

20

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

these unrealized losses are credit related, but are rather a reflection of current market yields and/or marketplace bid-ask spreads.  The Company has reviewed its Non-Agency MBS that are in an unrealized loss position to identify those securities with losses that are other-than-temporary based on an assessment of changes in expected cash flows for such securities, which considers recent bond performance and, where possible, expected future performance of the underlying collateral.

The Company did not recognize any credit-related OTTI losses through earnings related to its Non-Agency MBS during the three and nine months ended September 30, 2018 and three months ended September 30, 2017. The Company recognized credit-related OTTI losses through earnings related to its Non-Agency MBS of $1.0 million during the nine months ended September 30, 2017.

Non-Agency MBS on which OTTI is recognized have experienced, or are expected to experience, credit-related adverse cash flow changes.  The Company’s estimate of cash flows for these Non-Agency MBS is based on its review of the underlying mortgage loans securing these MBS.  The Company considers information available about the structure of the securitization, including structural credit enhancement, if any, and the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, year of origination, LTVs, geographic concentrations, as well as Rating Agency reports, general market assessments, and dialogue with market participants.  Changes in the Company’s evaluation of each of these factors impacts the cash flows expected to be collected at the OTTI assessment date. For Non-Agency MBS purchased at a discount to par that were assessed for and had no OTTI recorded this period, such cash flow estimates indicated that the amount of expected losses decreased compared to the previous OTTI assessment date. These positive cash flow changes are primarily driven by recent improvements in LTVs due to loan amortization and home price appreciation, which, in turn, positively impacts the Company’s estimates of default rates and loss severities for the underlying collateral. In addition, voluntary prepayments (i.e., loans that prepay in full with no loss) have generally trended higher relative to the Company’s assumptions for these MBS which also positively impacts the Company’s estimate of expected loss. Overall, the combination of higher voluntary prepayments and lower LTVs supports the Company’s assessment that such MBS are not other-than-temporarily impaired.

The following table presents the composition of OTTI charges recorded by the Company for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,				Nine Months Ended   September 30,
(In Thousands)	2018		2017		2018		2017
Total OTTI losses	$	—	$	—	$	—	$	(63	)
OTTI reclassified from OCI	—		—		—		(969		)
OTTI recognized in earnings	$	—	$	—	$	—	$	(1,032	)

The following table presents a roll-forward of the credit loss component of OTTI on the Company’s Non-Agency MBS for which a non-credit component of OTTI was previously recognized in OCI.  Changes in the credit loss component of OTTI are presented based upon whether the current period is the first time OTTI was recorded on a security or a subsequent OTTI charge was recorded.

	Three Months Ended   September 30,		Nine Months Ended   September 30,
(In Thousands)	2018		2018
Credit loss component of OTTI at beginning of period	$	38,337	$	38,337
Additions for credit related OTTI not previously recognized	—		—
Subsequent additional credit related OTTI recorded	—		—
Credit loss component of OTTI at end of period	$	38,337	$	38,337

21

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

Purchase Discounts on Non-Agency MBS

The following tables present the changes in the components of the Company’s purchase discount on its Non-Agency MBS between purchase discount designated as Credit Reserve and OTTI and accretable purchase discount for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30, 2018						Three Months Ended   September 30, 2017
(In Thousands)	Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)			Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)
Balance at beginning of period	$	(553,596	)	$	(202,248	)	$	(626,498	)	$	(257,967	)
Impact of RMBS Issuer Settlement (2)	—			(2,734		)	—			—
Accretion of discount	—			20,115			—			18,621
Realized credit losses	12,042			—			13,982			—
Purchases	(1,975		)	1,368			—			(1,929		)
Sales	1,552			1,974			4,620			11,244
Transfers/release of credit reserve	10,220			(10,220		)	14,762			(14,762		)
Balance at end of period	$	(531,757	)	$	(191,745	)	$	(593,134	)	$	(244,793	)

	Nine Months Ended   September 30, 2018						Nine Months Ended   September 30, 2017
(In Thousands)	Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)			Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)
Balance at beginning of period	$	(593,227	)	$	(215,325	)	$	(694,241	)	$	(278,191	)
Impact of RMBS Issuer Settlement (2)(3)	—			(14,822		)	—			—
Accretion of discount	—			54,860			—			60,461
Realized credit losses	31,443			—			39,445			—
Purchases	(2,510		)	1,856			(484		)	(3,449		)
Sales	7,144			7,079			29,398			10,166
Net impairment losses recognized in earnings	—			—			(1,032		)	—
Transfers/release of credit reserve	25,393			(25,393		)	33,780			(33,780		)
Balance at end of period	$	(531,757	)	$	(191,745	)	$	(593,134	)	$	(244,793	)

(1) Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security.

(2) Includes the impact of approximately $2.7 million of cash proceeds (a one-time payment) received by the Company during the three and nine months ended September 30, 2018 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by Lehman Brothers Holdings Inc.

(3) Includes the impact of approximately $12.1 million of cash proceeds (a one-time payment) received by the Company during the nine months ended September 30, 2018 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by JP Morgan Chase & Co. and affiliated entities.

MSR Related Assets

(a)Term Notes Backed by MSR Related Collateral

At September 30, 2018 and December 31, 2017, the Company had $505.2 million and $381.8 million, respectively, of term notes issued by SPVs that have acquired rights to receive cash flows representing the servicing fees and/or excess servicing spread associated with certain MSRs. Payment of principal and interest on these term notes is considered to be largely dependent on cash flows generated by the underlying MSRs, as this impacts the cash flows available to the SPV that issued the term notes.

22

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

At September 30, 2018, these term notes had an amortized cost of $504.3 million, gross unrealized gains of approximately $922,000, a weighted average yield of 5.15% and a weighted average term to maturity of 4.5 years. At December 31, 2017, the term notes had an amortized cost of $381.0 million, unrealized gains of $804,000, a weighted average yield of 5.80% and a weighted average term to maturity of 3.4 years.

(b) Corporate Loans

The Company has made or participated in loans to provide financing to entities that originate residential mortgage loans and own the related MSRs. These corporate loans are secured by MSRs, as well as certain other unencumbered assets owned by the borrower.

During the three months ended September 30, 2018, the Company participated in a loan where the Company committed to lend $100.0 million of which approximately $60.1 million was drawn at September 30, 2018. At September 30, 2018, the coupon paid by the borrower on the drawn amount is 5.64%, the remaining term associated with the loan is 1.9 years and the remaining commitment period on any undrawn amount is 1.9 years. During the remaining commitment period, the Company receives a commitment fee between 0.25% and 1.0% based on the undrawn amount of the loan.

In December 2016, the Company entered into a loan agreement under the terms of which it had committed to lend $130.0 million, of which approximately $124.2 million was drawn at March 31, 2018. This loan was paid in full during the three months ended June 30, 2018, at which time any remaining commitment was extinguished.

For the three and nine months ended September 30, 2018, the Company recognized interest income on its corporate loans of $138,000 and $3.8 million including discount accretion and commitment fee income of $19,000 and $1.3 million, respectively. In addition, the Company recorded $136,000 of Other Income consisting of deferred commitment fees recognized upon repayment of a corporate loan during the nine months ended September 30, 2018. For the three and nine months ended September 30, 2017, the Company recognized interest income on its corporate loans of approximately $2.1 million and $5.7 million including discount accretion and commitment fee income of approximately $76,000 and $212,000, respectively.

Impact of AFS Securities on AOCI

The following table presents the impact of the Company’s AFS securities on its AOCI for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended September 30,						Nine Months Ended September 30,
(In Thousands)	2018			2017			2018			2017
AOCI from AFS securities:
Unrealized gain on AFS securities at beginning of period	$	548,551		$	668,223		$	620,648		$	620,403
Unrealized loss on Agency MBS, net	(9,177		)	(3,032		)	(27,507		)	(22,241		)
Unrealized (loss)/gain on Non-Agency MBS, net	(25,101		)	10,020			(62,743		)	93,429
Reclassification adjustment for MBS sales included in net income	(9,455		)	(14,935		)	(25,580		)	(30,283		)
Reclassification adjustment for OTTI included in net income	—			—			—			(1,032		)
Change in AOCI from AFS securities	(43,733		)	(7,947		)	(115,830		)	39,873
Balance at end of period	$	504,818		$	660,276		$	504,818		$	660,276

23

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

Interest Income on MBS, CRT Securities and MSR Related Assets

The following table presents the components of interest income on the Company’s MBS, CRT securities and MSR related assets for the three and nine months ended September 30, 2018 and 2017: 

	Three Months Ended September 30,						Nine Months Ended September 30,
(In Thousands)	2018			2017			2018			2017
Agency MBS
Coupon interest	$	21,549		$	23,473		$	62,546		$	74,589
Effective yield adjustment (1)	(7,217		)	(7,940		)	(19,751		)	(24,575		)
Interest income	$	14,332		$	15,533		$	42,795		$	50,014
Legacy Non-Agency MBS
Coupon interest	$	27,026		$	30,688		$	83,791		$	97,796
Effective yield adjustment (2)(3)	18,984			18,005			53,648			59,033
Interest income	$	46,010		$	48,693		$	137,439		$	156,829
RPL/NPL MBS
Coupon interest	$	11,526		$	13,947		$	31,167		$	54,475
Effective yield adjustment (1)(4)	1,131			612			1,206			1,424
Interest income	$	12,657		$	14,559		$	32,373		$	55,899
CRT securities
Coupon interest	$	7,257		$	7,868		$	23,484		$	19,712
Effective yield adjustment (2)	491			808			2,455			3,186
Interest income	$	7,748		$	8,676		$	25,939		$	22,898
MSR related assets
Coupon interest	$	6,407		$	7,117		$	19,005		$	17,621
Effective yield adjustment (1)	—			77			1,244			212
Interest income	$	6,407		$	7,194		$	20,249		$	17,833

(1)  Includes amortization of premium paid net of accretion of purchase discount.  For Agency MBS, RPL/NPL MBS and the corporate loan secured by MSRs, interest income is recorded at an effective yield, which reflects net premium amortization/accretion based on actual prepayment activity.

(2) The effective yield adjustment is the difference between the net income calculated using the net yield, which is based on management’s estimates of the amount and timing of future cash flows, less the current coupon yield.

(3) Includes accretion income recognized due to the impact of redemptions of certain securities that had been previously been purchased at a discount of $2.3 million during the three months ended September 30, 2018 and $2.3 million and $1.7 million during the nine months ended September 30, 2018 and 2017, respectively.

(4) Includes accretion income recognized due to the impact of redemptions of certain securities that had been previously been purchased at a discount of $1.1 million and $575,000 during the three months ended September 30, 2018 and 2017, respectively and $1.2 million during each of the nine months ended September 30, 2018 and 2017, respectively.

24

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

4.    Residential Whole Loans

Included on the Company’s consolidated balance sheets at September 30, 2018 and December 31, 2017 are approximately $3.9 billion and $2.2 billion, respectively, of residential whole loans arising from the Company’s interests in certain trusts established to acquire the loans and certain entities established in connection with its loan securitization transactions. The Company has assessed that these entities are required to be consolidated for financial reporting purposes.

Residential Whole Loans, at Carrying Value

The following table presents the components of the Company’s Residential whole loans, at carrying value at September 30, 2018 and December 31, 2017:

(Dollars In Thousands)	September 30, 2018		December 31, 2017
Purchased credit impaired loans	$	825,614	$	790,879
Other loans at carrying value:
Non-QM loans	989,818		55,612
Rehabilitation loans	329,301		56,706
Single-family rental loans	79,699		5,319
Seasoned performing loans	247,135		—
Total other loans at carrying value	$	1,645,953	$	117,637
Total Residential whole loans, at carrying value	$	2,471,567	$	908,516
Number of loans	9,900		4,800

The following table presents additional information regarding the Company’s Residential whole loans, at carrying value at September 30, 2018:

September 30, 2018

	Carrying Value		Unpaid Principal Balance (“UPB”)		Weighted Average Coupon (1)		Weighted Average Term to Maturity (Months)	Weighted Average LTV Ratio (2)		Aging by UPB
												Past Due Days
(Dollars In Thousands)										Current		30-59		60-89		90+
Purchased credit impaired loans	$	825,614	$	1,034,890	4.36	%	304	87	%	N/A		N/A		N/A		N/A
Other loans at carrying value:(3)
Non-QM loans	989,818		956,162		6.18		358	66		$	944,564	$	8,564	$	1,865	$	1,169
Rehabilitation loans	329,301		329,301		7.51		9	65		309,951		12,836		3,620		2,894
Single-family rental loans	79,699		79,563		5.84		355	68		78,172		870		—		521
Seasoned performing loans	240,362		260,770		4.05		194	49		239,025		20,373		635		737
Residential whole loans, at carrying value, total or weighted average	$	2,464,794	$	2,660,686	5.46	%	278

(1) Weighted average is calculated based on the interest bearing principal balance of each loan within the related category. For loans acquired with servicing rights released by the seller, interest rates included in the calculation do not reflect loan servicing fees. For loans acquired with servicing rights retained by the seller, interest rates included in the calculation are net of servicing fees.

(2) LTV represents the ratio of the total unpaid principal balance of the loan, to the estimated value of the collateral securing the related loan. For Rehabilitation loans, the LTV generally represents the ratio of the maximum unpaid principal balance of the loan, including unfunded commitments, to the estimated after repaired value of the collateral securing the related loan. For certain Rehabilitation loans, an after repaired valuation is not obtained during loan underwriting. For these loans, the LTV represents the ratio of the current unpaid principal balance of the loan, to the “as is” estimated value of the collateral securing the related loan.

(3) Excluded from the table above are approximately $6.8 million of other loans held at carrying value for which the closing of the purchase transaction had not occurred as of September 30, 2018.

25

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

Purchased Credit Impaired Loans

As of September 30, 2018, the Company had established an allowance for loan losses of approximately $461,000 on its purchased credit impaired loans held at carrying value. For the three and nine months ended September 30, 2018, a provision for loan losses of approximately $164,000 and $131,000 was recorded, respectively, which is included in Operating and Other expense on the Company’s consolidated statements of operations. For the three and nine months ended September 30, 2017, a net reversal of provision for loan losses of approximately $57,000 and $672,000 was recorded, respectively.

The following table presents the activity in the Company’s allowance for loan losses on its purchased credit impaired loans held at carrying value for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,					Nine Months Ended   September 30,
(In Thousands)	2018		2017			2018		2017
Balance at the beginning of period	$	297	$	375		$	330	$	990
Provisions/(reversal of provisions) for loan losses	164		(57		)	131		(672		)
Balance at the end of period	$	461	$	318		$	461	$	318

The following table presents information regarding the estimates of the contractually required payments, the cash flows expected to be collected, and the estimated fair value of the purchased credit impaired loans held at carrying value acquired by the Company for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended  September 30, (1)						Nine Months Ended  September 30, (1)
(In Thousands)	2018			2017			2018			2017
Contractually required principal and interest	$	154,911		$	185,234		$	154,911		$	185,234
Contractual cash flows not expected to be collected (non-accretable yield)	(15,378		)	(33,448		)	(15,378		)	(33,448		)
Expected cash flows to be collected	139,533			151,786			139,533			151,786
Interest component of expected cash flows (accretable yield)	(41,947		)	(53,916		)	(41,947		)	(53,916		)
Fair value at the date of acquisition	$	97,586		$	97,870		$	97,586		$	97,870

(1) Included in the activity presented for the three and nine months ended September 30, 2018 and 2017 are approximately $54.9 million and $97.9 million of purchase credit impaired loans held at carrying value the Company committed to purchase during the three months endedJune 30, 2018 and 2017, but for which the closing of the purchase transaction occurred during the three months endedSeptember 30, 2018 and 2017, respectively.

26

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

The following table presents accretable yield activity for the Company’s purchased credit impaired loans held at carrying value for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended September 30, (1)						Nine Months Ended September 30, (1)
(In Thousands)	2018			2017			2018			2017
Balance at beginning of period	$	401,075		$	318,125		$	421,872		$	334,379
Additions	41,947			53,916			41,947			53,916
Accretion	(11,198		)	(9,026		)	(33,139		)	(26,219		)
Liquidations and other	(8,378		)	—			(23,388		)	—
Reclassifications (to)/from non-accretable difference, net	9,694			303			25,848			1,242
Balance at end of period	$	433,140		$	363,318		$	433,140		$	363,318

(1) Included in the activity presented for the three and nine months ended September 30, 2018 and 2017 are approximately $54.9 million and $97.9 million of purchase credit impaired loans held at carrying value the Company committed to purchase during the three months endedJune 30, 2018 and 2017, but for which the closing of the purchase transaction occurred during the three months endedSeptember 30, 2018 and 2017, respectively.

Accretable yield for purchased credit impaired residential whole loans is the excess of loan cash flows expected to be collected over the purchase price. The cash flows expected to be collected represent the Company’s estimate of the amount and timing of undiscounted principal and interest cash flows. Additions include accretable yield estimates for purchases made during the period and reclassification to accretable yield from non-accretable yield. Accretable yield is reduced by accretion during the period. The reclassifications between accretable and non-accretable yield and the accretion of interest income are based on changes in estimates regarding loan performance and the value of the underlying real estate securing the loans. In future periods, as the Company updates estimates of cash flows expected to be collected from the loans and the underlying collateral, the accretable yield may change. Therefore, the amount of accretable income recorded during the three and nine months ended September 30, 2018 is not necessarily indicative of future results.

Other Loans at Carrying Value

As of September 30, 2018, there were ten loans held at carrying value, that have been placed on non-accrual status as they are more than 90 days delinquent and had not yet become current with respect to the contractually required payments under the loan. Such loans have an unpaid balance of approximately $5.3 million. These non-performing loans represent approximately 0.3% of the total outstanding principal balance of all of the Company’s Other Loans at Carrying Value. Management has assessed the recoverability of these loans and based on estimates of the value of the underlying collateral, no allowance for loan loss reserves has been recorded as of September 30, 2018.

In connection with purchased Rehabilitation loans, the Company has unfunded commitments of $43.9 million.

27

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

Residential Whole Loans, at Fair Value

Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at time of acquisition. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations.

The following table presents information regarding the Company’s residential whole loans held at fair value at September 30, 2018 and December 31, 2017:

(Dollars in Thousands)	September 30, 2018 (1)			December 31, 2017
Less than 60 Days Past Due:
Outstanding principal balance	$	585,024		$	488,600
Aggregate fair value	$	544,890		$	446,616
Weighted Average LTV Ratio (2)	76.17		%	74.98		%
Number of loans	2,775			2,323
60 Days to 89 Days Past Due:
Outstanding principal balance	$	70,018		$	45,955
Aggregate fair value	$	62,043		$	37,927
Weighted Average LTV Ratio (2)	77.62		%	89.25		%
Number of loans	319			207
90 Days or More Past Due:
Outstanding principal balance	$	972,488		$	1,027,818
Aggregate fair value	$	840,634		$	840,572
Weighted Average LTV Ratio (2)	89.48		%	94.50		%
Number of loans	3,416			3,984
Total Residential whole loans, at fair value	$	1,447,567		$	1,325,115

(1) Excluded from the table above are approximately $1.8 million of residential whole loans held at fair value for which the closing of the purchase transaction had not occurred as of September 30, 2018.

(2) LTV represents the ratio of the total unpaid principal balance of the loan, to the estimated value of the collateral securing the related loan. Excluded from the calculation of weighted average LTV are certain low value loans secured by vacant lots, for which the LTV ratio is not meaningful.

The following table presents the components of Net gain on residential whole loans held at fair value for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,				Nine Months Ended   September 30,
(In Thousands)	2018		2017		2018		2017
Coupon payments and other income received (1)	$	17,634	$	9,824	$	52,034	$	27,971
Net unrealized gains	8,442		5,289		26,788		12,499
Net gain on payoff/liquidation of loans	3,251		1,456		10,203		3,076
Net gain on transfers to REO	5,615		2,110		16,858		5,114
Total	$	34,942	$	18,679	$	105,883	$	48,660

(1) Primarily includes coupon interest payments received upon the liquidation of previously delinquent mortgage loans, recurring coupon interest payments received on mortgage loans that are contractually current, and cash payments received from private mortgage insurance on liquidated loans.

28

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

5.    Other Assets

The following table presents the components of the Company’s Other assets at September 30, 2018 and December 31, 2017:

(In Thousands)	September 30, 2018		December 31, 2017
Securities obtained and pledged as collateral, at fair value	$	—	$	504,062
REO	223,105		152,356
MBS and loan related receivables	101,578		54,640
Swaps, at fair value	22,311		679
Goodwill	7,189		7,189
Other	51,886		23,983
Total Other Assets	$	406,069	$	742,909

(a)  Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as Collateral

In connection with its financing strategy for Non-Agency MBS, in prior periods the Company obtained securities as collateral under collateralized financing arrangements.  Securities obtained as collateral in connection with these transactions are recorded at fair value, with a liability, representing the obligation to return the collateral obtained, recorded in Other liabilities.  While beneficial ownership of securities obtained remains with the counterparty, the Company had the right to transfer the collateral obtained or to pledge it as part of a subsequent collateralized financing transaction. During the three months ended September 30, 2018, these financing arrangements were unwound and the related securities obtained as collateral were returned to the counterparty. 

(b) Real Estate Owned

At September 30, 2018, the Company had 979 REO properties with an aggregate carrying value of $223.1 million. At December 31, 2017, the Company had 709 REO properties with an aggregate carrying value of $152.4 million.

During the three and nine months ended September 30, 2018, the Company reclassified to REO 240 and 795 mortgage loans, respectively at an aggregate estimated fair value less estimated selling costs of $58.1 million and $161.6 million, respectively, at the time of transfer. During the three and nine months ended September 30, 2017, the Company reclassified to REO 174 and 521 mortgage loans, respectively at an aggregate estimated fair value less estimated selling cost of $38.9 million and $97.4 million, respectively, at the time of transfer. Such transfers occur when the Company takes possession of the property by foreclosing on the borrower or completes a “deed-in-lieu of foreclosure” transaction. From time to time, the Company also acquires REO in connection with transactions to acquire residential whole loans.

At September 30, 2018, $214.4 million of residential real estate property was held by the Company that was acquired either through a completed foreclosure proceeding or from completion of a deed-in-lieu of foreclosure or similar legal agreement. In addition, formal foreclosure proceedings were in process with respect to $48.7 million of residential whole loans held at carrying value and $720.1 million of residential whole loans held at fair value at September 30, 2018.

During the three and nine months ended September 30, 2018, the Company sold 157 and 537 REO properties for consideration of $29.9 million and $96.0 million, realizing net gains of approximately $2.0 million and $6.6 million, respectively. During the three and nine months ended September 30, 2017, the Company sold 139 and 368 REO properties for consideration of $18.4 million and $53.0 million, realizing net gain of approximately $805,000 and $2.8 million, respectively. These amounts are included in Other Income, net on the Company’s consolidated statements of operations. In addition, following an updated assessment of liquidation amounts expected to be realized that was performed on all REO held at the end of the third quarters of 2018 and 2017, downward adjustments of approximately $4.1 million and $3.1 million were recorded to reflect certain REO properties at the lower of cost or estimated fair value as of September 30, 2018 and 2017, respectively.

29

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

The following table presents the activity in the Company’s REO for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,						Nine Months Ended September 30,
(In Thousands)	2018			2017			2018			2017
Balance at beginning of period	$	192,162		$	104,443		$	152,356		$	80,503
Adjustments to record at lower of cost or fair value	(4,056		)	(3,129		)	(11,592		)	(7,306		)
Transfer from residential whole loans (1)	58,051			38,944			161,572			97,388
Purchases and capital improvements	4,897			15,342			10,179			17,224
Disposals	(27,949		)	(17,621		)	(89,410		)	(49,830		)
Balance at end of period	$	223,105		$	137,979		$	223,105		$	137,979

(1)  Includes net gain recorded on transfer of approximately $5.8 million and $2.8 million, for the three months ended September 30, 2018 and 2017, respectively; and approximately $17.0 million and $5.3 million for the nine months ended September 30, 2018 and 2017, respectively.

(c)Derivative Instruments

The Company’s derivative instruments are currently comprised of Swaps, the majority of which are designated as cash flow hedges against the interest rate risk associated with its borrowings. In addition, in connection with managing risks associated with purchases of longer duration Agency MBS, the Company has also entered into Swaps that are not designated as hedges for accounting purposes. The following table presents the fair value of the Company’s derivative instruments and their balance sheet location at September 30, 2018 and December 31, 2017:

			September 30, 2018				December 31, 2017
Derivative Instrument (1)	Designation	Balance Sheet Location	Notional Amount		Fair Value		Notional Amount		Fair Value
(In Thousands)
Swaps	Hedging	Other assets	$	2,122,000	$	18,650	$	750,000	$	679
Swaps	Hedging	Other liabilities	$	—	$	—	$	1,800,000	$	—
Swaps	Non-Hedging	Other assets	$	515,000	$	3,661	$	—	$	—

(1) Represents Swaps executed bilaterally with a counterparty in the over-the-counter market but then novated to a central clearing house, whereby the central clearing house becomes the counterparty to both of the original counterparties.

Swaps

The following table presents the assets pledged as collateral against the Company’s Swap contracts at September 30, 2018 and December 31, 2017:

(In Thousands)	September 30, 2018		December 31, 2017
Agency MBS, at fair value	$	2,877	$	21,756
Restricted cash	—		6,405
Total assets pledged against Swaps	$	2,877	$	28,161

Swaps designated as hedges, or a portion thereof, could become ineffective in the future if the associated repurchase agreements that such derivatives hedge fail to exist or fail to have terms that match those of the derivatives that hedge such borrowings.  At September 30, 2018, all of the Company’s derivatives that were designated in a hedging relationship were deemed effective for hedging purposes.

The Company’s Swaps designated as hedging transactions have the effect of modifying the repricing characteristics of the Company’s repurchase agreements and cash flows for such liabilities.  To date, no cost has been incurred at the inception of a

30

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

Swap (except for certain transaction fees related to entering into Swaps cleared though a central clearing house), pursuant to which the Company agrees to pay a fixed rate of interest and receive a variable interest rate, generally based on one-month or three-month London Interbank Offered Rate (“LIBOR”), on the notional amount of the Swap. The Company did not recognize any change in the value of its existing Swaps designated as hedges through earnings as a result of hedge ineffectiveness during the three and nine months ended September 30, 2018 and 2017.

At September 30, 2018, the Company had Swaps with an aggregate notional amount of $2.6 billion and extended 32 months on average with a maximum term of approximately 121 months. 

The following table presents information about the Company’s Swaps at September 30, 2018 and December 31, 2017:

	September 30, 2018						December 31, 2017
	Notional Amount		Weighted Average Fixed-Pay Interest Rate		Weighted Average Variable Interest Rate (2)		Notional Amount		Weighted Average Fixed-Pay Interest Rate		Weighted Average Variable Interest Rate (2)
Maturity (1)
(Dollars in Thousands)
Within 30 days	$	—	—	%	—	%	$	—	—	%	—	%
Over 30 days to 3 months	—		—		—		—		—		—
Over 3 months to 6 months	100,000		1.71		2.21		50,000		1.45		1.56
Over 6 months to 12 months	100,000		1.71		2.21		500,000		1.50		1.46
Over 12 months to 24 months	1,630,000		2.27		2.20		200,000		1.71		1.54
Over 24 months to 36 months	322,000		2.34		2.17		1,500,000		2.22		1.51
Over 36 months to 48 months	—		—		—		200,000		2.20		1.53
Over 48 months to 60 months	355,000		2.85		2.28		—		—		—
Over 60 months to 72 months	—		—		—		100,000		2.75		1.50
Over 72 months to 84 months	—		—		—		—		—		—
Over 84 months	130,000		2.94		2.32		—		—		—
Total Swaps	$	2,637,000	2.35	%	2.21	%	$	2,550,000	2.04	%	1.50	%

(1)  Each maturity category reflects contractual amortization and/or maturity of notional amounts.

(2)  Reflects the benchmark variable rate due from the counterparty at the date presented, which rate adjusts monthly or quarterly based on one-month or three-month LIBOR, respectively.

The following table presents the net impact of the Company’s derivative hedging instruments on its interest expense and the weighted average interest rate paid and received for such Swaps for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,						Nine Months Ended   September 30,
(Dollars in Thousands)	2018			2017			2018			2017
Interest expense attributable to Swaps	$	547		$	5,310		$	4,187		$	19,606
Weighted average Swap rate paid	2.19		%	2.04		%	2.09		%	1.96		%
Weighted average Swap rate received	2.09		%	1.23		%	1.86		%	1.00		%

During the three and nine months ended September 30, 2018, the Company recorded net gains on Swaps not designated in hedging relationships of $4.0 million and $4.4 million, respectively. These amounts are included in Other income, net on the Company’s consolidated statements of operations. All of the Company’s Swaps were designated in hedging relationships during the three and nine months ended September 30, 2017.

31

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

Impact of Derivative Hedging Instruments on AOCI

The following table presents the impact of the Company’s derivative hedging instruments on its AOCI for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,					Nine Months Ended   September 30,
(In Thousands)	2018		2017			2018			2017
AOCI from derivative hedging instruments:
Balance at beginning of period	$	16,160	$	(35,841	)	$	(11,424	)	$	(46,721	)
Net gain on Swaps	5,390		5,791			32,974			16,671
Balance at end of period	$	21,550	$	(30,050	)	$	21,550		$	(30,050	)

6.      Repurchase Agreements

The Company’s repurchase agreements are accounted for as secured borrowings and bear interest that is generally LIBOR-based.  (See Notes 2(k) and 7)  At September 30, 2018, the Company’s borrowings under repurchase agreements had a weighted average remaining term-to-interest rate reset of 25 days and an effective repricing period of 11 months, including the impact of related Swaps.  At December 31, 2017, the Company’s borrowings under repurchase agreements had a weighted average remaining term-to-interest rate reset of 16 days and an effective repricing period of 11 months, including the impact of related Swaps.

32

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

The following table presents information with respect to the Company’s borrowings under repurchase agreements and associated assets pledged as collateral at September 30, 2018 and December 31, 2017:

(Dollars in Thousands)	September 30, 2018			December 31, 2017
Repurchase agreement borrowings secured by Agency MBS	$	2,584,097		$	2,501,340
Fair value of Agency MBS pledged as collateral under repurchase agreements	$	2,792,396		$	2,705,754
Weighted average haircut on Agency MBS (1)	4.48		%	4.65		%
Repurchase agreement borrowings secured by Legacy Non-Agency MBS	$	1,592,067		$	1,256,033
Fair value of Legacy Non-Agency MBS pledged as collateral under repurchase agreements	$	2,075,540		$	1,652,983
Weighted average haircut on Legacy Non-Agency MBS (1)	21.70		%	21.87		%
Repurchase agreement borrowings secured by RPL/NPL MBS	$	913,249		$	567,140
Fair value of RPL/NPL MBS pledged as collateral under repurchase agreements	$	1,161,568		$	726,540
Weighted average haircut on RPL/NPL MBS (1)	21.22		%	22.05		%
Repurchase agreements secured by U.S. Treasuries	$	—		$	470,334
Fair value of U.S. Treasuries pledged as collateral under repurchase agreements	$	—		$	472,095
Weighted average haircut on U.S. Treasuries (1)	—		%	1.47		%
Repurchase agreements secured by CRT securities	$	405,168		$	459,058
Fair value of CRT securities pledged as collateral under repurchase agreements	$	504,931		$	595,900
Weighted average haircut on CRT securities (1)	19.73		%	22.16		%
Repurchase agreements secured by MSR related assets	$	435,762		$	317,255
Fair value of MSR related assets pledged as collateral under repurchase agreements	$	565,272		$	482,158
Weighted average haircut on MSR related assets (1)	22.56		%	33.19		%
Repurchase agreements secured by residential whole loans (2)	$	1,347,946		$	1,043,747
Fair value of residential whole loans pledged as collateral under repurchase agreements (3)	$	1,888,445		$	1,474,704
Weighted average haircut on residential whole loans (1)	21.93		%	26.10		%

(1) Haircut represents the percentage amount by which the collateral value is contractually required to exceed the loan amount.

(2) Excludes $19,000 and $206,000 of unamortized debt issuance costs at September 30, 2018 and December 31, 2017, respectively.

(3) At September 30, 2018 includes Non-Agency MBS with an aggregate fair value of $27.0 million obtained in connection with the Company’s loan securitization transactions that are eliminated in consolidation.

The following table presents repricing information about the Company’s borrowings under repurchase agreements, which does not reflect the impact of associated derivative hedging instruments, at September 30, 2018 and December 31, 2017:

	September 30, 2018				December 31, 2017
	Balance		Weighted Average Interest Rate		Balance		Weighted Average Interest Rate
Time Until Interest Rate Reset
(Dollars in Thousands)
Within 30 days	$	6,985,487	3.01	%	$	6,161,008	2.39	%
Over 30 days to 3 months	29,501		2.48		453,899		2.76
Over 3 months to 12 months	263,301		3.09		—		—
Total repurchase agreements	7,278,289		3.01	%	6,614,907		2.42	%
Less debt issuance costs	19				206
Total repurchase agreements less debt   issuance costs	$	7,278,270			$	6,614,701

33

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

The following table presents contractual maturity information about the Company’s borrowings under repurchase agreements, all of which are accounted for as secured borrowings, at September 30, 2018, and does not reflect the impact of derivative contracts that hedge such repurchase agreements:

	September 30, 2018
Contractual Maturity	Overnight			Within 30 Days			Over 30 Days to 3 Months			Over 3 Months to 12 Months			Over 12 months			Total
(Dollars in Thousands)
Agency MBS	$	—		$	2,570,990		$	13,107		$	—		$	—		$	2,584,097
Legacy Non-Agency MBS	—			1,544,995			47,072			—			—			1,592,067
RPL/NPL MBS	—			887,087			26,162			—			—			913,249
CRT securities	—			399,064			6,104			—			—			405,168
MSR related assets	—			342,704			93,058			—			—			435,762
Residential whole loans	—			267,129			376,936			703,881			—			1,347,946
Total (1)	$	—		$	6,011,969		$	562,439		$	703,881		$	—		$	7,278,289
Weighted Average Interest Rate	—		%	2.85		%	3.73		%	3.80		%	—		%	3.01		%
Gross amount of recognized liabilities for repurchase agreements in Note 8																$	7,278,289
Amounts related to repurchase agreements not included in offsetting disclosure in Note 8																$	—

(1) Excludes $19,000 of unamortized debt issuance costs at September 30, 2018.

Undrawn Financing Commitment

In connection with the financing of MSR related assets, the Company has obtained a financing commitment of up to $75.0 million, of which $45.1 million was utilized and was outstanding as of September 30, 2018. The Company pays a commitment fee ranging from 0.125% to 0.5% of the undrawn amount, depending on the amount of financing utilized.

34

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

The Company had repurchase agreement borrowings with 28 and 31 counterparties at September 30, 2018 and December 31, 2017. The following table presents information with respect to each counterparty under repurchase agreements for which the Company had greater than 5% of stockholders’ equity at risk in the aggregate at September 30, 2018:

	September 30, 2018
	Counterparty Rating (1)	Amount  at Risk (2)		Weighted  Average Months  to Maturity for Repurchase Agreements	Percent of Stockholders’ Equity
Counterparty
(Dollars in Thousands)
Barclay's Bank	BBB/Aa3/A	$	346,185	4	9.8	%
Goldman Sachs (3)	BBB+/A3/A	305,862		1	8.6
Wells Fargo (4)	A+/Aa2/AA-	252,651		5	7.1
RBC (5)	AA-/Aa2/AA	243,731		1	6.9

(1) As rated at September 30, 2018 by S&P, Moody’s and Fitch, Inc., respectively.  The counterparty rating presented is the lowest published for these entities.

(2) The amount at risk reflects the difference between (a) the amount loaned to the Company through repurchase agreements, including interest payable, and (b) the cash and the fair value of the securities pledged by the Company as collateral, including accrued interest receivable on such securities.

(3) Includes $171.3 million at risk with Goldman Sachs Bank USA and $134.6 million at risk with Goldman Sachs Lending Partners.

(4) Includes $241.0 million at risk with Wells Fargo Bank, NA and $11.7 million at risk with Wells Fargo Securities LLC.

(5) Includes $237.6 million at risk with RBC Barbados and $6.1 million at risk with RBC New York. Counterparty ratings are not published for RBC Barbados and RBS Capital Market LLC.

7. Collateral Positions

The Company pledges securities or cash as collateral to its counterparties pursuant to its borrowings under repurchase agreements and for initial margin payments on centrally cleared Swaps. In addition, the Company receives securities or cash as collateral pursuant to financing provided under reverse repurchase agreements.  The Company exchanges collateral with its counterparties based on changes in the fair value, notional amount and term of the associated repurchase agreements and Swap contracts, as applicable.  In connection with these margining practices, either the Company or its counterparty may be required to pledge cash or securities as collateral.  When the Company’s pledged collateral exceeds the required margin, the Company may initiate a reverse margin call, at which time the counterparty may either return the excess collateral or provide collateral to the Company in the form of cash or equivalent securities.

35

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

The following table summarizes the fair value of the Company’s collateral positions, which includes collateral pledged and collateral held, with respect to its borrowings under repurchase agreements, reverse repurchase agreements and derivative hedging instruments at September 30, 2018 and December 31, 2017: 

	September 30, 2018				December 31, 2017
(In Thousands)	Assets Pledged		Collateral Held		Assets Pledged		Collateral Held
Derivative Hedging Instruments:
Agency MBS	$	2,877	$	—	$	21,756	$	—
Cash (1)	—		—		6,405		—
	2,877		—		28,161		—
Repurchase Agreement Borrowings:
Agency MBS	2,792,396		—		2,705,754		—
Legacy Non-Agency MBS (2)	2,075,540		—		1,652,983		—
RPL/NPL MBS	1,161,568		—		726,540		—
U.S. Treasury securities	—		—		472,095		—
CRT securities	504,931		—		595,900		—
MSR related assets	565,272		—		482,158		—
Residential whole loans (3)	1,888,445		—		1,474,704		—
Cash (1)	6,489		—		6,902		—
	8,994,641		—		8,117,036		—
Reverse Repurchase Agreements:
U.S. Treasury securities	—		—		—		504,062
	—		—		—		504,062
Total	$	8,997,518	$	—	$	8,145,197	$	504,062

(1)  Cash pledged as collateral is reported as Restricted cash on the Company’s consolidated balance sheets.

(2)  In addition, at December 31, 2017$688.1 million of Legacy Non-Agency MBS were pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty.

(3) At September 30, 2018 includes Non-Agency MBS with an aggregate fair value of $27.0 million obtained in connection with the Company’s loan securitization transactions that are eliminated in consolidation.

The following table presents detailed information about the Company’s assets pledged as collateral pursuant to its borrowings under repurchase agreements and derivative hedging instruments at September 30, 2018:

	September 30, 2018
	Assets Pledged Under Repurchase  Agreements						Assets Pledged Against Derivative Hedging Instruments						Total Fair Value of Assets Pledged and Accrued Interest
(In Thousands)	Fair Value		Amortized Cost		Accrued  Interest on Pledged  Assets		Fair Value/  Carrying  Value		Amortized Cost		Accrued Interest on  Pledged  Assets
Agency MBS	$	2,792,396	$	2,842,022	$	8,527	$	2,877	$	3,036	$	7	$	2,803,807
Legacy Non-Agency MBS	2,075,540		1,548,906		8,531		—		—		—		2,084,071
RPL/NPL MBS	1,161,568		1,162,829		984		—		—		—		1,162,552
CRT securities	504,931		472,217		436		—		—		—		505,367
MSR related assets	565,272		564,350		644		—		—		—		565,916
Residential whole loans (1)(2)	1,888,445		1,861,387		8,485		—		—		—		1,896,930
Cash (3)	6,489		6,489		—		—		—		—		6,489
Total	$	8,994,641	$	8,458,200	$	27,607	$	2,877	$	3,036	$	7	$	9,025,132

(1) Includes residential whole loans held at carrying value with an aggregate fair value of $1.2 billion and aggregate amortized cost of $1.1 billion and residential whole loans held at fair value with an aggregate fair value and amortized cost of $685.1 million.

(2) Includes Non-Agency MBS with an aggregate fair value and amortized cost of $27.0 million obtained in connection with the Company’s loan securitization transactions that are eliminated in consolidation.

(3) Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets.

36

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

8.    Offsetting Assets and Liabilities

The following tables present information about certain assets and liabilities that are subject to master netting arrangements (or similar agreements) and may potentially be offset on the Company’s consolidated balance sheets at September 30, 2018 and December 31, 2017:

Offsetting of Financial Assets and Derivative Assets

	Gross Amounts of Recognized Assets		Gross Amounts Offset in the Consolidated Balance Sheets		Net Amounts of Assets Presented in the Consolidated Balance Sheets		Gross Amounts Not Offset in  the Consolidated Balance Sheets					Net Amount
(In Thousands)							Financial Instruments			Cash  Collateral  Received
September 30, 2018
Swaps, at fair value	$	22,311	$	—	$	22,311	$	(22,311	)	$	—	$	—
Total	$	22,311	$	—	$	22,311	$	(22,311	)	$	—	$	—
December 31, 2017
Swaps, at fair value	$	679	$	—	$	679	$	(679	)	$	—	$	—
Total	$	679	$	—	$	679	$	(679	)	$	—	$	—

Offsetting of Financial Liabilities and Derivative Liabilities

	Gross Amounts of Recognized Liabilities		Gross Amounts Offset in the Consolidated Balance Sheets		Net Amounts of Liabilities Presented in the Consolidated Balance Sheets		Gross Amounts Not Offset in the  Consolidated Balance Sheets						Net Amount
(In Thousands)							Financial  Instruments (1)			Cash  Collateral  Pledged (1)
September 30, 2018
Swaps, at fair value (2)	$	—	$	—	$	—	$	—		$	—		$	—
Repurchase agreements (3)(4)	7,278,289		—		7,278,289		(7,271,800		)	(6,489		)	—
Total	$	7,278,289	$	—	$	7,278,289	$	(7,271,800	)	$	(6,489	)	$	—
December 31, 2017
Swaps, at fair value (2)	$	—	$	—	$	—	$	—		$	—		$	—
Repurchase agreements (3)(4)	6,614,907		—		6,614,907		(6,608,005		)	(6,902		)	—
Total	$	6,614,907	$	—	$	6,614,907	$	(6,608,005	)	$	(6,902	)	$	—

(1) Amounts disclosed in the Financial Instruments column of the above table represent collateral pledged that is available to be offset against liability balances associated with repurchase agreements.  Amounts disclosed in the Cash Collateral Pledged column of the above table represent amounts pledged as collateral against repurchase agreements.

(2) The fair value of securities pledged against the Company’s Swaps was $2.9 million and $21.8 million at September 30, 2018 and December 31, 2017, respectively. Beginning in January 2017, variation margin payments on the Company’s cleared Swaps are treated as a legal settlement of the exposure under the Swap contract. Previously such payments were treated as collateral pledged against the exposure under the Swap contract. The effect of this change is to reduce what would have otherwise been reported as fair value of the Swap.

(3) The fair value of financial instruments pledged against the Company’s repurchase agreements was $9.0 billion and $8.1 billion at September 30, 2018 and December 31, 2017, respectively.

(4) Excludes $19,000 and $206,000 of unamortized debt issuance costs at September 30, 2018 and December 31, 2017, respectively.

Nature of Setoff Rights

In the Company’s consolidated balance sheets, all balances associated with repurchase agreements are presented on a gross basis. Certain of the Company’s repurchase agreement and derivative transactions are governed by underlying agreements that generally provide for a right of setoff in the event of default or in the event of a bankruptcy of either party to the transaction.   

37

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

9. Other Liabilities

The following table presents the components of the Company’s Other liabilities at September 30, 2018 and December 31, 2017:

(In Thousands)	September 30, 2018		December 31, 2017
Securitized debt (1)	$	714,203	$	363,944
Obligation to return securities held as collateral, at fair value	—		504,062
Senior Notes	96,805		96,773
Dividends and dividend equivalents payable	90,136		79,771
Accrued interest payable	11,630		12,263
Payable for unsettled MBS and residential whole loans purchases	10,888		—
Accrued expenses and other	27,821		21,584
Total Other Liabilities	$	951,483	$	1,078,397

(1) Securitized debt represents third-party liabilities of consolidated VIEs and excludes liabilities of the VIEs acquired by the Company that are eliminated in consolidation. The third-party beneficial interest holders in the VIEs have no recourse to the general credit of the Company. (See Notes 10 and 15 for further discussion.)

Senior Notes

On April 11, 2012, the Company issued $100.0 million in aggregate principal amount of its Senior Notes in an underwritten public offering.  The total net proceeds to the Company from the offering of the Senior Notes were approximately $96.6 million, after deducting offering expenses and the underwriting discount.  The Senior Notes bear interest at a fixed rate of 8.00% per year, paid quarterly in arrears on January 15, April 15, July 15 and October 15 of each year and will mature on April 15, 2042.  The Senior Notes have an effective interest rate, including the impact of amortization to interest expense of debt issuance costs, of 8.31%. The Company may redeem the Senior Notes, in whole or in part, at any time on or after April 15, 2017, at a redemption price equal to 100% of the principal amount redeemed plus accrued and unpaid interest to, but not excluding, the redemption date.

The Senior Notes are the Company’s senior unsecured obligations and are subordinate to all of the Company’s secured indebtedness, which includes the Company’s repurchase agreements and other financing arrangements, to the extent of the value of the collateral securing such indebtedness.

10.    Commitments and Contingencies

(a) Lease Commitments

The Company pays monthly rent pursuant to two operating leases.  The lease term for the Company’s headquarters in New York, New York extends through June 30, 2020.  The lease provides for aggregate cash payments ranging over time of approximately $2.5 million per year, paid on a monthly basis, exclusive of escalation charges.  In addition, as part of this lease agreement, the Company has provided the landlord a $785,000 irrevocable standby letter of credit fully collateralized by cash.  The letter of credit may be drawn upon by the landlord in the event that the Company defaults under certain terms of the lease.  In addition, the Company has a lease through December 31, 2021 for its off-site back-up facility located in Rockville Centre, New York, which provides for, among other things, lease payments totaling $32,000 annually.

(b)Representations and Warranties in Connection with Loan Securitization Transactions

In connection with the loan securitization transactions entered into by the Company, the Company has the obligation under certain circumstances to repurchase assets previously transferred to securitization vehicles upon breach of certain representations and warranties. As of September 30, 2018, the Company had no reserve established for repurchases of loans and was not aware of any material unsettled repurchase claims that would require the establishment of such a reserve.  (See Note 15)

38

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

(c) Corporate Loan

The Company has participated in a loan to provide financing to an entity that originates loans and owns MSRs. The loan is secured by certain MSRs, as well as certain other unencumbered assets owned by the borrower. Under the terms of the participation agreement, the Company has committed to provide financing of $100.0 million of which approximately $60.1 million was drawn at September 30, 2018. (See Note 3)

(d)Rehabilitation Loan Commitments

At September 30, 2018, the Company had unfunded commitments of $43.9 million in connection with its purchased Rehabilitation loans. (See Note 4)

(e)MBS Purchase Commitments

At September 30, 2018, the Company had a commitment to purchase a Non-Agency MBS at an estimated price of $2.3 million. The expected settlement amount is included in the Non-Agency MBS balances presented at fair value on the Company’s consolidated balance sheets, with a corresponding liability recorded in Other liabilities and included in Payable for unsettled MBS and residential whole loan purchases.

(f)Residential Whole Loan Purchase Commitments

At September 30, 2018, the Company has agreed, subject to the completion of due diligence and customary closing conditions, to purchase residential whole loans with an aggregate estimated purchase price of $8.6 million, of which $6.8 million is presented in other loans held at carrying value and $1.8 million in residential whole loans held at fair value with a corresponding liability recorded in Other liabilities and included in Payable for unsettled MBS and residential whole loan purchases.

11.    Stockholders’ Equity

(a) Preferred Stock

On April 15, 2013, the Company completed the issuance of 8.0 million shares of its 7.50% Series B Cumulative Redeemable Preferred Stock (“Series B Preferred Stock”) with a par value of $0.01 per share, and a liquidation preference of $25.00 per share plus accrued and unpaid dividends, in an underwritten public offering. The Company’s Series B Preferred Stock is entitled to receive a dividend at a rate of 7.50% per year on the $25.00 liquidation preference before the Company’s common stock is paid any dividends and is senior to the Company’s common stock with respect to distributions upon liquidation, dissolution or winding up. Dividends on the Series B Preferred Stock are payable quarterly in arrears on or about March 31, June 30, September 30 and December 31 of each year. The Series B Preferred Stock is redeemable at $25.00 per share plus accrued and unpaid dividends (whether or not authorized or declared) exclusively at the Company’s option commencing on April 15, 2018 (subject to the Company’s right, under limited circumstances, to redeem the Series B Preferred Stock prior to that date in order to preserve its qualification as a REIT) and upon certain specified change in control transactions in which the Company’s common stock and the acquiring or surviving entity common securities would not be listed on the New York Stock Exchange (the “NYSE”), the NYSE American or NASDAQ, or any successor exchange.

The Series B Preferred Stock generally does not have any voting rights, subject to an exception in the event the Company fails to pay dividends on such stock for six or more quarterly periods (whether or not consecutive).  Under such circumstances, the Series B Preferred Stock will be entitled to vote to elect two additional directors to the Company’s Board of Directors (the “Board”), until all unpaid dividends have been paid or declared and set apart for payment.  In addition, certain material and adverse changes to the terms of the Series B Preferred Stock cannot be made without the affirmative vote of holders of at least 66 2/3% of the outstanding shares of Series B Preferred Stock.

39

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2018 through September 30, 2018:

Declaration Date	Record Date	Payment Date	Dividend Per Share
August 20, 2018	September 7, 2018	September 28, 2018	$	0.46875
May 17, 2018	June 4, 2018	June 29, 2018	0.46875
February 20, 2018	March 2, 2018	March 30, 2018	0.46875

(b)  Dividends on Common Stock

The following table presents cash dividends declared by the Company on its common stock from January 1, 2018 through September 30, 2018:

Declaration Date (1)	Record Date	Payment Date	Dividend Per Share
September 13, 2018	October 1, 2018	October 31, 2018	$	0.20	(1)
June 7, 2018	June 29, 2018	July 31, 2018	0.20
March 7, 2018	March 29, 2018	April 30, 2018	0.20

(1)  At September 30, 2018, the Company had accrued dividends and dividend equivalents payable of $90.1 million related to the common stock dividend declared on September 13, 2018.

(c) Public Offering of Common Stock

The table below presents information with respect to shares of the Company’s common stock issued through public offerings during the nine months ended September 30, 2018 and the year ended December 31, 2017.

Share Issue Date	Shares Issued		Gross Proceeds Per Share		Gross Proceeds
(In Thousands, Except Per Share Amounts)
August 7, 2018	50,875	(1)	$	7.78	$	395,807	(1)
May 10, 2017	23,000		7.85		180,550		(2)

(1) Includes approximately 875,000 shares issued on September 5, 2018 pursuant to the exercise of the underwriters’ option to purchase additional shares. The Company incurred approximately $6.5 million of underwriting discounts and related expenses in connection with this equity offering.

(2) The Company incurred approximately $2.3 million of underwriting discounts and related expenses in connection with this equity offering.

(d) Discount Waiver, Direct Stock Purchase and Dividend Reinvestment Plan (“DRSPP”)

On September 16, 2016, the Company filed a shelf registration statement on Form S-3 with the SEC under the Securities Act of 1933, as amended (the “1933 Act”), for the purpose of registering additional common stock for sale through its DRSPP.  Pursuant to Rule 462(e) of the 1933 Act, this shelf registration statement became effective automatically upon filing with the SEC and, when combined with the unused portion of the Company’s previous DRSPP shelf registration statements, registered an aggregate of 15 million shares of common stock.  The Company’s DRSPP is designed to provide existing stockholders and new investors with a convenient and economical way to purchase shares of common stock through the automatic reinvestment of dividends and/or optional cash investments.  At September 30, 2018, approximately 11.9 million shares of common stock remained available for issuance pursuant to the DRSPP shelf registration statement.

During the three and nine months ended September 30, 2018, the Company issued 64,731 and 302,264 shares of common stock through the DRSPP, raising net proceeds of approximately $519,000 and $2.2 million, respectively.  From the inception of

40

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

the DRSPP in September 2003 through September 30, 2018, the Company issued 33,978,241 shares pursuant to the DRSPP, raising net proceeds of $283.7 million.

(e)  Stock Repurchase Program

As previously disclosed, in August 2005, the Company’s Board authorized a stock repurchase program (the “Repurchase Program”) to repurchase up to 4.0 million shares of its outstanding common stock.  The Board reaffirmed such authorization in May 2010.  In December 2013, the Board increased the number of shares authorized under the Repurchase Program to an aggregate of 10.0 million. Such authorization does not have an expiration date and, at present, there is no intention to modify or otherwise rescind such authorization.  Subject to applicable securities laws, repurchases of common stock under the Repurchase Program are made at times and in amounts as the Company deems appropriate, (including, in our discretion, through the use of one or more plans adopted under Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended (the “1934 Act”)) using available cash resources.  Shares of common stock repurchased by the Company under the Repurchase Program are cancelled and, until reissued by the Company, are deemed to be authorized but unissued shares of the Company’s common stock.  The Repurchase Program may be suspended or discontinued by the Company at any time and without prior notice. The Company did not repurchase any shares of its common stock during the nine months ended September 30, 2018.  At September 30, 2018, 6,616,355 shares remained authorized for repurchase under the Repurchase Program.

(f) Accumulated Other Comprehensive Income/(Loss)

The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2018:

	Three Months Ended   September 30, 2018								Nine Months Ended   September 30, 2018
(In Thousands)	Net Unrealized Gain/(Loss) on AFS Securities			Net  (Loss)/Gain on Swaps		Total AOCI			Net Unrealized Gain/(Loss) on AFS Securities			Net  (Loss)/Gain on Swaps			Total AOCI
Balance at beginning of period	$	548,551		$	16,160	$	564,711		$	620,648		$	(11,424	)	$	609,224
OCI before reclassifications	(34,278		)	5,390		(28,888		)	(90,250		)	32,974			(57,276		)
Amounts reclassified from AOCI (1)	(9,455		)	—		(9,455		)	(25,580		)	—			(25,580		)
Net OCI during the period (2)	(43,733		)	5,390		(38,343		)	(115,830		)	32,974			(82,856		)
Balance at end of period	$	504,818		$	21,550	$	526,368		$	504,818		$	21,550		$	526,368

(1)  See separate table below for details about these reclassifications.

(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).

The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2017:

	Three Months Ended   September 30, 2017									Nine Months Ended   September 30, 2017
(In Thousands)	Net Unrealized Gain/(Loss) on AFS Securities			Net  (Loss)/Gain on Swaps			Total AOCI			Net Unrealized Gain/(Loss) on AFS Securities			Net  (Loss)/Gain on Swaps			Total AOCI
Balance at beginning of period	$	668,223		$	(35,841	)	$	632,382		$	620,403		$	(46,721	)	$	573,682
OCI before reclassifications	6,988			5,791			12,779			71,188			16,671			87,859
Amounts reclassified from AOCI (1)	(14,935		)	—			(14,935		)	(31,315		)	—			(31,315		)
Net OCI during the period (2)	(7,947		)	5,791			(2,156		)	39,873			16,671			56,544
Balance at end of period	$	660,276		$	(30,050	)	$	630,226		$	660,276		$	(30,050	)	$	630,226

(1)  See separate table below for details about these reclassifications.

(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).

41

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and nine months ended September 30, 2018:

	Three Months Ended   September 30, 2018			Nine Months Ended   September 30, 2018
Details about AOCI Components	Amounts Reclassified from AOCI						Affected Line Item in the Statement Where Net Income is Presented
(In Thousands)
AFS Securities:
Realized gain on sale of securities	$	(9,455	)	$	(25,580	)	Net gain on sales of investment securities
Total AFS Securities	$	(9,455	)	$	(25,580	)
Total reclassifications for period	$	(9,455	)	$	(25,580	)

The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and nine months ended September 30, 2017:

	Three Months Ended   September 30, 2017			Nine Months Ended   September 30, 2017
Details about AOCI Components	Amounts Reclassified from AOCI						Affected Line Item in the Statement Where Net Income is Presented
(In Thousands)
AFS Securities:
Realized gain on sale of securities	$	(14,935	)	$	(30,283	)	Net gain on sales of investment securities
OTTI recognized in earnings	—			(1,032		)	Net impairment losses recognized in earnings
Total AFS Securities	$	(14,935	)	$	(31,315	)
Total reclassifications for period	$	(14,935	)	$	(31,315	)

On securities for which OTTI had been recognized in prior periods, the Company did not have any unrealized losses recorded in AOCI at September 30, 2018 and December 31, 2017.

42

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

12.    EPS Calculation

The following table presents a reconciliation of the earnings and shares used in calculating basic and diluted EPS for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,						Nine Months Ended   September 30,
(In Thousands, Except Per Share Amounts)	2018			2017			2018			2017
Numerator:
Net income	$	87,132		$	63,805		$	240,922		$	221,799
Dividends declared on preferred stock	(3,750		)	(3,750		)	(11,250		)	(11,250		)
Dividends, dividend equivalents and undistributed earnings allocated to participating securities	(472		)	(409		)	(1,393		)	(1,299		)
Net income to common stockholders - basic and diluted	$	82,910		$	59,646		$	228,279		$	209,250
Denominator:
Weighted average common shares for basic and diluted earnings per share (1)	428,713			396,698			408,614			385,282
Basic and diluted earnings per share	$	0.19		$	0.15		$	0.56		$	0.54

(1) At September 30, 2018, the Company had approximately 2.2 million equity instruments outstanding that were not included in the calculation of diluted EPS for the three and nine months ended September 30, 2018, as their inclusion would have been anti-dilutive.  These equity instruments reflect RSUs (based on current estimate of expected share settlement amount) with a weighted average grant date fair value of $6.72. These equity instruments may have a dilutive impact on future EPS.

13.    Equity Compensation, Employment Agreements and Other Benefit Plans

(a)  Equity Compensation Plan

In accordance with the terms of the Company’s Equity Plan, which was adopted by the Company’s stockholders on May 21, 2015 (and which amended and restated the Company’s 2010 Equity Compensation Plan), directors, officers and employees of the Company and any of its subsidiaries and other persons expected to provide significant services for the Company and any of its subsidiaries are eligible to receive grants of stock options (“Options”), restricted stock, RSUs, dividend equivalent rights and other stock-based awards under the Equity Plan.

Subject to certain exceptions, stock-based awards relating to a maximum of 12.0 million shares of common stock may be granted under the Equity Plan; forfeitures and/or awards that expire unexercised do not count towards this limit.  At September 30, 2018, approximately 5.7 million shares of common stock remained available for grant in connection with stock-based awards under the Equity Plan.  A participant may generally not receive stock-based awards in excess of 1.5 million shares of common stock in any one year and no award may be granted to any person who, assuming exercise of all Options and payment of all awards held by such person, would own or be deemed to own more than 9.8% of the outstanding shares of the Company’s common stock.  Unless previously terminated by the Board, awards may be granted under the Equity Plan until May 20, 2025.

Restricted Stock Units

Under the terms of the Equity Plan, RSUs are instruments that provide the holder with the right to receive, subject to the satisfaction of conditions set by the Compensation Committee at the time of grant, a payment of a specified value, which may be a share of the Company’s common stock, the fair market value of a share of the Company’s common stock, or such fair market value to the extent in excess of an established base value, on the applicable settlement date.  Although the Equity Plan permits the Company to issue RSUs that can settle in cash, all of the Company’s outstanding RSUs as of September 30, 2018 are designated to be settled in shares of the Company’s common stock.  The Company did not grant any RSUs during the three months endedSeptember 30, 2018 and 2017 and granted 843,802 and 898,945 during the nine months ended September 30, 2018 and 2017, respectively. There were 20,000 RSUs forfeited during the nine months ended September 30, 2018. There were no RSUs forfeited during the nine months ended September 30, 2017. All RSUs outstanding at September 30, 2018 may be entitled to receive dividend

43

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

equivalent payments depending on the terms and conditions of the award either in cash at the time dividends are paid by the Company, or for certain performance-based RSU awards, as a grant of stock at the time such awards are settled.  At September 30, 2018 and December 31, 2017, the Company had unrecognized compensation expense of $6.2 million and $4.1 million, respectively, related to RSUs.  The unrecognized compensation expense at September 30, 2018 is expected to be recognized over a weighted average period of 1.8 years.

Restricted Stock

The Company did not award any shares of restricted common stock during the nine months ended September 30, 2018 and 2017. At September 30, 2018, the Company did not have any unvested shares of restricted common stock outstanding.

Dividend Equivalents

A dividend equivalent is a right to receive a distribution equal to the dividend distributions that would be paid on a share of the Company’s common stock.  Dividend equivalents may be granted as a separate instrument or may be a right associated with the grant of another award (e.g., an RSU) under the Equity Plan, and they are paid in cash or other consideration at such times and in accordance with such rules, terms and conditions, as the Compensation Committee may determine in its discretion. 

Expense Recognized for Equity-Based Compensation Instruments

The following table presents the Company’s expenses related to its equity-based compensation instruments for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,				Nine Months Ended   September 30,
(In Thousands)	2018		2017		2018		2017
RSUs	$	1,082	$	1,836	$	3,891	$	5,194
Restricted shares of common stock	—		74		—		175
Total	$	1,082	$	1,910	$	3,891	$	5,369

(b)  Employment Agreements

At September 30, 2018, the Company had employment agreements with four of its officers, with varying terms that provide for, among other things, base salary, bonus and change-in-control payments upon the occurrence of certain triggering events.

(c)  Deferred Compensation Plans

The Company administers deferred compensation plans for its senior officers and non-employee directors (collectively, the “Deferred Plans”), pursuant to which participants may elect to defer up to 100% of certain cash compensation.  The Deferred Plans are designed to align participants’ interests with those of the Company’s stockholders.

Amounts deferred under the Deferred Plans are considered to be converted into “stock units” of the Company.  Stock units do not represent stock of the Company, but rather are a liability of the Company that changes in value as would equivalent shares of the Company’s common stock.  Deferred compensation liabilities are settled in cash at the termination of the deferral period, based on the value of the stock units at that time.  The Deferred Plans are non-qualified plans under the Employee Retirement Income Security Act of 1974 and, as such, are not funded.  Prior to the time that the deferred accounts are settled, participants are unsecured creditors of the Company.

44

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

The Company’s liability for stock units in the Deferred Plans is based on the market price of the Company’s common stock at the measurement date.  The following table presents the Company’s expenses related to its Deferred Plans for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,					Nine Months Ended   September 30,
(In Thousands)	2018			2017		2018		2017
Non-employee directors	$	(22	)	$	125	$	—	$	339
Total	$	(22	)	$	125	$	—	$	339

The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through September 30, 2018 and December 31, 2017 that had not been distributed and the Company’s associated liability for such deferrals at September 30, 2018 and December 31, 2017:

	September 30, 2018				December 31, 2017
(In Thousands)	Undistributed Income Deferred (1)		Liability Under Deferred Plans		Undistributed Income Deferred (1)		Liability Under Deferred Plans
Non-employee directors	$	2,100	$	2,420	$	1,688	$	2,056
Total	$	2,100	$	2,420	$	1,688	$	2,056

(1)  Represents the cumulative amounts that were deferred by participants through September 30, 2018 and December 31, 2017, which had not been distributed through such respective date.

(d)  Savings Plan

The Company sponsors a tax-qualified employee savings plan (the “Savings Plan”) in accordance with Section 401(k) of the Code.  Subject to certain restrictions, all of the Company’s employees are eligible to make tax-deferred contributions to the Savings Plan subject to limitations under applicable law.  Participant’s accounts are self-directed and the Company bears the costs of administering the Savings Plan.  The Company matches 100% of the first 3% of eligible compensation deferred by employees and 50% of the next 2%, subject to a maximum as provided by the Code.  The Company has elected to operate the Savings Plan under the applicable safe harbor provisions of the Code, whereby among other things, the Company must make contributions for all participating employees and all matches contributed by the Company immediately vest 100%.  For the three months ended September 30, 2018 and 2017, the Company recognized expenses for matching contributions of $89,000 and $87,500, respectively, and $282,000 and $262,500 for the nine months ended September 30, 2018 and 2017, respectively.

14.  Fair Value of Financial Instruments

A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.  The three levels of valuation hierarchy are defined as follows:

Level 1 — Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2 — Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

Level 3 — Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

The following describes the valuation methodologies used for the Company’s financial instruments measured at fair value on a recurring basis, as well as the general classification of such instruments pursuant to the valuation hierarchy.

45

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as Collateral

The fair value of U.S. Treasury securities obtained as collateral and the associated obligation to return securities obtained as collateral are based upon prices obtained from a third-party pricing service, which are indicative of market activity.  Securities obtained as collateral are classified as Level 1 in the fair value hierarchy.

MBS and CRT Securities

The Company determines the fair value of its Agency MBS based upon prices obtained from third-party pricing services, which are indicative of market activity, and repurchase agreement counterparties.

For Agency MBS, the valuation methodology of the Company’s third-party pricing services incorporate commonly used market pricing methods, trading activity observed in the marketplace and other data inputs.  The methodology also considers the underlying characteristics of each security, which are also observable inputs, including: collateral vintage, coupon, maturity date, loan age, reset date, collateral type, periodic and life cap, geography, and prepayment speeds.  Management analyzes pricing data received from third-party pricing services and compares it to other indications of fair value including data received from repurchase agreement counterparties and its own observations of trading activity observed in the marketplace.

In determining the fair value of the Company’s Non-Agency MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services and brokers as well as dialogue with market participants.  In valuing Non-Agency MBS, the Company understands that pricing services use observable inputs that include, in addition to trading activity observed in the marketplace, loan delinquency data, credit enhancement levels and vintage, which are taken into account to assign pricing factors such as spread and prepayment assumptions.  For tranches of Legacy Non-Agency MBS that are cross-collateralized, performance of all collateral groups involved in the tranche are considered.  The Company collects and considers current market intelligence on all major markets, including benchmark security evaluations and bid-lists from various sources, when available.

The Company’s Legacy Non-Agency MBS, RPL/NPL MBS and CRT securities are valued using various market data points as described above, which management considers directly or indirectly observable parameters.  Accordingly, these securities are classified as Level 2 in the fair value hierarchy.

Term Notes Backed by MSR Related Collateral

The Company’s valuation process for term notes backed by MSR related collateral considers a number of factors, including a comparable bond analysis performed by a third-party pricing service which involves determining a pricing spread at issuance of the term note. The pricing spread is used at each subsequent valuation date to determine an implied yield to maturity of the term note, which is used to derive an indicative market value for the security. This indicative market value is further reviewed by the Company and may be adjusted to ensure it reflects a realistic exit price at the valuation date given the structural features of these securities. At September 30, 2018, the indicative implied yields used in the valuation of these securities ranged from 4.9% to 6.2%. The weighted average indicative yield to maturity was 5.62%. Other factors taken into consideration include indicative values provided by repurchase agreement counterparties, estimated changes in fair value of the related underlying MSR collateral and the financial performance of the ultimate parent or sponsoring entity of the issuer, which has provided a guarantee that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the related underlying MSR collateral be insufficient. As this process includes significant unobservable inputs, these securities are classified as Level 3 in the fair value hierarchy.

46

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

Residential Whole Loans, at Fair Value

The Company determines the fair value of its residential whole loans held at fair value after considering valuations obtained from a third-party that specializes in providing valuations of residential mortgage loans. The valuation approach applied generally depends on whether the loan is considered performing or non-performing at the date the valuation is performed. For performing loans, estimates of fair value are derived using a discounted cash flow approach, where estimates of cash flows are determined from the scheduled payments, adjusted using forecasted prepayment, default and loss given default rates. For non-performing loans, asset liquidation cash flows are derived based on the estimated time to liquidate the loan, expected costs and home price appreciation. Estimated cash flows for both performing and non-performing loans are discounted at yields considered appropriate to arrive at a reasonable exit price for the asset. Indications of loan value such as actual trades, bids, offers and generic market color may be used in determining the appropriate discount yield. The Company’s residential whole loans held at fair value are classified as Level 3 in the fair value hierarchy.

Swaps

All of the Company’s Swaps are cleared by a central clearing house. Valuations provided by the clearing house are used for purposes of determining the fair value of the Company’s Swaps. Such valuations obtained are tested with internally developed models that apply readily observable market parameters.  As the Company’s Swaps are subject to the clearing house’s margin requirements, no credit valuation adjustment was considered necessary in determining the fair value of such instruments.  Beginning in January 2017, variation margin payments on the Company’s cleared Swaps are treated as a legal settlement of the exposure under the Swap contract. Previously such payments were treated as collateral pledged against the exposure under the Swap contract. The effect of this change is to reduce what would have otherwise been reported as fair value of the Swap. Swaps are classified as Level 2 in the fair value hierarchy.

Changes to the valuation methodologies used with respect to the Company’s financial instruments are reviewed by management to ensure any such changes result in appropriate exit price valuations.  The Company will refine its valuation methodologies as markets and products develop and pricing methodologies evolve.  The methods described above may produce fair value estimates that may not be indicative of net realizable value or reflective of future fair values.  Furthermore, while the Company believes its valuation methods are appropriate and consistent with those used by market participants, the use of different methodologies, or assumptions, to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.  The Company uses inputs that are current as of the measurement date, which may include periods of market dislocation, during which price transparency may be reduced.  The Company reviews the classification of its financial instruments within the fair value hierarchy on a quarterly basis, and management may conclude that its financial instruments should be reclassified to a different level in the future.

47

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

The following tables present the Company’s financial instruments carried at fair value on a recurring basis as of September 30, 2018 and December 31, 2017, on the consolidated balance sheets by the valuation hierarchy, as previously described:

Fair Value at September 30, 2018

(In Thousands)	Level 1		Level 2		Level 3		Total
Assets:
Agency MBS	$	—	$	2,905,490	$	—	$	2,905,490
Non-Agency MBS	—		3,334,610		—		3,334,610
CRT securities	—		538,945		—		538,945
Term notes backed by MSR related collateral	—		—		505,195		505,195
Residential whole loans, at fair value	—		—		1,449,365		1,449,365
Securities obtained and pledged as collateral	—		—		—		—
Swaps	—		22,311		—		22,311
Total assets carried at fair value	$	—	$	6,801,356	$	1,954,560	$	8,755,916
Liabilities:
Obligation to return securities obtained as collateral	$	—	$	—	$	—	$	—
Total liabilities carried at fair value	$	—	$	—	$	—	$	—

Fair Value at December 31, 2017

(In Thousands)	Level 1		Level 2		Level 3		Total
Assets:
Agency MBS	$	—	$	2,824,681	$	—	$	2,824,681
Non-Agency MBS	—		3,533,966		—		3,533,966
CRT securities	—		664,403		—		664,403
Term notes backed by MSR related collateral	—		—		381,804		381,804
Residential whole loans, at fair value	—		—		1,325,115		1,325,115
Securities obtained and pledged as collateral	504,062		—		—		504,062
Swaps	—		679		—		679
Total assets carried at fair value	$	504,062	$	7,023,729	$	1,706,919	$	9,234,710
Liabilities:
Obligation to return securities obtained as collateral	$	504,062	$	—	$	—	$	504,062
Total liabilities carried at fair value	$	504,062	$	—	$	—	$	504,062

48

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

Changes in Level 3 Assets Measured at Fair Value on a Recurring Basis

The following table presents additional information for the three and nine months ended September 30, 2018 and 2017 about the Company’s Residential whole loans, at fair value, which are classified as Level 3 and measured at fair value on a recurring basis:

	Residential Whole Loans, at Fair Value (1)
	Three Months Ended September 30,						Nine Months Ended September 30,
(In Thousands)	2018			2017			2018			2017
Balance at beginning of period	$	1,468,540		$	744,072		$	1,325,115		$	814,682
Purchases and capitalized advances (2)	76,566			284,930			393,867			295,094
Changes in fair value recorded in Net gain on residential whole loans held at fair value	8,442			5,289			26,788			12,499
Collection of principal, net of liquidation gains/losses	(54,331		)	(17,670		)	(155,199		)	(53,366		)
Repurchases	(561		)	(257		)	(1,623		)	(1,013		)
Transfer to REO	(51,089		)	(33,214		)	(141,381		)	(84,746		)
Balance at end of period	$	1,447,567		$	983,150		$	1,447,567		$	983,150

(1) Excludes approximately $1.8 million and $120.4 million of residential whole loans held at fair value for which the closing of the purchase transaction had not occurred as of September 30, 2018 and 2017, respectively.

(2) Included in the activity presented for the three and nine months ended September 30, 2018 and 2017 are approximately $34.4 million and$92.7 million of loans the Company committed to purchase during the three months ended June 30, 2018 and year ended December 31, 2017, but for which the closing of the purchase transaction occurred during the three and nine months ended September 30, 2018 and 2017, respectively.

The following table presents additional information for the three and nine months ended September 30, 2018 and 2017 about the Company’s investments in term notes backed by MSR related collateral held at fair value, which are classified as Level 3 and measured at fair value on a recurring basis:

	Term Notes Backed by MSR Related Collateral
	Three Months Ended September 30,						Nine Months Ended September 30,
(In Thousands)	2018			2017			2018			2017 (1)
Balance at beginning of period	$	381,390		$	273,961		$	381,804		$	—
Purchases	290,042			161,000			439,392			311,000
Collection of principal	(166,120		)	(123,961		)	(316,120		)	(140,980		)
Changes in unrealized gain/losses	(117		)	563			119			563
Transfers from Level 2 to Level 3 (1)	—			—			—			140,980
Balance at end of period	$	505,195		$	311,563		$	505,195		$	311,563

(1) Investments in term notes backed by MSR related collateral were transferred from Level 2 to Level 3 during the nine months endedSeptember 30, 2017 as there had been very limited secondary market trading in these securities since issuance. Transfers between levels are deemed to take place on the first day of the reporting period in which the transfer has taken place.

The Company did not transfer any assets or liabilities from one level to another during the three and nine months ended September 30, 2018 and the three months endedSeptember 30, 2017.

49

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

Fair Value Methodology for Level 3 Financial Instruments

Residential Whole Loans, at Fair Value

The following tables present a summary of quantitative information about the significant unobservable inputs used in the fair value measurement of the Company’s residential whole loans held at fair value for which it has utilized Level 3 inputs to determine fair value as of September 30, 2018 and December 31, 2017:

	September 30, 2018
(Dollars in Thousands)	Fair Value (1)		Valuation Technique	Unobservable Input	Weighted Average (2)			Range
Residential whole loans, at fair value	$	693,874	Discounted cash flow	Discount rate	5.3		%	4.5-8.0%
				Prepayment rate	3.8		%	0.0-13.5%
				Default rate	2.7		%	0.0-31.0%
				Loss severity	13.0		%	0.0-100.0%
	$	683,566	Liquidation model	Discount rate	8.2		%	6.1-50.0%
				Annual change in home prices	3.3		%	(1.0)-11.8%
				Liquidation timeline (in years)	1.8			0.1-4.5
				Current value of underlying properties (3)	$	767		$2-$7,950
Total	$	1,377,440

	December 31, 2017
(Dollars in Thousands)	Fair Value (1)		Valuation Technique	Unobservable Input	Weighted Average (2)			Range
Residential whole loans, at fair value	$	358,871	Discounted cash flow	Discount rate	5.5		%	4.5-13.0%
				Prepayment rate	4.1		%	1.15-15.1%
				Default rate	2.9		%	0.0-6.5%
				Loss severity	13.8		%	0.0-100.0%
	$	592,940	Liquidation model	Discount rate	8.0		%	6.1-50.0%
				Annual change in home prices	2.5		%	(8.0)-8.8%
				Liquidation timeline (in years)	1.6			0.1-4.5
				Current value of underlying properties (3)	$	772		$0-$9,900
Total	$	951,811

(1) Excludes approximately $70.1 million and $373.3 million of loans for which management considers the purchase price continues to reflect the fair value of such loans at September 30, 2018 and December 31, 2017, respectively.

(2) Amounts are weighted based on the fair value of the underlying loan.

(3) The simple average value of the properties underlying residential whole loans held at fair value valued via a liquidation model was approximately$378,000 and $336,000 as of September 30, 2018 and December 31, 2017, respectively.

50

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

The following table presents the carrying values and estimated fair values of the Company’s financial instruments at September 30, 2018 and December 31, 2017:

	September 30, 2018				December 31, 2017
	Carrying Value		Estimated Fair Value		Carrying Value		Estimated Fair Value
(In Thousands)
Financial Assets:
Agency MBS	$	2,905,490	$	2,905,490	$	2,824,681	$	2,824,681
Non-Agency MBS	3,334,610		3,334,610		3,533,966		3,533,966
CRT securities	538,945		538,945		664,403		664,403
MSR related assets	565,272		565,272		492,080		493,026
Residential whole loans, at carrying value	2,471,567		2,549,927		908,516		988,688
Residential whole loans, at fair value	1,449,365		1,449,365		1,325,115		1,325,115
Securities obtained and pledged as collateral	—		—		504,062		504,062
Cash and cash equivalents	104,186		104,186		449,757		449,757
Restricted cash	6,489		6,489		13,307		13,307
Swaps	22,311		22,311		679		679
Financial Liabilities (1):
Repurchase agreements	7,278,270		7,289,006		6,614,701		6,623,255
Securitized debt	714,203		713,783		363,944		366,109
Obligation to return securities obtained as collateral	—		—		504,062		504,062
Senior Notes	96,805		100,791		96,773		103,729

(1) Carrying value of securitized debt, Senior Notes and certain repurchase agreements is net of associated debt issuance costs.

In addition to the methodologies used to determine the fair value of the Company’s financial assets and liabilities reported at fair value on a recurring basis discussed on pages 45-50, the following methods and assumptions were used by the Company in arriving at the fair value of the Company’s other financial instruments presented in the above table that are not reported at fair value on a recurring basis:

Residential Whole Loans, at Carrying Value:  The Company generally determines the fair value of its residential whole loans held at carrying value using the same approach applied for residential whole loans held at fair value. Given the short duration of the Company’s Rehabilitation loans, these investments are determined to have a carrying value which approximates fair value. The Company’s residential whole loans held at carrying value are classified as Level 3 in the fair value hierarchy.

Cash and Cash Equivalents and Restricted Cash:  Cash and cash equivalents and restricted cash are comprised of cash held in overnight money market investments and demand deposit accounts.  At September 30, 2018 and December 31, 2017, the Company’s money market funds were invested in securities issued by the U.S. Government or its agencies, instrumentalities, and sponsored entities, and repurchase agreements involving the securities described above.  Given the overnight term and assessed credit risk, the Company’s investments in money market funds are determined to have a fair value equal to their carrying value.

Corporate Loans: The Company determines the fair value of its Corporate loans after considering recent past and expected future loan performance, recent financial performance of the borrower and estimates of the current value of the underlying collateral, which includes certain MSRs and other assets of the borrower that are pledged to secure the borrowing. The Company’s investment in Corporate loans are classified as Level 3 in the fair value hierarchy.

Repurchase Agreements:  The fair value of repurchase agreements reflects the present value of the contractual cash flows discounted at market interest rates at the valuation date for repurchase agreements with a term equivalent to the remaining term to interest rate repricing, which may be at maturity.  Such interest rates are estimated based on LIBOR rates observed in the market.  The Company’s repurchase agreements are classified as Level 2 in the fair value hierarchy.

51

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

Securitized Debt:  In determining the fair value of securitized debt, management considers a number of observable market data points, including prices obtained from pricing services and brokers as well as dialogue with market participants. Accordingly, the Company’s securitized debt is classified as Level 2 in the fair value hierarchy.

Senior Notes:  The fair value of the Senior Notes is determined using the end of day market price quoted on the NYSE at the reporting date.  The Company’s Senior Notes are classified as Level 1 in the fair value hierarchy.

The Company holds REO at the lower of the current carrying amount or fair value less estimated selling costs. At September 30, 2018 and December 31, 2017, the Company’s REO had an aggregate carrying value of $223.1 million and $152.4 million, and an aggregate estimated fair value of $246.0 million and $175.8 million, respectively. The Company classifies fair value measurements of REO as Level 3 in the fair value hierarchy.

15.  Use of Special Purpose Entities and Variable Interest Entities

A Special Purpose Entity (“SPE”) is an entity designed to fulfill a specific limited need of the company that organized it.  SPEs are often used to facilitate transactions that involve securitizing financial assets or resecuritizing previously securitized financial assets.  The objective of such transactions may include obtaining non-recourse financing, obtaining liquidity or refinancing the underlying financial assets on improved terms.  Securitization involves transferring assets to a SPE to convert all or a portion of those assets into cash before they would have been realized in the normal course of business, through the SPE’s issuance of debt or equity instruments.  Investors in an SPE usually have recourse only to the assets in the SPE and, depending on the overall structure of the transaction, may benefit from various forms of credit enhancement such as over-collateralization in the form of excess assets in the SPE, priority with respect to receipt of cash flows relative to holders of other debt or equity instruments issued by the SPE, or a line of credit or other form of liquidity agreement that is designed with the objective of ensuring that investors receive principal and/or interest cash flow on the investment in accordance with the terms of their investment agreement. 

The Company has entered into several financing transactions that resulted in the Company consolidating as VIEs the SPEs that were created to facilitate these transactions. See Note 2(r) for a discussion of the accounting policies applied to the consolidation of VIEs and transfers of financial assets in connection with financing transactions.

The Company has engaged in loan securitizations and in prior years, MBS resecuritization transactions, primarily for the purpose of obtaining improved overall financing terms as well as non-recourse financing on a portion of its residential whole loan and Non-Agency MBS portfolios. Notwithstanding the Company’s participation in these transactions, the risks facing the Company are largely unchanged as the Company remains economically exposed to the first loss position on the underlying assets transferred to the VIEs.

Loan Securitization Transactions

In July 2018, as part of a loan securitization transaction, the Company sold residential whole loans with an aggregate unpaid principal balance of $347.7 million to an entity that the Company consolidates as a VIE. In connection with the transaction, third-party investors purchased $236.0 million face amount of senior bonds (“Senior Bonds”) with a coupon rate of 4.164%. As a result of this transaction, the Company acquired $101.7 million face amount of non-rated certificates issued by the securitization vehicle, and received $236.0 million in cash, excluding expenses, accrued interest, and underwriting fees.

In May 2018, as part of a loan securitization transaction, the Company sold residential whole loans with an aggregate unpaid principal balance of $319.1 million to an entity that the Company consolidates as a VIE. In connection with the transaction, third-party investors purchased $184.0 million face amount of Senior Bonds with a coupon rate of 3.875%. As a result of this transaction, the Company acquired $46.4 million face amount of non-rated certificates issued by the securitization vehicle, and received $184.0 million in cash, excluding expenses, accrued interest, and underwriting fees.

52

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

The following table summarizes the key details of the loan securitization transactions the Company has been involved in to date:

(Dollars in Thousands)	September 30, 2018				December 31, 2017
Aggregate unpaid principal balance of residential whole loans sold	$	1,290,029			$	620,924
Face amount of Senior Bonds issued by the VIE and purchased by third-party investors	$	802,817			$	382,847
Outstanding amount of Senior Bonds	$	714,203		(1)	$	363,944		(1)
Weighted average fixed rate for Senior Bonds issued	3.65		%	(2)	3.14		%	(2)
Face amount of Senior Support Certificates received by the Company (3)	$	275,174			$	127,001
Cash received	$	802,815			$	382,845

(1) Net of $4.1 million and $2.3 million of deferred financing costs at September 30, 2018 and December 31, 2017, respectively.

(2) At September 30, 2018 and December 31, 2017, $604.7 million and $233.7 million, respectively, of Senior Bonds sold in securitization transactions contained a contractual coupon step-up feature whereby the coupon increases by 300 basis points at 36 months from issuance if the bond is not redeemed before such date.

(3) Provides credit support to the Senior Bonds sold to third-party investors in the securitization transactions.

As of September 30, 2018 and December 31, 2017, as a result of the transactions described above, securitized loans with a carrying value of approximately $215.1 million and $183.2 million are included in “Residential whole loans, at carrying value,” securitized loans with a fair value of approximately $723.8 million and $289.3 million are included in “Residential whole loans, at fair value,” and REO with a carrying value approximately $61.0 million and $5.5 million are included in “Other assets” on the Company’s consolidated balance sheets, respectively. As of September 30, 2018 and December 31, 2017, the aggregate carrying value of Senior Bonds issued by consolidated VIEs was $714.2 million and $363.9 million, respectively.  These Senior Bonds are disclosed as “Securitized debt” and are included in Other liabilities on the Company’s consolidated balance sheets.  The holders of the securitized debt have no recourse to the general credit of the Company, but the Company does have the obligation, under certain circumstances to repurchase assets from the VIE upon the breach of certain representations and warranties with respect to the residential whole loans sold to the VIE.  In the absence of such a breach, the Company has no obligation to provide any other explicit or implicit support to any VIE.

The Company concluded that the entities created to facilitate the loan securitization transactions are VIEs.  The Company then completed an analysis of whether each VIE created to facilitate the securitization transactions should be consolidated by the Company, based on consideration of its involvement in each VIE, including the design and purpose of the SPE, and whether its involvement reflected a controlling financial interest that resulted in the Company being deemed the primary beneficiary of each VIE.  In determining whether the Company would be considered the primary beneficiary, the following factors were assessed:

• whether the Company has both the power to direct the activities that most significantly impact the economic performance of the VIE;  and

• whether the Company has a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE.

Based on its evaluation of the factors discussed above, including its involvement in the purpose and design of the entity, the Company determined that it was required to consolidate each VIE created to facilitate the loan securitization transactions.

53

MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2018

Residential Whole Loans and REO (including Residential Whole Loans and REO transferred to consolidated VIEs)

Included on the Company’s consolidated balance sheets as of September 30, 2018 and December 31, 2017 are a total of $3.9 billion and $2.2 billion of residential whole loans, of which approximately $2.5 billion and $908.5 million are reported at carrying value and $1.4 billion and $1.3 billion are reported at fair value, respectively. In addition, at September 30, 2018 and December 31, 2017, the Company had REO with an aggregate carrying value of $223.1 million and $152.4 million, and an aggregate estimated fair value of $246.0 million and $175.8 million, respectively. The inclusion of these assets arises from the Company’s interests in certain trusts established to acquire the loans and entities established in connection with its loan securitization transactions. The Company has assessed that these entities are required to be consolidated. During the three and nine months ended September 30, 2018, the Company recognized interest income from residential whole loans reported at carrying value of approximately $29.5 million and $61.8 million, respectively. During the three and nine months ended September 30, 2017, the Company recognized interest income from residential whole loans reported at carrying value of approximately $9.0 million and $26.2 million, respectively. These amounts are included in Interest Income on the Company’s consolidated statements of operations. In addition, the Company recognized net gains on residential whole loans held at fair value during the three and nine months ended September 30, 2018 of approximately $34.9 million and $105.9 million, respectively. During the three and nine months ended September 30, 2017, the Company recognized net gains on residential whole loans held at fair value $18.7 million and $48.7 million, respectively. These amounts are included in Other Income, net on the Company’s consolidated statements of operations. (See Note 4)

54

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

In this Quarterly Report on Form 10-Q, we refer to MFA Financial, Inc. and its subsidiaries as “the Company,” “MFA,” “we,” “us,” or “our,” unless we specifically state otherwise or the context otherwise indicates.

The following discussion should be read in conjunction with our financial statements and accompanying notes included in Item 1 of this Quarterly Report on Form 10-Q as well as our Annual Report on Form 10-K for the year ended December 31, 2017.

Forward Looking Statements

When used in this Quarterly Report on Form 10-Q, in future filings with the SEC or in press releases or other written or oral communications, statements which are not historical in nature, including those containing words such as “will,” “believe,” “expect,” “anticipate,” “estimate,” “plan,” “continue,” “intend,” “should,” “could,” “would,” “may” the negative of these words or similar expressions, are intended to identify “forward-looking statements” within the meaning of Section 27A of the 1933 Act and Section 21E of the 1934 Act and, as such, may involve known and unknown risks, uncertainties and assumptions.

These forward-looking statements include information about possible or assumed future results with respect to our business, financial condition, liquidity, results of operations, plans and objectives.  Statements regarding the following subjects, among others, may be forward-looking: changes in interest rates and the market (i.e., fair) value of our MBS, residential whole loans, CRT securities and other assets; changes in the prepayment rates on residential mortgage assets, an increase of which could result in a reduction of the yield on certain investments in our portfolio and an increase of which could require us to reinvest the proceeds received by us as a result of such prepayments in investments with lower coupons; credit risks underlying our assets, including changes in the default rates and management’s assumptions regarding default rates on the mortgage loans securing our Non-Agency MBS and relating to our residential whole loan portfolio; our ability to borrow to finance our assets and the terms, including the cost, maturity and other terms, of any such borrowings; implementation of or changes in government regulations or programs affecting our business; our estimates regarding taxable income the actual amount of which is dependent on a number of factors, including, but not limited to, changes in the amount of interest income and financing costs, the method elected by us to accrete the market discount on Non-Agency MBS and residential whole loans and the extent of prepayments, realized losses and changes in the composition of our Agency MBS, Non-Agency MBS and residential whole loan portfolios that may occur during the applicable tax period, including gain or loss on any MBS disposals and whole loan modifications, foreclosures and liquidations; the timing and amount of distributions to stockholders, which are declared and paid at the discretion of our Board and will depend on, among other things, our taxable income, our financial results and overall financial condition and liquidity, maintenance of our REIT qualification and such other factors as the Board deems relevant; our ability to maintain our qualification as a REIT for federal income tax purposes; our ability to maintain our exemption from registration under the Investment Company Act of 1940, as amended (or the Investment Company Act), including statements regarding the concept release issued by the SEC relating to interpretive issues under the Investment Company Act with respect to the status under the Investment Company Act of certain companies that are engaged in the business of acquiring mortgages and mortgage-related interests; our ability to continue growing our residential whole loan portfolio, which is dependent on, among other things, the supply of loans offered for sale in the market; expected returns on our investments in nonperforming residential whole loans (or NPLs), which are affected by, among other things, the length of time required to foreclose upon, sell, liquidate or otherwise reach a resolution of the property underlying the NPL, home price values, amounts advanced to carry the asset (e.g., taxes, insurance, maintenance expenses, etc. on the underlying property) and the amount ultimately realized upon resolution of the asset; targeted or expected returns on our investments in recently-originated loans, the performance of which is, similar to our other mortgage loan investments, subject to, among other things, prepayment risk, credit risk and financing cost associated with such investments; risks associated with our investments in MSR related assets, including servicing, regulatory and economic risks, and risks associated with investing in real estate assets, including changes in business conditions and the general economy.  These and other risks, uncertainties and factors, including those described in the annual, quarterly and current reports that we file with the SEC, could cause our actual results to differ materially from those projected in any forward-looking statements we make.  All forward-looking statements are based on beliefs, assumptions and expectations of our future performance, taking into account all information currently available.  Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made.  New risks and uncertainties arise over time and it is not possible to predict those events or how they may affect us.  Except as required by law, we are not obligated to, and do not intend to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

55

Business/General

We are a REIT primarily engaged in the business of investing, on a leveraged basis, in residential mortgage assets, including Agency MBS, Non-Agency MBS, residential whole loans, CRT securities and MSR related assets.  Our principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. We selectively invest in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return.

At September 30, 2018, we had total assets of approximately $11.8 billion, of which $6.2 billion, or 53.0%, represented our MBS portfolio.  At such date, our MBS portfolio was comprised of $2.9 billion of Agency MBS and $3.3 billion of Non-Agency MBS, which includes $2.2 billion of Legacy Non-Agency MBS and $1.2 billion of RPL/NPL MBS that are primarily structured with a contractual coupon step-up feature where the coupon increases from 300 - 400 basis points at 36 - 48 months from issuance or sooner. These RPL/NPL MBS are primarily backed by securitized re-performing and non-performing loans. In addition, at September 30, 2018, we had approximately $3.9 billion in residential whole loans acquired through interests in certain trusts established to acquire the loans, which represented approximately 33% of our total assets. During the third quarter of 2018 we continued to experience growth in our residential whole loan portfolio, which has been our fasting growing asset class over the last several quarters. In particular during the third quarter, our growth in this asset class was primarily through purchases or commitments to purchase newly or previously originated performing loans. Such loans, which as of September 30, 2018 comprise approximately 40% of our residential whole loans, include : (i) loans to finance (or refinance) one-to-four family residential properties and are not considered to meet the definition of a “Qualified Mortgage” in accordance with guidelines adopted by the Consumer Financial Protection Bureau (or Non-QM loans), (ii) short-term business purpose loans collateralized by residential properties made to non-occupant borrowers who intend to rehabilitate and sell the property for a profit (or Rehabilitation loans or Fix and Flip loans), (iii) loans to finance (or refinance) non-owner occupied one-to-four family residential properties that are rented to one or more tenants (or Single-family rental loans), and (iv) previously originated loans secured by residential real estate that is generally owner occupied (or Seasoned performing loans). Our remaining investment-related assets were primarily comprised of MSR related assets, CRT securities, cash and cash equivalents (including restricted cash), REO and MBS and loan-related receivables.

The results of our business operations are affected by a number of factors, many of which are beyond our control, and primarily depend on, among other things, the level of our net interest income, the market value of our assets, which is driven by numerous factors, including the supply and demand for residential mortgage assets in the marketplace, the terms and availability of adequate financing, general economic and real estate conditions (both on a national and local level), the impact of government actions in the real estate and mortgage sector, and the credit performance of our credit sensitive residential mortgage assets.  In recent periods, the impact on our results from changes in market values of certain financial instruments for which changes in fair value are recorded in net income each period, such as certain residential whole loans, Agency MBS, CRT securities and Swaps not designated as hedges, has increased. Our net interest income varies primarily as a result of changes in interest rates, the slope of the yield curve (i.e., the differential between long-term and short-term interest rates), borrowing costs (i.e., our interest expense) and prepayment speeds on our MBS, the behavior of which involves various risks and uncertainties.  Interest rates and conditional prepayment rates (or CPRs) (which measure the amount of unscheduled principal prepayment on a bond as a percentage of the bond balance), vary according to the type of investment, conditions in the financial markets, competition and other factors, none of which can be predicted with any certainty.

With respect to our business operations, increases in interest rates, in general, may over time cause:  (i) the interest expense associated with our borrowings to increase; (ii) the value of our residential mortgage assets and, correspondingly, our stockholders’ equity to decline; (iii) coupons on our adjustable rate assets to reset, on a delayed basis, to higher interest rates; (iv) prepayments on our assets to decline, thereby slowing the amortization of purchase premiums and the accretion of our purchase discounts; and (v) the value of our derivative hedging instruments and, correspondingly, our stockholders’ equity to increase.  Conversely, decreases in interest rates, in general, may over time cause:  (i) the interest expense associated with our borrowings to decrease; (ii) the value of our residential mortgage assets and, correspondingly, our stockholders’ equity to increase; (iii) coupons on our adjustable rate assets to reset, on a delayed basis, to lower interest rates; (iv) prepayments on assets to increase, thereby accelerating the amortization of purchase premiums and the accretion of our purchase discounts; and (v) the value of our derivative hedging instruments and, correspondingly, our stockholders’ equity to decrease.  In addition, our borrowing costs and credit lines are further affected by the type of collateral we pledge and general conditions in the credit market.

Our investments in residential mortgage assets expose us to credit risk, generally meaning that we are subject to credit losses due to the risk of delinquency, default and foreclosure on the underlying real estate collateral. We believe the discounted purchase prices paid on certain of these investments mitigate our risk of loss in the event that, as we expect on most such investments, we receive less than 100% of the par value of these investments.  Our investment process for credit sensitive assets focuses primarily on quantifying and pricing credit risk. 

56

Premiums arise when we acquire an MBS or loan at a price in excess of the aggregate principal balance of the mortgages securing the MBS (i.e., par value) or when we acquire residential whole loans at a price in excess of their aggregate principal balance.  Conversely, discounts arise when we acquire an MBS or loan at a price below the aggregate principal balance of the mortgages securing the MBS or when we acquire residential whole loans at a price below their aggregate principal balance.  Premiums paid are amortized against interest income and accretable purchase discounts on these investments are accreted to interest income.  Purchase premiums, which are primarily carried on our Agency MBS, certain CRT securities and Non-QM loans, are amortized against interest income over the life of the investment using the effective yield method, adjusted for actual prepayment activity.  An increase in the prepayment rate, as measured by the CPR, will typically accelerate the amortization of purchase premiums, thereby reducing the interest income earned on these assets. 

CPR levels are impacted by, among other things, conditions in the housing market, new regulations, government and private sector initiatives, interest rates, availability of credit to home borrowers, underwriting standards and the economy in general.  In particular, CPR reflects the conditional repayment rate (or CRR), which measures voluntary prepayments of mortgages collateralizing a particular MBS, and the conditional default rate (or CDR), which measures involuntary prepayments resulting from defaults.  CPRs on Agency MBS and Legacy Non-Agency MBS may differ significantly.  For the three months ended September 30, 2018, our Agency MBS portfolio experienced a weighted average CPR of 16.8%, and our Legacy Non-Agency MBS portfolio experienced a weighted average CPR of 16.8%. Over the last consecutive eight quarters, ending with September 30, 2018, the monthly weighted average CPR on our Agency and Legacy Non-Agency MBS portfolios ranged from a high of 18.4% experienced during the month ended July 31, 2017 to a low of 13.5%, experienced during the month ended March 31, 2018, with an average CPR over such quarters of 16.2%.

Our method of accounting for Non-Agency MBS purchased at significant discounts to par value requires us to make assumptions with respect to each security.  These assumptions include, but are not limited to, future interest rates, voluntary prepayment rates, default rates, mortgage modifications and loss severities.  As part of our Non-Agency MBS surveillance process, we track and compare each security’s actual performance over time to the performance expected at the time of purchase or, if we have modified our original purchase assumptions, to our revised performance expectations.  To the extent that actual performance or our expectation of future performance of our Non-Agency MBS deviates materially from our expected performance parameters, we may revise our performance expectations, such that the amount of purchase discount designated as credit discount may be increased or decreased over time.  Nevertheless, credit losses greater than those anticipated or in excess of the recorded purchase discount could occur, which could materially adversely impact our operating results.

It is our business strategy to hold our residential mortgage assets as long-term investments.  On at least a quarterly basis, excluding investments for which the fair value option has been elected or for which specialized loan accounting is otherwise applied, we assess our ability and intent to continue to hold each asset and, as part of this process, we monitor our MBS, CRT securities and MSR related assets that are designated as AFS for OTTI. A change in our ability and/or intent to continue to hold any of these securities that are in an unrealized loss position, or a deterioration in the underlying characteristics of these securities, could result in our recognizing future impairment charges or a loss upon the sale of any such security.  At September 30, 2018, we had net unrealized gains on our Non-Agency MBS of $548.8 million, comprised of gross unrealized gains of $550.9 million and gross unrealized losses of $2.1 million, and net unrealized losses of $50.4 million on our Agency MBS, comprised of gross unrealized losses of $66.1 million and gross unrealized gains of $15.7 million. At September 30, 2018, we did not intend to sell any securities in our portfolio that are designated as AFS and that were in an unrealized loss position, and we believe it is more likely than not that we will not be required to sell those securities before recovery of their amortized cost basis, which may be at their maturity.

We rely primarily on borrowings under repurchase agreements to finance our residential mortgage assets.  Our residential mortgage investments have longer-term contractual maturities than our borrowings under repurchase agreements.  Even though the majority of our investments have interest rates that adjust over time based on short-term changes in corresponding interest rate indices (typically following an initial fixed-rate period for our Hybrids), the interest rates we pay on our borrowings will typically change at a faster pace than the interest rates we earn on our investments.  In order to reduce this interest rate risk exposure, we may enter into derivative instruments, which at September 30, 2018 were comprised of Swaps.

The majority of our Swap derivative instruments are designated as cash-flow hedges against a portion of our current and forecasted LIBOR-based repurchase agreements.  While these Swaps do not extend the maturities of the associated repurchase agreement being hedged; they do, however, lock in a fixed rate of interest over their term for the notional amount of the Swap corresponding to the hedged item.

57

Recent Market Conditions and Our Strategy

At September 30, 2018, our residential mortgage asset portfolio, which includes MBS, residential whole loans and REO, CRT securities and MSR related assets was approximately $11.5 billion compared to $10.2 billion at June 30, 2018. For the remainder of 2018 we expect to continue to seek investment opportunities primarily focused on residential whole loans, as well as RPL/NPL MBS and MSR related assets as market opportunities arise.

The following table presents the activity for our residential mortgage asset portfolio for the three months endedSeptember 30, 2018:

(In Millions)	June 30, 2018		Runoff (1)			Acquisitions		Other (2)			September 30, 2018		Change
Residential whole loans and REO	$	3,601	$	(188	)	$	707	$	24		$	4,144	$	543
RPL/NPL MBS	909		(192		)	446		(1		)	1,162		253
MSR related assets	381		(166		)	350		—			565		184
CRT securities	571		(3		)	84		(113		)	539		(32		)
Legacy Non-Agency MBS	2,335		(145		)	2		(19		)	2,173		(162		)
Agency MBS	2,363		(192		)	758		(24		)	2,905		542
Totals	$	10,160	$	(886	)	$	2,347	$	(133	)	$	11,488	$	1,328

(1) Primarily includes principal repayments, cash collections on purchased credit impaired loans and sales of REO.

(2) Primarily includes sales, changes in fair value, net premium amortization/discount accretion and adjustments to record lower of cost or estimated fair value adjustments on REO. During the three months ended September 30, 2018, we sold certain CRT securities for $118.9 million, realizing gains of $13.0 million and sold certain Non-Agency MBS for $24.3 million, realizing gains of $3.4 million.

At September 30, 2018, our total recorded investment in residential whole loans and REO was $4.1 billion, or 36.1% of our residential mortgage asset portfolio. Of this amount, (i) $2.5 billion is presented as Residential whole loans, at carrying value (of which $825.6 million were purchased credit impaired loans and $1.6 billion were other loans held at carrying value), and (ii) $1.4 billion as Residential whole loans, at fair value, in our consolidated balance sheets. For the three months ended September 30, 2018, we recognized approximately $29.5 million of income on residential whole loans held at carrying value in Interest Income on our consolidated statements of operations, representing an effective yield of 5.89% (excluding servicing costs). In addition, we recorded a net gain on residential whole loans held at fair value of $34.9 million in Other Income, net in our consolidated statements of operations for the three months ended September 30, 2018. At September 30, 2018 and June 30, 2018, we had REO with an aggregate carrying value of $223.1 million and $192.2 million, respectively, which is included in Other assets on our consolidated balance sheets.

At the end of the third quarter of 2018, the average coupon on mortgages underlying our Agency MBS was higher compared to the end of the third quarter of 2017, due to upward resets on securities within the portfolio, purchases of higher yielding Agency MBS and the impact of the removal from the portfolio of Agency MBS sold during 2018.  As a result, the coupon yield on our Agency MBS portfolio increased to 3.32% for the three months ended September 30, 2018, from 2.98% for the three months ended September 30, 2017, and the net Agency MBS yield increased to 2.21% for the three months ended September 30, 2018 from 1.97% for the three months ended September 30, 2017. The net yield for our Legacy Non-Agency MBS portfolio was 10.76% for the three months ended September 30, 2018 compared to 8.93% for the three months ended September 30, 2017.  The increase in the net yield on our Legacy Non-Agency MBS portfolio reflects the improved performance of loans underlying the Legacy Non-Agency MBS portfolio, which has resulted in credit reserve releases and changes in interest rates since the third quarter of the prior year, higher accretion income recognized in the current quarter due to the impact of redemptions of certain securities that had been previously purchased at a discount as well as the impact of the cash proceeds received during 2018 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by JP Morgan Chase & Co. and affiliated entities. The net yield for our RPL/NPL MBS portfolio was 5.01% for the three months ended September 30, 2018 compared to 4.43% for the three months ended September 30, 2017.  The increase in the net yield reflects an increase in the average coupon yield to 4.56% for the three months ended September 30, 2018 from 4.24% for the three months ended September 30, 2017 and higher accretion income recognized in the current quarter due to the impact of redemptions of certain securities that had been previously purchased at a discount.

We believe that our $531.8 million Credit Reserve and OTTI appropriately factors in remaining uncertainties regarding underlying mortgage performance and the potential impact on future cash flows for our existing Legacy Non-Agency MBS portfolio.  In addition, while the majority of our Legacy Non-Agency MBS will not return their full face value due to loan defaults, we believe that they will deliver attractive loss adjusted yields due to our discounted amortized cost of 69% of face value at September 30, 2018. Home price appreciation and underlying mortgage loan amortization have decreased the LTV for many of

58

the mortgages underlying our Legacy Non-Agency portfolio. Home price appreciation during the past few years has generally been driven by a combination of limited housing supply due partly to low levels of new home construction, low mortgage rates and demographic-driven U.S. household formation. Lower LTVs lessen the likelihood of defaults and simultaneously decrease loss severities. Further, during 2017 and the nine months ended September 30, 2018, we have also observed faster voluntary prepayment (i.e., prepayment of loans in full with no loss) speeds than originally projected. The yields on our Legacy Non-Agency MBS that were purchased at a discount are generally positively impacted if prepayment rates on these securities exceed our prepayment assumptions. Based on these current conditions, we have reduced estimated future losses within our Legacy Non-Agency portfolio. As a result, during the three months ended September 30, 2018, $10.2 million was transferred from Credit Reserve to accretable discount.  This increase in accretable discount is expected to increase the interest income realized over the remaining life of our Legacy Non-Agency MBS. We believe that the majority of the impact on interest income from the reduction in Credit Reserve will occur over the next ten years.

Our book value per common share was $7.46 as of September 30, 2018, a decline from book value per common share of $7.54 as of June 30, 2018. This decrease was primarily due to lower unrealized gains on Legacy Non-Agency MBS and higher unrealized losses on Agency MBS, which were partially offset by an increase in the fair value of Swaps.

During the three months ended September 30, 2018, we issued approximately 50.9 million shares of common stock in a public offering, generating net proceeds of approximately $389.4 million. While the majority of proceeds raised have been deployed by the end of the quarter primarily through purchases of additional mortgage related assets, we expect to continue to focus on optimizing our capital structure through the use of leverage as we pursue additional investment opportunities going forward.

Repurchase agreement funding for our residential mortgage investments continued to be available to us from multiple counterparties during the third quarter of 2018.  Typically, repurchase agreement funding involving credit-sensitive investments is available at terms requiring higher collateralization and higher interest rates than for repurchase agreement funding involving Agency MBS.  At September 30, 2018, our debt consisted of borrowings under repurchase agreements with 28 counterparties, securitized debt, Senior Notes outstanding and payable for unsettled purchases, resulting in a debt-to-equity multiple of 2.3 times.  (See table on page 76 under Results of Operations that presents our quarterly leverage multiples since September 30, 2017.)

In July 2018, as part of a loan securitization transaction, we sold residential whole loans with an aggregate unpaid principal balance of $347.7 million to an entity that we consolidate as a VIE. In connection with the transaction, third-party investors purchased $236.0 million face amount of senior bonds with a coupon rate of 4.1637%. As a result of this transaction, we acquired $101.7 million face amount of non-rated certificates issued by the securitization vehicle, and received $236.0 million in cash, excluding expenses, accrued interest, and underwriting fees.

At September 30, 2018, we have access to various sources of liquidity which we estimate to be in excess of $412.1 million. This amount includes (i) $104.2 million of cash and cash equivalents; (ii) $188.2 million in estimated financing available from unpledged Agency MBS and from other Agency MBS collateral that is currently pledged in excess of contractual requirements; and (iii) $119.7 million in estimated financing available from unpledged Non-Agency MBS and from other Non-Agency MBS and CRT collateral that is currently pledged in excess of contractual requirements. Our sources of liquidity do not include restricted cash. In addition, we have $1.1 billion of unencumbered residential whole loans. We are evaluating potential opportunities to finance these assets including loan securitization. With access to multiple sources of liquidity and potential financing opportunities for unencumbered residential whole loans, we believe that we are positioned to continue to take advantage of investment opportunities within the residential mortgage marketplace. 

59

Information About Our Assets

The table below presents certain information about our asset allocation at September 30, 2018:

ASSET ALLOCATION

	Agency MBS			Legacy Non-Agency MBS			RPL/NPL MBS (1)			Credit Risk Transfer Securities			MSR Related Assets			Residential Whole Loans, at Carrying Value (2)			Residential Whole Loans, at Fair Value			Other, net (3)			Total
(Dollars in Millions)
Fair Value/Carrying Value	$	2,905		$	2,173		$	1,162		$	539		$	565		$	2,472		$	1,449		$	387		$	11,652
Less Payable for Unsettled Purchases	—			(2		)	—			—			—			(7		)	(2		)	—			(11		)
Less Repurchase Agreements	(2,584		)	(1,592		)	(913		)	(405		)	(436		)	(893		)	(455		)	—			(7,278		)
Less Securitized Debt	—			—			—			—			—			(173		)	(541		)	—			(714		)
Less Senior Notes	—			—			—			—			—			—			—			(97		)	(97		)
Net Equity Allocated	$	321		$	579		$	249		$	134		$	129		$	1,399		$	451		$	290		$	3,552
Debt/Net Equity Ratio (4)	8.0		x	2.8		x	3.7		x	3.0		x	3.4		x	0.8		x	2.2		x				2.3		x

(1) RPL/NPL MBS are backed primarily by securitized re-performing and non-performing loans. The securities are primarily structured such that the coupon increases from 300 - 400 basis points at 36 - 48 months from issuance or sooner. Included with the balance of Non-Agency MBS reported on our consolidated balance sheets.

(2) Includes $825.6 million of purchased credit impaired loans, $989.8 million of Non-QM loans, $329.3 million of Rehabilitation loans, $79.7 million of Single-family rental loans and $247.1 million of Seasoned performing loans. At September 30, 2018, the total fair value of these loans is estimated to be approximately $2.5 billion.

(3) Includes cash and cash equivalents and restricted cash, other assets and other liabilities.     

(4) Represents the sum of borrowings under repurchase agreements, securitized debt and payable for unsettled purchases as a multiple of net equity allocated.  The numerator of our Total Debt/Net Equity Ratio also includes Senior Notes.

60

Agency MBS

The following table presents certain information regarding the composition of our Agency MBS portfolio as of September 30, 2018 and December 31, 2017:

September 30, 2018

(Dollars in Thousands)	Current Face		Weighted Average Purchase Price		Weighted Average Market Price		Fair Value (1)		Weighted Average Loan Age (Months) (2)	Weighted Average Coupon (2)		3 Month Average CPR
15-Year Fixed Rate:
Low Loan Balance (3)	$	732,119	104.4	%	98.9	%	$	724,409	77	2.98	%	11.5	%
Generic	141,324		104.4		100.4		141,937		85	3.51		11.8
Total 15-Year Fixed Rate	$	873,443	104.4	%	99.2	%	$	866,346	78	3.06	%	11.5	%
30-Year Fixed Rate:
Generic	$	723,041	104.0	%	103.3	%	$	746,658	3	4.50	%	8.7	%
Total 30-Year Fixed Rate	$	723,041	104.0	%	103.3	%	$	746,658	3	4.50	%	8.7	%
Hybrid	$	1,183,989	103.5	%	103.6	%	$	1,226,396	104	3.70	%	22.0	%
CMO/Other	$	63,835	102.5	%	102.8	%	$	65,652	207	3.84	%	13.7	%
Total Portfolio	$	2,844,308	103.9	%	102.1	%	$	2,905,052	73	3.71	%	16.8	%

December 31, 2017

(Dollars in Thousands)	Current Face		Weighted Average Purchase Price		Weighted Average Market Price		Fair Value (1)		Weighted Average Loan Age (Months) (2)	Weighted Average Coupon (2)		3 Month Average CPR
15-Year Fixed Rate:
Low Loan Balance (3)	$	948,225	104.3	%	101.7	%	$	964,373	67	2.95	%	10.3	%
Generic	172,862		104.4		103.1		178,210		76	3.51		9.3
Total 15-Year Fixed Rate	$	1,121,087	104.3	%	101.9	%	$	1,142,583	68	3.04	%	10.2	%
Hybrid	$	1,540,431	103.5	%	103.9	%	$	1,601,107	96	3.27	%	17.1	%
CMO/Other	$	76,944	102.5	%	102.8	%	$	79,100	198	3.22	%	9.9	%
Total Portfolio	$	2,738,462	103.8	%	103.1	%	$	2,822,790	88	3.17	%	14.1	%

(1) Does not include principal payments receivable of $438,000 and $1.9 million at September 30, 2018 and December 31, 2017, respectively.

(2) Weighted average is based on MBS current face at September 30, 2018 and December 31, 2017, respectively.

(3) Low loan balance represents MBS collateralized by mortgages with an original loan balance of less than or equal to $175,000.

61

The following table presents certain information regarding our fixed-rate Agency MBS as of September 30, 2018 and December 31, 2017:

September 30, 2018

Coupon	Current Face		Weighted Average Purchase Price		Weighted Average Market Price		Fair Value (1)		Weighted Average Loan Age (Months) (2)	Weighted Average Loan Rate		Low Loan Balance and/or HARP (3)		3 Month Average CPR
(Dollars in Thousands)
15-Year Fixed Rate:
2.5%	$	425,636	104.1	%	97.5	%	$	414,790	70	3.02	%	100	%	9.9	%
3.0%	195,769		105.9		99.2		194,183		74	3.49		100		12.7
3.5%	4,080		103.5		100.7		4,106		95	4.17		100		14.0
4.0%	213,626		103.5		102.1		218,066		94	4.40		81		13.8
4.5%	34,332		105.3		102.5		35,201		98	4.88		34		9.9
Total 15-Year Fixed Rate	$	873,443	104.4	%	99.2	%	$	866,346	78	3.54	%	93	%	11.5	%
30-Year Fixed Rate:
4.5%	$	723,041	104.0	%	103.3	%	$	746,658	3	5.17	%	—	%	8.7	%
Total 30-Year Fixed Rate	$	723,041	104.0	%	103.3	%	$	746,658	3	5.17	%	—	%	8.7	%
Total Fixed Rate Portfolio	$	1,596,484	104.2	%	101.0	%	$	1,613,004	44	4.28	%	51	%	11.0	%

December 31, 2017

Coupon	Current Face		Weighted Average Purchase Price		Weighted Average Market Price		Fair Value (1)		Weighted Average Loan Age (Months) (2)	Weighted Average Loan Rate		Low Loan Balance and/or HARP (3)		3 Month Average CPR
(Dollars in Thousands)
15-Year Fixed Rate:
2.5%	$	579,002	104.0	%	100.5	%	$	581,867	60	3.04	%	100	%	9.3	%
3.0%	231,325		105.9		102.2		236,316		66	3.49		100		9.5
3.5%	5,403		103.5		103.4		5,586		86	4.18		100		23.0
4.0%	263,447		103.5		104.3		274,783		85	4.40		80		12.4
4.5%	41,910		105.2		105.1		44,031		89	4.88		34		10.2
Total 15-Year Fixed Rate	$	1,121,087	104.3	%	101.9	%	$	1,142,583	68	3.52	%	93	%	10.2	%

(1) Does not include principal payments receivable of $438,000 and $1.9 million at September 30, 2018 and December 31, 2017, respectively.

(2) Weighted average is based on MBS current face at September 30, 2018 and December 31, 2017, respectively.

(3) Low Loan Balance represents MBS collateralized by mortgages with an original loan balance less than or equal to $175,000.  Home Affordable Refinance Program (or HARP) MBS are backed by refinanced loans with LTVs greater than or equal to 80% at origination.

62

The following table presents certain information regarding our Hybrid Agency MBS as of September 30, 2018 and December 31, 2017:

September 30, 2018

(Dollars in Thousands)	Current Face		Weighted Average Purchase Price		Weighted Average Market Price		Fair Value (1)		Weighted Average Coupon (2)		Weighted Average Loan Age (Months) (2)	Weighted Average Months to Reset (3)	Interest Only (4)		3 Month Average CPR
Hybrid
Agency 3/1	$	71,402	102.6	%	105.0	%	$	74,952	3.99	%	148	5	—	%	15.2	%
Agency 5/1	$	506,821	103.3	%	104.5	%	$	529,421	4.07	%	115	6	15	%	23.4	%
Agency 7/1	436,654		103.7		103.5		452,069		3.42		93	8	20		25.0
Agency 10/1	169,112		104.3		100.5		169,954		3.18		84	38	59		12.3
Total Hybrids	$	1,183,989	103.5	%	103.6	%	$	1,226,396	3.70	%	104	11	22	%	22.0	%

December 31, 2017

(Dollars in Thousands)	Current Face		Weighted Average Purchase Price		Weighted Average Market Price		Fair Value (1)		Weighted Average Coupon (2)		Weighted Average Loan Age (Months) (2)	Weighted Average Months to Reset (3)	Interest Only (4)		3 Month Average CPR
Hybrid
Agency 3/1	$	92,790	102.5	%	104.9	%	$	97,314	3.44	%	138	6	8	%	16.8	%
Agency 5/1	$	661,581	103.3	%	104.5	%	$	691,660	3.45	%	107	5	23	%	17.5	%
Agency 7/1	589,843		103.6		103.6		611,207		3.06		84	11	28		18.4
Agency 10/1	196,217		104.2		102.4		200,926		3.16		75	46	57		12.0
Total Hybrids	$	1,540,431	103.5	%	103.9	%	$	1,601,107	3.27	%	96	13	28	%	17.1	%

(1) Does not include principal payments receivable of $438,000 and $1.9 million at September 30, 2018 and December 31, 2017, respectively.

(2) Weighted average is based on MBS current face at September 30, 2018 and December 31, 2017, respectively.

(3) Weighted average months to reset is the number of months remaining before the coupon interest rate resets.  At reset, the MBS coupon will adjust based upon the underlying benchmark interest rate index, margin and periodic or lifetime caps.  The months to reset do not reflect scheduled amortization or prepayments.

(4) Interest only represents MBS backed by mortgages currently in their interest-only period.  Percentage is based on MBS current face at September 30, 2018 and December 31, 2017, respectively.

63

Non-Agency MBS

The following table presents information with respect to our Non-Agency MBS at September 30, 2018 and December 31, 2017:

(In Thousands)	September 30, 2018				December 31, 2017
Non-Agency MBS
Face/Par	$	3,509,289			$	3,718,743
Fair Value	3,334,610				3,533,966
Amortized Cost	2,785,828				2,910,241
Purchase Discount Designated as Credit Reserve and OTTI	(531,757		)	(1)	(593,227		)	(2)
Purchase Discount Designated as Accretable	(191,745		)		(215,325		)
Purchase Premiums	41				50

(1) Includes discount designated as Credit Reserve of $519.6 million and OTTI of $12.2 million.

(2) Includes discount designated as Credit Reserve of $579.0 million and OTTI of $14.2 million.

Purchase Discounts on Non-Agency MBS

The following table presents the changes in the components of purchase discount on Non-Agency MBS with respect to purchase discount designated as Credit Reserve and OTTI, and accretable purchase discount, for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30, 2018						Three Months Ended   September 30, 2017
(In Thousands)	Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)			Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)
Balance at beginning of period	$	(553,596	)	$	(202,248	)	$	(626,498	)	$	(257,967	)
Impact of RMBS Issuer Settlement (2)	—			(2,734		)	—			—
Accretion of discount	—			20,115			—			18,621
Realized credit losses	12,042			—			13,982			—
Purchases	(1,975		)	1,368			—			(1,929		)
Sales	1,552			1,974			4,620			11,244
Transfers/release of credit reserve	10,220			(10,220		)	14,762			(14,762		)
Balance at end of period	$	(531,757	)	$	(191,745	)	$	(593,134	)	$	(244,793	)

	Nine Months Ended   September 30, 2018						Nine Months Ended   September 30, 2017
(In Thousands)	Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)			Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)
Balance at beginning of period	$	(593,227	)	$	(215,325	)	$	(694,241	)	$	(278,191	)
Impact of RMBS Issuer Settlement (2)(3)	—			(14,822		)	—			—
Accretion of discount	—			54,860			—			60,461
Realized credit losses	31,443			—			39,445			—
Purchases	(2,510		)	1,856			(484		)	(3,449		)
Sales	7,144			7,079			29,398			10,166
Net impairment losses recognized in earnings	—			—			(1,032		)	—
Transfers/release of credit reserve	25,393			(25,393		)	33,780			(33,780		)
Balance at end of period	$	(531,757	)	$	(191,745	)	$	(593,134	)	$	(244,793	)

(1) Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security.

(2) Includes the impact of approximately $2.7 million of cash proceeds (a one-time payment) received by the Company during the three and nine months ended September 30, 2018 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by Lehman Brothers Holdings Inc.

(3) Includes the impact of approximately $12.1 million of cash proceeds (a one-time payment) received by the Company during the nine months ended September 30, 2018 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by JP Morgan Chase & Co. and affiliated entities.

64

The following table presents information with respect to the yield components of our Non-Agency MBS for the three months endedSeptember 30, 2018 and 2017:

	Three Months Ended September 30, 2018				Three Months Ended September 30, 2017
	Legacy Non-Agency MBS		RPL/NPL MBS		Legacy Non-Agency MBS		RPL/NPL MBS
Non-Agency MBS
Coupon Yield (1)	6.32	%	4.56	%	5.63	%	4.24	%
Effective Yield Adjustment (2)	4.44		0.45		3.30		0.19
Net Yield	10.76	%	5.01	%	8.93	%	4.43	%

(1) Reflects the annualized coupon interest income divided by the average amortized cost.  The discounted purchase price on Legacy Non-Agency MBS causes the coupon yield to be higher than the pass-through coupon interest rate.

(2) The effective yield adjustment is the difference between the net yield, calculated utilizing management’s estimates of timing and amount of future cash flows for Legacy Non-Agency MBS and RPL/NPL MBS, less the current coupon yield.

Actual maturities of MBS are generally shorter than stated contractual maturities because actual maturities of MBS are affected by the contractual lives of the underlying mortgage loans, periodic payments of principal and prepayments of principal.  The following table presents certain information regarding the amortized costs, weighted average yields and contractual maturities of our MBS at September 30, 2018 and does not reflect the effect of prepayments or scheduled principal amortization on our MBS:

	Within One Year				One to Five Years				Five to Ten Years				Over Ten Years				Total MBS
(Dollars in Thousands)	Amortized Cost		Weighted Average Yield		Amortized Cost		Weighted Average Yield		Amortized Cost		Weighted Average Yield		Amortized Cost		Weighted Average Yield		Total Amortized Cost		Total Fair Value		Weighted Average Yield
Agency MBS:
Fannie Mae	$	—	—	%	$	43	1.95	%	$	530,680	1.97	%	$	1,391,577	2.20	%	$	1,922,300	$	1,896,739	2.13	%
Freddie Mac	—		—		—		—		382,608		1.79		645,845		4.29		1,028,453		1,003,583		3.36
Ginnie Mae	—		—		—		—		89		3.31		5,031		2.99		5,120		5,168		3.00
Total Agency MBS	$	—	—	%	$	43	1.95	%	$	913,377	1.90	%	$	2,042,453	2.86	%	$	2,955,873	$	2,905,490	2.56	%
Non-Agency MBS	$	—	—	%	$	312,399	4.25	%	$	2,554	4.50	%	$	2,470,875	8.54	%	$	2,785,828	$	3,334,610	8.05	%
Total MBS	$	—	—	%	$	312,442	4.25	%	$	915,931	1.91	%	$	4,513,328	5.97	%	$	5,741,701	$	6,240,100	5.23	%

CRT Securities

At September 30, 2018, our total investment in CRT securities was $538.9 million, with a net unrealized gain of $34.2 million, a weighted average yield of 5.75% and a weighted average time to maturity of 10.6 years. At December 31, 2017, our total investment in CRT securities was $664.4 million, with a net unrealized gain of $56.3 million, a weighted average yield of 6.02% and weighted average time to maturity of 9.2 years.

65

Residential Whole Loans

The following table presents the contractual maturities of our residential whole loans held by consolidated trusts and certain entities established in connection with our loan securitization transactions at September 30, 2018 and does not reflect estimates of prepayments or scheduled amortization. For purchased credit impaired loans held at carrying value, amounts presented are estimated based on the underlying loan contractual amounts.

(In Thousands)	Purchased Credit Impaired Loans, at Carrying Value		Other Loans, at Carrying Value (1)		Residential Whole Loans, at Fair Value (1)
Amount due:
Within one year	$	604	$	270,163	$	8,769
After one year:
Over one to five years	4,421		61,462		9,848
Over five years	820,589		1,307,555		1,428,950
Total due after one year	$	825,010	$	1,369,017	$	1,438,798
Total residential whole loans	$	825,614	$	1,639,180	$	1,447,567

(1) Excludes approximately $6.8 million of other loans held at carrying value and $1.8 million of residential whole loans held at fair value for which the closing of the purchase transaction had not occurred as of September 30, 2018.

The following table presents, at September 30, 2018, the dollar amount of certain of our residential whole loans contractually maturing after one year, and indicates whether the loans have fixed interest rates or adjustable interest rates:

(In Thousands)	Other Loans, at Carrying Value (1)(2)		Residential Whole Loans, at Fair Value (1)(2)
Interest rates:
Fixed	$	301,687	$	819,414
Adjustable	1,067,330		619,384
Total	$	1,369,017	$	1,438,798

(1) Includes loans on which borrowers have defaulted and are not making payments of principal and/or interest as of September 30, 2018.

(2) Excludes approximately $6.8 million of other loans held at carrying value and $1.8 million of residential whole loans held at fair value for which the closing of the purchase transaction had not occurred as of September 30, 2018.

Information is not presented for purchased credit impaired loans held at carrying value as income is recognized based on pools of assets with similar risk characteristics using an estimated yield based on cash flows expected to be collected over the lives of the loans in such pools rather than on the contractual coupons of the underlying loans.

66

Exposure to Financial Counterparties

We finance a significant portion of our residential mortgage assets with repurchase agreements. In connection with these financing arrangements, we pledge our assets as collateral to secure the borrowing. The amount of collateral pledged will typically exceed the amount of the financing with the extent of over-collateralization ranging from 3% to 5% of the amount borrowed for Agency MBS collateral, up to 30% for Non-Agency MBS and MSR related asset collateral, and up to 33% for residential whole loan collateral. Consequently, while repurchase agreement financing results in our recording a liability to the counterparty in our consolidated balance sheets, we are exposed to the counterparty, if during the term of the repurchase agreement financing, a lender should default on its obligation and we are not able to recover our pledged assets. The amount of this exposure is the difference between the amount loaned to us plus interest due to the counterparty and the fair value of the collateral pledged by us to the lender including accrued interest receivable on such collateral.

The table below summarizes our exposure to our counterparties at September 30, 2018, by country:

Country	Number of Counterparties	Repurchase Agreement Financing		Exposure (1)		Exposure as a Percentage of MFA Total Assets
(Dollars in Thousands)
European Countries:  (2)
United Kingdom	2	$	753,870	$	352,240	2.99	%
Switzerland	3	696,878		140,747		1.19
France	2	559,749		132,315		1.12
Holland	1	92,679		5,957		0.05
Total European	8	2,103,176		631,259		5.35	%
Other Countries:
United States	13	$	3,492,950	$	792,178	6.72	%
Canada (4)	2	884,458		243,731		2.07
Japan (5)	3	364,436		26,377		0.22
South Korea	1	320,016		26,237		0.22
China (5)	1	113,253		11,784		0.10
Total Other	20	5,175,113		1,100,307		9.33	%
Total	28	$	7,278,289	$	1,731,566	14.68	%

(1) Represents for each counterparty the amount of cash and/or securities pledged as collateral less the aggregate of repurchase agreement financing and net interest receivable/payable on all such instruments.

(2) Includes European-based counterparties as well as U.S.-domiciled subsidiaries of the European parent entity.

(3) Includes London branch of one counterparty and Cayman Islands branch of the other counterparty.

(4) Includes Canada-based counterparties as well as U.S.-domiciled subsidiaries of Canadian parent entities. In the case of one counterparty, also includes exposure of $237.6 million to a Barbados-based affiliate of the Canadian parent entity.

(5) Exposure is to U.S.-domiciled subsidiary of the Japanese or Chinese parent entity, as the case may be.

At September 30, 2018, we did not use credit default swaps or other forms of credit protection to hedge the exposures summarized in the table above.

Uncertainty in the global financial market and weak economic conditions in Europe, including as a result of the United Kingdom’s recent vote to leave the European Union (commonly known as “Brexit”), could potentially impact our major European financial counterparties, with the possibility that this would also impact the operations of their U.S. domiciled subsidiaries. This could adversely affect our financing and operations as well as those of the entire mortgage sector in general. Management monitors our exposure to our repurchase agreement counterparties on a regular basis, using various methods, including review of recent rating agency actions or other developments and by monitoring the amount of cash and securities collateral pledged and the associated loan amount under repurchase agreements with our counterparties. We intend to make reverse margin calls on our counterparties to recover excess collateral as permitted by the agreements governing our financing arrangements, or take other necessary actions to reduce the amount of our exposure to a counterparty when such actions are considered necessary. 

67

Tax Considerations

Current period estimated taxable income

We estimate that for the nine months ended September 30, 2018, our taxable income was approximately $257.7 million. Based on dividends paid or declared during the nine months ended September 30, 2018, we have undistributed taxable income of approximately $47.8 million, or $0.11 per share. We have until the filing of our 2018 tax return (due not later than October 15, 2019) to declare the distribution of any 2018 REIT taxable income not previously distributed.

Key differences between GAAP net income and REIT Taxable Income for Non-Agency MBS and Residential Whole Loans

Our total Non-Agency MBS portfolio for tax differs from our portfolio reported for GAAP primarily due to the fact that for tax purposes: (i) certain of the MBS contributed to the VIEs used to facilitate MBS resecuritization transactions were deemed to be sold; and (ii) the tax basis of underlying MBS considered to be reacquired in connection with the unwind of such transactions becomes the fair value of such securities at the time of the unwind. For GAAP reporting purposes the underlying MBS that were included in these MBS resecuritization transactions were not considered to be sold. Similarly, for tax purposes the residential whole loans contributed to the VIE used to facilitate our second quarter 2017 loan securitization transaction were deemed to be sold for tax purposes, but not for GAAP reporting purposes. In addition, for our Non-Agency MBS and residential whole loan tax portfolios, potential timing differences arise with respect to the accretion of market discount into income and recognition of realized losses for tax purposes as compared to GAAP.  Consequently, our REIT taxable income calculated in a given period may differ significantly from our GAAP net income.

The determination of taxable income attributable to Non-Agency MBS and residential whole loans is dependent on a number of factors, including principal payments, defaults, loss mitigation efforts and loss severities.  In estimating taxable income for Non-Agency MBS and residential whole loans during the year, management considers estimates of the amount of discount expected to be accreted.  Such estimates require significant judgment and actual results may differ from these estimates.  Moreover, the deductibility of realized losses from Non-Agency MBS and residential whole loans and their effect on market discount accretion are analyzed on an asset-by-asset basis and, while they will result in a reduction of taxable income, this reduction tends to occur gradually and primarily for Non-Agency MBS in periods after the realized losses are reported. In addition, for MBS resecuritization transactions that were treated as a sale of the underlying MBS for tax purposes, taxable gain or loss, if any, resulting from the unwind of such transactions is not recognized in GAAP net income.

Securitization transactions result in differences between GAAP net income and REIT Taxable Income

For tax purposes, depending on the transaction structure, a securitization and/or resecuritization transaction may be treated either as a sale or a financing of the underlying collateral.  Income recognized from securitization and resecuritization transactions will differ for tax and GAAP purposes.  For tax purposes, we own and may in the future acquire interests in securitization and/or resecuritization trusts, in which several of the classes of securities are or will be issued with original issue discount (or OID).  As the holder of the retained interests in the trust, we generally will be required to include OID in our current gross interest income over the term of the applicable securities as the OID accrues.  The rate at which the OID is recognized into taxable income is calculated using a constant rate of yield to maturity, with realized losses impacting the amount of OID recognized in REIT taxable income once they are actually incurred.  Under the Tax Cuts and Jobs Act (or TCJA), the timing of REIT taxable income may be affected by when we include such income for financial accounting purposes. For tax purposes, REIT taxable income may be recognized in excess of economic income (i.e., OID) or in advance of the corresponding cash flow from these assets, thereby affecting our dividend distribution requirement to stockholders. In addition, for securitization and/or resecuritization transactions that were treated as a sale of the underlying collateral for tax purposes, the unwind of any such transaction will likely result in a taxable gain or loss that is likely not recognized in GAAP net income since securitization and resecuritization transactions are typically accounted for as financing transactions for GAAP purposes. The tax basis of underlying residential whole loans or MBS re-acquired in connection with the unwind of such transactions becomes the fair market value of such assets at the time of the unwind.

Regulatory Developments

The U.S. Congress, Board of Governors of the Federal Reserve System, U.S. Treasury, Federal Deposit Insurance Corporation, SEC and other governmental and regulatory bodies have taken and continue to consider additional actions in response to the 2007-2008 financial crisis.  In particular, the Dodd-Frank Wall Street Reform and Consumer Protection Act (or the Dodd-Frank Act) created a new regulator, an independent bureau housed within the Federal Reserve System, and known as the Consumer Financial Protection Bureau (or the CFPB). The CFPB has broad authority over a wide range of consumer financial products and

68

services, including mortgage lending and servicing.  One portion of the Dodd-Frank Act, the Mortgage Reform and Anti-Predatory Lending Act (or Mortgage Reform Act), contains underwriting and servicing standards for the mortgage industry, restrictions on compensation for mortgage loan originators, and various other requirements related to mortgage origination.  In addition, the Dodd-Frank Act grants enforcement authority and broad discretionary regulatory authority to the CFPB to prohibit or condition terms, acts or practices relating to residential mortgage loans that the CFPB finds abusive, unfair, deceptive or predatory, as well as to take other actions that the CFPB finds are necessary or proper to ensure responsible affordable mortgage credit remains available to consumers.  The Dodd-Frank Act also affects the securitization of mortgages (and other assets) with requirements for risk retention by securitizers and requirements for regulating rating agencies.

The Dodd-Frank Act requires that numerous regulations be issued, many of which (including those mentioned above regarding servicing, underwriting and mortgage loan originator compensation) have only recently been implemented and operationalized. As a result, we are unable to fully predict at this time how the Dodd-Frank Act, as well as other laws or regulations that may be adopted in the future, will affect our business, results of operations and financial condition, or the environment for repurchase financing and other forms of borrowing, the investing environment for Agency MBS, Non-Agency MBS and/or residential mortgage loans, the securitization industry, Swaps and other derivatives.  However, at a minimum, we believe that the Dodd-Frank Act and the regulations promulgated thereunder are likely to continue to increase the economic and compliance costs for participants in the mortgage and securitization industries, including us.

In addition to the regulatory actions being implemented under the Dodd-Frank Act, on August 31, 2011, the SEC issued a concept release under which it is reviewing interpretive issues related to Section 3(c)(5)(C) of the Investment Company Act.  Section 3(c)(5)(C) excludes from the definition of “investment company” entities that are primarily engaged in, among other things, “purchasing or otherwise acquiring mortgages and other liens on and interests in real estate.”  Many companies that engage in the business of acquiring mortgages and mortgage-related instruments seek to rely on existing interpretations of the SEC Staff with respect to Section 3(c)(5)(C) so as not to be deemed an investment company for the purpose of regulation under the Investment Company Act.  In connection with the concept release, the SEC requested comments on, among other things, whether it should reconsider its existing interpretation of Section 3(c)(5)(C). To date the SEC has not taken or otherwise announced any further action in connection with the concept release.

The FHFA and both houses of Congress have discussed and considered separate measures intended to restructure the U.S. housing finance system and the operations of Fannie Mae and Freddie Mac. Congress may continue to consider legislation that would significantly reform the country’s mortgage finance system, including, among other things, eliminating Freddie Mac and Fannie Mae and replacing them with a single new MBS insurance agency. Many details remain unsettled, including the scope and costs of the agencies’ guarantee and their affordable housing mission, some of which could be addressed even in the absence of large-scale reform.  While the likelihood of enactment of major mortgage finance system reform in the short term remains uncertain, it is possible that the adoption of any such reforms could adversely affect the types of assets we can buy, the costs of these assets and our business operations.  As the FHFA and both houses of Congress continue to consider various measures intended to dramatically restructure the U.S. housing finance system and the operations of Fannie Mae and Freddie Mac, we expect debate and discussion on the topic to continue throughout 2018. In June 2018, the Trump Administration proposed a plan that would end the conservatorship of Fannie Mae and Freddie Mac and privatize the GSEs. However, we cannot be certain if any housing and/or mortgage-related legislation will emerge from committee, or be approved by Congress, and if so, what the effect would be on our business.

69

Results of Operations

Quarter Ended September 30, 2018 Compared to the Quarter Ended September 30, 2017

General

For the third quarter of 2018, we had net income available to our common stock and participating securities of $83.4 million, or $0.19 per basic and diluted common share, compared to net income available to common stock and participating securities of $60.1 million, or $0.15 per basic and diluted common share, for the third quarter of 2017. The increase in net income available to common stock and participating securities and the increase of this item on a per share basis primarily reflects higher net gains on our residential whole loans held at fair value and higher net interest income driven by increased investment in residential whole loans held at carrying value. In addition, operating and other expenses were higher in the prior year period primarily due to non-recurring expenses in relation to our contractual obligation to accelerate the vesting of certain share based awards and to make a death benefit payment to the estate of our former Chief Executive Officer.

Net Interest Income

Net interest income represents the difference between income on interest-earning assets and expense on interest-bearing liabilities.  Net interest income depends primarily upon the volume of interest-earning assets and interest-bearing liabilities and the corresponding interest rates earned or paid.  Our net interest income varies primarily as a result of changes in interest rates, the slope of the yield curve (i.e., the differential between long-term and short-term interest rates), borrowing costs (i.e., our interest expense) and prepayment speeds on our MBS.  Interest rates and CPRs (which measure the amount of unscheduled principal prepayment on a bond as a percentage of the bond balance) vary according to the type of investment, conditions in the financial markets, and other factors, none of which can be predicted with any certainty.

The changes in average interest-earning assets and average interest-bearing liabilities and their related yields and costs are discussed in greater detail below under “Interest Income” and “Interest Expense.”

For the third quarter of 2018, our net interest spread and margin were 2.41% and 2.82%, respectively, compared to a net interest spread and margin of 2.02% and 2.54%, respectively, for the third quarter of 2017. Our net interest income increased by $2.7 million, or 4.8%, to $58.6 million for the third quarter of 2018, from $55.9 million for the third quarter of 2017.  Current quarter net interest income on residential whole loans held at carrying value increased by approximately $16.0 million compared to the third quarter of 2017, primarily due increased investment in these assets. This increase was partially offset by a decrease of approximately $3.8 million in net interest income from Agency MBS and Non-Agency MBS compared to the third quarter of 2017, primarily due to lower average amounts invested in these securities and higher Agency MBS funding costs, partially offset by higher yields earned on Legacy Non-Agency MBS. In addition, net interest income also includes $10.6 million of interest expense associated with residential whole loans held at fair value, reflecting a $6.0 millionincrease in borrowing costs related to these investments compared to the third quarter of 2017. Coupon interest income received from residential whole loans held at fair value is presented as a component of the total income earned on these investments and therefore is included in Other Income, net rather than net interest income.

70

Analysis of Net Interest Income

The following table sets forth certain information about the average balances of our assets and liabilities and their related yields and costs for the three months ended September 30, 2018 and 2017.  Average yields are derived by dividing annualized interest income by the average amortized cost of the related assets, and average costs are derived by dividing annualized interest expense by the daily average balance of the related liabilities, for the periods shown.  The yields and costs include premium amortization and purchase discount accretion which are considered adjustments to interest rates.

	Three Months Ended September 30,
	2018							2017
(Dollars in Thousands)	Average Balance			Interest		Average Yield/Cost		Average Balance			Interest		Average Yield/Cost
Assets:
Interest-earning assets:
Agency MBS (1)	$	2,595,896		$	14,332	2.21	%	$	3,154,112		$	15,533	1.97	%
Legacy Non-Agency MBS (1)	1,709,704			46,010		10.76		2,182,148			48,693		8.93
RPL/NPL MBS (1)	1,010,910			12,657		5.01		1,315,737			14,559		4.43
Total MBS	5,316,510			72,999		5.49		6,651,997			78,785		4.74
CRT securities (1)	500,649			7,748		6.19		604,322			8,676		5.74
MSR related assets (1)	482,100			6,407		5.32		454,354			7,194		6.33
Residential whole loans, at carrying value (2)	2,003,913			29,524		5.89		609,538			9,026		5.92
Cash and cash equivalents (3)	181,242			754		1.66		657,331			1,452		0.88
Total interest-earning assets	8,484,414			117,432		5.54		8,977,542			105,133		4.68
Total non-interest-earning assets (2)	2,841,079							2,487,953
Total assets	$	11,325,493						$	11,465,495
Liabilities and stockholders’ equity:
Interest-bearing liabilities:
Total repurchase agreements (4)	$	6,594,050		$	50,881	3.02	%	$	7,022,913		$	46,303	2.58	%
Securitized debt	665,572			5,986		3.52		139,276			962		2.70
Senior Notes	96,797			2,011		8.31		96,756			2,010		8.31
Total interest-bearing liabilities	7,356,419			58,878		3.13		7,258,945			49,275		2.66
Total non-interest-bearing liabilities	554,082							927,877
Total liabilities	7,910,501							8,186,822
Stockholders’ equity	3,414,992							3,278,673
Total liabilities and stockholders’ equity	$	11,325,493						$	11,465,495
Net interest income/net interest rate spread (5)				$	58,554	2.41	%				$	55,858	2.02	%
Net interest-earning assets/net interest margin (6)	$	1,127,995				2.82	%	$	1,718,597				2.54	%
Ratio of interest-earning assets to interest-bearing liabilities	1.15		x					1.24		x

(1) Yields presented throughout this Quarterly Report on Form 10-Q are calculated using average amortized cost data for securities which excludes unrealized gains and losses and includes principal payments receivable on securities.  For GAAP reporting purposes, purchases and sales are reported on the trade date. Average amortized cost data used to determine yields is calculated based on the settlement date of the associated purchase or sale as interest income is not earned on purchased assets and continues to be earned on sold assets until settlement date.

(2) Excludes residential whole loans held at fair value that are reported as a component of total non-interest-earning assets.

(3) Includes average interest-earning cash, cash equivalents and restricted cash.

(4) Average cost of repurchase agreements includes the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration.

(5) Net interest rate spread reflects the difference between the yield on average interest-earning assets and average cost of funds.

(6) Net interest margin reflects annualized net interest income divided by average interest-earning assets.

71

Rate/Volume Analysis

The following table presents the extent to which changes in interest rates (yield/cost) and changes in the volume (average balance) of interest-earning assets and interest-bearing liabilities have affected our interest income and interest expense during the periods indicated.  Information is provided in each category with respect to: (i) the changes attributable to changes in volume (changes in average balance multiplied by prior rate); (ii) the changes attributable to changes in rate (changes in rate multiplied by prior average balance); and (iii) the net change.  The changes attributable to the combined impact of volume and rate have been allocated proportionately, based on absolute values, to the changes due to rate and volume.

	Three Months Ended September 30, 2018
	Compared to
	Three Months Ended September 30, 2017
	Increase/(Decrease) due to						Total Net Change in Interest Income/Expense
(In Thousands)	Volume			Rate
Interest-earning assets:
Agency MBS	$	(2,954	)	$	1,753		$	(1,201	)
Legacy Non-Agency MBS	(11,644		)	8,961			(2,683		)
RPL/NPL MBS	(3,659		)	1,757			(1,902		)
CRT securities	(1,568		)	640			(928		)
MSR related assets	420			(1,207		)	(787		)
Residential whole loans, at carrying value (1)	20,544			(46		)	20,498
Cash and cash equivalents	(1,470		)	772			(698		)
Total net change in income from interest-earning assets	$	(331	)	$	12,630		$	12,299
Interest-bearing liabilities:
Agency repurchase agreements	$	(2,500	)	$	2,979		$	479
Legacy Non-Agency repurchase agreements	(2,233		)	158			(2,075		)
RPL/NPL MBS repurchase agreements	(1,300		)	907			(393		)
CRT securities repurchase agreements	(24		)	625			601
MSR related assets repurchase agreements	616			(40		)	576
Residential whole loans at carrying value repurchase agreements	3,908			159			4,067
Residential whole loans at fair value repurchase agreements	535			788			1,323
Securitized debt	4,652			372			5,024
Senior Notes	1			—			1
Total net change in expense of interest-bearing liabilities	$	3,655		$	5,948		$	9,603
Net change in net interest income	$	(3,986	)	$	6,682		$	2,696

(1) Excludes residential whole loans held at fair value which are reported as a component of non-interest-earning assets.

72

The following table presents certain quarterly information regarding our net interest spread and net interest margin for the quarterly periods presented:

	Total Interest-Earning Assets and Interest- Bearing Liabilities
	Net Interest Spread (1)		Net Interest Margin (2)
Quarter Ended
September 30, 2018	2.41	%	2.82	%
June 30, 2018	2.30		2.66
March 31, 2018	2.25		2.64
December 31, 2017	2.08		2.54
September 30, 2017	2.02		2.54

(1) Reflects the difference between the yield on average interest-earning assets and average cost of funds.

(2) Reflects annualized net interest income divided by average interest-earning assets.

The following table presents the components of the net interest spread earned on our Agency MBS, Legacy Non-Agency MBS and RPL/NPL MBS for the quarterly periods presented:

	Agency MBS						Legacy Non-Agency MBS						RPL/NPL MBS						Total MBS
Quarter Ended	Net Yield  (1)		Cost of Funding (2)		Net Interest Rate Spread (3)		Net Yield  (1)		Cost of Funding (2)		Net Interest Rate Spread (3)		Net Yield  (1)		Cost of Funding (2)		Net Interest Rate Spread (3)		Net Yield  (1)		Cost of Funding (2)		Net Interest Rate Spread (3)
September 30, 2018	2.21	%	2.22	%	(0.01	)%	10.76	%	3.29	%	7.47	%	5.01	%	3.10	%	1.91	%	5.49	%	2.73	%	2.76	%
June 30, 2018	2.03		2.04		(0.01	)	9.89		3.30		6.59		4.52		3.19		1.33		5.16		2.64		2.52
March 31, 2018	2.21		1.91		0.30		9.44		3.29		6.15		4.36		2.94		1.42		5.06		2.53		2.53
December 31, 2017	2.08		1.79		0.29		9.12		3.29		5.83		4.27		2.72		1.55		4.85		2.44		2.41
September 30, 2017	1.97		1.75		0.22		8.93		3.26		5.67		4.43		2.69		1.74		4.74		2.41		2.33

(1) Reflects annualized interest income on MBS divided by average amortized cost of MBS.

(2) Reflects annualized interest expense divided by average balance of repurchase agreements, including the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration and securitized debt. Agency MBS cost of funding includes 6, 9, 26, 43 and 44 basis points and Legacy Non-Agency MBS cost of funding includes 5, 8, 30, 45 and 45 basis points associated with Swaps to hedge interest rate sensitivity on these assets for the quarters ended September 30, 2018, June 30, 2018, March 31, 2018, December 31, 2017 and September 30, 2017, respectively.

(3) Reflects the difference between the net yield on average MBS and average cost of funds on MBS.

Interest Income

Interest income on our Agency MBS for the third quarter of 2018decreased by $1.2 million, or 7.7%, to $14.3 million from $15.5 million for the third quarter of 2017.  This decrease primarily reflects a $558.2 milliondecrease in the average amortized cost of our Agency MBS portfolio to $2.6 billion for the third quarter of 2018 from $3.2 billion for the third quarter of 2017 partially offset by an increase in the net yield on our Agency MBS to 2.21% for the third quarter of 2018 from 1.97% for the third quarter of 2017. At the end of the third quarter of 2018, the average coupon on mortgages underlying our Agency MBS was higher compared to the end of the third quarter of 2017, due to upward resets on securities within the portfolio, purchases of higher yielding Agency MBS and the impact of the removal from the portfolio of Agency MBS sold during 2018.  In addition, for the third quarter of 2018, our Agency MBS portfolio experienced a 16.8% CPR and we recognized $7.2 million of net premium amortization compared to a CPR of 16.2% and $7.9 million of net premium amortization for the third quarter of 2017. At September 30, 2018, we had net purchase premiums on our Agency MBS of $111.1 million, or 3.9% of current par value, compared to net purchase premiums of $104.0 million, or 3.8% of par value, at December 31, 2017.

Interest income on our Non-Agency MBS decreased$4.6 million, or 7.2%, for the third quarter of 2018 to $58.7 million compared to $63.3 million for the third quarter of 2017. This decrease is primarily due to the decrease in the average amortized cost of our Non-Agency MBS portfolio of $777.3 million, or 22.2%, to $2.7 billion for the third quarter of 2018 from $3.5 billion for the third quarter of 2017. This decrease more than offset the impact of the higher yields generated on our Legacy Non-Agency

73

MBS portfolio, which were 10.76% for the third quarter of 2018 compared to 8.93% for the third quarter of 2017. The increase in the net yield on our Legacy Non-Agency MBS portfolio reflects the improved performance of loans underlying the Legacy Non-Agency MBS portfolio, which has resulted in credit reserve releases and changes in interest rates since the third quarter of the prior year, higher accretion income recognized in the current quarter due to the impact of redemptions of certain securities that had been previously purchased at a discount as well as the impact of the cash proceeds received during the second quarter of 2018 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by JP Morgan Chase & Co. and affiliated entities. Our RPL/NPL MBS portfolio yielded 5.01% for the third quarter of 2018 compared to 4.43% for the third quarter of 2017. The increase in the net yield primarily reflects an increase in the average coupon yield to 4.56% for the third quarter of 2018 from 4.24% for the third quarter of 2017 and higher accretion income recognized in the current quarter due to the impact of redemptions of certain securities that had been previously purchased at a discount.

During the third quarter of 2018, we recognized net purchase discount accretion of $20.1 million on our Non-Agency MBS, compared to $18.6 million for the third quarter of 2017.  At September 30, 2018, we had net purchase discounts of $722.8 million, including Credit Reserve and previously recognized OTTI of $531.8 million, on our Legacy Non-Agency MBS, or 30.8% of par value.  During the third quarter of 2018 we reallocated $10.2 million of purchase discount designated as Credit Reserve to accretable purchase discount.

The following table presents the coupon yield and net yields earned on our Agency MBS, Legacy Non-Agency MBS and RPL/NPL MBS and weighted average CPRs experienced for such MBS for the quarterly periods presented:

	Agency MBS						Legacy Non-Agency MBS						RPL/NPL MBS
Quarter Ended	Coupon Yield (1)		Net Yield (2)		3 Month Average CPR (3)		Coupon Yield (1)		Net Yield (2)		3 Month Average CPR (3)		Coupon Yield (1)		Net Yield (2)		3 Month Average Bond CPR (4)
September 30, 2018	3.32	%	2.21	%	16.8	%	6.32	%	10.76	%	16.8	%	4.56	%	5.01	%	19.6	%
June 30, 2018	3.09		2.03		16.2		6.09		9.89		15.8		4.49		4.52		20.4
March 31, 2018	3.02		2.21		12.7		5.91		9.44		14.9		4.35		4.36		14.0
December 31, 2017	3.00		2.08		14.1		5.82		9.12		16.3		4.24		4.27		20.1
September 30, 2017	2.98		1.97		16.2		5.63		8.93		18.7		4.24		4.43		26.2

(1) Reflects the annualized coupon interest income divided by the average amortized cost. The discounted purchase price on Legacy Non-Agency MBS causes the coupon yield to be higher than the pass-through coupon interest rate.

(2) Reflects annualized interest income on MBS divided by average amortized cost of MBS.

(3) 3 month average CPR weighted by positions as of the beginning of each month in the quarter.

(4) All principal payments are considered to be prepayments for CPR purposes.

Interest income on our residential whole loans held at carrying value increased by $20.5 million, or 227.1%, for the third quarter of 2018, to $29.5 million compared to $9.0 million for the third quarter of 2017. This increase primarily reflects a $1.4 billionincrease in the average balance of this portfolio to $2.0 billion for the third quarter of 2018 from $609.5 million for the third quarter of 2017 partially offset by a slight decrease in the yield (net of servicing costs) to 5.89% for the third quarter of 2018 from 5.92% for the third quarter of 2017.

Interest Expense

Our interest expense for the third quarter of 2018increased by $9.6 million to $58.9 million from $49.3 million for the third quarter of 2017.  This increase primarily reflects an increase in financing rates on our repurchase agreement financings, and an increase in our average borrowings and securitized debt to finance residential whole loans and MSR related assets, which was partially offset by a decrease in our average repurchase agreement borrowings to finance our MBS portfolio. The effective interest rate paid on our borrowings increased to 3.13% for the quarter ended September 30, 2018 from 2.66% for the quarter ended September 30, 2017. 

At September 30, 2018, we had repurchase agreement borrowings of $7.3 billion, of which $2.1 billion was hedged for accounting purposes with Swaps. Payments made and/or received on our Swaps designated as hedges for accounting purposes are a component of our borrowing costs and accounted for interest expense of $547,000, or 3 basis points, for the third quarter of 2018, as compared to interest expense of $5.3 million, or 29 basis points, for the third quarter of 2017.  The weighted average fixed-pay rate on our Swaps designated as hedges increased to 2.19% for the quarter ended September 30, 2018 from 2.04% for

74

the quarter ended and September 30, 2017.  The weighted average variable interest rate received on our Swaps designated as hedges increased to 2.09% for the quarter ended September 30, 2018 from 1.23% for the quarter ended September 30, 2017. 

We expect that our interest expense and funding costs for the remainder of 2018 will be impacted by market interest rates, the amount of our borrowings and incremental hedging activity, existing and future interest rates on our hedging instruments and the extent to which we execute additional longer-term structured financing transactions.  As a result of these variables, our borrowing costs cannot be predicted with any certainty.  (See Notes 5(c), 6 and 14 to the accompanying consolidated financial statements, included under Item 1 of this Quarterly Report on Form 10-Q.)

Other Income, net

For the third quarter of 2018, Other Income, net increased by $19.3 million, or 66.2%, to $48.4 million compared to $29.1 million for the third quarter of 2017.  The components of Other Income, net for the third quarter of 2018 and 2017 are summarized in the table below:

	Quarter Ended September 30,
(In Thousands)	2018			2017
Net gains on residential whole loans held at fair value	$	34,942		$	18,679
Liquidation gains on purchased credit impaired loans and other loan related income	3,172			2,958
Net loss on REO properties	(2,125		)	(2,324		)
Realized gains on MBS and CRT securities sold	16,415			14,934
Net unrealized loss on MBS and CRT securities held at fair value	(8,545		)	(5,220		)
Net gain on Swaps not designated as hedges for accounting purposes	4,002			—
OTTI and other	498			70
Total Other Income, net	$	48,359		$	29,097

Operating and Other Expense

For the third quarter of 2018, we had compensation and benefits and other general and administrative expenses of $11.0 million, or 1.29% of average equity, compared to $15.0 million, or 1.83% of average equity, for the third quarter of 2017.  Compensation and benefits expense decreased by approximately $4.0 million to $6.9 million for the third quarter of 2018, compared to $10.9 million for the third quarter of 2017, primarily due to the impact of non-recurring expenses recorded in the prior year quarter in relation to the our contractual obligation to accelerate the vesting of certain share based awards and to make a death benefit payment to the estate of our former Chief Executive Officer. Our other general and administrative expenses increased by $74,000 to $4.2 million for the quarter ended September 30, 2018 compared to $4.1 million for the quarter ended September 30, 2017.

Operating and Other Expense for the third quarter of 2018 also includes $8.8 million of loan servicing and other related operating expenses related to our residential whole loan activities. These expenses increased compared to the prior year period by approximately $2.6 million, or 41.8%, primarily due to higher non-recoverable advances on REO and higher loan and REO servicing fees, partially offset by lower loan acquisition related expenses.

75

Selected Financial Ratios

The following table presents information regarding certain of our financial ratios at or for the dates presented:

At or for the Quarter Ended	Return on Average Total Assets (1)		Return on Average Total Stockholders’ Equity (2)		Total Average Stockholders’ Equity to Total Average Assets (3)		Dividend Payout Ratio (4)	Leverage Multiple (5)	Book Value per Share of Common Stock (6)
September 30, 2018	2.94	%	10.21	%	30.15	%	1.05	2.3	$	7.46
June 30, 2018	2.58		8.74		31.19		1.18	2.3	7.54
March 31, 2018	2.93		10.27		29.91		1.00	2.2	7.62
December 31, 2017	3.47		12.29		29.33		0.83	2.3	7.70
September 30, 2017	2.10		7.78		28.60		1.33	2.4	7.70

(1) Reflects annualized net income available to common stock and participating securities divided by average total assets.

(2) Reflects annualized net income divided by average total stockholders’ equity.

(3) Reflects total average stockholders’ equity divided by total average assets.

(4) Reflects dividends declared per share of common stock divided by earnings per share.

(5) Represents the sum of borrowings under repurchase agreements, securitized debt, payable for unsettled purchases, obligations to return securities obtained as collateral and Senior Notes divided by stockholders’ equity.

(6) Reflects total stockholders’ equity less the preferred stock liquidation preference divided by total shares of common stock outstanding.

Nine Month Period Ended September 30, 2018 Compared to the Nine Month Period Ended September 30, 2017

General

For the nine months ended September 30, 2018, we had net income available to common stock and participating securities of $229.7 million, or $0.56 per basic and diluted common share, compared to net income available to common stock and participating securities of $210.5 million, or $0.54 per basic and diluted common share, for the nine months ended September 30, 2017. The increase in net income available to common stock and participating securities, and the increase of this item on a per share basis primarily reflects higher net gains on our residential whole loans held at fair value, a decrease in net interest income and lower net Other income, primarily driven by unrealized losses on MBS and CRT securities accounted for at fair value, compared to unrealized gains on CRT securities in the prior year period. In addition, operating and other expenses were higher for the nine month period ended September 30, 2018, primarily due to higher costs in connection with growing and servicing our residential whole loan portfolio, partially offset by lower compensation related expenses, as the prior year period included the impact of non-recurring expenses in relation to our contractual obligation to accelerate the vesting of certain share based awards and to make a death benefit payment to the estate of our former Chief Executive Officer.

Net Interest Income

For the nine months ended September 30, 2018, our net interest spread and margin were 2.32% and 2.71%, respectively, compared to a net interest spread and margin of 2.15% and 2.59%, respectively, for the nine months ended September 30, 2017. Our net interest income decreased by $22.2 million, or 12.1%, to $161.7 million for the nine months ended September 30, 2018, from $183.9 million for the nine months ended September 30, 2017.  For the nine months ended September 30, 2018, net interest income from Agency MBS and Non-Agency MBS declined compared to the nine months ended September 30, 2017, by approximately $33.1 million, primarily due to lower average amounts invested in these securities and higher funding costs, partially offset by higher yields earned on these securities. These decreases were partially offset by higher net interest income on residential whole loans held at carrying value, MSR related assets and CRT securities of approximately $27.8 million compared to the nine months ended September 30, 2017, primarily due to higher average balances invested in these assets. In addition, net interest income for the nine months ended September 30, 2018 also includes $29.6 million of interest expense associated with residential whole loans held at fair value, reflecting a $16.4 millionincrease in borrowing costs related to these investments compared to the nine months ended September 30, 2017. Coupon interest income received from residential whole loans held at fair value is presented as a component of the total income earned on these investments and therefore is included in Other Income, net rather than net interest income.

76

Analysis of Net Interest Income

The following table sets forth certain information about the average balances of our assets and liabilities and their related yields and costs for the nine months ended September 30, 2018 and 2017.  Average yields are derived by dividing annualized interest income by the average amortized cost of the related assets, and average costs are derived by dividing annualized interest expense by the daily average balance of the related liabilities, for the periods shown.  The yields and costs include premium amortization and purchase discount accretion which are considered adjustments to interest rates.

	Nine Months Ended September 30,
	2018							2017
	Average Balance			Interest		Average Yield/Cost		Average Balance			Interest		Average Yield/Cost
(Dollars in Thousands)
Assets:
Interest-earning assets:
Agency MBS (1)	$	2,654,925		$	42,795	2.15	%	$	3,383,373		$	50,014	1.97	%
Legacy Non-Agency MBS (1)	1,831,292			137,439		10.01		2,350,975			156,829		8.89
RPL/NPL MBS (1)	929,835			32,373		4.64		1,813,557			55,899		4.11
Total MBS	5,416,052			212,607		5.23		7,547,905			262,742		4.64
CRT securities (1)	556,258			25,939		6.22		520,585			22,898		5.86
MSR related assets (1)	440,979			20,249		6.12		376,811			17,833		6.31
Residential whole loans, at carrying value (2)	1,410,100			61,788		5.84		587,511			26,219		5.95
Cash and cash equivalents (3)	230,945			2,348		1.36		531,722			2,854		0.72
Total interest-earning assets	8,054,334			322,931		5.35		9,564,534			332,546		4.64
Total non-interest-earning assets (2)	2,785,653							2,207,939
Total assets	$	10,839,987						$	11,772,473
Liabilities and stockholders’ equity:
Interest-bearing liabilities:
Total repurchase agreements and other advances (4)	6,434,725			142,832		2.93		7,704,662			141,444		2.42
Securitized debt	486,352			12,378		3.36		57,073			1,173		2.71
Senior Notes	96,787			6,032		8.31		96,746			6,029		8.31
Total interest-bearing liabilities	7,017,864			161,242		3.03		7,858,481			148,646		2.49
Total non-interest-bearing liabilities	526,766							734,181
Total liabilities	7,544,630							8,592,662
Stockholders’ equity	3,295,357							3,179,811
Total liabilities and stockholders’ equity	$	10,839,987						$	11,772,473
Net interest income/ net interest rate spread (5)				$	161,689	2.32	%				$	183,900	2.15	%
Net interest-earning assets/ net interest margin (6)	$	1,036,470				2.71	%	$	1,706,053				2.59	%
Ratio of interest-earning assets to     interest-bearing liabilities	1.15		x					1.22		x

(1) Yields presented throughout this Quarterly Report on Form 10-Q are calculated using average amortized cost data for securities which excludes unrealized gains and losses and includes principal payments receivable on securities.  For GAAP reporting purposes, purchases and sales are reported on the trade date. Average amortized cost data used to determine yields is calculated based on the settlement date of the associated purchase or sale as interest income is not earned on purchased assets and continues to be earned on sold assets until settlement date.  

(2) Excludes residential whole loans held at fair value that are reported as a component of total non-interest-earning assets.

(3) Includes average interest-earning cash, cash equivalents and restricted cash.

(4) Average cost of repurchase agreements includes the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration.

(5) Net interest rate spread reflects the difference between the yield on average interest-earning assets and average cost of funds.

(6) Net interest margin reflects annualized net interest income divided by average interest-earning assets.

77

Rate/Volume Analysis

The following table presents the extent to which changes in interest rates (yield/cost) and changes in the volume (average balance) of interest-earning assets and interest-bearing liabilities have affected our interest income and interest expense during the periods indicated.  Information is provided in each category with respect to: (i) the changes attributable to changes in volume (changes in average balance multiplied by prior rate); (ii) the changes attributable to changes in rate (changes in rate multiplied by prior average balance); and (iii) the net change.  The changes attributable to the combined impact of volume and rate have been allocated proportionately, based on absolute values, to the changes due to rate and volume.

	Nine Months Ended September 30, 2018
	Compared to
	Nine Months Ended September 30, 2017
	Increase/(Decrease) due to						Total Net Change in Interest Income/Expense
(In Thousands)	Volume			Rate
Interest-earning assets:
Agency MBS	$	(11,467	)	$	4,248		$	(7,219	)
Legacy Non-Agency MBS	(37,470		)	18,080			(19,390		)
RPL/NPL MBS	(30,006		)	6,480			(23,526		)
CRT securities	1,619			1,422			3,041
MSR related assets	2,960			(544		)	2,416
Residential whole loans, at carrying value (1)	36,053			(484		)	35,569
Cash and cash equivalents	(2,174		)	1,668			(506		)
Total net change in income from interest-earning assets	$	(40,485	)	$	30,870		$	(9,615	)
Interest-bearing liabilities:
Agency repurchase agreements and other advances	$	(9,170	)	$	9,049		$	(121	)
Legacy Non-Agency repurchase agreements	(7,401		)	1,501			(5,900		)
RPL/NPL MBS repurchase agreements	(16,657		)	5,610			(11,047		)
CRT securities repurchase agreements	1,226			1,666			2,892
MSR related assets repurchase agreements	1,768			141			1,909
Residential whole loan at carrying value repurchase agreements	4,304			1,409			5,713
Residential whole loan at fair value repurchase agreements	5,470			2,472			7,942
Securitized debt	10,861			344			11,205
Senior Notes	3			—			3
Total net change in expense of interest-bearing liabilities	$	(9,596	)	$	22,192		$	12,596
Net change in net interest income	$	(30,889	)	$	8,678		$	(22,211	)

(1) Excludes residential whole loans held at fair value which are reported as a component of non-interest-earning assets.

The following table presents the components of the net interest spread earned on our Agency MBS, Legacy Non-Agency MBS and RPL/NPL MBS for the periods presented:

	Agency MBS						Legacy Non-Agency MBS						RPL/NPL MBS						Total MBS
Nine Months Ended	Net Yield  (1)		Cost of Funding  (2)		Net Interest Spread  (3)		Net Yield  (1)		Cost of Funding  (2)		Net Interest Spread  (3)		Net Yield  (1)		Cost of Funding  (2)		Net Interest Spread  (3)		Net Yield  (1)		Cost of Funding  (2)		Net Interest Spread  (3)
September 30, 2018	2.15	%	2.05	%	0.10	%	10.01	%	3.29	%	6.72	%	4.64	%	3.08	%	1.56	%	5.23	%	2.63	%	2.60	%
September 30, 2017	1.97	%	1.60	%	0.37	%	8.89	%	3.19	%	5.70	%	4.11	%	2.43	%	1.68	%	4.64	%	2.27	%	2.37	%

(1) Reflects annualized interest income on MBS divided by average amortized cost of MBS.

(2) Reflects annualized interest expense divided by average balance of repurchase agreements and other advances, including the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration, and securitized debt. Agency MBS cost of funding includes 14 and 51 basis points and Legacy Non-Agency MBS cost of funding includes 14 and 54 basis points associated with Swaps to hedge interest rate sensitivity on these assets for the nine months ended September 30, 2018 and 2017, respectively.

(3) Reflects the difference between the net yield on average MBS and average cost of funds on MBS.

78

Interest Income

Interest income on our Agency MBS for the nine months ended September 30, 2018decreased by $7.2 million, or 14.4%, to $42.8 million from $50.0 million for the nine months ended September 30, 2017.  This change primarily reflects a $728.4 milliondecrease in the average amortized cost of our Agency MBS portfolio to $2.7 billion for the nine months ended September 30, 2018 from $3.4 billion for the nine months ended September 30, 2017 partially offset by an increase in the net yield on our Agency MBS to 2.15% for the nine months ended September 30, 2018 from 1.97% for the nine months ended September 30, 2017.  At the end of the third quarter of 2018, the average coupon on mortgages underlying our Agency MBS was higher compared to the end of the third quarter of 2017.  In addition, during the nine months ended September 30, 2018, our Agency MBS portfolio experienced a 13.5% CPR and we recognized $19.8 million of net premium amortization compared to a CPR of 14.4% and $24.6 million of net premium amortization for the nine months ended September 30, 2017.  At September 30, 2018, we had net purchase premiums on our Agency MBS of $111.1 million, or 3.9% of current par value, compared to net purchase premiums of $104.0 million, or 3.8% of par value at December 31, 2017.

Interest income on our Non-Agency MBS decreased by $42.9 million, or 20.2%, for the nine months ended September 30, 2018 to $169.8 million compared to $212.7 million for the nine months ended September 30, 2017. This decrease is primarily due to the decrease in the average amortized cost of our Non-Agency MBS portfolio of $1.4 billion or 33.7%, to $2.8 billion from $4.2 billion for the nine months ended September 30, 2017.  This decrease more than offset the impact of the higher yields generated on our Legacy Non-Agency MBS portfolio, which were 10.01% for the nine months ended September 30, 2018 compared to 8.89% for the nine months ended September 30, 2017.  The increase in the net yield on our Legacy Non-Agency MBS portfolio reflects the improved performance of loans underlying the Legacy Non-Agency MBS portfolio, which has resulted in credit reserve releases and changes in interest rates since the third quarter of the prior year, higher accretion income recognized in the current quarter due to the impact of redemptions of certain securities that had been previously purchased at a discount as well as the impact of the cash proceeds received during the nine months ended September 30, 2018 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by JP Morgan Chase & Co. and affiliated entities. Our RPL/NPL MBS portfolio yielded 4.64% for the nine months ended September 30, 2018 compared to 4.11% for the nine months ended September 30, 2017. The increase in the net yield primarily reflects an increase in the average coupon yield to 4.47% for the nine months ended September 30, 2018 from 4.01% for the nine months ended September 30, 2017.

During the nine months ended September 30, 2018, we recognized net purchase discount accretion of $54.9 million on our Non-Agency MBS, compared to $60.5 million for the nine months ended September 30, 2017.  At September 30, 2018, we had net purchase discounts of $722.8 million, including Credit Reserve and previously recognized OTTI of $531.8 million, on our Legacy Non-Agency MBS, or 30.8% of par value.  During the nine months ended September 30, 2018 we reallocated $25.4 million of purchase discount designated as Credit Reserve to accretable purchase discount.

The following table presents the coupon yield and net yields earned on our Agency MBS, Legacy Non-Agency MBS and RPL/NPL MBS and weighted average CPRs experienced for such MBS for the periods presented:

	Agency MBS						Legacy Non-Agency MBS						RPL/NPL MBS
Nine Months Ended	Coupon Yield (1)		Net Yield (2)		9 Month Average CPR (3)		Coupon Yield (1)		Net Yield (2)		9 Month Average CPR (3)		Coupon Yield (1)		Net Yield (2)		9 Month Average Bond CPR (4)
September 30, 2018	3.14	%	2.15	%	13.5	%	6.10	%	10.01	%	14.3	%	4.47	%	4.64	%	18.0	%
September 30, 2017	2.94		1.97		14.4		5.55		8.89		16.3		4.01		4.11		32.2

(1) Reflects the annualized coupon interest income divided by the average amortized cost. The discounted purchase price on Legacy Non-Agency MBS causes the coupon yield to be higher than the pass-through coupon interest rate.

(2) Reflects annualized interest income on MBS divided by average amortized cost of MBS.

(3) 9 month average CPR weighted by positions as of the beginning of each month in the quarter.

(4) All principal payments are considered to be prepayments for CPR purposes.

Interest income on our residential whole loans held at carrying value increased by $35.6 million, or 135.7%, for the nine months ended September 30, 2018 to $61.8 million compared to $26.2 million for the nine months ended September 30, 2017. This increase primarily reflects a $822.6 millionincrease in the average balance of this portfolio to $1.4 billion for the nine months ended September 30, 2018 from $587.5 million for the nine months ended September 30, 2017 partially offset by a decrease in the yield (net of servicing costs) to 5.84% for the nine months ended September 30, 2018 from 5.95% for the nine months ended September 30, 2017.

79

Interest Expense

Our interest expense for the nine months ended September 30, 2018increased by $12.6 million, or 8.5%, to $161.2 million, from $148.6 million for the nine months ended September 30, 2017.  This increase primarily reflects an increase in financing rates on our repurchase agreement financings, an increase in our average borrowings and securitized debt to finance residential whole loans, MSR related assets and CRT securities, which was partially offset by a decrease in our average repurchase agreement borrowings and other advances to finance our MBS portfolio. The effective interest rate paid on our borrowings increased to 3.03% for the nine months ended September 30, 2018, from 2.49% for the nine months ended September 30, 2017. 

Payments made and/or received on our Swaps designated as hedges for accounting purposes are a component of our borrowing costs and accounted for interest expense of $4.2 million, or 8 basis points, for the nine months ended September 30, 2018, compared to interest expense of $19.6 million, or 33 basis points, for the nine months ended September 30, 2017.  The weighted average fixed-pay rate on our Swaps designated as hedges increased to 2.09% for the nine months ended September 30, 2018 from 1.96% for the nine months ended September 30, 2017.  The weighted average variable interest rate received on our Swaps designated as hedges increased to 1.86% for the nine months ended September 30, 2018 from 1.00% for the nine months ended September 30, 2017.

Other Income, net

For the nine months ended September 30, 2018, Other Income, net increased by $44.0 million, or 47.3%, to $137.0 million compared to $93.0 million for the nine months ended September 30, 2017.  The components of Other Income, net for the nine months ended September 30, 2018 and 2017 are summarized in the table below:

	Nine Months Ended   September 30,
(In Thousands)	2018			2017
Net gains on residential whole loans held at fair value	$	105,883		$	48,660
Liquidation gains on purchased credit impaired loans and other loan related income	10,018			4,835
Net loss on REO properties	(4,899		)	(4,463		)
Realized gains on MBS and CRT securities sold	32,661			30,530
Net unrealized (loss)/gain on MBS and CRT securities held at fair value	(11,776		)	14,173
Net gain on Swaps not designated as hedges for accounting purposes	4,355			—
OTTI and other	783			(733		)
Total Other Income, net:	$	137,025		$	93,002

Operating and Other Expense

During the nine months ended September 30, 2018, we had compensation and benefits and other general and administrative expenses of $34.2 million, or 1.38% of average equity, compared to $40.3 million, or 1.69% of average equity, for the nine months ended September 30, 2017.  Compensation and benefits expense decreased$5.6 million to $20.7 million for the nine months ended September 30, 2018, compared to $26.3 million for the nine months ended September 30, 2017, which includes the impact of non-recurring expenses recorded in the third quarter of 2017 in relation to the our contractual obligation to accelerate the vesting of certain share based awards and to make a death benefit payment to the estate of our former Chief Executive Officer. Our other general and administrative expenses decreased by $491,000 to $13.6 million for the nine months ended September 30, 2018 compared to $14.1 million for the nine months ended September 30, 2017, primarily due to higher costs in the prior period associated with loan securitization transactions and lower costs associated with deferred compensation to Directors in the current year period, partially offset by an increase in professional services related costs in the current year period. 

Operating and Other Expense during the nine months ended September 30, 2018 also includes $23.6 million of loan servicing and other related operating expenses related to our residential whole loan activities. These expenses increased compared to the prior year period by approximately $8.8 million, or 59.4%, primarily due to increased loan servicing and related fees, increases in non-recoverable advances on REO. In addition, the prior period included the impact of a reversal of allowance for loan losses recorded against purchased credit impact residential whole loans, while the current year period included a small increase in the allowance for loan losses.

80

Selected Financial Ratios

The following table presents information regarding certain of our financial ratios at or for the dates presented:

At or for the Nine Months Ended	Return on Average Total Assets (1)		Return on Average Total Stockholders’ Equity (2)		Total Average Stockholders’ Equity to Total Average Assets (3)		Dividend Payout Ratio (4)	Leverage Multiple (5)	Book Value per Share of Common Stock (6)
September 30, 2018	2.82	%	9.75	%	30.40	%	1.07	2.3	$	7.46
September 30, 2017	2.38		9.30		27.01		1.11	2.4	7.70

(1) Reflects annualized net income available to common stock and participating securities divided by average total assets.

(2) Reflects annualized net income divided by average total stockholders’ equity.

(3) Reflects total average stockholders’ equity divided by total average assets.

(4) Reflects dividends declared per share of common stock divided by earnings per share.

(5) Represents the sum of borrowings under repurchase agreements, securitized debt, payable for unsettled purchases, obligations to return securities obtained as collateral and Senior Notes divided by stockholders’ equity.

(6) Reflects total stockholders’ equity less the preferred stock liquidation preference divided by total shares of common stock outstanding.

Recent Accounting Standards to Be Adopted in Future Periods

Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement

In August 2018, the FASB issued ASU 2018-13, Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurements (or ASU 2018-13). The amendments in ASU 2018-13 eliminate, add and modify certain disclosure requirements for fair value measurements as part of the FASB’s disclosure framework project, which aims to improve the effectiveness of disclosures in the notes to financial statements by focusing on requirements that are the most important to the users. The guidance in this ASU is effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019, but entities are permitted to early adopt either the entire standard or only the provisions that eliminate or modify the requirements. The guidance on changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 measurements, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively. All other amendments should be applied retrospectively. We do not expect that adoption of ASU 2018-13 will have a significant impact on our financial position or financial statement disclosures.

Compensation - Stock Compensation - Improvements to Nonemployee Share-Based Payment Accounting

In June 2018, the FASB issued ASU 2018-07, Improvements to Nonemployee Share-Based Payment Accounting (or ASU 2018-07). The amendments in this ASU simplify the accounting for share-based payments to nonemployees by aligning it with the accounting for share-based payments to employees, with certain exceptions. The amendments in ASU 2018-07 do not change existing guidance on accounting for share-based payment transactions for employees. ASU 2018-07 is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted, but no earlier than an entity’s adoption of FASB Accounting Standards Codification Topic 606, Revenue from Contracts with Customers. An entity should apply the amendments of this ASU to all new awards granted after the date of adoption. In addition, entities will apply the new guidance to equity-classified nonemployee awards for which a measurement date has not been established and liability-classified nonemployee awards that have not been settled as of date of adoption by recognizing a cumulative-effect adjustment to retained earnings as of the beginning of the annual period of adoption. We are currently evaluating the effect that ASU 2018-07 will have on our consolidated financial statements and related disclosures, but do not anticipate that adoption of the new standard would have a significant impact.

Derivatives and Hedging - Targeted Improvements to Accounting for Hedging Activities

In August 2017, the FASB issued ASU 2017-12, Targeted Improvements to Accounting for Hedging Activities (or ASU 2017-12). The amendments in this ASU expand an entity’s ability to hedge non-financial and financial risk components and reduce complexity in fair value hedges of interest rate risk. The new guidance eliminates the requirement to separately measure and report hedge ineffectiveness and requires the entire change in the fair value of a hedging instrument to be presented in the same income statement line as the hedged item. ASU 2017-12 also simplifies certain documentation and assessment requirements and modifies the accounting for components excluded from the assessment of hedge effectiveness. ASU 2017-12 is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early application is permitted in any interim period or fiscal year before the effective date. An entity should apply the amendments of this ASU to

81

cash flow and net investment hedge relationships that exist on the date of adoption using a modified retrospective approach. The presentation and disclosure requirements of ASU 2017-12 should be applied prospectively. In addition, certain transition elections may be made by an entity upon adoption to allow for existing hedging relationships to transition to the newly allowable alternatives within this ASU. We are currently evaluating the effect that ASU 2017-12 will have on our consolidated financial statements and related disclosures, but do not anticipate that adoption of the new standard would have a significant impact.

Receivables - Nonrefundable Fees and Other Costs

In March 2017, the FASB issued ASU 2017-08, Premium Amortization on Purchased Callable Debt Securities (or ASU 2017-08). The amendments in this ASU shorten the amortization period for certain purchased callable debt securities held at a premium to the earliest call date. ASU 2017-08 is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early application is permitted in any interim period or fiscal year before the effective date. An entity should apply the amendments of this ASU on the date of adoption using a modified retrospective approach through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. We are currently evaluating the effect that ASU 2017-08 will have on our consolidated financial statements and expect to complete our evaluation in the fourth fiscal quarter of 2018.

Financial Instruments - Credit Losses - Measurement of Credit Losses on Financial Instruments

In June 2016, the FASB issued ASU 2016-13, Measurements of Credit Losses on Financial Instruments (or ASU 2016-13). The amendments in ASU 2016-13 require entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. Entities will now use forward-looking information to better inform their credit loss estimates. ASU 2016-13 also requires enhanced financial statement disclosures to help financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. ASU 2016-13 is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted for all entities for annual periods beginning after December 15, 2018, and interim periods therein. The amendments in this ASU are required to be applied by recording a cumulative-effect adjustment to equity as of the beginning of the first reporting period in which the guidance is effective. A prospective transition approach is required for debt securities for which an OTTI had been recognized before the effective date. We will continue to monitor and evaluate the potential effects that ASU 2016-13 will have on our consolidated financial statements and related disclosures.

Under ASU 2016-13, credit losses for available-for-sale debt securities should be measured in a manner similar to current GAAP. However, the amendments in this ASU require that credit losses be recorded through an allowance for credit losses, which will allow subsequent reversals in credit loss estimates to be recognized in current income. In addition, the allowance on available-for-sale debt securities will be limited to the extent that the fair value is less than the amortized cost. Based on our initial evaluation of the amendments in this ASU, we anticipate being required to make changes to the way we account for credit impairment losses on our available-for-sale debt securities. Under our current accounting, credit impairment losses are generally required to be recorded as OTTI, which directly reduce the carrying amount of impaired securities, and are recorded in earnings and are not reversed if expected cash flows subsequently recover. Under the new guidance, credit impairments on such securities will be recorded as an allowance for credit losses that are also recorded in earnings, but the allowance can be reversed through earnings in a subsequent period if expected cash flows subsequently recover.

In addition, we expect that the new guidance will also result in changes to the accounting and presentation of our residential whole loans held at carrying value. We currently anticipate that, upon adoption, the guidance will result in an increase in the gross carrying amount of our purchased credit impaired loans held at carrying value by the amount of the allowance for loan losses calculated under the new guidance. Thereafter, changes in the expected cash flows of such assets are expected to result in the recognition (or reversal) of an allowance for loan losses that will impact earnings. In addition, we expect that the guidance will result in an increase in the allowance for credit losses for our Other Loans at Carrying Value, with a resulting negative adjustment to retained earnings.

Leases

In February 2016, the FASB issued ASU 2016-02, Leases (or ASU 2016-02). The amendments in this ASU establish a right-of-use model that requires a lessee to record a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. ASU 2016-02 is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the

82

financial statements, with certain practical expedients available. Our significant lease contracts are discussed in Note 10(a) of the accompanying consolidated financial statements. While we continue to evaluate the potential impact that adoption of ASU 2016-02 will have on our financial reporting, given the relatively limited nature and extent of lease financing transactions that we have entered into, we do not expect that the adoption of ASU 2016-02 will have a significant impact on our financial position or financial statement disclosures.

Liquidity and Capital Resources

General

Our principal sources of cash generally consist of borrowings under repurchase agreements and other collateralized financings, payments of principal and interest we receive on our investment portfolio, cash generated from our operating results and, to the extent such transactions are entered into, proceeds from capital market and structured financing transactions.  Our most significant uses of cash are generally to pay principal and interest on our financing transactions, to purchase residential mortgage assets, to make dividend payments on our capital stock, to fund our operations and to make other investments that we consider appropriate.

We seek to employ a diverse capital raising strategy under which we may issue capital stock and other types of securities. To the extent we raise additional funds through capital market transactions, we currently anticipate using the net proceeds from such transactions to acquire additional residential mortgage-related assets, consistent with our investment policy, and for working capital, which may include, among other things, the repayment of our financing transactions.  There can be no assurance, however, that we will be able to access the capital markets at any particular time or on any particular terms.  We have available for issuance an unlimited amount (subject to the terms and limitations of our charter) of common stock, preferred stock, depositary shares representing preferred stock, warrants, debt securities, rights and/or units pursuant to our automatic shelf registration statement and, at September 30, 2018, we had approximately 11.9 million shares of common stock available for issuance pursuant to our DRSPP shelf registration statement.  During the nine months ended September 30, 2018, we issued 302,264 shares of common stock through our DRSPP, raising net proceeds of approximately $2.2 million. During the three months ended September 30, 2018, we issued approximately 50.9 million shares of common stock in a public offering, generating net proceeds of approximately $389.4 million.

Our borrowings under repurchase agreements are uncommitted and renewable at the discretion of our lenders and, as such, our lenders could determine to reduce or terminate our access to future borrowings at virtually any time.  The terms of the repurchase transaction borrowings under our master repurchase agreements, as such terms relate to repayment, margin requirements and the segregation of all securities that are the subject of repurchase transactions, generally conform to the terms contained in the standard master repurchase agreement published by the Securities Industry and Financial Markets Association (or SIFMA) or the global master repurchase agreement published by SIFMA and the International Capital Market Association.  In addition, each lender typically requires that we include supplemental terms and conditions to the standard master repurchase agreement.  Typical supplemental terms and conditions, which differ by lender, may include changes to the margin maintenance requirements, required haircuts (as defined below), purchase price maintenance requirements, requirements that all controversies related to the repurchase agreement be litigated in a particular jurisdiction and cross default and setoff provisions.

With respect to margin maintenance requirements for repurchase agreements secured by harder to value assets, such as Non-Agency MBS, residential whole loans and MSR related assets, margin calls are typically determined by our counterparties based on their assessment of changes in the fair value of the underlying collateral and in accordance with the agreed upon haircuts specified in the transaction confirmation with the counterparty.  We address margin call requests in accordance with the required terms specified in the applicable repurchase agreement and such requests are typically satisfied by posting additional cash or collateral on the same business day.  We review margin calls made by counterparties and assess them for reasonableness by comparing the counterparty valuation against our valuation determination.  When we believe that a margin call is unnecessary because our assessment of collateral value differs from the counterparty valuation, we typically hold discussions with the counterparty and are able to resolve the matter.  In the unlikely event that resolution cannot be reached, we will look to resolve the dispute based on the remedies available to us under the terms of the repurchase agreement, which in some instances may include the engagement of a third-party to review collateral valuations.  For other agreements that do not include such provisions, we could resolve the matter by substituting collateral as permitted in accordance with the agreement or otherwise request the counterparty to return the collateral in exchange for cash to unwind the financing.

83

The following table presents information regarding the margin requirements, or the percentage amount by which the collateral value is contractually required to exceed the loan amount (this difference is referred to as the “haircut”), on our repurchase agreements at September 30, 2018 and December 31, 2017:

At September 30, 2018	Weighted Average Haircut		Low		High
Repurchase agreement borrowings secured by:
Agency MBS	4.48	%	3.00	%	5.00	%
Legacy Non-Agency MBS	21.70		15.00		30.00
RPL/NPL MBS	21.22		15.00		30.00
CRT securities	19.73		16.67		25.00
MSR related assets	22.56		20.00		30.00
Residential whole loans	21.93		8.00		33.00
At December 31, 2017	Weighted Average Haircut		Low		High
Repurchase agreement borrowings secured by:
Agency MBS	4.65	%	3.00	%	8.00	%
Legacy Non-Agency MBS	21.87		15.00		35.00
RPL/NPL MBS	22.05		20.00		27.50
U.S. Treasury securities	1.47		1.00		2.00
CRT securities	22.16		15.00		25.00
MSR related assets	33.19		30.00		50.00
Residential whole loans	26.10		20.00		35.00

During the first nine months of 2018, the weighted average haircut requirements for the respective underlying collateral types for our repurchase agreements have remained fairly consistent compared to the end of 2017. Weighted average haircuts have decreased on MSR related assets, CRT securities and residential whole loans.

Repurchase agreement funding for our residential mortgage investments has been available to us at generally attractive market terms from multiple counterparties.  Typically, due to the risks inherent in credit sensitive residential mortgage investments, repurchase agreement funding involving such investments is available at terms requiring higher collateralization and higher interest rates than repurchase agreement funding secured by Agency MBS and U.S. Treasury securities.  Therefore, we generally expect to be able to finance our acquisitions of Agency MBS on more favorable terms than financing for credit sensitive investments.

We maintain cash and cash equivalents, unpledged Agency and Non-Agency MBS and collateral in excess of margin requirements held by our counterparties (or collectively, “cash and other unpledged collateral”) to meet routine margin calls and protect against unforeseen reductions in our borrowing capabilities.  Our ability to meet future margin calls will be impacted by our ability to use cash or obtain financing from unpledged collateral, which can vary based on the market value of such collateral, our cash position and margin requirements.  Our cash position fluctuates based on the timing of our operating, investing and financing activities and is managed based on our anticipated cash needs.  (See our Consolidated Statements of Cash Flows, included under Item 1 of this Quarterly Report on Form 10-Q and “Interest Rate Risk” included under Item 3 of this Quarterly Report on Form 10-Q.)

At September 30, 2018, we had a total of $9.0 billion of MBS, CRT securities, residential whole loans and MSR related assets and $6.5 million of restricted cash pledged against our repurchase agreements. At September 30, 2018, we have access to various sources of liquidity which we estimate exceeds $412.1 million. This includes (i) $104.2 million of cash and cash equivalents; (ii) $188.2 million in estimated financing available from unpledged Agency MBS and other Agency MBS collateral that is currently pledged in excess of contractual requirements; and (iii) $119.7 million in estimated financing available from unpledged Non-Agency MBS and from other Non-Agency MBS and CRT collateral that is currently pledged in excess of contractual requirements. Our sources of liquidity do not include restricted cash. In addition, we have $1.1 billion of unencumbered residential whole loans. We are evaluating potential opportunities to finance these assets, including loan securitization.

84

The table below presents certain information about our borrowings under repurchase agreements and securitized debt:

	Repurchase Agreements						Securitized Debt
Quarter Ended (1)	Quarterly Average Balance		End of Period Balance		Maximum Balance at Any Month-End		Quarterly Average Balance		End of Period Balance		Maximum Balance at Any Month-End
(In Thousands)
September 30, 2018	$	6,594,050	$	7,278,270	$	7,278,270	$	665,572	$	714,203	$	744,521
June 30, 2018	6,189,916		5,892,228		6,319,178		432,283		518,655		523,490
March 31, 2018	6,519,390		6,558,860		6,558,860		357,819		351,278		361,002
December 31, 2017	6,661,020		6,614,701		6,760,360		212,445		363,944		363,944
September 30, 2017	7,022,913		6,871,443		7,023,702		139,276		137,327		141,088

(1) The information presented in the table above excludes Senior Notes issued in April 2012. The outstanding balance of Senior Notes has been unchanged at $100.0 million since issuance.

Cash Flows and Liquidity for the Nine Months Ended September 30, 2018

Our cash, cash equivalents and restricted cash decreased by $352.4 million during the nine months ended September 30, 2018, reflecting: $1.6 billion used in our investing activities; $1.2 billion provided by our financing activities; and $90.3 million provided by our operating activities.

At both September 30, 2018 and December 31, 2017, our debt-to-equity multiple was 2.3 times. At September 30, 2018, we had borrowings under repurchase agreements of $7.3 billion with 28 counterparties, of which $2.6 billion were secured by Agency MBS, $1.6 billion were secured by Legacy Non-Agency MBS, $913.2 million were secured by RPL/NPL MBS, $405.2 million were secured by CRT securities, $435.8 million were secured by MSR related assets and $1.3 billion were secured by residential whole loans.  We continue to have available capacity under our repurchase agreement credit lines.  In addition, at September 30, 2018, we had securitized debt of $714.2 million in connection with our loan securitization transactions. At December 31, 2017, we had borrowings under repurchase agreements of $6.6 billion with 31 counterparties, of which $2.5 billion were secured by Agency MBS, $1.3 billion were secured by Legacy Non-Agency MBS, $567.1 million were secured by RPL/NPL MBS, $470.3 million were secured by U.S. Treasuries, $459.1 million were secured by CRT securities, $317.3 million were secured by MSR related assets and $1.0 billion were secured by residential whole loans. In addition, at December 31, 2017, we had securitized debt of $363.9 million in connection with our loan securitization transactions.

During the nine months ended September 30, 2018, $1.6 billion was provided by our investing activities.  We paid $2.2 billion for purchases of residential whole loans and capitalized advances, and purchased $512.5 million of MSR related assets, $647.3 million of Non-Agency MBS, $795.9 million of Agency MBS, and $104.6 million of CRT securities funded with cash and repurchase agreement borrowings.  In addition, during the nine months ended September 30, 2018, we received cash of $1.8 billion from prepayments and scheduled amortization on our MBS, CRT securities and MSR related assets, of which $547.6 million was attributable to Agency MBS, $797.4 million was from Non-Agency MBS, $11.8 million was from CRT securities and $440.3 million was attributable to MSR related assets, and we sold certain of our investment securities for $341.6 million, realizing net gains of $32.7 million. While we generally intend to hold our MBS and CRT securities as long-term investments, we may sell certain of our securities in order to manage our interest rate risk and liquidity needs, meet other operating objectives and adapt to market conditions. During the nine months ended September 30, 2018 we received $345.9 million of principal payments on residential whole loans and $93.6 million of proceeds on sales of REO. 

In connection with our repurchase agreement borrowings and Swaps, we routinely receive margin calls/reverse margin calls from our counterparties and make margin calls to our counterparties.  Margin calls and reverse margin calls, which requirements vary over time, may occur daily between us and any of our counterparties when the value of collateral pledged changes from the amount contractually required.  The value of securities pledged as collateral fluctuates reflecting changes in: (i) the face (or par) value of our MBS; (ii) market interest rates and/or other market conditions; and (iii) the market value of our Swaps.  Margin calls/reverse margin calls are satisfied when we pledge/receive additional collateral in the form of additional securities and/or cash.

85

The table below summarizes our margin activity with respect to our repurchase agreement financings for the quarterly periods presented:

	Collateral Pledged to Meet Margin Calls						Cash and Securities Received for Reverse Margin Calls		Net Assets Received/(Pledged) for Margin Activity
For the Quarter Ended (1)	Fair Value of Securities Pledged		Cash Pledged		Aggregate Assets Pledged For Margin Calls
(In Thousands)
September 30, 2018	$	61,492	$	3,005	$	64,497	$	8,294	$	(56,203	)
June 30, 2018	44,278		—		44,278		20,001		(24,277		)
March 31, 2018	40,831		—		40,831		18,835		(21,996		)
December 31, 2017	87,960		—		87,960		80,105		(7,855		)
September 30, 2017	83,513		—		83,513		53,499		(30,014		)

(1) Excludes variation margin payments on the Company’s cleared Swaps which are treated as a legal settlement of the exposure under the Swap contract.

We are subject to various financial covenants under our repurchase agreements and derivative contracts, which include minimum net worth and/or profitability requirements, maximum debt-to-equity ratios and minimum market capitalization requirements.  We have maintained compliance with all of our financial covenants through September 30, 2018.

During the nine months ended September 30, 2018, we paid $239.6 million for cash dividends on our common stock and dividend equivalents and paid cash dividends of $11.3 million on our preferred stock. On September 13, 2018, we declared our third quarter 2018 dividend on our common stock of $0.20 per share; on October 31, 2018, we paid this dividend, which totaled approximately $90.1 million, including dividend equivalents of approximately $241,000. 

We believe that we have adequate financial resources to meet our current obligations, including margin calls, as they come due, to fund dividends we declare and to actively pursue our investment strategies.  However, should the value of our MBS suddenly decrease, significant margin calls on our repurchase agreement borrowings could result and our liquidity position could be materially and adversely affected.  Further, should market liquidity tighten, our repurchase agreement counterparties may increase our margin requirements on new financings, reducing our ability to use leverage.  Access to financing may also be negatively impacted by the ongoing volatility in the world financial markets, potentially adversely impacting our current or potential lenders’ ability or willingness to provide us with financing. In addition, there is no assurance that favorable market conditions will continue to permit us to consummate additional securitization transactions if we determine to seek that form of financing.

Off-Balance Sheet Arrangements

We have not participated in transactions that create relationships with unconsolidated entities or financial partnerships which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

Inflation

Substantially all of our assets and liabilities are financial in nature.  As a result, changes in interest rates and other factors impact our performance far more than does inflation.  Our results of operations and reported assets, liabilities and equity are measured with reference to historical cost or fair value without considering inflation.

86

Item 3.  Quantitative and Qualitative Disclosures About Market Risk.

We seek to manage our risks related to interest rates, liquidity, prepayment speeds, market value and the credit quality of our assets while, at the same time, seeking to provide an opportunity to stockholders to realize attractive total returns through ownership of our capital stock.  While we do not seek to avoid risk, we seek, consistent with our investment policies, to:  assume risk that can be quantified based on management’s judgment and experience and actively manage such risk; earn sufficient returns to justify the taking of such risks; and maintain capital levels consistent with the risks that we undertake.

Interest Rate Risk

We generally acquire interest-rate sensitive assets and fund them with interest-rate sensitive liabilities, a portion of which are hedged with Swaps. We are exposed to interest rate risk on our residential mortgage assets, as well as on our liabilities. Changes in interest rates can affect our net interest income and the fair value of our assets and liabilities.

We finance the majority of our investments in residential mortgage assets with short-term repurchase agreements. In general, when interest rates change, the borrowing costs of our repurchase agreements (net of the impact of Swaps) change more quickly than the yield on our assets. In a rising interest rate environment, the borrowing costs of our repurchase agreements may increase faster than the interest income on our assets, thereby reducing our net income. In order to mitigate compression in net income based on such interest rate movements, we use Swaps to lock in a portion of the net interest spread between assets and liabilities.

When interest rates change, the fair value of our residential mortgage assets could change at a different rate than the fair value of our liabilities. We measure the sensitivity of our portfolio to changes in interest rates by estimating the duration of our assets and liabilities. Duration is the approximate percentage change in fair value for a 100 basis point parallel shift in the yield curve. In general, our assets have higher duration than our liabilities and in order to reduce this exposure we use Swaps to reduce the gap in duration between our assets and liabilities.

In calculating the duration of our Agency MBS we take into account the characteristics of the underlying mortgage loans including whether the underlying loans are fixed rate, adjustable or hybrid; coupon, expected prepayment rates and lifetime and periodic caps. We use third-party financial models, combined with management’s assumptions and observed empirical data when estimating the duration of our Agency MBS.

In analyzing the interest rate sensitivity of our Legacy Non-Agency MBS we take into account the characteristics of the underlying mortgage loans, including credit quality and whether the underlying loans are fixed-rate, adjustable or hybrid. We estimate the duration of our Legacy Non-Agency MBS using management’s assumptions.

The majority of our RPL/NPL MBS deal structures contain a contractual coupon step-up feature where the coupon increases from 300 - 400 basis points at 36 - 48 months from issuance or sooner. Therefore, we believe their fair value exhibits little sensitivity to changes in interest rates. We estimate the duration of these securities using management’s assumptions.

The fair value of our re-performing residential whole loans is dependent on the value of the underlying real estate collateral, past and expected delinquency status of the borrower as well as the level of interest rates. Because the borrower is not delinquent on their mortgage payments but is less likely to prepay the loan due to weak credit history and/or high LTV, we believe our re-performing residential whole loans exhibit positive duration. We estimate the duration of our re-performing residential whole loans using management’s assumptions.

The fair value of our Non-QM loans and Single family rental loans are dependent on the value of the underlying real estate collateral, as well as the level of interest rates. Because these loans are primarily newly or recently originated performing loans, we believe these investments exhibit positive duration. Given the short duration of the Company’s Rehabilitation loans, we believe the fair value of these loans exhibits little sensitivity to changes in interest rates. We estimate the duration of these other loans held at carrying value using management’s assumptions.

The fair value of our non-performing residential whole loans is primarily dependent on the value of the underlying real estate collateral and the time required for collateral liquidation. Since neither the value of the collateral nor the liquidation timeline is generally sensitive to interest rates, we believe their fair value exhibits little sensitivity to interest rates. We estimate the duration of our non-performing residential whole loans using management’s assumptions.

We use Swaps as part of our overall interest rate risk management strategy. Such derivative financial instruments are intended to act as a hedge against future interest rate increases on our repurchase agreement financings, which rates are typically highly

87

correlated with LIBOR. While our derivatives do not extend the maturities of our borrowings under repurchase agreements, they do, in effect, lock in a fixed rate of interest over their term for a corresponding amount of our repurchase agreement financings that are hedged. 

At September 30, 2018, MFA’s $5.1 billion of Agency MBS and Legacy Non-Agency MBS were backed by Hybrid, adjustable and fixed-rate mortgages.  Additional information about these MBS, including average months to reset and three-month average CPR, is presented below:

	Agency MBS					Legacy Non-Agency MBS (1)					Total (1)
Time to Reset	Fair Value (2)		Average Months to Reset (3)	3 Month  Average CPR (4)		Fair Value		Average Months to Reset (3)	3 Month  Average CPR (4)		Fair Value (2)		Average Months to Reset (3)	3 Month  Average CPR (4)
(Dollars in Thousands)
< 2 years (5)	$	1,150,471	6	22.7	%	$	1,417,756	4	18.6	%	$	2,568,227	5	20.3	%
2-5 years	131,924		44	12.6		—		—	—		131,924		44	12.6
> 5 years	9,653		82	10.7		—		—	—		9,653		82	10.7
ARM-MBS Total	$	1,292,048	11	21.6	%	$	1,417,756	4	18.6	%	$	2,709,804	7	19.9	%
15-year fixed (6)	$	866,346		11.5	%	$	1,915		17.6	%	$	868,261		11.5	%
30-year fixed (6)	746,658			8.7		719,047			13.4		1,465,705			12.5
40-year fixed (6)	—			—		34,324			16.7		34,324			16.7
Fixed-Rate Total	$	1,613,004		11.0	%	$	755,286		13.6	%	$	2,368,290		12.2	%
MBS Total	$	2,905,052		16.8	%	$	2,173,042		16.8	%	$	5,078,094		16.8	%

(1) Excludes $1.2 billion of RPL/NPL MBS. Refer to table below for further information.

(2) Does not include principal payments receivable of $438,000.

(3) Months to reset is the number of months remaining before the coupon interest rate resets.  At reset, the MBS coupon will adjust based upon the underlying benchmark interest rate index, margin and periodic and/or lifetime caps.  The months to reset do not reflect scheduled amortization or prepayments.

(4) 3 month average CPR weighted by positions as of the beginning of each month in the quarter.

(5) Includes floating-rate MBS that may be collateralized by fixed-rate mortgages.

(6) Information presented based on data available at time of loan origination.

The following table presents certain information about our RPL/NPL MBS portfolio at September 30, 2018:

(Dollars in Thousands)	Fair Value		Net Coupon		Months to Step-Up (1)	3 Month Average Bond CPR (2)
Re-Performing loans	$	97,871	4.36	%	31	11.4	%
Non-Performing loans	1,063,697		4.66		24	19.9
Total RPL/NPL MBS	$	1,161,568	4.63	%	24	19.6	%

(1) Months to step-up is the weighted average number of months remaining before the coupon interest rate increases pursuant to the first coupon reset. We anticipate that the securities will be redeemed prior to the step-up date.

(2) All principal payments are considered to be prepayments for CPR purposes.

At September 30, 2018, our CRT securities and MSR related assets had a fair value of $538.9 million and $565.3 million, respectively, and their coupons reset monthly based on one-month LIBOR.

88

Shock Table

The information presented in the following “Shock Table” projects the potential impact of sudden parallel changes in interest rates on our net interest income and portfolio value, including the impact of Swaps, over the next 12 months based on the assets in our investment portfolio at September 30, 2018.  All changes in income and value are measured as the percentage change from the projected net interest income and portfolio value under the base interest rate scenario at September 30, 2018.

Change in Interest Rates	Estimated Value of Assets (1)		Estimated Value of Swaps			Estimated Value of Financial Instruments		Change in Estimated Value			Percentage Change in Net Interest Income		Percentage Change in Portfolio Value
(Dollars in Thousands)
+100 Basis Point Increase	$	11,486,783	$	69,382		$	11,556,165	$	(146,619	)	(2.98	)%	(1.25	)%
+ 50 Basis Point Increase	$	11,582,562	$	47,581		$	11,630,143	$	(72,641	)	(1.19	)%	(0.62	)%
Actual at September 30, 2018	$	11,677,003	$	25,781		$	11,702,784	$	—		—		—
- 50 Basis Point Decrease	$	11,770,104	$	3,980		$	11,774,084	$	71,300		(0.05	)%	0.61	%
-100 Basis Point Decrease	$	11,861,867	$	(17,820	)	$	11,844,047	$	141,263		(0.20	)%	1.21	%

(1)   Such assets include MBS and CRT securities, residential whole loans and REO, MSR related assets, cash and cash equivalents and restricted cash.

Certain assumptions have been made in connection with the calculation of the information set forth in the Shock Table and, as such, there can be no assurance that assumed events will occur or that other events will not occur that would affect the outcomes.  The base interest rate scenario assumes interest rates at September 30, 2018.  The analysis presented utilizes assumptions and estimates based on management’s judgment and experience.  Furthermore, while we generally expect to retain the majority of our assets and the associated interest rate risk to maturity, future purchases and sales of assets could materially change our interest rate risk profile.  It should be specifically noted that the information set forth in the above table and all related disclosure constitute forward-looking statements within the meaning of Section 27A of the 1933 Act and Section 21E of the 1934 Act.  Actual results could differ significantly from those estimated in the Shock Table above.

The Shock Table quantifies the potential changes in net interest income and portfolio value, which includes the value of our Swaps (which are carried at fair value), should interest rates immediately change (i.e., are shocked).  The Shock Table presents the estimated impact of interest rates instantaneously rising 50 and 100 basis points, and falling 50 and 100 basis points.  The cash flows associated with our portfolio of MBS for each rate shock are calculated based on assumptions, including, but not limited to, prepayment speeds, yield on replacement assets, the slope of the yield curve and composition of our portfolio.  Assumptions made with respect to the interest rate sensitive liabilities include anticipated interest rates, collateral requirements as a percent of repurchase agreement financings, and the amounts and terms of borrowing.  At September 30, 2018, we applied a floor of 0% for all anticipated interest rates included in our assumptions.  Due to this floor, it is anticipated that any hypothetical interest rate shock decrease would have a limited positive impact on our funding costs; however, because prepayments speeds are unaffected by this floor, it is expected that any increase in our prepayment speeds (occurring as a result of any interest rate shock decrease or otherwise) could result in an acceleration of premium amortization on our Agency MBS and discount accretion on our Non-Agency MBS and in the reinvestment of principal repayments in lower yielding assets.  As a result, because the presence of this floor limits the positive impact of interest rate decrease on our funding costs, hypothetical interest rate shock decreases could cause a decline in the fair value of our financial instruments and our net interest income.

At September 30, 2018, the impact on portfolio value was approximated using estimated effective duration (i.e., the price sensitivity to changes in interest rates), including the effect of Swaps, of 1.14 which is the weighted average of 2.28 for our Agency MBS, 0.92 for our Non-Agency investments, 2.24 for our Residential whole loans, (2.40) for our Swaps, and 0.17 for our Other assets and cash and cash equivalents. Estimated convexity (i.e., the approximate change in duration relative to the change in interest rates) of the portfolio was (0.18), which is the weighted average of (0.74) for our Agency MBS, zero for our Swaps, zero for our Non-Agency MBS, zero for our Residential whole loans and zero for our Other assets and cash and cash equivalents. The impact on our net interest income is driven mainly by the difference between portfolio yield and cost of funding of our repurchase agreements, which includes the cost and/or benefit from Swaps.  Our asset/liability structure is generally such that an increase in interest rates would be expected to result in a decrease in net interest income, as our borrowings are generally shorter in term than our interest-earning assets. When interest rates are shocked, prepayment assumptions are adjusted based on management’s expectations along with the results from the prepayment model.

89

Credit Risk

Although we do not believe that we are exposed to credit risk in our Agency MBS portfolio, we are exposed to credit risk through our credit-sensitive residential mortgage investments, in particular Legacy Non-Agency MBS and residential whole loans and to a lesser extent our investments in RPL/NPL MBS, CRT securities and MSR related assets. Our exposure to credit risk from our credit sensitive investments is discussed in more detail below:

Legacy Non-Agency MBS

Our investment process for Legacy Non-Agency MBS involves analysis focused primarily on quantifying and pricing credit risk.  When we purchase Legacy Non-Agency MBS, we assign certain assumptions to each of the MBS, including but not limited to, future interest rates, voluntary prepayment rates, mortgage modifications, default rates and loss severities, and generally allocate a portion of the purchase discount as a Credit Reserve which provides credit protection for such securities.  As part of our surveillance process, we review our Legacy Non-Agency MBS by tracking their actual performance compared to the securities’ expected performance at purchase or, if we have modified our original purchase assumptions, compared to our revised performance expectations.  To the extent that actual performance of a Legacy Non-Agency MBS is less favorable than its expected performance, we may revise our performance expectations.  As a result, we could reduce the accretable discount on the security and/or recognize an other-than-temporary impairment through earnings, either of which could have a material adverse impact on our operating results. 

In evaluating our asset/liability management and Legacy Non-Agency MBS credit performance, we consider the credit characteristics of the mortgage loans underlying our Legacy Non-Agency MBS.  The following table presents certain information about our Legacy Non-Agency MBS portfolio at September 30, 2018.  Information presented with respect to the weighted average Fair Isaac Corporation (or FICO) scores and other information aggregated based on information reported at the time of mortgage origination are historical and, as such, do not reflect the impact of the general changes in home prices or changes in borrowers’ credit scores or the current use of the mortgaged properties.

90

The information in the table below is presented as of September 30, 2018:

	Securities with Average Loan FICO of 715 or Higher (1)									Securities with Average Loan FICO Below 715 (1)
Year of Securitization (2)	2007			2006			2005 and Prior			2007			2006			2005 and Prior			Total
(Dollars in Thousands)
Number of securities	84			59			71			32			57			63			366
MBS current face (3)	$	660,718		$	376,587		$	375,917		$	149,747		$	390,180		$	389,760		$	2,342,909
Total purchase discounts, net (3)	$	(205,614	)	$	(114,752	)	$	(80,410	)	$	(50,452	)	$	(154,324	)	$	(117,207	)	$	(722,759	)
Purchase discount designated as Credit Reserve and OTTI (3)(4)	$	(143,372	)	$	(58,869	)	$	(45,135	)	$	(41,112	)	$	(149,794	)	$	(93,476	)	$	(531,758	)
Purchase discount designated as Credit Reserve and OTTI as percentage of current face	21.7		%	15.6		%	12.0		%	27.5		%	38.4		%	24.0		%	22.7		%
MBS amortized cost (3)	$	455,104		$	261,835		$	295,507		$	99,295		$	235,856		$	272,553		$	1,620,150
MBS fair value (3)	$	613,637		$	353,729		$	362,391		$	137,360		$	338,212		$	364,882		$	2,170,211
Weighted average fair value to current face	92.9		%	93.9		%	96.4		%	91.7		%	86.7		%	93.6		%	92.6		%
Weighted average coupon (5)	4.47		%	3.87		%	4.34		%	5.16		%	5.14		%	4.93		%	4.59		%
Weighted average loan age (months) (5)(6)	137			146			161			142			148			160			148
Weighted average current loan size (5)(6)	$	487		$	482		$	283		$	326		$	248		$	242		$	362
Percentage amortizing (7)	100		%	99		%	100		%	99		%	99		%	100		%	100		%
Weighted average FICO score at origination (5)(8)	729			728			726			705			702			703			718
Owner-occupied loans	91.1		%	91.5		%	86.7		%	85.4		%	86.8		%	85.0		%	88.4		%
Rate-term refinancings	31.1		%	22.4		%	14.2		%	22.8		%	15.6		%	14.4		%	21.1		%
Cash-out refinancings	35.0		%	36.2		%	27.1		%	44.0		%	45.9		%	40.4		%	37.2		%
3 Month CPR (6)	17.5		%	19.5		%	22.2		%	14.1		%	13.6		%	14.4		%	17.2		%
3 Month CRR (6)(9)	14.4		%	15.7		%	19.4		%	10.4		%	9.5		%	12.4		%	14.0		%
3 Month CDR (6)(9)	3.6		%	4.5		%	3.7		%	4.3		%	4.7		%	2.4		%	3.8		%
3 Month loss severity	71.1		%	55.4		%	35.8		%	78.6		%	68.3		%	58.3		%	61.3		%
60+ days delinquent (8)	11.6		%	10.3		%	8.7		%	14.0		%	12.4		%	11.4		%	11.2		%
Percentage of always current borrowers (Lifetime) (10)	27.6		%	27.8		%	34.6		%	25.0		%	21.2		%	26.4		%	27.3		%
Percentage of always current borrowers (12M) (11)	74.0		%	76.6		%	77.8		%	70.5		%	70.4		%	72.2		%	73.9		%

(1) FICO score is used by major credit bureaus to indicate a borrower’s creditworthiness at time of loan origination.

(2) Information presented based on the initial year of securitization of the underlying collateral. Certain of our Non-Agency MBS have been resecuritized.  The historical information presented in the table is based on the initial securitization date and data available at the time of original securitization (and not the date of resecuritization). No information has been updated with respect to any MBS that have been resecuritized.

(3) Excludes Non-Agency MBS issued since 2012 in which the underlying collateral consists of RPL/NPL MBS. These Non-Agency MBS have a current face of $1.2 billion, amortized cost of $1.2 billion, fair value of $1.2 billion and purchase discounts of $702,000 at September 30, 2018.

(4) Purchase discounts designated as Credit Reserve and OTTI are not expected to be accreted into interest income.

(5) Weighted average is based on MBS current face at September 30, 2018.

(6) Information provided is based on loans for individual groups owned by us.

(7) Percentage of face amount for which the original mortgage note contractually calls for principal amortization in the current period.

(8) Information provided is based on loans for all groups that provide credit enhancement for MBS with credit enhancement.

(9) CRR represents voluntary prepayments and CDR represents involuntary prepayments.

(10) Percentage of face amount of loans for which the borrower has not been delinquent since origination.

(11) Percentage of face amount of loans for which the borrower has not been delinquent in the last twelve months.

91

The mortgages securing our Legacy Non-Agency MBS are located in many geographic regions across the United States.  The following table presents the five largest geographic concentrations by state of the mortgages collateralizing our Legacy Non-Agency MBS at September 30, 2018:

Property Location	Percent of Unpaid Principal Balance
California	42.5	%
Florida	7.9	%
New York	7.3	%
New Jersey	4.0	%
Maryland	4.0	%

RPL/NPL MBS

These securities are backed by re-performing and non-performing loans, were purchased primarily at prices around par and represent the senior and mezzanine tranches of the related securitizations. The majority of these securities are structured with significant credit enhancement (typically approximately 50%) and the subordinate tranches absorb all credit losses (until those tranches are extinguished) and typically receive no cash flow (interest or principal) until the senior tranche is paid off. Prior to purchase, we analyze the deal structure in order to assess the associated credit risk. Subsequent to purchase, the ongoing credit risk associated with the deal is evaluated by analyzing the extent to which actual credit losses occur that result in a reduction in the amount of subordination enjoyed by our bond.

CRT Securities

We are exposed to potential credit losses from our investments in CRT securities issued by Fannie Mae and Freddie Mac. While CRT securities are debt obligations of these GSEs, payment of principal on these securities is not guaranteed. As an investor in a CRT security, we may incur a loss if losses on the mortgage loans in the reference pool exceed the credit enhancement on the underlying CRT security owned by us. We assess the credit risk associated with our investments in CRT securities by assessing the current and expected future performance of the associated reference pool.

MSR Related Assets

Term Notes

We have invested in certain term notes that are issued by SPVs that have acquired rights to receive cash flows representing the servicing fees and/or excess servicing spread associated with certain MSRs. Payment of principal and interest on these term notes is considered by us to be largely dependent on the cash flows generated by the underlying MSRs as this impacts the cash flows available to the SPV that issued the term notes. Credit risk borne by the holders of the term notes is also mitigated by structural credit support in the form of over-collateralization. In addition, credit support is also provided by a corporate guarantee from the ultimate parent or sponsor of the SPV that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the underlying MSRs be insufficient.

Corporate Loan

We have participated in a loan to provide financing to an entity that originates residential whole loans and owns the related MSRs. We assess the credit risk associated with this loan participation by considering various factors, including the current status of the loan, changes in fair value of the MSRs that secure the loan and the recent financial performance of the borrower.

Residential Whole Loans

We are also exposed to credit risk from our investments in residential whole loans. Our investment process for residential whole loans is generally similar to that used for Legacy Non-Agency MBS and is likewise focused on quantifying and pricing credit risk. Non-Performing and purchase credit impaired loans are acquired at purchase prices that are generally discounted to the contractual loan balances based on a number of factors, including the impaired credit history of the borrower and the value of the collateral securing the loan. In addition, as we generally own the master-servicing rights associated with these loans, our process is also focused on selecting a sub-servicer with the appropriate expertise to mitigate losses and maximize our overall return. This involves, among other things, performing due diligence on the sub-servicer prior to their engagement as well as

92

ongoing oversight and surveillance. To the extent that delinquencies and defaults on these loans are higher than our expectation at the time the loans were purchased, the discounted purchase price at which the asset is acquired is intended to provide a level of protection against financial loss.

Credit risk on more recently originated performing loans is mitigated through our process to underwrite the loan before it is purchased and includes an assessment of the borrower’s financial condition and ability to repay the loan, nature of the collateral and LTV, including after-repair LTV for the majority of our Rehabilitation loans.

The following table presents the five largest geographic concentrations by state of our residential whole loan portfolio at September 30, 2018:

Property Location	Percent of Interest-Bearing Unpaid Principal Balance (1)
California	31.6	%
Florida	10.7	%
New York	10.4	%
New Jersey	6.6	%
Maryland	3.8	%

(1) Excludes approximately $8.6 million of residential whole loans for which the closing of the purchase transaction had not occurred as of September 30, 2018.

Liquidity Risk

The primary liquidity risk we face arises from financing long-maturity assets with shorter-term borrowings primarily in the form of repurchase agreement financings.  We pledge residential mortgage assets and cash to secure our repurchase agreements and Swaps.  At September 30, 2018, we had access to various sources of liquidity which we estimate to be in excess of $412.1 million, an amount which includes: (i) $104.2 million of cash and cash equivalents, (ii) $188.2 million in estimated financing available from unpledged Agency MBS and other Agency MBS collateral that are currently pledged in excess of contractual requirements, and (iii) $119.7 million in estimated financing available from currently unpledged Non-Agency MBS and from other Non-Agency MBS and CRT collateral that is currently pledged in excess of contractual requirements.  Our sources of liquidity do not include restricted cash. In addition, we have $1.1 billion of unencumbered residential whole loans. We are evaluating potential opportunities to finance these assets including loan securitization. Should the value of our residential mortgage assets pledged as collateral suddenly decrease, margin calls under our repurchase agreements would likely increase, causing an adverse change in our liquidity position.  Additionally, if one or more of our financing counterparties chose not to provide ongoing funding, our ability to finance our long-maturity assets would decline or be available on possibly less advantageous terms. As such, we cannot assure you that we will always be able to roll over our repurchase agreement financings.  Further, should market liquidity tighten, our repurchase agreement counterparties may increase our margin requirements on new financings, including repurchase agreement borrowings that we roll with the same counterparty, reducing our ability to use leverage.

Prepayment Risk

Premiums arise when we acquire an MBS or loan at a price in excess of the aggregate principal balance of the mortgages securing the MBS (i.e., par value) or when we acquire residential whole loans at a price in excess of their aggregate principal balance.  Conversely, discounts arise when we acquire an MBS or loan at a price below the aggregate principal balance of the mortgages securing the MBS or when we acquire residential whole loans at a price below their aggregate principal balance.  Premiums paid are amortized against interest income and accretable purchase discounts on these investments are accreted to interest income.  Purchase premiums, which are primarily carried on our Agency MBS, certain CRT securities and Non-QM loans, are amortized against interest income over the life of the investment using the effective yield method, adjusted for actual prepayment activity.  An increase in the prepayment rate, as measured by the CPR, will typically accelerate the amortization of purchase premiums, thereby reducing the interest income earned on these assets.  Generally, if prepayments on Non-Agency MBS and residential whole loans purchased at significant discounts and not accounted for at fair value are less than anticipated, we expect that the income recognized on these assets will be reduced and impairments and/or loan loss reserves may result.

93

Item 4.  Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures

Management, under the direction of its Chief Executive Officer and Chief Financial Officer, is responsible for maintaining disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the 1934 Act) that are designed to ensure that information required to be disclosed in reports filed or submitted under the 1934 Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and that such information is accumulated and communicated to management, including the Company’s Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosures.

In connection with the preparation of this Quarterly Report on Form 10-Q, management reviewed and evaluated the Company’s disclosure controls and procedures.  The evaluation was performed under the direction of the Company’s Chief Executive Officer and Chief Financial Officer to determine the effectiveness, as of September 30, 2018, of the design and operation of the Company’s disclosure controls and procedures.  Based on that review and evaluation, the Chief Executive Officer and the Chief Financial Officer have concluded that the Company’s current disclosure controls and procedures, as designed and implemented, were effective as of September 30, 2018. Notwithstanding the foregoing, a control system, no matter how well designed, implemented and operated, can provide only reasonable, not absolute, assurance that it will detect or uncover failures within the Company to disclose material information otherwise required to be set forth in the Company’s current periodic reports.

(b) Changes in Internal Control over Financial Reporting

There have been no changes in the Company’s internal control over financial reporting that occurred during the quarter ended September 30, 2018 that materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.

94

PART II. OTHER INFORMATION

Item 1.  Legal Proceedings

There are no material pending legal proceedings to which we are a party or any of our assets are subject.

Item 1A. Risk Factors

For a discussion of the Company’s risk factors, see Part 1, Item 1A. “Risk Factors” of the Company’s Annual Report on Form 10-K for the year ended December 31, 2017. There are no material changes from the risk factors set forth in such Annual Report on Form 10-K. However, the risks and uncertainties that the Company faces are not limited to those set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017. Additional risks and uncertainties not currently known to the Company (or that it currently believes to be immaterial) may also adversely affect the Company’s business and the trading price of our securities.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

Purchases of Equity Securities

As previously disclosed, in August 2005, the Company’s Board authorized a Repurchase Program, to repurchase up to 4.0 million shares of the Company’s outstanding common stock under the Repurchase Program.  The Board reaffirmed such authorization in May 2010.  In December, 2013, the Company’s Board increased the number of shares authorized for repurchase to an aggregate of 10.0 million shares (under which approximately 6.6 million shares remain available for repurchase). Such authorization does not have an expiration date and, at present, there is no intention to modify or otherwise rescind such authorization.  Subject to applicable securities laws, repurchases of common stock under the Repurchase Program are made at times and in amounts as we deem appropriate (including, in our discretion, through the use of one or more plans adopted under Rule 10b-5-1 promulgated under the 1934 Act), using available cash resources.  Shares of common stock repurchased by the Company under the Repurchase Program are cancelled and, until reissued by the Company, are deemed to be authorized but unissued shares of the Company’s common stock.  The Repurchase Program may be suspended or discontinued by the Company at any time and without prior notice.

The Company engaged in no share repurchase activity during the third quarter of 2018 pursuant to the Repurchase Program nor did it withhold any restricted shares (under the terms of grants under our Equity Plan) to offset tax withholding obligations that occur upon the vesting and release of restricted stock awards and/or RSUs. 

Item 3.  Defaults Upon Senior Securities

None.

Item 4.  Mine Safety Disclosures

None.

Item 5.  Other Information

None.

Item 6. Exhibits

The list of exhibits required to be filed as exhibits to this report are listed on page E-1 hereof, under “Exhibit Index,” which is incorporated herein by reference.

95

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 6, 2018	MFA FINANCIAL, INC.
	(Registrant)
	By:	/s/ Stephen D. Yarad
		Stephen D. Yarad
		Chief Financial Officer
		(Principal Financial Officer)

96

EXHIBIT INDEX

The following exhibits are filed as part of this Quarterly Report:

Exhibit	Description
31.1	Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*	XBRL Instance Document
101.SCH*	XBRL Taxonomy Extension Schema Document
101.CAL*	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*	XBRL Taxonomy Extension Label Linkbase Document
101.PRE*	XBRL Taxonomy Extension Presentation Linkbase Document

*These interactive data files are furnished and deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of  the Securities Act of 1933, as amended, deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

E-1

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Craig L. Knutson, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of MFA Financial, Inc. (the “Registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors:

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: November 6, 2018
By:	/s/ Craig L. Knutson
	Name: Craig L. Knutson
	Title: President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Stephen D. Yarad, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of MFA Financial, Inc. (the “Registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors:

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: November 6, 2018
By:	/s/ Stephen D. Yarad
	Name: Stephen D. Yarad
	Title: Chief Financial Officer

EX-32.1

Exhibit 32.1

Certification of Chief Executive Officer

Pursuant to 18 U.S.C. Section 1350, as Adopted

Pursuant to Section 906 of The Sarbanes-Oxley Act of 2002

The undersigned, the Chief Executive Officer of MFA Financial, Inc. (the “Company”), hereby certifies on the date hereof, pursuant to 18 U.S.C. 1350(a), as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002, that, to my knowledge, the Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2018 (the “Form 10-Q”), filed herewith by the Company, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ Craig L. Knutson	Date: November 6, 2018
	Name: Craig L. Knutson
	Title: President and Chief Executive Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes—Oxley Act of 2002, and is not being “filed” as part of the Form 10-Q or as a separate disclosure document for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liability under that section.  This certification shall not be deemed to be incorporated by reference to any filing under the Securities Act of 1933, as amended, or the Exchange Act except to the extent that this Exhibit 32.1 is expressly and specifically incorporated by reference in any such filing.

A signed original of this statement required by Section 906 had been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

Certification of Chief Financial Officer

Pursuant to 18 U.S.C. Section 1350, as Adopted

Pursuant to Section 906 of The Sarbanes-Oxley Act of 2002

The undersigned, the Chief Financial Officer of MFA Financial, Inc. (the “Company”), hereby certifies on the date hereof, pursuant to 18 U.S.C. 1350(a), as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002, that, to my knowledge, the Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2018 (the “Form 10-Q”), filed herewith by the Company, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ Stephen D. Yarad	Date: November 6, 2018
	Name: Stephen D. Yarad
	Title: Chief Financial Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes—Oxley Act of 2002, and is not being “filed” as part of the Form 10-Q or as a separate disclosure document for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liability under that section.  This certification shall not be deemed to be incorporated by reference to any filing under the Securities Act of 1933, as amended, or the Exchange Act except to the extent that this Exhibit 32.2 is expressly and specifically incorporated by reference in any such filing.

A signed original of this statement required by Section 906 had been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2018	Oct. 31, 2018
Document and Entity Information
Entity Registrant Name	MFA FINANCIAL, INC.
Entity Central Index Key	0001055160
Document Type	10-Q
Document Period End Date	Sep. 30, 2018
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		449,546,435
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q3
Entity Small Business	false
Entity Emerging Growth Company	false

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Sep. 30, 2018	Dec. 31, 2017
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities:
Mortgage-backed securities and credit risk transfer securities		$ 6,779,045	$ 7,023,050
Mortgage servicing rights (“MSR”) related assets ($565,272 and $482,158 pledged as collateral, respectively)		565,272	492,080
Residential whole loans, at carrying value ($1,149,293 and $448,689 pledged as collateral, respectively)	[1]	2,471,567	908,516
Residential whole loans, at fair value ($685,095 and $996,226 pledged as collateral, respectively)	[1]	1,449,365	1,325,115
Cash and cash equivalents		104,186	449,757
Restricted cash		6,489	13,307
Other assets		406,069	742,909
Total Assets		11,781,993	10,954,734
Liabilities:
Repurchase agreements		7,278,270	6,614,701
Other liabilities		951,483	1,078,397
Total Liabilities		8,229,753	7,693,098
Commitments and contingencies (See Note 10)
Stockholders’ Equity:
Preferred stock, $.01 par value; 7.50% Series B cumulative redeemable; 8,050 shares authorized; 8,000 shares issued and outstanding ($200,000 aggregate liquidation preference)		80	80
Common stock, $.01 par value; 886,950 shares authorized; 449,472 and 397,831 shares issued and outstanding, respectively		4,495	3,978
Additional paid-in capital, in excess of par		3,620,268	3,227,304
Accumulated deficit		(598,971)	(578,950)
Accumulated other comprehensive income		526,368	609,224
Total Stockholders’ Equity		3,552,240	3,261,636
Total Liabilities and Stockholders’ Equity		11,781,993	10,954,734
Non-Agency MBS Transferred to Consolidated VIEs
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities:
Residential whole loans, at carrying value ($1,149,293 and $448,689 pledged as collateral, respectively)		215,100	183,200
Residential whole loans, at fair value ($685,095 and $996,226 pledged as collateral, respectively)		723,800	289,300
Agency MBS
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities:
Mortgage-backed securities and credit risk transfer securities		2,905,490	2,824,681
Liabilities:
Repurchase agreements		2,584,097	2,501,340
Non-Agency MBS
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities:
Mortgage-backed securities and credit risk transfer securities		3,334,610	3,533,966
Liabilities:
Repurchase agreements		1,592,067	1,256,033
Non-Agency MBS | Non-Agency MBS
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities:
Mortgage-backed securities and credit risk transfer securities		3,334,610	3,533,966
CRT securities
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities:
Mortgage-backed securities and credit risk transfer securities		538,945	664,403
Liabilities:
Repurchase agreements		$ 405,168	$ 459,058

[1] Includes approximately $215.1 million and $183.2 million of Residential whole loans, at carrying value and $723.8 million and $289.3 million of Residential whole loans, at fair value transferred to consolidated variable interest entities (“VIEs”) at September 30, 2018 and December 31, 2017, respectively. Such assets can be used only to settle the obligations of the VIEs.

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
MSR Related Assets, pledged as collateral (in dollars)	$ 565,272,000	$ 482,158,000
Residential whole loans, carrying value	1,149,293,000	448,689,000
Residential whole loans, fair value	$ 685,095,000	$ 996,226,000
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	8,050,000	8,050,000
Preferred stock, dividend rate (as a percent)	7.50%	7.50%
Preferred stock, shares issued	8,000,000	8,000,000
Preferred stock, shares outstanding	8,000,000	8,000,000
Preferred stock, aggregate liquidation preference (in dollars)	$ 200,000,000	$ 200,000,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	886,950,000	886,950,000
Common stock, shares issued	449,472,000	397,831,000
Common stock, shares outstanding	449,472,000	397,831,000
Collateral Pledged | Agency MBS
Securities, at fair value, pledged as collateral	$ 2,795,273,000	$ 2,727,510,000
Collateral Pledged | Non-Agency MBS
Securities, at fair value, pledged as collateral	3,237,108,000	2,379,523,000
Collateral Pledged | CRT securities
Securities, at fair value, pledged as collateral	$ 504,931,000	$ 595,900,000

XML

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Interest Income:
MSR related assets	$ 6,407	$ 7,194	$ 20,249	$ 17,833
Residential whole loans held at carrying value	29,524	9,026	61,788	26,219
Cash and cash equivalent investments	754	1,452	2,348	2,854
Interest Income	117,432	105,133	322,931	332,546
Interest Expense:
Repurchase agreements and other advances	50,881	46,303	142,832	141,444
Other interest expense	7,997	2,972	18,410	7,202
Interest Expense	58,878	49,275	161,242	148,646
Net Interest Income	58,554	55,858	161,689	183,900
Other Income, net:
Net gain on residential whole loans held at fair value	34,942	18,679	105,883	48,660
Net gain on sales of investment securities	16,415	14,933	32,661	30,530
Other, net	(2,998)	(4,515)	(1,519)	13,812
Other Income, net	48,359	29,097	137,025	93,002
Operating and Other Expense:
Compensation and benefits	6,868	10,892	20,654	26,258
Other general and administrative expense	4,155	4,081	13,569	14,060
Loan servicing and other related operating expenses	8,758	6,177	23,569	14,785
Operating and Other Expense	19,781	21,150	57,792	55,103
Net Income	87,132	63,805	240,922	221,799
Less Preferred Stock Dividends	3,750	3,750	11,250	11,250
Net Income Available to Common Stock and Participating Securities	$ 83,382	$ 60,055	$ 229,672	$ 210,549
Earnings per Common Share - Basic and Diluted (in dollars per share)	$ 0.19	$ 0.15	$ 0.56	$ 0.54
Dividends Declared per Share of Common Stock (in dollars per share)	$ 0.20	$ 0.20	$ 0.60	$ 0.60
Agency MBS
Interest Income:
Securities	$ 14,332	$ 15,533	$ 42,795	$ 50,014
Non-Agency MBS | Non-Agency MBS
Interest Income:
Securities	58,667	63,252	169,812	212,728
CRT securities
Interest Income:
Securities	$ 7,748	$ 8,676	$ 25,939	$ 22,898

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Net income	$ 87,132	$ 63,805	$ 240,922	$ 221,799
Other Comprehensive Income/(Loss):
Reclassification adjustment for MBS sales included in net income	(9,455)	(14,935)	(25,580)	(30,283)
Reclassification adjustment for other-than-temporary impairments included in net income	0	0	0	(1,032)
Derivative hedging instrument fair value changes, net	5,390	5,791	32,974	16,671
Other Comprehensive (Loss)/Income	(38,343)	(2,156)	(82,856)	56,544
Comprehensive income before preferred stock dividends	48,789	61,649	158,066	278,343
Dividends declared on preferred stock	(3,750)	(3,750)	(11,250)	(11,250)
Comprehensive Income Available to Common Stock and Participating Securities	45,039	57,899	146,816	267,093
Agency MBS
Other Comprehensive Income/(Loss):
Unrealized (loss)/gain, net	(9,177)	(3,032)	(27,507)	(22,241)
Non-Agency MBS
Other Comprehensive Income/(Loss):
Unrealized (loss)/gain, net	$ (25,101)	$ 10,020	$ (62,743)	$ 93,429

XML

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands		Total	Preferred Stock Preferred Stock 7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share	Common Stock		Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income
Balance (in shares) at Dec. 31, 2016			8,000,000	371,854,000
Balance at Dec. 31, 2016		$ 3,033,902	$ 80	$ 3,719		$ 3,029,062	$ (572,641)	$ 573,682
Increase (Decrease) in Stockholders' Equity
Net income		221,799					221,799
Issuance of common stock, net of expenses (in shares)	[1]			25,726,000
Issuance of common stock, net of expenses	[1]	190,515		$ 250		190,265
Repurchase of shares of common stock (in shares)	[1]			(641,000)
Repurchase of shares of common stock	[1]	(5,158)				(5,158)
Equity based compensation expense		5,209				5,209
Accrued dividends attributable to stock-based awards		20				20
Dividends declared on common stock		(233,244)					(233,244)
Dividends declared on preferred stock		(11,250)					(11,250)
Dividends attributable to dividend equivalents		(686)					(686)
Change in unrealized gains on MBS, net		39,873						39,873
Derivative hedging instrument fair value changes, net		16,671						16,671
Balance (in shares) at Sep. 30, 2017			8,000,000	396,939,000
Balance at Sep. 30, 2017		3,257,651	$ 80	$ 3,969		3,219,398	(596,022)	630,226
Increase (Decrease) in Stockholders' Equity
Adjustments related to tax withholding for share-based compensation				$ 5,200
Shares paid for tax withholding for share based compensation (in shares)				640,748
Balance (in shares) at Dec. 31, 2017			8,000,000	397,831,000
Balance at Dec. 31, 2017		3,261,636	$ 80	$ 3,978		3,227,304	(578,950)	609,224
Increase (Decrease) in Stockholders' Equity
Net income		240,922					240,922
Issuance of common stock, net of expenses (in shares)	[1]			51,892,000
Issuance of common stock, net of expenses	[1]	$ 391,582		$ 517		391,065
Repurchase of shares of common stock (in shares)		0		(251,000)	[1]
Repurchase of shares of common stock	[1]	$ (1,957)				(1,957)
Equity based compensation expense		3,887				3,887
Accrued dividends attributable to stock-based awards		(31)				(31)
Dividends declared on common stock		(249,287)					(249,287)
Dividends declared on preferred stock		(11,250)					(11,250)
Dividends attributable to dividend equivalents		(701)					(701)
Change in unrealized gains on MBS, net		(115,830)						(115,830)
Derivative hedging instrument fair value changes, net		32,974						32,974
Balance (in shares) at Sep. 30, 2018			8,000,000	449,472,000
Balance at Sep. 30, 2018		$ 3,552,240	$ 80	$ 4,495		$ 3,620,268	$ (598,971)	$ 526,368
Increase (Decrease) in Stockholders' Equity
Adjustments related to tax withholding for share-based compensation				$ 2,000
Shares paid for tax withholding for share based compensation (in shares)				250,946

[1] For the nine months ended September 30, 2018 and 2017, includes approximately $2.0 million (250,946 shares) and $5.2 million (640,748 shares), respectively surrendered for tax purposes related to equity-based compensation awards.

XML

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) - $ / shares		9 Months Ended	12 Months Ended
	Apr. 15, 2013	Sep. 30, 2018	Dec. 31, 2017
Preferred Stock, dividend rate		7.50%	7.50%
Preferred Stock | Preferred Stock 7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share
Preferred Stock, dividend rate	7.50%	7.50%	7.50%
Preferred Stock, liquidation preference per share (in dollars per share)	$ 25.00	$ 25.00	$ 25

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash Flows From Operating Activities:
Net income	$ 240,922	$ 221,799
Adjustments to reconcile net income to net cash provided by operating activities:
Gain on sales of MBS, CRT securities and U.S. Treasury securities	(32,661)	(30,530)
Gain on sales of real estate owned	(6,582)	(2,844)
Gain on liquidation of residential whole loans	(18,598)	(7,178)
Other-than-temporary impairment charges	0	1,032
Accretion of purchase discounts on MBS and CRT securities, residential whole loans and MSR related assets	(64,211)	(67,065)
Amortization of purchase premiums on MBS, CRT securities, and residential whole loans	21,141	23,766
Depreciation and amortization on real estate, fixed assets and other assets	1,354	1,199
Equity-based compensation expense	3,891	5,369
Unrealized gain on residential whole loans at fair value	(26,788)	(12,499)
Unrealized losses/(gains) on MBS and CRT securities	2,767	(11,932)
(Increase)/decrease in other assets and other	(31,018)	10,538
Increase/(decrease) in other liabilities	33	(10,248)
Net cash provided by operating activities	90,250	121,407
Cash Flows From Investing Activities:
Principal payments on MBS, CRT securities and MSR related assets	1,797,012	3,387,673
Proceeds from sales of MBS, CRT securities and U.S. Treasury securities	341,589	222,143
Purchases of MBS, CRT securities, MSR related assets and U.S. Treasury securities	(2,021,914)	(1,425,717)
Purchases of residential whole loans and capitalized advances	(2,158,105)	(391,613)
Principal payments on residential whole loans	345,917	105,549
Proceeds from sales of real estate owned	93,635	51,834
Purchases of real estate owned and capital improvements	(10,179)	(17,224)
Redemption of Federal Home Loan Bank stock	0	10,422
Additions to leasehold improvements, furniture and fixtures	(1,009)	(596)
Net cash (used in)/provided by investing activities	(1,613,054)	1,942,471
Cash Flows From Financing Activities:
Principal payments on repurchase agreements and other advances	(48,988,034)	(57,118,263)
Proceeds from borrowings under repurchase agreements	49,651,416	55,302,002
Proceeds from issuance of securitized debt	419,970	147,847
Principal payments on securitized debt	(67,945)	(9,140)
Payments made for securitization related costs	(2,472)	(1,520)
Payments made for settlements on interest rate swap agreements (“Swaps”)	(40,885)	(30,050)
Proceeds from settlements on Swaps	57,656	0
Proceeds from issuances of common stock	391,932	190,928
Payments made for costs related to common stock issuances	(350)	(412)
Dividends paid on preferred stock	(11,250)	(11,250)
Dividends paid on common stock and dividend equivalents	(239,623)	(228,982)
Net cash provided by/(used in) financing activities	1,170,415	(1,758,840)
Net (decrease)/increase in cash, cash equivalents and restricted cash	(352,389)	305,038
Cash, cash equivalents and restricted cash at beginning of period	463,064	318,575
Cash, cash equivalents and restricted cash at end of period	110,675	623,613
Non-cash Investing and Financing Activities:
Net (decrease)/increase in securities obtained as collateral/obligation to return securities obtained as collateral	(505,850)	131,930
Transfer from residential whole loans to real estate owned	161,572	97,388
Dividends and dividend equivalents declared and unpaid	90,136	79,605
Payable for unsettled MBS and residential whole loans purchases	$ 10,888	$ 124,006

XML

Organization

9 Months Ended

Sep. 30, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization

Organization

MFA Financial, Inc. (the “Company”) was incorporated in Maryland on July 24, 1997 and began operations on April 10, 1998.  The Company has elected to be treated as a real estate investment trust (“REIT”) for U.S. federal income tax purposes.  In order to maintain its qualification as a REIT, the Company must comply with a number of requirements under federal tax law, including that it must distribute at least 90% of its annual REIT taxable income to its stockholders.  The Company has elected to treat certain of its subsidiaries as a taxable REIT subsidiary (“TRS”). In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate related business. (See Note 2(o))

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

(a)  Basis of Presentation and Consolidation

The interim unaudited consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”).  Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been condensed or omitted according to these SEC rules and regulations.  Management believes that the disclosures included in these interim unaudited consolidated financial statements are adequate to make the information presented not misleading.  The accompanying unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.  In the opinion of management, all normal and recurring adjustments necessary to present fairly the financial condition of the Company at September 30, 2018 and results of operations for all periods presented have been made.  The results of operations for the three and nine months ended September 30, 2018 should not be construed as indicative of the results to be expected for the full year.

The accompanying consolidated financial statements of the Company have been prepared on the accrual basis of accounting in accordance with GAAP.  The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Although the Company’s estimates contemplate current conditions and how it expects them to change in the future, it is reasonably possible that actual conditions could differ from those estimates, which could materially impact the Company’s results of operations and its financial condition.  Management has made significant estimates in several areas, including other-than-temporary impairment (“OTTI”) on MBS (See Note 3), valuation of MBS, CRT securities and MSR related assets (See Notes 3 and 14), income recognition and valuation of residential whole loans (See Notes 4 and 14), valuation of derivative instruments (See Notes 5(c) and 14) and income recognition on certain Non-Agency MBS (defined below) purchased at a discount. (See Note 3)  In addition, estimates are used in the determination of taxable income used in the assessment of REIT compliance and contingent liabilities for related taxes, penalties and interest. (See Note 2(o))  Actual results could differ from those estimates.

The Company has one reportable segment as it manages its business and analyzes and reports its results of operations on the basis of one operating segment; investing, on a leveraged basis, in residential mortgage assets.

The consolidated financial statements of the Company include the accounts of all subsidiaries; all intercompany accounts and transactions have been eliminated. In addition, the Company consolidates entities established to facilitate transactions related to the acquisition and securitization of residential whole loans as well as MBS resecuritization transactions completed in prior years. Certain prior period amounts have been reclassified to conform to the current period presentation.

(b)  MBS and CRT Securities

The Company has investments in residential MBS that are issued or guaranteed as to principal and/or interest by a federally chartered corporation, such as the Federal National Mortgage Association (“Fannie Mae”) or the Federal Home Loan Mortgage Corporation (“Freddie Mac”), or an agency of the U.S. Government, such as the Government National Mortgage Association (“Ginnie Mae”) (collectively, “Agency MBS”), and residential MBS that are not guaranteed by any agency of the U.S. Government or any federally chartered corporation (“Non-Agency MBS”). In addition, the Company has investments in CRT securities that are issued by Fannie Mae and Freddie Mac. The coupon payments on CRT securities are paid by Fannie Mae and Freddie Mac and the principal payments received are based on the performance of loans in a reference pool of previously securitized MBS. As the loans in the underlying reference pool are paid, the principal balance of the CRT securities is paid. As an investor in a CRT security, the Company may incur a loss if certain defined credit events occur, including, for certain CRT securities, if the loans in the reference pool experience delinquencies exceeding specified thresholds.

Designation

MBS that the Company generally intends to hold until maturity, but that it may sell from time to time as part of the overall management of its business, are designated as “available-for-sale” (“AFS”). Such MBS are carried at their fair value with unrealized gains and losses excluded from earnings (except when an OTTI is recognized, as discussed below) and reported in Accumulated other comprehensive income/(loss) (“AOCI”), a component of Stockholders’ Equity.

Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of AOCI to earnings as a realized gain or loss using the specific identification method.

The Company has elected the fair value option for certain of its Agency MBS that it does not intend to hold to maturity. These securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statements of operations.

The Company has elected the fair value option for its CRT securities as it considers this method of accounting to more appropriately reflect the risk sharing structure of these securities. Such securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statements of operations.

Revenue Recognition, Premium Amortization and Discount Accretion

Interest income on securities is accrued based on the outstanding principal balance and their contractual terms. Premiums and discounts associated with Agency MBS and Non-Agency MBS assessed as high credit quality at the time of purchase are amortized into interest income over the life of such securities using the effective yield method. Adjustments to premium amortization are made for actual prepayment activity.

Interest income on the Non-Agency MBS that were purchased at a discount to par value and/or are considered to be of less than high credit quality is recognized based on the security’s effective interest rate which is the security’s internal rate of return (“IRR”). The IRR is determined using management’s estimate of the projected cash flows for each security, which are based on the Company’s observation of current information and events and include assumptions related to fluctuations in interest rates, prepayment speeds and the timing and amount of credit losses. On at least a quarterly basis, the Company reviews and, if appropriate, makes adjustments to its cash flow projections based on input and analysis received from external sources, internal models, and its judgment about interest rates, prepayment rates, the timing and amount of credit losses, and other factors. Changes in cash flows from those originally projected, or from those estimated at the last evaluation, may result in a prospective change in the IRR/ interest income recognized on these securities or in the recognition of OTTIs.  (See Note 3)

Based on the projected cash flows from the Company’s Non-Agency MBS purchased at a discount to par value, a portion of the purchase discount may be designated as non-accretable purchase discount (“Credit Reserve”), which effectively mitigates the Company’s risk of loss on the mortgages collateralizing such MBS and is not expected to be accreted into interest income.  The amount designated as Credit Reserve may be adjusted over time, based on the actual performance of the security, its underlying collateral, actual and projected cash flow from such collateral, economic conditions and other factors.  If the performance of a security with a Credit Reserve is more favorable than forecasted, a portion of the amount designated as Credit Reserve may be reallocated to accretable discount and recognized into interest income over time.  Conversely, if the performance of a security with a Credit Reserve is less favorable than forecasted, the amount designated as Credit Reserve may be increased, or impairment charges and write-downs of such securities to a new cost basis could result.

Determination of Fair Value for MBS and CRT Securities

In determining the fair value of the Company’s MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity.  (See Note 14)

Impairments/OTTI

When the fair value of an AFS security is less than its amortized cost at the balance sheet date, the security is considered impaired.  The Company assesses its impaired securities on at least a quarterly basis and designates such impairments as either “temporary” or “other-than-temporary.”  If the Company intends to sell an impaired security, or it is more likely than not that it will be required to sell the impaired security before its anticipated recovery, then the Company must recognize an OTTI through charges to earnings equal to the entire difference between the investment’s amortized cost and its fair value at the balance sheet date.  If the Company does not expect to sell an other-than-temporarily impaired security, only the portion of the impairment related to credit losses is recognized through charges to earnings with the remainder recognized through AOCI on the consolidated balance sheets.  Impairments recognized through other comprehensive income/(loss) (“OCI”) do not impact earnings.  Following the recognition of an OTTI through earnings, a new cost basis is established for the security and may not be adjusted for subsequent recoveries in fair value through earnings.  However, OTTIs recognized through charges to earnings may be accreted back to the amortized cost basis of the security on a prospective basis through interest income.  The determination as to whether an OTTI exists and, if so, the amount of credit impairment recognized in earnings is subjective, as such determinations are based on factual information available at the time of assessment as well as the Company’s estimates of the future performance and cash flow projections.  As a result, the timing and amount of OTTIs constitute material estimates that are susceptible to significant change.  (See Note 3)

Non-Agency MBS that are assessed to be of less than high credit quality and on which impairments are recognized have experienced, or are expected to experience, credit-related adverse cash flow changes.  The Company’s estimate of cash flows for its Non-Agency MBS is based on its review of the underlying mortgage loans securing the MBS.  The Company considers information available about the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, year of origination, loan-to-value ratios (“LTVs”), geographic concentrations and dialogue with market participants.  As a result, significant judgment is used in the Company’s analysis to determine the expected cash flows for its Non-Agency MBS.  In determining the OTTI related to credit losses for securities that were purchased at significant discounts to par and/or are considered to be of less than high credit quality, the Company compares the present value of the remaining cash flows expected to be collected at the purchase date (or last date previously revised) against the present value of the cash flows expected to be collected at the current financial reporting date.  The discount rate used to calculate the present value of expected future cash flows is the current yield used for income recognition purposes.  Impairment assessment for Non-Agency MBS that were purchased at prices close to par and/or are otherwise considered to be of high credit quality involves comparing the present value of the remaining cash flows expected to be collected against the amortized cost of the security at the assessment date.  The discount rate used to calculate the present value of the expected future cash flows is based on the instrument’s IRR.

Balance Sheet Presentation

The Company’s MBS and CRT Securities pledged as collateral against repurchase agreements and Swaps are included on the consolidated balance sheets with the fair value of the securities pledged disclosed parenthetically.  Purchases and sales of securities are recorded on the trade date. 

(c) MSR Related Assets

The Company has investments in financial instruments whose cash flows are considered to be largely dependent on underlying MSRs that either directly or indirectly act as collateral for the investment. These financial instruments, which are referred to as MSR related assets, are discussed in more detail below. The Company’s MSR related assets pledged as collateral against repurchase agreements are included in the consolidated balance sheets with the amounts pledged disclosed parenthetically. Purchases and sales of MSR related assets are recorded on the trade date. (See Notes 3, 6, 7 and 14)

Term Notes Backed by MSR Related Collateral

The Company has invested in term notes that are issued by special purpose vehicles (“SPV”) that have acquired rights to receive cash flows representing the servicing fees and/or excess servicing spread associated with certain MSRs. The Company considers payment of principal and interest on these term notes to be largely dependent on the cash flows generated by the underlying MSRs as this impacts the cash flows available to the SPV that issued the term notes. Credit risk borne by the holders of the term notes is also mitigated by structural credit support in the form of over-collateralization. Credit support is also provided by a corporate guarantee from the ultimate parent or sponsor of the SPV that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the underlying MSRs be insufficient.

The Company’s term notes backed by MSR related collateral are reported at fair value on the Company’s consolidated balance sheets with unrealized gains and losses excluded from earnings and reported in AOCI. Interest income is recognized on an accrual basis on the Company’s consolidated statements of operations. The Company’s valuation process for such notes considers a number of factors, including a comparable bond analysis performed by a third-party pricing service which involves determining a pricing spread at issuance of the term note. The pricing spread is used at each subsequent valuation date to determine an implied yield to maturity of the term note, which is then used to derive an indicative market value for the security. This indicative market value is further reviewed by the Company and may be adjusted to ensure it reflects a realistic exit price at the valuation date given the structural features of these securities. Other factors taken into consideration include indicative values provided by repurchase agreement counterparties, estimated changes in fair value of the related underlying MSR collateral and the financial performance of the ultimate parent or sponsoring entity of the issuer, which has provided a guarantee that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the related underlying MSR collateral be insufficient.

Corporate Loans

The Company has made or participated in loans to provide financing to entities that originate residential mortgage loans and own the related MSRs. These corporate loans are generally secured by certain MSRs, as well as certain other unencumbered assets owned by the borrower.

Corporate loans are recorded on the Company’s consolidated balance sheets at the drawn amount, on which interest income is recognized on an accrual basis on the Company’s consolidated statements of operations. Commitment fees received on the undrawn amount are deferred and recognized as interest income over the remaining loan term at the time of draw. At the end of the commitment period, any remaining deferred commitment fees are recorded as Other Income on the Company’s consolidated statements of operations. The Company evaluates the recoverability of its corporate loans on a quarterly basis considering various factors, including the current status of the loan, changes in the fair value of the MSRs that secure the loan and the recent financial performance of the borrower.

(d)  Residential Whole Loans (including Residential Whole Loans transferred to consolidated VIEs)

Residential whole loans included in the Company’s consolidated balance sheets are primarily comprised of pools of fixed and adjustable rate residential mortgage loans acquired through consolidated trusts in secondary market transactions, with the majority at discounted purchase prices. The accounting model utilized by the Company is determined at the time each loan package is initially acquired and is generally based on the delinquency status of the majority of the underlying borrowers in the package at acquisition. The accounting model described below for purchased credit impaired loans that are held at carrying value is typically utilized by the Company for purchased credit impaired loans where the underlying borrower has a delinquency status of less than 60 days at the acquisition date. The Company may also purchase newly or recently originated loans that are performing as of the purchase date. Such loans are typically held at carrying value, but the accounting methods for income recognition and determination and measurement of any required loan loss reserves differ to those used for purchased credit impaired loans held at carrying value. The accounting model described below for residential whole loans held at fair value is typically utilized by the Company for loans where the underlying borrower has a delinquency status of 60 days or more at the acquisition date. The accounting model initially applied is not subsequently changed.

The Company’s residential whole loans pledged as collateral against repurchase agreements are included in the consolidated balance sheets with amounts pledged disclosed parenthetically.  Purchases and sales of residential whole loans are recorded on the trade date, with amounts recorded reflecting management’s current estimate of assets that will be acquired or disposed at the closing of the transaction. This estimate is subject to revision at the closing of the transaction, pending the outcome of due diligence performed prior to closing. Recorded amounts of residential whole loans for which the closing of the purchase transaction is yet to occur are not eligible to be pledged as collateral against any repurchase agreement financing until the closing of the purchase transaction. (See Notes 4, 6, 7, 14 and 15)

Residential Whole Loans at Carrying Value

Purchased Credit Impaired Loans

The Company has elected to account for these loans as credit impaired as they were acquired at discounted prices that reflect, in part, the impaired credit history of the borrower. Substantially all of these loans have previously experienced payment delinquencies and the amount owed may exceed the value of the property pledged as collateral. Consequently, these loans generally have a higher likelihood of default than newly originated mortgage loans with LTVs of 80% or less to creditworthy borrowers. The Company believes that amounts paid to acquire these loans represent fair market value at the date of acquisition. Loans considered credit impaired are initially recorded at the purchase price with no allowance for loan losses. Subsequent to acquisition, the recorded amount for these loans reflects the original investment amount, plus accretion of interest income, less principal and interest cash flows received. These loans are presented on the Company’s consolidated balance sheets at carrying value, which reflects the recorded amount reduced by any allowance for loan losses established subsequent to acquisition.

Under the application of the accounting model for purchased credit impaired loans, the Company may aggregate into pools loans acquired in the same fiscal quarter that are assessed as having similar risk characteristics. For each pool established, or on an individual loans basis for loans not aggregated into pools, the Company estimates at acquisition, and periodically on at least a quarterly basis, the principal and interest cash flows expected to be collected. The difference between the cash flows expected to be collected and the carrying amount of the loans is referred to as the “accretable yield.” This amount is accreted as interest income over the life of the loans using an effective interest rate (level yield) methodology. Interest income recorded each period reflects the amount of accretable yield recognized and not the coupon interest payments received on the underlying loans. The difference between contractually required principal and interest payments and the cash flows expected to be collected is referred to as the “non-accretable difference,” and includes estimates of both the effect of prepayments and expected credit losses over the life of the underlying loans.

A decrease in expected cash flows in subsequent periods may indicate impairment at the pool and/or individual loan level, thus requiring the establishment of an allowance for loan losses by a charge to the provision for loan losses. The allowance for loan losses generally represents the present value of cash flows expected at acquisition, adjusted for any increases due to changes in estimated cash flows, that are subsequently no longer expected to be received at the relevant measurement date. Under the accounting model applied to credit impaired loans, a significant increase in expected cash flows in subsequent periods first reduces any previously recognized allowance for loan losses and then will result in a recalculation in the amount of accretable yield. The adjustment of accretable yield due to a significant increase in expected cash flows is accounted for prospectively as a change in estimate and results in reclassification from nonaccretable difference to accretable yield.

Other Loans at Carrying Value

The Company also has investments in loans that are not considered to be credit impaired at purchase. To date such loans have included newly or previously originated performing loans that are primarily comprised of: (i) loans to finance (or refinance) one-to-four family residential properties and are not considered to meet the definition of a “Qualified Mortgage” in accordance with guidelines adopted by the Consumer Financial Protection Bureau (“Non-QM loans”), (ii) short-term business purpose loans collateralized by residential properties made to non-occupant borrowers who intend to rehabilitate and sell the property for a profit (“Rehabilitation loans” or “Fix and Flip loans”), (iii) loans to finance (or refinance) non-owner occupied one-to-four family residential properties that are rented to one or more tenants (“Single-family rental loans”), and (iv) previously originated loans secured by residential real estate that is generally owner occupied (“Seasoned performing loans”), (collectively “Other Loans at Carrying Value”). The Company’s Other Loans at Carrying Value are initially recorded at their purchase price. Interest income on Other Loans at Carrying Value purchased at par is accrued based on each loan’s current interest bearing balance and current interest rate, net of related servicing costs. Interest income on such loans purchased at a premium/discount to par is recorded each period based on the contractual coupon net of any premium or discount and related servicing costs, and adjusted for actual prepayment activity.

An allowance for loan losses is recorded when, based on current information and events, it is probable that the Company will be unable to collect all amounts due according to the existing contractual terms of the loan agreement. Any required loan loss allowance would typically be measured based on fair value of the collateral securing the loan and would reduce the carrying value of the loan with a corresponding charge to earnings. Significant judgments are required in determining any allowance for loan loss, including assumptions regarding the loan cash flows expected to be collected, the value of the underlying collateral and the ability of the Company to collect on any other forms of security, such as a personal guaranty provided either by the borrower or an affiliate of the borrower. Income recognition is suspended for loans at the earlier of the date at which payments become 90 days past due or when, in the opinion of management, a full recovery of income and principal becomes doubtful. When the ultimate collectability of the principal of an impaired loan is in doubt, all payments are applied to principal under the cost recovery method. When the ultimate collectability of the principal of an impaired loan is not in doubt, interest income is recorded under the cash basis method as interest payments are received. Interest accruals are resumed when the loan becomes contractually current and performance is demonstrated to be resumed. A loan is written off when it is no longer realizable and/or it is legally discharged.

Residential Whole Loans at Fair Value

Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at time of acquisition. For the majority of these loans, there is significant uncertainty associated with estimating the timing of and amount of cash flows that will be collected. Further, the cash flows ultimately collected may be dependent on the value of the property securing the loan. Consequently, the Company considers that accounting for these loans at fair value should result in a better reflection over time of the economic returns for the majority of these loans. The Company determines the fair value of its residential whole loans held at fair value after considering portfolio valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans and trading activity observed in the market place. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations.

Cash received reflecting coupon payments on residential whole loans held at fair value is not included in Interest Income, but rather is presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations. Cash outflows associated with loan-related advances made by the Company on behalf of the borrower are included in the basis of the loan and are reflected in Net gain on residential whole loans held at fair value.

(e)  Cash and Cash Equivalents

Cash and cash equivalents include cash on deposit with financial institutions and investments in money market funds, all of which have original maturities of three months or less.  Cash and cash equivalents may also include cash pledged as collateral to the Company by its repurchase agreement counterparties as a result of reverse margin calls (i.e., margin calls made by the Company).  At September 30, 2018 and December 31, 2017, the Company had cash and cash equivalents of $104.2 million and $449.8 million, respectively. The Company’s investments in overnight money market funds, which are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency, were $71.1 million and $354.0 million at September 30, 2018 and December 31, 2017, respectively.  (See Notes 7 and 14)

(f) Restricted Cash

Restricted cash represents the Company’s cash held by its counterparties in connection with certain of the Company’s repurchase agreements that is not available to the Company for general corporate purposes. Restricted cash may be applied against amounts due to repurchase agreement counterparties, or may be returned to the Company when the related collateral requirements are exceeded or at the maturity of the repurchase agreement.  The Company had aggregate restricted cash held as collateral or otherwise in connection with its repurchase agreements of $6.5 million and $13.3 million at September 30, 2018 and December 31, 2017, respectively.  (See Notes 5(c), 6, 7 and 14)

(g)  Goodwill

At September 30, 2018 and December 31, 2017, the Company had goodwill of $7.2 million, which represents the unamortized portion of the excess of the fair value of its common stock issued over the fair value of net assets acquired in connection with its formation in 1998.  Goodwill is tested for impairment at least annually, or more frequently under certain circumstances, at the entity level.  Through September 30, 2018, the Company had not recognized any impairment against its goodwill. Goodwill is included in Other assets on the Company’s consolidated balance sheets.

(h) Real Estate Owned (“REO”)

REO represents real estate acquired by the Company, including through foreclosure, deed in lieu of foreclosure, or purchased in connection with the acquisition of residential whole loans. REO acquired through foreclosure or deed in lieu of foreclosure is initially recorded at fair value less estimated selling costs. REO acquired in connection with the acquisition of residential whole loans is initially recorded at its purchase price. Subsequent to acquisition, REO is reported, at each reporting date, at the lower of the current carrying amount or fair value less estimated selling costs and for presentation purposes is included in Other assets on the Company’s consolidated balance sheets. Changes in fair value that result in an adjustment to the reported amount of an REO property that has a fair value at or below its carrying amount are reported in Other Income, net on the Company’s consolidated statements of operations. (See Note 5(b))

(i)  Depreciation

Leasehold Improvements and Other Depreciable Assets

Depreciation is computed on the straight-line method over the estimated useful life of the related assets or, in the case of leasehold improvements, over the shorter of the useful life or the lease term.  Furniture, fixtures, computers and related hardware have estimated useful lives ranging from five to eight years at the time of purchase.

(j)  Loan Securitization and Other Debt Issuance Costs

Loan securitization related costs are costs associated with the issuance of beneficial interests by consolidated VIEs and incurred by the Company in connection with various financing transactions completed by the Company.  Other debt issuance and related costs include costs incurred by the Company in connection with issuing 8% Senior Notes due 2042 (“Senior Notes”) and certain other repurchase agreement financings. These costs may include underwriting, rating agency, legal, accounting and other fees.  Such costs, which reflect deferred charges, are included on the Company’s consolidated balance sheets as a direct deduction from the corresponding debt liability. These deferred charges are amortized as an adjustment to interest expense using the effective interest method. For Senior Notes and other repurchase agreement financings, such costs are amortized over the shorter of the period to the expected or stated legal maturity of the debt instruments. The Company periodically reviews the recoverability of these deferred costs and in the event an impairment charge is required, such amount will be included in Operating and Other Expense on the Company’s consolidated statements of operations.

(k)  Repurchase Agreements

The Company finances the holdings of a significant portion of its residential mortgage assets with repurchase agreements.  Under repurchase agreements, the Company sells securities to a lender and agrees to repurchase the same securities in the future for a price that is higher than the original sale price.  The difference between the sale price that the Company receives and the repurchase price that the Company pays represents interest paid to the lender.  Although legally structured as sale and repurchase transactions, the Company accounts for repurchase agreements as secured borrowings. Under its repurchase agreements, the Company pledges its securities as collateral to secure the borrowing, which is equal in value to a specified percentage of the fair value of the pledged collateral, while the Company retains beneficial ownership of the pledged collateral.  At the maturity of a repurchase financing, unless the repurchase financing is renewed with the same counterparty, the Company is required to repay the loan including any accrued interest and concurrently receives back its pledged collateral from the lender.  With the consent of the lender, the Company may renew a repurchase financing at the then prevailing financing terms.  Margin calls, whereby a lender requires that the Company pledge additional securities or cash as collateral to secure borrowings under its repurchase financing with such lender, are routinely experienced by the Company when the value of the MBS pledged as collateral declines as a result of principal amortization and prepayments or due to changes in market interest rates, spreads or other market conditions.  The Company also may make margin calls on counterparties when collateral values increase.

The Company’s repurchase financings typically have terms ranging from one month to six months at inception, but may also have longer or shorter terms.  Should a counterparty decide not to renew a repurchase financing at maturity, the Company must either refinance elsewhere or be in a position to satisfy the obligation.  If, during the term of a repurchase financing, a lender should default on its obligation, the Company might experience difficulty recovering its pledged assets which could result in an unsecured claim against the lender for the difference between the amount loaned to the Company plus interest due to the counterparty and the fair value of the collateral pledged by the Company to such lender, including accrued interest receivable or such collateral.  (See Notes 6, 7 and 14)

In addition to the repurchase agreement financing arrangements discussed above, as part of its financing strategy for Non-Agency MBS, the Company in prior periods entered into contemporaneous repurchase and reverse repurchase agreements with a single counterparty.  Under a typical reverse repurchase agreement, the Company buys securities from a borrower for cash and agrees to sell the same securities in the future for a price that is higher than the original purchase price.  The difference between the purchase price the Company originally paid and the sale price represents interest received from the borrower.  In contrast, the contemporaneous repurchase and reverse repurchase transactions effectively resulted in the Company pledging Non-Agency MBS as collateral to the counterparty in connection with the repurchase agreement financing and obtaining U.S. Treasury securities as collateral from the same counterparty in connection with the reverse repurchase agreement.  No net cash was exchanged between the Company and counterparty at the inception of the transactions.  Securities obtained and pledged as collateral are recorded in Other assets on the Company’s consolidated balance sheets.  Interest income is recorded on the reverse repurchase agreement and interest expense is recorded on the repurchase agreement on an accrual basis.   The Company’s liability to the counterparty in prior periods in connection with this financing arrangement is recorded in Other liabilities on the Company’s consolidated balance sheets and disclosed as “Obligation to return securities obtained as collateral, at fair value.”  (See Note 5(a))

(l)  Equity-Based Compensation

Compensation expense for equity-based awards that are subject to vesting conditions, is recognized ratably over the vesting period of such awards, based upon the fair value of such awards at the grant date.  For certain awards granted prior to January 1, 2017, compensation expense recognized included the impact of estimated forfeitures, with any changes in estimated forfeiture rates accounted for as a change in estimate. Upon adoption of new accounting guidance that was effective for the Company on January 1, 2017, the Company made a policy election to account for forfeitures as they occur.

Beginning in 2014, the Company has made annual grants of restricted stock units (“RSUs”) certain of which cliff vest after a three-year period and others of which cliff vest after a three-year period, subject to the achievement of certain performance criteria based on a formula tied to the Company’s achievement of average total stockholder return during that three-year period, as well as the total shareholder return (“TSR”) of the Company relative to the TSR of a group of peer companies (over the three-year period) selected by the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) at the date of grant. The features in these awards related to the attainment of total stockholder return over a specified period constitute a “market condition” which impacts the amount of compensation expense recognized for these awards.  Specifically, the uncertainty regarding the achievement of the market condition was reflected in the grant date fair valuation of the RSUs, which is recognized as compensation expense over the relevant vesting period.  The amount of compensation expense recognized is not dependent on whether the market condition was or will be achieved.

The Company makes dividend equivalent payments in connection with certain of its equity-based awards.   A dividend equivalent is a right to receive a distribution equal to the dividend distributions that would be paid on a share of the Company’s common stock.  Dividend equivalents may be granted as a separate instrument or may be a right associated with the grant of another award (e.g., an RSU) under the Company’s Equity Compensation Plan (the “Equity Plan”), and they are paid in cash or other consideration at such times and in accordance with such rules, terms and conditions, as the Compensation Committee may determine in its discretion.  Payments pursuant to dividend equivalents are generally charged to Stockholders’ Equity to the extent that the attached equity awards are expected to vest.  Compensation expense is recognized for payments made for dividend equivalents to the extent that the attached equity awards (i) do not or are not expected to vest and (ii) grantees are not required to return payments of dividends or dividend equivalents to the Company.  (See Notes 2(m) and 13)

(m)  Earnings per Common Share (“EPS”)

Basic EPS is computed using the two-class method, which includes the weighted-average number of shares of common stock outstanding during the period and an estimate of other securities that participate in dividends, such as the Company’s unvested restricted stock and RSUs that have non-forfeitable rights to dividends and dividend equivalents attached to/associated with RSUs and vested stock options to arrive at total common equivalent shares.  In applying the two-class method, earnings are allocated to both shares of common stock and estimated securities that participate in dividends based on their respective weighted-average shares outstanding for the period.  For the diluted EPS calculation, common equivalent shares are further adjusted for the effect of dilutive unexercised stock options and RSUs outstanding that are unvested and have dividends that are subject to forfeiture using the treasury stock method.  Under the treasury stock method, common equivalent shares are calculated assuming that all dilutive common stock equivalents are exercised and the proceeds, along with future compensation expenses associated with such instruments, are used to repurchase shares of the Company’s outstanding common stock at the average market price during the reported period.  (See Note 12)

(n)  Comprehensive Income/(Loss)

The Company’s comprehensive income/(loss) available to common stock and participating securities includes net income, the change in net unrealized gains/(losses) on its AFS securities and derivative hedging instruments, (to the extent that such changes are not recorded in earnings), adjusted by realized net gains/(losses) reclassified out of AOCI for sold AFS securities and is reduced by dividends declared on the Company’s preferred stock and issuance costs of redeemed preferred stock.

(o)  U.S. Federal Income Taxes

The Company has elected to be taxed as a REIT under the provisions of the Internal Revenue Code of 1986, as amended, (the “Code”) and the corresponding provisions of state law.  The Company expects to operate in a manner that will enable it to satisfy the various requirements to maintain its status as a REIT for federal income tax purposes. In order to maintain its status as a REIT, the Company must, among other things, distribute at least 90% of its REIT taxable income (excluding net long-term capital gains) to stockholders in the timeframe permitted by the Code.  As long as the Company maintains its status as a REIT, the Company will not be subject to regular federal income tax to the extent that it distributes 100% of its REIT taxable income (including net long-term capital gains) to its stockholders within the permitted timeframe.  Should this not occur, the Company would be subject to federal taxes at prevailing corporate tax rates on the difference between its REIT taxable income and the amounts deemed to be distributed for that tax year.  As the Company’s objective is to distribute 100% of its REIT taxable income to its stockholders within the permitted timeframe, no provision for current or deferred income taxes has been made in the accompanying consolidated financial statements.  Should the Company incur a liability for corporate income tax, such amounts would be recorded as REIT income tax expense on the Company’s consolidated statements of operations. Furthermore, if the Company fails to distribute during each calendar year, or by the end of January following the calendar year in the case of distributions with declaration and record dates falling in the last three months of the calendar year, at least the sum of (i) 85% its REIT ordinary income for such year, (ii) 95% of its REIT capital gain income for such year, and (iii) any undistributed taxable income from prior periods, the Company would be subject to a 4% nondeductible excise tax on the excess of the required distribution over the amounts actually distributed. To the extent that the Company incurs interest, penalties or related excise taxes in connection with its tax obligations, including as a result of its assessment of uncertain tax positions, such amounts will be included in Operating and Other Expense on the Company’s consolidated statements of operations.

In addition, the Company has elected to treat certain of its subsidiaries as a TRS. In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. Generally, a domestic TRS is subject to U.S. federal, state and local corporate income taxes. Since a portion of the Company’s business may be conducted through one or more TRS, its income earned by TRS may be subject to corporate income taxation. To maintain the Company’s REIT election, no more than 20% of the value of a REIT’s assets at the end of each calendar quarter may consist of stock or securities in TRS. For purposes of the determination of U.S. federal and state income taxes, the Company’s subsidiaries that elected to be treated as a TRS record current or deferred income taxes based on differences (both permanent and timing) between the determination of their taxable income and net income under GAAP. No deferred tax benefit was recorded by the Company for the nine months endedSeptember 30, 2018 and 2017, as a valuation allowance for the full amount of the associated deferred tax asset was recognized as its recovery is not considered more likely than not.

 Based on its analysis of any potential uncertain tax positions, the Company concluded that it does not have any material uncertain tax positions that meet the relevant recognition or measurement criteria as of September 30, 2018, December 31, 2017, or September 30, 2017. The Company filed its 2017 tax return prior to October 15, 2018. The Company’s tax returns for tax years 2015 through 2017 are open to examination.

(p)  Derivative Financial Instruments

The Company may use a variety of derivative instruments to economically hedge a portion of its exposure to market risks, including interest rate risk and prepayment risk. The objective of the Company’s risk management strategy is to reduce fluctuations in net book value over a range of interest rate scenarios. In particular, the Company attempts to mitigate the risk of the cost of its variable rate liabilities increasing during a period of rising interest rates. The Company’s derivative instruments are currently comprised of Swaps, the majority of which are designated as cash flow hedges against the interest rate risk associated with its borrowings.

Swaps

The Company documents its risk-management policies, including objectives and strategies, as they relate to its hedging activities and the relationship between the hedging instrument and the hedged liability for all Swaps designated as hedging transactions.  The Company assesses, both at inception of a hedge and on a quarterly basis thereafter, whether or not the hedge is “highly effective.”

Swaps are carried on the Company’s consolidated balance sheets at fair value, in Other assets, if their fair value is positive, or in Other liabilities, if their fair value is negative.  Beginning in January 2017, variation margin payments on the Company’s Swaps that have been novated to a clearing house are treated as a legal settlement of the exposure under the Swap contract. Previously such payments were treated as collateral pledged against the exposure under the Swap contract. The effect of this change is to reduce what would have otherwise been reported as fair value of the Swap. All of the Company’s Swaps have been novated to a central clearing house. Changes in the fair value of the Company’s Swaps designated in hedging transactions are recorded in OCI provided that the hedge remains effective.  Changes in fair value for any ineffective amount of a Swap are recognized in earnings.  The Company has not recognized any change in the value of its existing Swaps designated as hedges through earnings as a result of hedge ineffectiveness. Periodic payments accrued in connection with Swaps designated as hedges are included in interest expense, and are treated as an operating cash flow.

The Company discontinues hedge accounting on a prospective basis and recognizes changes in fair value through earnings when: (i) it is determined that the derivative is no longer effective in offsetting cash flows of a hedged item (including forecasted transactions); (ii) it is no longer probable that the forecasted transaction will occur; or (iii) it is determined that designating the derivative as a hedge is no longer appropriate. (See Notes 5(c), 7 and 14)

Changes in the fair value of the Company’s Swaps not designated in hedging transactions are recorded in Other income, net on the Company’s consolidated statement of operations.

(q)  Fair Value Measurements and the Fair Value Option for Financial Assets and Financial Liabilities

The Company’s presentation of fair value for its financial assets and liabilities is determined within a framework that stipulates that the fair value of a financial asset or liability is an exchange price in an orderly transaction between market participants to sell the asset or transfer the liability in the market in which the reporting entity would transact for the asset or liability, that is, the principal or most advantageous market for the asset or liability.  The transaction to sell the asset or transfer the liability is a hypothetical transaction at the measurement date, considered from the perspective of a market participant that holds the asset or owes the liability.  This definition of fair value focuses on exit price and prioritizes the use of market-based inputs over entity-specific inputs when determining fair value.  In addition, the framework for measuring fair value establishes a three-level hierarchy for fair value measurements based upon the observability of inputs to the valuation of an asset or liability as of the measurement date. 

In addition to the financial instruments that it is required to report at fair value, the Company has elected the fair value option for certain of its residential whole loans, Agency MBS and CRT securities at time of acquisition. Subsequent changes in the fair value of these financial instruments are reported in Other income, net, in the Company’s consolidated statements of operations. A decision to elect the fair value option for an eligible financial instrument, which may be made on an instrument by instrument basis, is irrevocable. (See Notes 2(b), 2(d), 3, 4 and 14)

(r)  Variable Interest Entities

An entity is referred to as a VIE if it meets at least one of the following criteria:  (i) the entity has equity that is insufficient to permit the entity to finance its activities without additional subordinated financial support of other parties; or (ii) as a group, the holders of the equity investment at risk lack (a) the power to direct the activities of an entity that most significantly impact the entity’s economic performance; (b) the obligation to absorb the expected losses; or (c) the right to receive the expected residual returns; or (iii) have disproportional voting rights and the entity’s activities are conducted on behalf of the investor that has disproportionately few voting rights.

The Company consolidates a VIE when it has both the power to direct the activities that most significantly impact the economic performance of the VIE and a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE.   The Company is required to reconsider its evaluation of whether to consolidate a VIE each reporting period, based upon changes in the facts and circumstances pertaining to the VIE.

The Company has entered into several financing transactions which resulted in the Company consolidating the VIEs that were created to facilitate these transactions.  In determining the accounting treatment to be applied to these transactions, the Company concluded that the entities used to facilitate these transactions were VIEs and that they should be consolidated.  If the Company had determined that consolidation was not required, it would have then assessed whether the transfers of the underlying assets would qualify as sale or should be accounted for as secured financings under GAAP. (See Note 15)

The Company also includes on its consolidated balance sheets certain financial assets and liabilities that are acquired/issued by trusts and/or other special purpose entities that have been evaluated as being required to be consolidated by the Company under the applicable accounting guidance.

(s)  Offering Costs Related to Issuance and Redemption of Preferred Stock

Offering costs related to issuance of preferred stock are recorded as a reduction in Additional paid-in capital, a component of Stockholders’ Equity, at the time such preferred stock is issued. On redemption of preferred stock, any excess of the fair value of the consideration transferred to the holders of the preferred stock over the carrying amount of the preferred stock in the Company’s consolidated balance sheets is included in the determination of Net Income Available to Common Stock and Participating Securities in the calculation of EPS.

(t)  New Accounting Standards and Interpretations

Accounting Standards Adopted in 2018

Compensation - Stock Compensation - Scope of Modification Accounting

In May 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-09, Scope of Modification Accounting (“ASU 2017-09”). The amendments in ASU 2017-09 provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. Pursuant to this ASU, an entity should account for the effects of a modification unless all of the following are met: (1) the fair value (or calculated value or intrinsic value, if such an alternative measurement method is used) of the modified award is the same as the fair value (or calculated value or intrinsic value, if such an alternative measurement method is used) of the original award immediately before the original award is modified; (2) the vesting conditions of the modified award are the same as the vesting conditions of the original award immediately before the original award is modified; and (3) the classification of the modified award as an equity instrument or a liability instrument is the same as the classification of the original award immediately before the original award date is modified. The Company adopted ASU 2017-09 on January 1, 2018 and its adoption did not have an impact on its financial position or financial statement disclosures.

Statement of Cash Flows - Restricted Cash

In November 2016, the FASB issued ASU 2016-18, Restricted Cash (“ASU 2016-18”). ASU 2016-18 clarifies how entities should present restricted cash and restricted cash equivalents in the statement of cash flows with the objective of reducing the existing diversity in practice. The amendments in ASU 2016-18 require restricted cash and restricted cash equivalents to be included with cash and cash equivalents when reconciling the beginning-of-period and end-of period total amounts shown on the statement of cash flows. The Company adopted ASU 2016-18 on January 1, 2018 and its adoption did not have a significant impact on its financial position or financial statement disclosures.

Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments

In August 2016, the FASB issued ASU 2016-15, Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”). The amendments in ASU 2016-15 provide guidance for eight specific cash flow classification issues, certain cash receipts and cash payments on the statement of cash flows with the objective of reducing the existing diversity in practice. The Company adopted ASU 2016-15 on January 1, 2018 and its adoption did not have a significant impact on its financial position or financial statement disclosures.

Financial Instruments - Overall - Recognition and Measurement of Financial Assets and Financial Liabilities

In January 2016, the FASB issued ASU 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”). The amendments in this ASU affect all entities that hold financial assets or owe financial liabilities, and address certain aspects of recognition, measurement, presentation, and disclosure of financial instruments.  The classification and measurement guidance of investments in debt securities and loans are not affected by the amendments in this ASU. ASU 2016-01 was effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017.  The Company’s adoption of this ASU on January 1, 2018 did not have a significant impact on the Company’s financial position or financial statement disclosures as the classification and measurement of its investments in debt securities and loans were not affected by the amendments in this ASU.

Revenue from Contracts with Customers

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”).  The ASU requires an entity to recognize revenue in an amount that reflects the consideration to which it expects to be entitled for the transfer of promised goods or services to customers.  ASU 2014-09 replaced most existing revenue recognition guidance in GAAP when it became effective. The Company adopted this ASU on January 1, 2018 and its adoption did not have a material impact on the Company’s financial position or financial statement disclosures as the majority of the Company’s revenues are generated by financial instruments that are explicitly scoped out of this ASU. On adoption of the new standard on January 1, 2018, the Company recorded a transition adjustment, under the modified retrospective approach, of approximately $295,000 to the opening balance of retained earnings in order to reflect the recognition of a gain on sale of REO that was previously deferred under the prior accounting guidance.

XML

MBS, CRT Securities and MSR Related Assets

9 Months Ended

Sep. 30, 2018

Investments, Debt and Equity Securities [Abstract]

MBS, CRT Securities and MSR Related Assets

MBS, CRT Securities and MSR Related Assets

Agency and Non-Agency MBS

The Company’s MBS are comprised of Agency MBS and Non-Agency MBS which include MBS issued prior to 2008 (“Legacy Non-Agency MBS”). These MBS are secured by:  (i) hybrid mortgages (“Hybrids”), which have interest rates that are fixed for a specified period of time and, thereafter, generally adjust annually to an increment over a specified interest rate index; (ii) adjustable-rate mortgages (“ARMs”), which have interest rates that reset annually or more frequently (collectively, “ARM-MBS”); and (iii) 15 and 30 year fixed-rate mortgages for Agency MBS and, for Non-Agency MBS, 30-year and longer-term fixed rate mortgages. In addition, the Company’s MBS are also comprised of MBS backed by securitized re-performing/non-performing loans (“RPL/NPL MBS”), where the cash flows of the bond may not reflect the contractual cash flows of the underlying collateral. The Company’s RPL/NPL MBS are primarily structured with a contractual coupon step-up feature where the coupon increases from 300 - 400 basis points at 36 - 48 months from issuance or sooner. The Company pledges a significant portion of its MBS as collateral against its borrowings under repurchase agreements and Swaps.  (See Note 7)

Agency MBS: Agency MBS are guaranteed as to principal and/or interest by a federally chartered corporation, such as Fannie Mae or Freddie Mac, or an agency of the U.S. Government, such as Ginnie Mae.  The payment of principal and/or interest on Ginnie Mae MBS is explicitly backed by the full faith and credit of the U.S. Government.  Since the third quarter of 2008, Fannie Mae and Freddie Mac have been under the conservatorship of the Federal Housing Finance Agency, which significantly strengthened the backing for these government-sponsored entities.

Non-Agency MBS:  The Company’s Non-Agency MBS are primarily secured by pools of residential mortgages, which are not guaranteed by an agency of the U.S. Government or any federally chartered corporation.  Credit risk associated with Non-Agency MBS is regularly assessed as new information regarding the underlying collateral becomes available and based on updated estimates of cash flows generated by the underlying collateral.

CRT Securities

CRT securities are debt obligations issued by Fannie Mae and Freddie Mac. The payments of principal and interest on the CRT securities are paid by Fannie Mae or Freddie Mac, as the case may be, on a monthly basis, and are dependent on the performance of loans in a reference pool of Agency MBS securitized by the issuing entity. As an investor in a CRT security, the Company may incur a loss if losses on the mortgage loans in the reference pool exceed the credit enhancement on the underlying CRT security owned by the Company. The Company assesses the credit risk associated with CRT securities by assessing the current and expected future performance of the associated reference pool. The Company pledges a portion of its CRT securities as collateral against its borrowings under repurchase agreements.  (See Note 7)

The following tables present certain information about the Company’s MBS and CRT securities at September 30, 2018 and December 31, 2017:

September 30, 2018

(In Thousands)	Principal/ Current Face		Purchase Premiums		Accretable Purchase Discounts			Discount Designated as Credit Reserve and  OTTI (1)			Amortized Cost (2)		Fair Value		Gross Unrealized Gains		Gross Unrealized Losses			Net Unrealized Gain/(Loss)
Agency MBS: (3)
Fannie Mae	$	1,851,447	$	70,882	$	(29	)	$	—		$	1,922,300	$	1,896,739	$	14,650	$	(40,211	)	$	(25,561	)
Freddie Mac	987,833		40,183		—			—			1,028,453		1,003,583		1,027		(25,897		)	(24,870		)
Ginnie Mae	5,028		92		—			—			5,120		5,168		48		—			48
Total Agency MBS	2,844,308		111,157		(29		)	—			2,955,873		2,905,490		15,725		(66,108		)	(50,383		)
Non-Agency MBS:
Expected to Recover Par (4)(5)	1,343,835		41		(23,835		)	—			1,320,041		1,343,272		25,146		(1,915		)	23,231
Expected to Recover Less than Par (4)	2,165,454		—		(167,910		)	(531,757		)	1,465,787		1,991,338		525,770		(219		)	525,551
Total Non-Agency MBS (6)	3,509,289		41		(191,745		)	(531,757		)	2,785,828		3,334,610		550,916		(2,134		)	548,782
Total MBS	6,353,597		111,198		(191,774		)	(531,757		)	5,741,701		6,240,100		566,641		(68,242		)	498,399
CRT securities (7)	495,018		9,936		(178		)	—			504,776		538,945		34,173		(4		)	34,169
Total MBS and CRT securities	$	6,848,615	$	121,134	$	(191,952	)	$	(531,757	)	$	6,246,477	$	6,779,045	$	600,814	$	(68,246	)	$	532,568

December 31, 2017

(In Thousands)	Principal/ Current Face		Purchase Premiums		Accretable Purchase Discounts			Discount Designated as Credit Reserve and  OTTI (1)			Amortized Cost (2)		Fair Value		Gross Unrealized Gains		Gross Unrealized Losses			Net Unrealized Gain/(Loss)
Agency MBS: (3)
Fannie Mae	$	2,170,974	$	82,271	$	(40	)	$	—		$	2,253,205	$	2,246,600	$	21,736	$	(28,341	)	$	(6,605	)
Freddie Mac	561,346		21,683		—			—			584,920		571,748		1,624		(14,796		)	(13,172		)
Ginnie Mae	6,142		112		—			—			6,254		6,333		79		—			79
Total Agency MBS	2,738,462		104,066		(40		)	—			2,844,379		2,824,681		23,439		(43,137		)	(19,698		)
Non-Agency MBS:
Expected to Recover Par (4)(5)	1,128,808		50		(22,737		)	—			1,106,121		1,132,205		26,518		(434		)	26,084
Expected to Recover Less than Par (4)	2,589,935		—		(192,588		)	(593,227		)	1,804,120		2,401,761		597,660		(19		)	597,641
Total Non-Agency MBS (6)	3,718,743		50		(215,325		)	(593,227		)	2,910,241		3,533,966		624,178		(453		)	623,725
Total MBS	6,457,205		104,116		(215,365		)	(593,227		)	5,754,620		6,358,647		647,617		(43,590		)	604,027
CRT securities (7)	602,799		8,887		(3,550		)	—			608,136		664,403		56,290		(23		)	56,267
Total MBS and CRT securities	$	7,060,004	$	113,003	$	(218,915	)	$	(593,227	)	$	6,362,756	$	7,023,050	$	703,907	$	(43,613	)	$	660,294

(1) Discount designated as Credit Reserve and amounts related to OTTI are generally not expected to be accreted into interest income.  Amounts disclosed at September 30, 2018 reflect Credit Reserve of $519.6 million and OTTI of $12.2 million.  Amounts disclosed at December 31, 2017 reflect Credit Reserve of $579.0 million and OTTI of $14.2 million.

(2) Includes principal payments receivable of $438,000 and $1.9 million at September 30, 2018 and December 31, 2017, respectively, which are not included in the Principal/Current Face.

(3) Amounts disclosed at September 30, 2018 include Agency MBS with a fair value of $746.7 million for which the fair value option has been elected. Such securities had no unrealized gains and gross unrealized losses of approximately $5.5 million at September 30, 2018. The Company did not have any Agency MBS for which the fair value option had been elected at December 31, 2017.

(4) Based on management’s current estimates of future principal cash flows expected to be received.

(5) Includes RPL/NPL MBS, which at September 30, 2018 had a $1.2 billion Principal/Current face, $1.2 billion amortized cost and $1.2 billion fair value. At December 31, 2017, RPL/NPL MBS had a $922.0 million Principal/Current face, $920.1 million amortized cost and $923.1 millionfair value.

(6) At September 30, 2018 and December 31, 2017, the Company expected to recover approximately 85% and 84% of the then-current face amount of Non-Agency MBS, respectively.

(7) Amounts disclosed at September 30, 2018 includes CRT securities with a fair value of $538.9 million for which the fair value option has been elected. Such securities had gross unrealized gains of approximately $34.2 million and gross unrealized losses of approximately $4,000 at September 30, 2018. Amounts disclosed at December 31, 2017 includes CRT securities with a fair value of $528.9 million for which the fair value option has been elected. Such securities had gross unrealized gains of approximately $40.5 million and gross unrealized losses of approximately $23,000 at December 31, 2017.

Sales of MBS and CRT Securities

During the nine months ended September 30, 2018, the Company sold certain Agency MBS for $75.3 million realizing losses of $3.8 million. The Company also sold certain CRT securities during the three and nine months ended September 30, 2018 for $118.9 million and $222.9 million, realizing gains of $13.0 million and $24.2 million, respectively. In addition, during the three and nine months ended September 30, 2018, the Company sold certain Non-Agency MBS for $24.3 million and $43.7 million, realizing gains of $3.4 million and $12.2 million, respectively. During the three and nine months ended September 30, 2017, the Company sold certain Non-Agency MBS for $44.5 million and $83.1 million, realizing gains of $14.9 million and $30.8 million, respectively. The Company has no continuing involvement with any of the sold MBS.

Unrealized Losses on MBS and CRT Securities

The following table presents information about the Company’s MBS and CRT securities that were in an unrealized loss position at September 30, 2018:

Unrealized Loss Position For:

	Less than 12 Months					12 Months or more					Total
	Fair Value		Unrealized Losses		Number of Securities	Fair Value		Unrealized Losses		Number of Securities	Fair Value		Unrealized Losses
(Dollars in Thousands)
Agency MBS: (1)
Fannie Mae	$	438,980	$	4,293	105	$	838,566	$	35,918	251	$	1,277,546	$	40,211
Freddie Mac	668,566		6,020		37	298,083		19,877		103	966,649		25,897
Total Agency MBS	1,107,546		10,313		142	1,136,649		55,795		354	2,244,195		66,108
Non-Agency MBS:
Expected to Recover Par (2)	435,011		1,849		15	3,877		66		7	438,888		1,915
Expected to Recover Less than Par (2)	44,630		219		6	—		—		—	44,630		219
Total Non-Agency MBS	479,641		2,068		21	3,877		66		7	483,518		2,134
Total MBS	1,587,187		12,381		163	1,140,526		55,861		361	2,727,713		68,242
CRT securities (3)	15,754		4		4	—		—		—	15,754		4
Total MBS and CRT securities	$	1,602,941	$	12,385	167	$	1,140,526	$	55,861	361	$	2,743,467	$	68,246

(1) Amounts disclosed at September 30, 2018 include Agency MBS with a fair value of $746.7 million on which the fair value option has been elected. Such securities had unrealized losses of $5.5 million at September 30, 2018. 

(2) Based on management’s current estimates of future principal cash flows expected to be received.

(3) Amounts disclosed at September 30, 2018 represent CRT securities on which the fair value option has been elected.

At September 30, 2018, the Company did not intend to sell any of its investments that were in an unrealized loss position, and it is “more likely than not” that the Company will not be required to sell these securities before recovery of their amortized cost basis, which may be at their maturity. 

Gross unrealized losses on the Company’s Agency MBS were $66.1 million at September 30, 2018.  Agency MBS are issued by Government Sponsored Entities (“GSEs”) and enjoy either the implicit or explicit backing of the full faith and credit of the U.S. Government. While the Company’s Agency MBS are not rated by any rating agency, they are currently perceived by market participants to be of high credit quality, with risk of default limited to the unlikely event that the U.S. Government would not continue to support the GSEs. Given the credit quality inherent in Agency MBS, the Company does not consider any of the current impairments on its Agency MBS to be credit related. In assessing whether it is more likely than not that it will be required to sell any impaired security before its anticipated recovery, which may be at its maturity, the Company considers for each impaired security, the significance of each investment, the amount of impairment, the projected future performance of such impaired securities, as well as the Company’s current and anticipated leverage capacity and liquidity position. Based on these analyses, the Company determined that at September 30, 2018 any unrealized losses on its Agency MBS were temporary.

Gross unrealized losses on the Company’s Non-Agency MBS were $2.1 million at September 30, 2018. Based upon the most recent evaluation, the Company does not consider these unrealized losses to be indicative of OTTI and does not believe that these unrealized losses are credit related, but are rather a reflection of current market yields and/or marketplace bid-ask spreads.  The Company has reviewed its Non-Agency MBS that are in an unrealized loss position to identify those securities with losses that are other-than-temporary based on an assessment of changes in expected cash flows for such securities, which considers recent bond performance and, where possible, expected future performance of the underlying collateral.

The Company did not recognize any credit-related OTTI losses through earnings related to its Non-Agency MBS during the three and nine months ended September 30, 2018 and three months ended September 30, 2017. The Company recognized credit-related OTTI losses through earnings related to its Non-Agency MBS of $1.0 million during the nine months ended September 30, 2017.

Non-Agency MBS on which OTTI is recognized have experienced, or are expected to experience, credit-related adverse cash flow changes.  The Company’s estimate of cash flows for these Non-Agency MBS is based on its review of the underlying mortgage loans securing these MBS.  The Company considers information available about the structure of the securitization, including structural credit enhancement, if any, and the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, year of origination, LTVs, geographic concentrations, as well as Rating Agency reports, general market assessments, and dialogue with market participants.  Changes in the Company’s evaluation of each of these factors impacts the cash flows expected to be collected at the OTTI assessment date. For Non-Agency MBS purchased at a discount to par that were assessed for and had no OTTI recorded this period, such cash flow estimates indicated that the amount of expected losses decreased compared to the previous OTTI assessment date. These positive cash flow changes are primarily driven by recent improvements in LTVs due to loan amortization and home price appreciation, which, in turn, positively impacts the Company’s estimates of default rates and loss severities for the underlying collateral. In addition, voluntary prepayments (i.e., loans that prepay in full with no loss) have generally trended higher relative to the Company’s assumptions for these MBS which also positively impacts the Company’s estimate of expected loss. Overall, the combination of higher voluntary prepayments and lower LTVs supports the Company’s assessment that such MBS are not other-than-temporarily impaired.

The following table presents the composition of OTTI charges recorded by the Company for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,				Nine Months Ended   September 30,
(In Thousands)	2018		2017		2018		2017
Total OTTI losses	$	—	$	—	$	—	$	(63	)
OTTI reclassified from OCI	—		—		—		(969		)
OTTI recognized in earnings	$	—	$	—	$	—	$	(1,032	)

The following table presents a roll-forward of the credit loss component of OTTI on the Company’s Non-Agency MBS for which a non-credit component of OTTI was previously recognized in OCI.  Changes in the credit loss component of OTTI are presented based upon whether the current period is the first time OTTI was recorded on a security or a subsequent OTTI charge was recorded.

	Three Months Ended   September 30,		Nine Months Ended   September 30,
(In Thousands)	2018		2018
Credit loss component of OTTI at beginning of period	$	38,337	$	38,337
Additions for credit related OTTI not previously recognized	—		—
Subsequent additional credit related OTTI recorded	—		—
Credit loss component of OTTI at end of period	$	38,337	$	38,337

Purchase Discounts on Non-Agency MBS

The following tables present the changes in the components of the Company’s purchase discount on its Non-Agency MBS between purchase discount designated as Credit Reserve and OTTI and accretable purchase discount for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30, 2018						Three Months Ended   September 30, 2017
(In Thousands)	Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)			Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)
Balance at beginning of period	$	(553,596	)	$	(202,248	)	$	(626,498	)	$	(257,967	)
Impact of RMBS Issuer Settlement (2)	—			(2,734		)	—			—
Accretion of discount	—			20,115			—			18,621
Realized credit losses	12,042			—			13,982			—
Purchases	(1,975		)	1,368			—			(1,929		)
Sales	1,552			1,974			4,620			11,244
Transfers/release of credit reserve	10,220			(10,220		)	14,762			(14,762		)
Balance at end of period	$	(531,757	)	$	(191,745	)	$	(593,134	)	$	(244,793	)

	Nine Months Ended   September 30, 2018						Nine Months Ended   September 30, 2017
(In Thousands)	Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)			Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)
Balance at beginning of period	$	(593,227	)	$	(215,325	)	$	(694,241	)	$	(278,191	)
Impact of RMBS Issuer Settlement (2)(3)	—			(14,822		)	—			—
Accretion of discount	—			54,860			—			60,461
Realized credit losses	31,443			—			39,445			—
Purchases	(2,510		)	1,856			(484		)	(3,449		)
Sales	7,144			7,079			29,398			10,166
Net impairment losses recognized in earnings	—			—			(1,032		)	—
Transfers/release of credit reserve	25,393			(25,393		)	33,780			(33,780		)
Balance at end of period	$	(531,757	)	$	(191,745	)	$	(593,134	)	$	(244,793	)

(1) Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security.

(2) Includes the impact of approximately $2.7 million of cash proceeds (a one-time payment) received by the Company during the three and nine months ended September 30, 2018 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by Lehman Brothers Holdings Inc.

(3) Includes the impact of approximately $12.1 million of cash proceeds (a one-time payment) received by the Company during the nine months ended September 30, 2018 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by JP Morgan Chase & Co. and affiliated entities.

MSR Related Assets

(a)Term Notes Backed by MSR Related Collateral

At September 30, 2018 and December 31, 2017, the Company had $505.2 million and $381.8 million, respectively, of term notes issued by SPVs that have acquired rights to receive cash flows representing the servicing fees and/or excess servicing spread associated with certain MSRs. Payment of principal and interest on these term notes is considered to be largely dependent on cash flows generated by the underlying MSRs, as this impacts the cash flows available to the SPV that issued the term notes.

At September 30, 2018, these term notes had an amortized cost of $504.3 million, gross unrealized gains of approximately $922,000, a weighted average yield of 5.15% and a weighted average term to maturity of 4.5 years. At December 31, 2017, the term notes had an amortized cost of $381.0 million, unrealized gains of $804,000, a weighted average yield of 5.80% and a weighted average term to maturity of 3.4 years.

(b) Corporate Loans

The Company has made or participated in loans to provide financing to entities that originate residential mortgage loans and own the related MSRs. These corporate loans are secured by MSRs, as well as certain other unencumbered assets owned by the borrower.

During the three months ended September 30, 2018, the Company participated in a loan where the Company committed to lend $100.0 million of which approximately $60.1 million was drawn at September 30, 2018. At September 30, 2018, the coupon paid by the borrower on the drawn amount is 5.64%, the remaining term associated with the loan is 1.9 years and the remaining commitment period on any undrawn amount is 1.9 years. During the remaining commitment period, the Company receives a commitment fee between 0.25% and 1.0% based on the undrawn amount of the loan.

In December 2016, the Company entered into a loan agreement under the terms of which it had committed to lend $130.0 million, of which approximately $124.2 million was drawn at March 31, 2018. This loan was paid in full during the three months ended June 30, 2018, at which time any remaining commitment was extinguished.

For the three and nine months ended September 30, 2018, the Company recognized interest income on its corporate loans of $138,000 and $3.8 million including discount accretion and commitment fee income of $19,000 and $1.3 million, respectively. In addition, the Company recorded $136,000 of Other Income consisting of deferred commitment fees recognized upon repayment of a corporate loan during the nine months ended September 30, 2018. For the three and nine months ended September 30, 2017, the Company recognized interest income on its corporate loans of approximately $2.1 million and $5.7 million including discount accretion and commitment fee income of approximately $76,000 and $212,000, respectively.

Impact of AFS Securities on AOCI

The following table presents the impact of the Company’s AFS securities on its AOCI for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended September 30,						Nine Months Ended September 30,
(In Thousands)	2018			2017			2018			2017
AOCI from AFS securities:
Unrealized gain on AFS securities at beginning of period	$	548,551		$	668,223		$	620,648		$	620,403
Unrealized loss on Agency MBS, net	(9,177		)	(3,032		)	(27,507		)	(22,241		)
Unrealized (loss)/gain on Non-Agency MBS, net	(25,101		)	10,020			(62,743		)	93,429
Reclassification adjustment for MBS sales included in net income	(9,455		)	(14,935		)	(25,580		)	(30,283		)
Reclassification adjustment for OTTI included in net income	—			—			—			(1,032		)
Change in AOCI from AFS securities	(43,733		)	(7,947		)	(115,830		)	39,873
Balance at end of period	$	504,818		$	660,276		$	504,818		$	660,276

Interest Income on MBS, CRT Securities and MSR Related Assets

The following table presents the components of interest income on the Company’s MBS, CRT securities and MSR related assets for the three and nine months ended September 30, 2018 and 2017: 

	Three Months Ended September 30,						Nine Months Ended September 30,
(In Thousands)	2018			2017			2018			2017
Agency MBS
Coupon interest	$	21,549		$	23,473		$	62,546		$	74,589
Effective yield adjustment (1)	(7,217		)	(7,940		)	(19,751		)	(24,575		)
Interest income	$	14,332		$	15,533		$	42,795		$	50,014
Legacy Non-Agency MBS
Coupon interest	$	27,026		$	30,688		$	83,791		$	97,796
Effective yield adjustment (2)(3)	18,984			18,005			53,648			59,033
Interest income	$	46,010		$	48,693		$	137,439		$	156,829
RPL/NPL MBS
Coupon interest	$	11,526		$	13,947		$	31,167		$	54,475
Effective yield adjustment (1)(4)	1,131			612			1,206			1,424
Interest income	$	12,657		$	14,559		$	32,373		$	55,899
CRT securities
Coupon interest	$	7,257		$	7,868		$	23,484		$	19,712
Effective yield adjustment (2)	491			808			2,455			3,186
Interest income	$	7,748		$	8,676		$	25,939		$	22,898
MSR related assets
Coupon interest	$	6,407		$	7,117		$	19,005		$	17,621
Effective yield adjustment (1)	—			77			1,244			212
Interest income	$	6,407		$	7,194		$	20,249		$	17,833

(1)  Includes amortization of premium paid net of accretion of purchase discount.  For Agency MBS, RPL/NPL MBS and the corporate loan secured by MSRs, interest income is recorded at an effective yield, which reflects net premium amortization/accretion based on actual prepayment activity.

(2) The effective yield adjustment is the difference between the net income calculated using the net yield, which is based on management’s estimates of the amount and timing of future cash flows, less the current coupon yield.

(3) Includes accretion income recognized due to the impact of redemptions of certain securities that had been previously been purchased at a discount of $2.3 million during the three months ended September 30, 2018 and $2.3 million and $1.7 million during the nine months ended September 30, 2018 and 2017, respectively.

(4) Includes accretion income recognized due to the impact of redemptions of certain securities that had been previously been purchased at a discount of $1.1 million and $575,000 during the three months ended September 30, 2018 and 2017, respectively and $1.2 million during each of the nine months ended September 30, 2018 and 2017, respectively.

XML

Residential Whole Loans

9 Months Ended

Sep. 30, 2018

Receivables [Abstract]

Residential Whole Loans

Residential Whole Loans

Included on the Company’s consolidated balance sheets at September 30, 2018 and December 31, 2017 are approximately $3.9 billion and $2.2 billion, respectively, of residential whole loans arising from the Company’s interests in certain trusts established to acquire the loans and certain entities established in connection with its loan securitization transactions. The Company has assessed that these entities are required to be consolidated for financial reporting purposes.

Residential Whole Loans, at Carrying Value

The following table presents the components of the Company’s Residential whole loans, at carrying value at September 30, 2018 and December 31, 2017:

(Dollars In Thousands)	September 30, 2018		December 31, 2017
Purchased credit impaired loans	$	825,614	$	790,879
Other loans at carrying value:
Non-QM loans	989,818		55,612
Rehabilitation loans	329,301		56,706
Single-family rental loans	79,699		5,319
Seasoned performing loans	247,135		—
Total other loans at carrying value	$	1,645,953	$	117,637
Total Residential whole loans, at carrying value	$	2,471,567	$	908,516
Number of loans	9,900		4,800

The following table presents additional information regarding the Company’s Residential whole loans, at carrying value at September 30, 2018:

September 30, 2018

	Carrying Value		Unpaid Principal Balance (“UPB”)		Weighted Average Coupon (1)		Weighted Average Term to Maturity (Months)	Weighted Average LTV Ratio (2)		Aging by UPB
												Past Due Days
(Dollars In Thousands)										Current		30-59		60-89		90+
Purchased credit impaired loans	$	825,614	$	1,034,890	4.36	%	304	87	%	N/A		N/A		N/A		N/A
Other loans at carrying value:(3)
Non-QM loans	989,818		956,162		6.18		358	66		$	944,564	$	8,564	$	1,865	$	1,169
Rehabilitation loans	329,301		329,301		7.51		9	65		309,951		12,836		3,620		2,894
Single-family rental loans	79,699		79,563		5.84		355	68		78,172		870		—		521
Seasoned performing loans	240,362		260,770		4.05		194	49		239,025		20,373		635		737
Residential whole loans, at carrying value, total or weighted average	$	2,464,794	$	2,660,686	5.46	%	278

(1) Weighted average is calculated based on the interest bearing principal balance of each loan within the related category. For loans acquired with servicing rights released by the seller, interest rates included in the calculation do not reflect loan servicing fees. For loans acquired with servicing rights retained by the seller, interest rates included in the calculation are net of servicing fees.

(2) LTV represents the ratio of the total unpaid principal balance of the loan, to the estimated value of the collateral securing the related loan. For Rehabilitation loans, the LTV generally represents the ratio of the maximum unpaid principal balance of the loan, including unfunded commitments, to the estimated after repaired value of the collateral securing the related loan. For certain Rehabilitation loans, an after repaired valuation is not obtained during loan underwriting. For these loans, the LTV represents the ratio of the current unpaid principal balance of the loan, to the “as is” estimated value of the collateral securing the related loan.

(3) Excluded from the table above are approximately $6.8 million of other loans held at carrying value for which the closing of the purchase transaction had not occurred as of September 30, 2018.

Purchased Credit Impaired Loans

As of September 30, 2018, the Company had established an allowance for loan losses of approximately $461,000 on its purchased credit impaired loans held at carrying value. For the three and nine months ended September 30, 2018, a provision for loan losses of approximately $164,000 and $131,000 was recorded, respectively, which is included in Operating and Other expense on the Company’s consolidated statements of operations. For the three and nine months ended September 30, 2017, a net reversal of provision for loan losses of approximately $57,000 and $672,000 was recorded, respectively.

The following table presents the activity in the Company’s allowance for loan losses on its purchased credit impaired loans held at carrying value for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,					Nine Months Ended   September 30,
(In Thousands)	2018		2017			2018		2017
Balance at the beginning of period	$	297	$	375		$	330	$	990
Provisions/(reversal of provisions) for loan losses	164		(57		)	131		(672		)
Balance at the end of period	$	461	$	318		$	461	$	318

The following table presents information regarding the estimates of the contractually required payments, the cash flows expected to be collected, and the estimated fair value of the purchased credit impaired loans held at carrying value acquired by the Company for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended  September 30, (1)						Nine Months Ended  September 30, (1)
(In Thousands)	2018			2017			2018			2017
Contractually required principal and interest	$	154,911		$	185,234		$	154,911		$	185,234
Contractual cash flows not expected to be collected (non-accretable yield)	(15,378		)	(33,448		)	(15,378		)	(33,448		)
Expected cash flows to be collected	139,533			151,786			139,533			151,786
Interest component of expected cash flows (accretable yield)	(41,947		)	(53,916		)	(41,947		)	(53,916		)
Fair value at the date of acquisition	$	97,586		$	97,870		$	97,586		$	97,870

(1) Included in the activity presented for the three and nine months ended September 30, 2018 and 2017 are approximately $54.9 million and $97.9 million of purchase credit impaired loans held at carrying value the Company committed to purchase during the three months endedJune 30, 2018 and 2017, but for which the closing of the purchase transaction occurred during the three months endedSeptember 30, 2018 and 2017, respectively.

The following table presents accretable yield activity for the Company’s purchased credit impaired loans held at carrying value for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended September 30, (1)						Nine Months Ended September 30, (1)
(In Thousands)	2018			2017			2018			2017
Balance at beginning of period	$	401,075		$	318,125		$	421,872		$	334,379
Additions	41,947			53,916			41,947			53,916
Accretion	(11,198		)	(9,026		)	(33,139		)	(26,219		)
Liquidations and other	(8,378		)	—			(23,388		)	—
Reclassifications (to)/from non-accretable difference, net	9,694			303			25,848			1,242
Balance at end of period	$	433,140		$	363,318		$	433,140		$	363,318

(1) Included in the activity presented for the three and nine months ended September 30, 2018 and 2017 are approximately $54.9 million and $97.9 million of purchase credit impaired loans held at carrying value the Company committed to purchase during the three months endedJune 30, 2018 and 2017, but for which the closing of the purchase transaction occurred during the three months endedSeptember 30, 2018 and 2017, respectively.

Accretable yield for purchased credit impaired residential whole loans is the excess of loan cash flows expected to be collected over the purchase price. The cash flows expected to be collected represent the Company’s estimate of the amount and timing of undiscounted principal and interest cash flows. Additions include accretable yield estimates for purchases made during the period and reclassification to accretable yield from non-accretable yield. Accretable yield is reduced by accretion during the period. The reclassifications between accretable and non-accretable yield and the accretion of interest income are based on changes in estimates regarding loan performance and the value of the underlying real estate securing the loans. In future periods, as the Company updates estimates of cash flows expected to be collected from the loans and the underlying collateral, the accretable yield may change. Therefore, the amount of accretable income recorded during the three and nine months ended September 30, 2018 is not necessarily indicative of future results.

Other Loans at Carrying Value

As of September 30, 2018, there were ten loans held at carrying value, that have been placed on non-accrual status as they are more than 90 days delinquent and had not yet become current with respect to the contractually required payments under the loan. Such loans have an unpaid balance of approximately $5.3 million. These non-performing loans represent approximately 0.3% of the total outstanding principal balance of all of the Company’s Other Loans at Carrying Value. Management has assessed the recoverability of these loans and based on estimates of the value of the underlying collateral, no allowance for loan loss reserves has been recorded as of September 30, 2018.

In connection with purchased Rehabilitation loans, the Company has unfunded commitments of $43.9 million.

Residential Whole Loans, at Fair Value

Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at time of acquisition. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations.

The following table presents information regarding the Company’s residential whole loans held at fair value at September 30, 2018 and December 31, 2017:

(Dollars in Thousands)	September 30, 2018 (1)			December 31, 2017
Less than 60 Days Past Due:
Outstanding principal balance	$	585,024		$	488,600
Aggregate fair value	$	544,890		$	446,616
Weighted Average LTV Ratio (2)	76.17		%	74.98		%
Number of loans	2,775			2,323
60 Days to 89 Days Past Due:
Outstanding principal balance	$	70,018		$	45,955
Aggregate fair value	$	62,043		$	37,927
Weighted Average LTV Ratio (2)	77.62		%	89.25		%
Number of loans	319			207
90 Days or More Past Due:
Outstanding principal balance	$	972,488		$	1,027,818
Aggregate fair value	$	840,634		$	840,572
Weighted Average LTV Ratio (2)	89.48		%	94.50		%
Number of loans	3,416			3,984
Total Residential whole loans, at fair value	$	1,447,567		$	1,325,115

(1) Excluded from the table above are approximately $1.8 million of residential whole loans held at fair value for which the closing of the purchase transaction had not occurred as of September 30, 2018.

(2) LTV represents the ratio of the total unpaid principal balance of the loan, to the estimated value of the collateral securing the related loan. Excluded from the calculation of weighted average LTV are certain low value loans secured by vacant lots, for which the LTV ratio is not meaningful.

The following table presents the components of Net gain on residential whole loans held at fair value for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,				Nine Months Ended   September 30,
(In Thousands)	2018		2017		2018		2017
Coupon payments and other income received (1)	$	17,634	$	9,824	$	52,034	$	27,971
Net unrealized gains	8,442		5,289		26,788		12,499
Net gain on payoff/liquidation of loans	3,251		1,456		10,203		3,076
Net gain on transfers to REO	5,615		2,110		16,858		5,114
Total	$	34,942	$	18,679	$	105,883	$	48,660

(1) Primarily includes coupon interest payments received upon the liquidation of previously delinquent mortgage loans, recurring coupon interest payments received on mortgage loans that are contractually current, and cash payments received from private mortgage insurance on liquidated loans.

XML

Other Assets

9 Months Ended

Sep. 30, 2018

Other Assets [Abstract]

Other Assets

Other Assets

The following table presents the components of the Company’s Other assets at September 30, 2018 and December 31, 2017:

(In Thousands)	September 30, 2018		December 31, 2017
Securities obtained and pledged as collateral, at fair value	$	—	$	504,062
REO	223,105		152,356
MBS and loan related receivables	101,578		54,640
Swaps, at fair value	22,311		679
Goodwill	7,189		7,189
Other	51,886		23,983
Total Other Assets	$	406,069	$	742,909

(a)  Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as Collateral

In connection with its financing strategy for Non-Agency MBS, in prior periods the Company obtained securities as collateral under collateralized financing arrangements.  Securities obtained as collateral in connection with these transactions are recorded at fair value, with a liability, representing the obligation to return the collateral obtained, recorded in Other liabilities.  While beneficial ownership of securities obtained remains with the counterparty, the Company had the right to transfer the collateral obtained or to pledge it as part of a subsequent collateralized financing transaction. During the three months ended September 30, 2018, these financing arrangements were unwound and the related securities obtained as collateral were returned to the counterparty.

(b) Real Estate Owned

At September 30, 2018, the Company had 979 REO properties with an aggregate carrying value of $223.1 million. At December 31, 2017, the Company had 709 REO properties with an aggregate carrying value of $152.4 million.

During the three and nine months ended September 30, 2018, the Company reclassified to REO 240 and 795 mortgage loans, respectively at an aggregate estimated fair value less estimated selling costs of $58.1 million and $161.6 million, respectively, at the time of transfer. During the three and nine months ended September 30, 2017, the Company reclassified to REO 174 and 521 mortgage loans, respectively at an aggregate estimated fair value less estimated selling cost of $38.9 million and $97.4 million, respectively, at the time of transfer. Such transfers occur when the Company takes possession of the property by foreclosing on the borrower or completes a “deed-in-lieu of foreclosure” transaction. From time to time, the Company also acquires REO in connection with transactions to acquire residential whole loans.

At September 30, 2018, $214.4 million of residential real estate property was held by the Company that was acquired either through a completed foreclosure proceeding or from completion of a deed-in-lieu of foreclosure or similar legal agreement. In addition, formal foreclosure proceedings were in process with respect to $48.7 million of residential whole loans held at carrying value and $720.1 million of residential whole loans held at fair value at September 30, 2018.

During the three and nine months ended September 30, 2018, the Company sold 157 and 537 REO properties for consideration of $29.9 million and $96.0 million, realizing net gains of approximately $2.0 million and $6.6 million, respectively. During the three and nine months ended September 30, 2017, the Company sold 139 and 368 REO properties for consideration of $18.4 million and $53.0 million, realizing net gain of approximately $805,000 and $2.8 million, respectively. These amounts are included in Other Income, net on the Company’s consolidated statements of operations. In addition, following an updated assessment of liquidation amounts expected to be realized that was performed on all REO held at the end of the third quarters of 2018 and 2017, downward adjustments of approximately $4.1 million and $3.1 million were recorded to reflect certain REO properties at the lower of cost or estimated fair value as of September 30, 2018 and 2017, respectively.

The following table presents the activity in the Company’s REO for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,						Nine Months Ended September 30,
(In Thousands)	2018			2017			2018			2017
Balance at beginning of period	$	192,162		$	104,443		$	152,356		$	80,503
Adjustments to record at lower of cost or fair value	(4,056		)	(3,129		)	(11,592		)	(7,306		)
Transfer from residential whole loans (1)	58,051			38,944			161,572			97,388
Purchases and capital improvements	4,897			15,342			10,179			17,224
Disposals	(27,949		)	(17,621		)	(89,410		)	(49,830		)
Balance at end of period	$	223,105		$	137,979		$	223,105		$	137,979

(1)  Includes net gain recorded on transfer of approximately $5.8 million and $2.8 million, for the three months ended September 30, 2018 and 2017, respectively; and approximately $17.0 million and $5.3 million for the nine months ended September 30, 2018 and 2017, respectively.

(c)Derivative Instruments

The Company’s derivative instruments are currently comprised of Swaps, the majority of which are designated as cash flow hedges against the interest rate risk associated with its borrowings. In addition, in connection with managing risks associated with purchases of longer duration Agency MBS, the Company has also entered into Swaps that are not designated as hedges for accounting purposes. The following table presents the fair value of the Company’s derivative instruments and their balance sheet location at September 30, 2018 and December 31, 2017:

			September 30, 2018				December 31, 2017
Derivative Instrument (1)	Designation	Balance Sheet Location	Notional Amount		Fair Value		Notional Amount		Fair Value
(In Thousands)
Swaps	Hedging	Other assets	$	2,122,000	$	18,650	$	750,000	$	679
Swaps	Hedging	Other liabilities	$	—	$	—	$	1,800,000	$	—
Swaps	Non-Hedging	Other assets	$	515,000	$	3,661	$	—	$	—

(1) Represents Swaps executed bilaterally with a counterparty in the over-the-counter market but then novated to a central clearing house, whereby the central clearing house becomes the counterparty to both of the original counterparties.

Swaps

The following table presents the assets pledged as collateral against the Company’s Swap contracts at September 30, 2018 and December 31, 2017:

(In Thousands)	September 30, 2018		December 31, 2017
Agency MBS, at fair value	$	2,877	$	21,756
Restricted cash	—		6,405
Total assets pledged against Swaps	$	2,877	$	28,161

Swaps designated as hedges, or a portion thereof, could become ineffective in the future if the associated repurchase agreements that such derivatives hedge fail to exist or fail to have terms that match those of the derivatives that hedge such borrowings.  At September 30, 2018, all of the Company’s derivatives that were designated in a hedging relationship were deemed effective for hedging purposes.

The Company’s Swaps designated as hedging transactions have the effect of modifying the repricing characteristics of the Company’s repurchase agreements and cash flows for such liabilities.  To date, no cost has been incurred at the inception of a Swap (except for certain transaction fees related to entering into Swaps cleared though a central clearing house), pursuant to which the Company agrees to pay a fixed rate of interest and receive a variable interest rate, generally based on one-month or three-month London Interbank Offered Rate (“LIBOR”), on the notional amount of the Swap. The Company did not recognize any change in the value of its existing Swaps designated as hedges through earnings as a result of hedge ineffectiveness during the three and nine months ended September 30, 2018 and 2017.

At September 30, 2018, the Company had Swaps with an aggregate notional amount of $2.6 billion and extended 32 months on average with a maximum term of approximately 121 months. 

The following table presents information about the Company’s Swaps at September 30, 2018 and December 31, 2017:

	September 30, 2018						December 31, 2017
	Notional Amount		Weighted Average Fixed-Pay Interest Rate		Weighted Average Variable Interest Rate (2)		Notional Amount		Weighted Average Fixed-Pay Interest Rate		Weighted Average Variable Interest Rate (2)
Maturity (1)
(Dollars in Thousands)
Within 30 days	$	—	—	%	—	%	$	—	—	%	—	%
Over 30 days to 3 months	—		—		—		—		—		—
Over 3 months to 6 months	100,000		1.71		2.21		50,000		1.45		1.56
Over 6 months to 12 months	100,000		1.71		2.21		500,000		1.50		1.46
Over 12 months to 24 months	1,630,000		2.27		2.20		200,000		1.71		1.54
Over 24 months to 36 months	322,000		2.34		2.17		1,500,000		2.22		1.51
Over 36 months to 48 months	—		—		—		200,000		2.20		1.53
Over 48 months to 60 months	355,000		2.85		2.28		—		—		—
Over 60 months to 72 months	—		—		—		100,000		2.75		1.50
Over 72 months to 84 months	—		—		—		—		—		—
Over 84 months	130,000		2.94		2.32		—		—		—
Total Swaps	$	2,637,000	2.35	%	2.21	%	$	2,550,000	2.04	%	1.50	%

(1)  Each maturity category reflects contractual amortization and/or maturity of notional amounts.

(2)  Reflects the benchmark variable rate due from the counterparty at the date presented, which rate adjusts monthly or quarterly based on one-month or three-month LIBOR, respectively.

The following table presents the net impact of the Company’s derivative hedging instruments on its interest expense and the weighted average interest rate paid and received for such Swaps for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,						Nine Months Ended   September 30,
(Dollars in Thousands)	2018			2017			2018			2017
Interest expense attributable to Swaps	$	547		$	5,310		$	4,187		$	19,606
Weighted average Swap rate paid	2.19		%	2.04		%	2.09		%	1.96		%
Weighted average Swap rate received	2.09		%	1.23		%	1.86		%	1.00		%

During the three and nine months ended September 30, 2018, the Company recorded net gains on Swaps not designated in hedging relationships of $4.0 million and $4.4 million, respectively. These amounts are included in Other income, net on the Company’s consolidated statements of operations. All of the Company’s Swaps were designated in hedging relationships during the three and nine months ended September 30, 2017.

Impact of Derivative Hedging Instruments on AOCI

The following table presents the impact of the Company’s derivative hedging instruments on its AOCI for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,					Nine Months Ended   September 30,
(In Thousands)	2018		2017			2018			2017
AOCI from derivative hedging instruments:
Balance at beginning of period	$	16,160	$	(35,841	)	$	(11,424	)	$	(46,721	)
Net gain on Swaps	5,390		5,791			32,974			16,671
Balance at end of period	$	21,550	$	(30,050	)	$	21,550		$	(30,050	)

XML

Repurchase Agreements

9 Months Ended

Sep. 30, 2018

Disclosure of Repurchase Agreements [Abstract]

Repurchase Agreements

Repurchase Agreements

The Company’s repurchase agreements are accounted for as secured borrowings and bear interest that is generally LIBOR-based.  (See Notes 2(k) and 7)  At September 30, 2018, the Company’s borrowings under repurchase agreements had a weighted average remaining term-to-interest rate reset of 25 days and an effective repricing period of 11 months, including the impact of related Swaps.  At December 31, 2017, the Company’s borrowings under repurchase agreements had a weighted average remaining term-to-interest rate reset of 16 days and an effective repricing period of 11 months, including the impact of related Swaps.

The following table presents information with respect to the Company’s borrowings under repurchase agreements and associated assets pledged as collateral at September 30, 2018 and December 31, 2017:

(Dollars in Thousands)	September 30, 2018			December 31, 2017
Repurchase agreement borrowings secured by Agency MBS	$	2,584,097		$	2,501,340
Fair value of Agency MBS pledged as collateral under repurchase agreements	$	2,792,396		$	2,705,754
Weighted average haircut on Agency MBS (1)	4.48		%	4.65		%
Repurchase agreement borrowings secured by Legacy Non-Agency MBS	$	1,592,067		$	1,256,033
Fair value of Legacy Non-Agency MBS pledged as collateral under repurchase agreements	$	2,075,540		$	1,652,983
Weighted average haircut on Legacy Non-Agency MBS (1)	21.70		%	21.87		%
Repurchase agreement borrowings secured by RPL/NPL MBS	$	913,249		$	567,140
Fair value of RPL/NPL MBS pledged as collateral under repurchase agreements	$	1,161,568		$	726,540
Weighted average haircut on RPL/NPL MBS (1)	21.22		%	22.05		%
Repurchase agreements secured by U.S. Treasuries	$	—		$	470,334
Fair value of U.S. Treasuries pledged as collateral under repurchase agreements	$	—		$	472,095
Weighted average haircut on U.S. Treasuries (1)	—		%	1.47		%
Repurchase agreements secured by CRT securities	$	405,168		$	459,058
Fair value of CRT securities pledged as collateral under repurchase agreements	$	504,931		$	595,900
Weighted average haircut on CRT securities (1)	19.73		%	22.16		%
Repurchase agreements secured by MSR related assets	$	435,762		$	317,255
Fair value of MSR related assets pledged as collateral under repurchase agreements	$	565,272		$	482,158
Weighted average haircut on MSR related assets (1)	22.56		%	33.19		%
Repurchase agreements secured by residential whole loans (2)	$	1,347,946		$	1,043,747
Fair value of residential whole loans pledged as collateral under repurchase agreements (3)	$	1,888,445		$	1,474,704
Weighted average haircut on residential whole loans (1)	21.93		%	26.10		%

(1) Haircut represents the percentage amount by which the collateral value is contractually required to exceed the loan amount.

(2) Excludes $19,000 and $206,000 of unamortized debt issuance costs at September 30, 2018 and December 31, 2017, respectively.

(3) At September 30, 2018 includes Non-Agency MBS with an aggregate fair value of $27.0 million obtained in connection with the Company’s loan securitization transactions that are eliminated in consolidation.

The following table presents repricing information about the Company’s borrowings under repurchase agreements, which does not reflect the impact of associated derivative hedging instruments, at September 30, 2018 and December 31, 2017:

	September 30, 2018				December 31, 2017
	Balance		Weighted Average Interest Rate		Balance		Weighted Average Interest Rate
Time Until Interest Rate Reset
(Dollars in Thousands)
Within 30 days	$	6,985,487	3.01	%	$	6,161,008	2.39	%
Over 30 days to 3 months	29,501		2.48		453,899		2.76
Over 3 months to 12 months	263,301		3.09		—		—
Total repurchase agreements	7,278,289		3.01	%	6,614,907		2.42	%
Less debt issuance costs	19				206
Total repurchase agreements less debt   issuance costs	$	7,278,270			$	6,614,701

The following table presents contractual maturity information about the Company’s borrowings under repurchase agreements, all of which are accounted for as secured borrowings, at September 30, 2018, and does not reflect the impact of derivative contracts that hedge such repurchase agreements:

	September 30, 2018
Contractual Maturity	Overnight			Within 30 Days			Over 30 Days to 3 Months			Over 3 Months to 12 Months			Over 12 months			Total
(Dollars in Thousands)
Agency MBS	$	—		$	2,570,990		$	13,107		$	—		$	—		$	2,584,097
Legacy Non-Agency MBS	—			1,544,995			47,072			—			—			1,592,067
RPL/NPL MBS	—			887,087			26,162			—			—			913,249
CRT securities	—			399,064			6,104			—			—			405,168
MSR related assets	—			342,704			93,058			—			—			435,762
Residential whole loans	—			267,129			376,936			703,881			—			1,347,946
Total (1)	$	—		$	6,011,969		$	562,439		$	703,881		$	—		$	7,278,289
Weighted Average Interest Rate	—		%	2.85		%	3.73		%	3.80		%	—		%	3.01		%
Gross amount of recognized liabilities for repurchase agreements in Note 8																$	7,278,289
Amounts related to repurchase agreements not included in offsetting disclosure in Note 8																$	—

(1) Excludes $19,000 of unamortized debt issuance costs at September 30, 2018.

Undrawn Financing Commitment

In connection with the financing of MSR related assets, the Company has obtained a financing commitment of up to $75.0 million, of which $45.1 million was utilized and was outstanding as of September 30, 2018. The Company pays a commitment fee ranging from 0.125% to 0.5% of the undrawn amount, depending on the amount of financing utilized.

The Company had repurchase agreement borrowings with 28 and 31 counterparties at September 30, 2018 and December 31, 2017. The following table presents information with respect to each counterparty under repurchase agreements for which the Company had greater than 5% of stockholders’ equity at risk in the aggregate at September 30, 2018:

	September 30, 2018
	Counterparty Rating (1)	Amount  at Risk (2)		Weighted  Average Months  to Maturity for Repurchase Agreements	Percent of Stockholders’ Equity
Counterparty
(Dollars in Thousands)
Barclay's Bank	BBB/Aa3/A	$	346,185	4	9.8	%
Goldman Sachs (3)	BBB+/A3/A	305,862		1	8.6
Wells Fargo (4)	A+/Aa2/AA-	252,651		5	7.1
RBC (5)	AA-/Aa2/AA	243,731		1	6.9

(1) As rated at September 30, 2018 by S&P, Moody’s and Fitch, Inc., respectively.  The counterparty rating presented is the lowest published for these entities.

(2) The amount at risk reflects the difference between (a) the amount loaned to the Company through repurchase agreements, including interest payable, and (b) the cash and the fair value of the securities pledged by the Company as collateral, including accrued interest receivable on such securities.

(3) Includes $171.3 million at risk with Goldman Sachs Bank USA and $134.6 million at risk with Goldman Sachs Lending Partners.

(4) Includes $241.0 million at risk with Wells Fargo Bank, NA and $11.7 million at risk with Wells Fargo Securities LLC.

(5) Includes $237.6 million at risk with RBC Barbados and $6.1 million at risk with RBC New York. Counterparty ratings are not published for RBC Barbados and RBS Capital Market LLC.

XML

Collateral Positions

9 Months Ended

Sep. 30, 2018

Collateral Positions

Collateral Positions

Collateral Positions

The Company pledges securities or cash as collateral to its counterparties pursuant to its borrowings under repurchase agreements and for initial margin payments on centrally cleared Swaps. In addition, the Company receives securities or cash as collateral pursuant to financing provided under reverse repurchase agreements.  The Company exchanges collateral with its counterparties based on changes in the fair value, notional amount and term of the associated repurchase agreements and Swap contracts, as applicable.  In connection with these margining practices, either the Company or its counterparty may be required to pledge cash or securities as collateral.  When the Company’s pledged collateral exceeds the required margin, the Company may initiate a reverse margin call, at which time the counterparty may either return the excess collateral or provide collateral to the Company in the form of cash or equivalent securities.

The following table summarizes the fair value of the Company’s collateral positions, which includes collateral pledged and collateral held, with respect to its borrowings under repurchase agreements, reverse repurchase agreements and derivative hedging instruments at September 30, 2018 and December 31, 2017: 

	September 30, 2018				December 31, 2017
(In Thousands)	Assets Pledged		Collateral Held		Assets Pledged		Collateral Held
Derivative Hedging Instruments:
Agency MBS	$	2,877	$	—	$	21,756	$	—
Cash (1)	—		—		6,405		—
	2,877		—		28,161		—
Repurchase Agreement Borrowings:
Agency MBS	2,792,396		—		2,705,754		—
Legacy Non-Agency MBS (2)	2,075,540		—		1,652,983		—
RPL/NPL MBS	1,161,568		—		726,540		—
U.S. Treasury securities	—		—		472,095		—
CRT securities	504,931		—		595,900		—
MSR related assets	565,272		—		482,158		—
Residential whole loans (3)	1,888,445		—		1,474,704		—
Cash (1)	6,489		—		6,902		—
	8,994,641		—		8,117,036		—
Reverse Repurchase Agreements:
U.S. Treasury securities	—		—		—		504,062
	—		—		—		504,062
Total	$	8,997,518	$	—	$	8,145,197	$	504,062

(1)  Cash pledged as collateral is reported as Restricted cash on the Company’s consolidated balance sheets.

(2)  In addition, at December 31, 2017$688.1 million of Legacy Non-Agency MBS were pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty.

(3) At September 30, 2018 includes Non-Agency MBS with an aggregate fair value of $27.0 million obtained in connection with the Company’s loan securitization transactions that are eliminated in consolidation.

The following table presents detailed information about the Company’s assets pledged as collateral pursuant to its borrowings under repurchase agreements and derivative hedging instruments at September 30, 2018:

	September 30, 2018
	Assets Pledged Under Repurchase  Agreements						Assets Pledged Against Derivative Hedging Instruments						Total Fair Value of Assets Pledged and Accrued Interest
(In Thousands)	Fair Value		Amortized Cost		Accrued  Interest on Pledged  Assets		Fair Value/  Carrying  Value		Amortized Cost		Accrued Interest on  Pledged  Assets
Agency MBS	$	2,792,396	$	2,842,022	$	8,527	$	2,877	$	3,036	$	7	$	2,803,807
Legacy Non-Agency MBS	2,075,540		1,548,906		8,531		—		—		—		2,084,071
RPL/NPL MBS	1,161,568		1,162,829		984		—		—		—		1,162,552
CRT securities	504,931		472,217		436		—		—		—		505,367
MSR related assets	565,272		564,350		644		—		—		—		565,916
Residential whole loans (1)(2)	1,888,445		1,861,387		8,485		—		—		—		1,896,930
Cash (3)	6,489		6,489		—		—		—		—		6,489
Total	$	8,994,641	$	8,458,200	$	27,607	$	2,877	$	3,036	$	7	$	9,025,132

(1) Includes residential whole loans held at carrying value with an aggregate fair value of $1.2 billion and aggregate amortized cost of $1.1 billion and residential whole loans held at fair value with an aggregate fair value and amortized cost of $685.1 million.

(2) Includes Non-Agency MBS with an aggregate fair value and amortized cost of $27.0 million obtained in connection with the Company’s loan securitization transactions that are eliminated in consolidation.

(3) Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets.

XML

Offsetting Assets and Liabilities

9 Months Ended

Sep. 30, 2018

Offsetting [Abstract]

Offsetting Assets and Liabilities

Offsetting Assets and Liabilities

The following tables present information about certain assets and liabilities that are subject to master netting arrangements (or similar agreements) and may potentially be offset on the Company’s consolidated balance sheets at September 30, 2018 and December 31, 2017:

Offsetting of Financial Assets and Derivative Assets

	Gross Amounts of Recognized Assets		Gross Amounts Offset in the Consolidated Balance Sheets		Net Amounts of Assets Presented in the Consolidated Balance Sheets		Gross Amounts Not Offset in  the Consolidated Balance Sheets					Net Amount
(In Thousands)							Financial Instruments			Cash  Collateral  Received
September 30, 2018
Swaps, at fair value	$	22,311	$	—	$	22,311	$	(22,311	)	$	—	$	—
Total	$	22,311	$	—	$	22,311	$	(22,311	)	$	—	$	—
December 31, 2017
Swaps, at fair value	$	679	$	—	$	679	$	(679	)	$	—	$	—
Total	$	679	$	—	$	679	$	(679	)	$	—	$	—

Offsetting of Financial Liabilities and Derivative Liabilities

	Gross Amounts of Recognized Liabilities		Gross Amounts Offset in the Consolidated Balance Sheets		Net Amounts of Liabilities Presented in the Consolidated Balance Sheets		Gross Amounts Not Offset in the  Consolidated Balance Sheets						Net Amount
(In Thousands)							Financial  Instruments (1)			Cash  Collateral  Pledged (1)
September 30, 2018
Swaps, at fair value (2)	$	—	$	—	$	—	$	—		$	—		$	—
Repurchase agreements (3)(4)	7,278,289		—		7,278,289		(7,271,800		)	(6,489		)	—
Total	$	7,278,289	$	—	$	7,278,289	$	(7,271,800	)	$	(6,489	)	$	—
December 31, 2017
Swaps, at fair value (2)	$	—	$	—	$	—	$	—		$	—		$	—
Repurchase agreements (3)(4)	6,614,907		—		6,614,907		(6,608,005		)	(6,902		)	—
Total	$	6,614,907	$	—	$	6,614,907	$	(6,608,005	)	$	(6,902	)	$	—

(1) Amounts disclosed in the Financial Instruments column of the above table represent collateral pledged that is available to be offset against liability balances associated with repurchase agreements.  Amounts disclosed in the Cash Collateral Pledged column of the above table represent amounts pledged as collateral against repurchase agreements.

(2) The fair value of securities pledged against the Company’s Swaps was $2.9 million and $21.8 million at September 30, 2018 and December 31, 2017, respectively. Beginning in January 2017, variation margin payments on the Company’s cleared Swaps are treated as a legal settlement of the exposure under the Swap contract. Previously such payments were treated as collateral pledged against the exposure under the Swap contract. The effect of this change is to reduce what would have otherwise been reported as fair value of the Swap.

(3) The fair value of financial instruments pledged against the Company’s repurchase agreements was $9.0 billion and $8.1 billion at September 30, 2018 and December 31, 2017, respectively.

(4) Excludes $19,000 and $206,000 of unamortized debt issuance costs at September 30, 2018 and December 31, 2017, respectively.

Nature of Setoff Rights

In the Company’s consolidated balance sheets, all balances associated with repurchase agreements are presented on a gross basis. Certain of the Company’s repurchase agreement and derivative transactions are governed by underlying agreements that generally provide for a right of setoff in the event of default or in the event of a bankruptcy of either party to the transaction. 

XML

Other Liabilities

9 Months Ended

Sep. 30, 2018

Other Liabilities [Abstract]

Other Liabilities

Other Liabilities

The following table presents the components of the Company’s Other liabilities at September 30, 2018 and December 31, 2017:

(In Thousands)	September 30, 2018		December 31, 2017
Securitized debt (1)	$	714,203	$	363,944
Obligation to return securities held as collateral, at fair value	—		504,062
Senior Notes	96,805		96,773
Dividends and dividend equivalents payable	90,136		79,771
Accrued interest payable	11,630		12,263
Payable for unsettled MBS and residential whole loans purchases	10,888		—
Accrued expenses and other	27,821		21,584
Total Other Liabilities	$	951,483	$	1,078,397

(1) Securitized debt represents third-party liabilities of consolidated VIEs and excludes liabilities of the VIEs acquired by the Company that are eliminated in consolidation. The third-party beneficial interest holders in the VIEs have no recourse to the general credit of the Company. (See Notes 10 and 15 for further discussion.)

Senior Notes

On April 11, 2012, the Company issued $100.0 million in aggregate principal amount of its Senior Notes in an underwritten public offering.  The total net proceeds to the Company from the offering of the Senior Notes were approximately $96.6 million, after deducting offering expenses and the underwriting discount.  The Senior Notes bear interest at a fixed rate of 8.00% per year, paid quarterly in arrears on January 15, April 15, July 15 and October 15 of each year and will mature on April 15, 2042.  The Senior Notes have an effective interest rate, including the impact of amortization to interest expense of debt issuance costs, of 8.31%. The Company may redeem the Senior Notes, in whole or in part, at any time on or after April 15, 2017, at a redemption price equal to 100% of the principal amount redeemed plus accrued and unpaid interest to, but not excluding, the redemption date.

The Senior Notes are the Company’s senior unsecured obligations and are subordinate to all of the Company’s secured indebtedness, which includes the Company’s repurchase agreements and other financing arrangements, to the extent of the value of the collateral securing such indebtedness.

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2018

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

(a) Lease Commitments

The Company pays monthly rent pursuant to two operating leases.  The lease term for the Company’s headquarters in New York, New York extends through June 30, 2020.  The lease provides for aggregate cash payments ranging over time of approximately $2.5 million per year, paid on a monthly basis, exclusive of escalation charges.  In addition, as part of this lease agreement, the Company has provided the landlord a $785,000 irrevocable standby letter of credit fully collateralized by cash.  The letter of credit may be drawn upon by the landlord in the event that the Company defaults under certain terms of the lease.  In addition, the Company has a lease through December 31, 2021 for its off-site back-up facility located in Rockville Centre, New York, which provides for, among other things, lease payments totaling $32,000 annually.

(b)Representations and Warranties in Connection with Loan Securitization Transactions

In connection with the loan securitization transactions entered into by the Company, the Company has the obligation under certain circumstances to repurchase assets previously transferred to securitization vehicles upon breach of certain representations and warranties. As of September 30, 2018, the Company had no reserve established for repurchases of loans and was not aware of any material unsettled repurchase claims that would require the establishment of such a reserve.  (See Note 15)

(c) Corporate Loan

The Company has participated in a loan to provide financing to an entity that originates loans and owns MSRs. The loan is secured by certain MSRs, as well as certain other unencumbered assets owned by the borrower. Under the terms of the participation agreement, the Company has committed to provide financing of $100.0 million of which approximately $60.1 million was drawn at September 30, 2018. (See Note 3)

(d)Rehabilitation Loan Commitments

At September 30, 2018, the Company had unfunded commitments of $43.9 million in connection with its purchased Rehabilitation loans. (See Note 4)

(e)MBS Purchase Commitments

At September 30, 2018, the Company had a commitment to purchase a Non-Agency MBS at an estimated price of $2.3 million. The expected settlement amount is included in the Non-Agency MBS balances presented at fair value on the Company’s consolidated balance sheets, with a corresponding liability recorded in Other liabilities and included in Payable for unsettled MBS and residential whole loan purchases.

(f)Residential Whole Loan Purchase Commitments

At September 30, 2018, the Company has agreed, subject to the completion of due diligence and customary closing conditions, to purchase residential whole loans with an aggregate estimated purchase price of $8.6 million, of which $6.8 million is presented in other loans held at carrying value and $1.8 million in residential whole loans held at fair value with a corresponding liability recorded in Other liabilities and included in Payable for unsettled MBS and residential whole loan purchases.

XML

Stockholders' Equity

9 Months Ended

Sep. 30, 2018

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Stockholders’ Equity

(a) Preferred Stock

On April 15, 2013, the Company completed the issuance of 8.0 million shares of its 7.50% Series B Cumulative Redeemable Preferred Stock (“Series B Preferred Stock”) with a par value of $0.01 per share, and a liquidation preference of $25.00 per share plus accrued and unpaid dividends, in an underwritten public offering. The Company’s Series B Preferred Stock is entitled to receive a dividend at a rate of 7.50% per year on the $25.00 liquidation preference before the Company’s common stock is paid any dividends and is senior to the Company’s common stock with respect to distributions upon liquidation, dissolution or winding up. Dividends on the Series B Preferred Stock are payable quarterly in arrears on or about March 31, June 30, September 30 and December 31 of each year. The Series B Preferred Stock is redeemable at $25.00 per share plus accrued and unpaid dividends (whether or not authorized or declared) exclusively at the Company’s option commencing on April 15, 2018 (subject to the Company’s right, under limited circumstances, to redeem the Series B Preferred Stock prior to that date in order to preserve its qualification as a REIT) and upon certain specified change in control transactions in which the Company’s common stock and the acquiring or surviving entity common securities would not be listed on the New York Stock Exchange (the “NYSE”), the NYSE American or NASDAQ, or any successor exchange.

The Series B Preferred Stock generally does not have any voting rights, subject to an exception in the event the Company fails to pay dividends on such stock for six or more quarterly periods (whether or not consecutive).  Under such circumstances, the Series B Preferred Stock will be entitled to vote to elect two additional directors to the Company’s Board of Directors (the “Board”), until all unpaid dividends have been paid or declared and set apart for payment.  In addition, certain material and adverse changes to the terms of the Series B Preferred Stock cannot be made without the affirmative vote of holders of at least 66 2/3% of the outstanding shares of Series B Preferred Stock.

The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2018 through September 30, 2018:

Declaration Date	Record Date	Payment Date	Dividend Per Share
August 20, 2018	September 7, 2018	September 28, 2018	$	0.46875
May 17, 2018	June 4, 2018	June 29, 2018	0.46875
February 20, 2018	March 2, 2018	March 30, 2018	0.46875

(b)  Dividends on Common Stock

The following table presents cash dividends declared by the Company on its common stock from January 1, 2018 through September 30, 2018:

Declaration Date (1)	Record Date	Payment Date	Dividend Per Share
September 13, 2018	October 1, 2018	October 31, 2018	$	0.20	(1)
June 7, 2018	June 29, 2018	July 31, 2018	0.20
March 7, 2018	March 29, 2018	April 30, 2018	0.20

(1)  At September 30, 2018, the Company had accrued dividends and dividend equivalents payable of $90.1 million related to the common stock dividend declared on September 13, 2018.

(c) Public Offering of Common Stock

The table below presents information with respect to shares of the Company’s common stock issued through public offerings during the nine months ended September 30, 2018 and the year ended December 31, 2017.

Share Issue Date	Shares Issued		Gross Proceeds Per Share		Gross Proceeds
(In Thousands, Except Per Share Amounts)
August 7, 2018	50,875	(1)	$	7.78	$	395,807	(1)
May 10, 2017	23,000		7.85		180,550		(2)

(1) Includes approximately 875,000 shares issued on September 5, 2018 pursuant to the exercise of the underwriters’ option to purchase additional shares. The Company incurred approximately $6.5 million of underwriting discounts and related expenses in connection with this equity offering.

(2) The Company incurred approximately $2.3 million of underwriting discounts and related expenses in connection with this equity offering.

(d) Discount Waiver, Direct Stock Purchase and Dividend Reinvestment Plan (“DRSPP”)

On September 16, 2016, the Company filed a shelf registration statement on Form S-3 with the SEC under the Securities Act of 1933, as amended (the “1933 Act”), for the purpose of registering additional common stock for sale through its DRSPP.  Pursuant to Rule 462(e) of the 1933 Act, this shelf registration statement became effective automatically upon filing with the SEC and, when combined with the unused portion of the Company’s previous DRSPP shelf registration statements, registered an aggregate of 15 million shares of common stock.  The Company’s DRSPP is designed to provide existing stockholders and new investors with a convenient and economical way to purchase shares of common stock through the automatic reinvestment of dividends and/or optional cash investments.  At September 30, 2018, approximately 11.9 million shares of common stock remained available for issuance pursuant to the DRSPP shelf registration statement.

During the three and nine months ended September 30, 2018, the Company issued 64,731 and 302,264 shares of common stock through the DRSPP, raising net proceeds of approximately $519,000 and $2.2 million, respectively.  From the inception of the DRSPP in September 2003 through September 30, 2018, the Company issued 33,978,241 shares pursuant to the DRSPP, raising net proceeds of $283.7 million.

(e)  Stock Repurchase Program

As previously disclosed, in August 2005, the Company’s Board authorized a stock repurchase program (the “Repurchase Program”) to repurchase up to 4.0 million shares of its outstanding common stock.  The Board reaffirmed such authorization in May 2010.  In December 2013, the Board increased the number of shares authorized under the Repurchase Program to an aggregate of 10.0 million. Such authorization does not have an expiration date and, at present, there is no intention to modify or otherwise rescind such authorization.  Subject to applicable securities laws, repurchases of common stock under the Repurchase Program are made at times and in amounts as the Company deems appropriate, (including, in our discretion, through the use of one or more plans adopted under Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended (the “1934 Act”)) using available cash resources.  Shares of common stock repurchased by the Company under the Repurchase Program are cancelled and, until reissued by the Company, are deemed to be authorized but unissued shares of the Company’s common stock.  The Repurchase Program may be suspended or discontinued by the Company at any time and without prior notice. The Company did not repurchase any shares of its common stock during the nine months ended September 30, 2018.  At September 30, 2018, 6,616,355 shares remained authorized for repurchase under the Repurchase Program.

(f) Accumulated Other Comprehensive Income/(Loss)

The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2018:

	Three Months Ended   September 30, 2018								Nine Months Ended   September 30, 2018
(In Thousands)	Net Unrealized Gain/(Loss) on AFS Securities			Net  (Loss)/Gain on Swaps		Total AOCI			Net Unrealized Gain/(Loss) on AFS Securities			Net  (Loss)/Gain on Swaps			Total AOCI
Balance at beginning of period	$	548,551		$	16,160	$	564,711		$	620,648		$	(11,424	)	$	609,224
OCI before reclassifications	(34,278		)	5,390		(28,888		)	(90,250		)	32,974			(57,276		)
Amounts reclassified from AOCI (1)	(9,455		)	—		(9,455		)	(25,580		)	—			(25,580		)
Net OCI during the period (2)	(43,733		)	5,390		(38,343		)	(115,830		)	32,974			(82,856		)
Balance at end of period	$	504,818		$	21,550	$	526,368		$	504,818		$	21,550		$	526,368

(1)  See separate table below for details about these reclassifications.

(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).

The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2017:

	Three Months Ended   September 30, 2017									Nine Months Ended   September 30, 2017
(In Thousands)	Net Unrealized Gain/(Loss) on AFS Securities			Net  (Loss)/Gain on Swaps			Total AOCI			Net Unrealized Gain/(Loss) on AFS Securities			Net  (Loss)/Gain on Swaps			Total AOCI
Balance at beginning of period	$	668,223		$	(35,841	)	$	632,382		$	620,403		$	(46,721	)	$	573,682
OCI before reclassifications	6,988			5,791			12,779			71,188			16,671			87,859
Amounts reclassified from AOCI (1)	(14,935		)	—			(14,935		)	(31,315		)	—			(31,315		)
Net OCI during the period (2)	(7,947		)	5,791			(2,156		)	39,873			16,671			56,544
Balance at end of period	$	660,276		$	(30,050	)	$	630,226		$	660,276		$	(30,050	)	$	630,226

(1)  See separate table below for details about these reclassifications.

(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).

The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and nine months ended September 30, 2018:

	Three Months Ended   September 30, 2018			Nine Months Ended   September 30, 2018
Details about AOCI Components	Amounts Reclassified from AOCI						Affected Line Item in the Statement Where Net Income is Presented
(In Thousands)
AFS Securities:
Realized gain on sale of securities	$	(9,455	)	$	(25,580	)	Net gain on sales of investment securities
Total AFS Securities	$	(9,455	)	$	(25,580	)
Total reclassifications for period	$	(9,455	)	$	(25,580	)

The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and nine months ended September 30, 2017:

	Three Months Ended   September 30, 2017			Nine Months Ended   September 30, 2017
Details about AOCI Components	Amounts Reclassified from AOCI						Affected Line Item in the Statement Where Net Income is Presented
(In Thousands)
AFS Securities:
Realized gain on sale of securities	$	(14,935	)	$	(30,283	)	Net gain on sales of investment securities
OTTI recognized in earnings	—			(1,032		)	Net impairment losses recognized in earnings
Total AFS Securities	$	(14,935	)	$	(31,315	)
Total reclassifications for period	$	(14,935	)	$	(31,315	)

On securities for which OTTI had been recognized in prior periods, the Company did not have any unrealized losses recorded in AOCI at September 30, 2018 and December 31, 2017.

XML

EPS Calculation

9 Months Ended

Sep. 30, 2018

Earnings Per Share [Abstract]

EPS Calculation

EPS Calculation

The following table presents a reconciliation of the earnings and shares used in calculating basic and diluted EPS for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,						Nine Months Ended   September 30,
(In Thousands, Except Per Share Amounts)	2018			2017			2018			2017
Numerator:
Net income	$	87,132		$	63,805		$	240,922		$	221,799
Dividends declared on preferred stock	(3,750		)	(3,750		)	(11,250		)	(11,250		)
Dividends, dividend equivalents and undistributed earnings allocated to participating securities	(472		)	(409		)	(1,393		)	(1,299		)
Net income to common stockholders - basic and diluted	$	82,910		$	59,646		$	228,279		$	209,250
Denominator:
Weighted average common shares for basic and diluted earnings per share (1)	428,713			396,698			408,614			385,282
Basic and diluted earnings per share	$	0.19		$	0.15		$	0.56		$	0.54

(1) At September 30, 2018, the Company had approximately 2.2 million equity instruments outstanding that were not included in the calculation of diluted EPS for the three and nine months ended September 30, 2018, as their inclusion would have been anti-dilutive.  These equity instruments reflect RSUs (based on current estimate of expected share settlement amount) with a weighted average grant date fair value of $6.72. These equity instruments may have a dilutive impact on future EPS.

XML

Equity Compensation, Employment Agreements and Other Benefit Plans

9 Months Ended

Sep. 30, 2018

Compensation Related Costs [Abstract]

Equity Compensation, Employment Agreements and Other Benefit Plans

Equity Compensation, Employment Agreements and Other Benefit Plans

(a)  Equity Compensation Plan

In accordance with the terms of the Company’s Equity Plan, which was adopted by the Company’s stockholders on May 21, 2015 (and which amended and restated the Company’s 2010 Equity Compensation Plan), directors, officers and employees of the Company and any of its subsidiaries and other persons expected to provide significant services for the Company and any of its subsidiaries are eligible to receive grants of stock options (“Options”), restricted stock, RSUs, dividend equivalent rights and other stock-based awards under the Equity Plan.

Subject to certain exceptions, stock-based awards relating to a maximum of 12.0 million shares of common stock may be granted under the Equity Plan; forfeitures and/or awards that expire unexercised do not count towards this limit.  At September 30, 2018, approximately 5.7 million shares of common stock remained available for grant in connection with stock-based awards under the Equity Plan.  A participant may generally not receive stock-based awards in excess of 1.5 million shares of common stock in any one year and no award may be granted to any person who, assuming exercise of all Options and payment of all awards held by such person, would own or be deemed to own more than 9.8% of the outstanding shares of the Company’s common stock.  Unless previously terminated by the Board, awards may be granted under the Equity Plan until May 20, 2025.

Restricted Stock Units

Under the terms of the Equity Plan, RSUs are instruments that provide the holder with the right to receive, subject to the satisfaction of conditions set by the Compensation Committee at the time of grant, a payment of a specified value, which may be a share of the Company’s common stock, the fair market value of a share of the Company’s common stock, or such fair market value to the extent in excess of an established base value, on the applicable settlement date.  Although the Equity Plan permits the Company to issue RSUs that can settle in cash, all of the Company’s outstanding RSUs as of September 30, 2018 are designated to be settled in shares of the Company’s common stock.  The Company did not grant any RSUs during the three months endedSeptember 30, 2018 and 2017 and granted 843,802 and 898,945 during the nine months ended September 30, 2018 and 2017, respectively. There were 20,000 RSUs forfeited during the nine months ended September 30, 2018. There were no RSUs forfeited during the nine months ended September 30, 2017. All RSUs outstanding at September 30, 2018 may be entitled to receive dividend equivalent payments depending on the terms and conditions of the award either in cash at the time dividends are paid by the Company, or for certain performance-based RSU awards, as a grant of stock at the time such awards are settled.  At September 30, 2018 and December 31, 2017, the Company had unrecognized compensation expense of $6.2 million and $4.1 million, respectively, related to RSUs.  The unrecognized compensation expense at September 30, 2018 is expected to be recognized over a weighted average period of 1.8 years.

Restricted Stock

The Company did not award any shares of restricted common stock during the nine months ended September 30, 2018 and 2017. At September 30, 2018, the Company did not have any unvested shares of restricted common stock outstanding.

Dividend Equivalents

A dividend equivalent is a right to receive a distribution equal to the dividend distributions that would be paid on a share of the Company’s common stock.  Dividend equivalents may be granted as a separate instrument or may be a right associated with the grant of another award (e.g., an RSU) under the Equity Plan, and they are paid in cash or other consideration at such times and in accordance with such rules, terms and conditions, as the Compensation Committee may determine in its discretion. 

Expense Recognized for Equity-Based Compensation Instruments

The following table presents the Company’s expenses related to its equity-based compensation instruments for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,				Nine Months Ended   September 30,
(In Thousands)	2018		2017		2018		2017
RSUs	$	1,082	$	1,836	$	3,891	$	5,194
Restricted shares of common stock	—		74		—		175
Total	$	1,082	$	1,910	$	3,891	$	5,369

(b)  Employment Agreements

At September 30, 2018, the Company had employment agreements with four of its officers, with varying terms that provide for, among other things, base salary, bonus and change-in-control payments upon the occurrence of certain triggering events.

(c)  Deferred Compensation Plans

The Company administers deferred compensation plans for its senior officers and non-employee directors (collectively, the “Deferred Plans”), pursuant to which participants may elect to defer up to 100% of certain cash compensation.  The Deferred Plans are designed to align participants’ interests with those of the Company’s stockholders.

Amounts deferred under the Deferred Plans are considered to be converted into “stock units” of the Company.  Stock units do not represent stock of the Company, but rather are a liability of the Company that changes in value as would equivalent shares of the Company’s common stock.  Deferred compensation liabilities are settled in cash at the termination of the deferral period, based on the value of the stock units at that time.  The Deferred Plans are non-qualified plans under the Employee Retirement Income Security Act of 1974 and, as such, are not funded.  Prior to the time that the deferred accounts are settled, participants are unsecured creditors of the Company.

The Company’s liability for stock units in the Deferred Plans is based on the market price of the Company’s common stock at the measurement date.  The following table presents the Company’s expenses related to its Deferred Plans for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,					Nine Months Ended   September 30,
(In Thousands)	2018			2017		2018		2017
Non-employee directors	$	(22	)	$	125	$	—	$	339
Total	$	(22	)	$	125	$	—	$	339

The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through September 30, 2018 and December 31, 2017 that had not been distributed and the Company’s associated liability for such deferrals at September 30, 2018 and December 31, 2017:

	September 30, 2018				December 31, 2017
(In Thousands)	Undistributed Income Deferred (1)		Liability Under Deferred Plans		Undistributed Income Deferred (1)		Liability Under Deferred Plans
Non-employee directors	$	2,100	$	2,420	$	1,688	$	2,056
Total	$	2,100	$	2,420	$	1,688	$	2,056

(1)  Represents the cumulative amounts that were deferred by participants through September 30, 2018 and December 31, 2017, which had not been distributed through such respective date.

(d)  Savings Plan

The Company sponsors a tax-qualified employee savings plan (the “Savings Plan”) in accordance with Section 401(k) of the Code.  Subject to certain restrictions, all of the Company’s employees are eligible to make tax-deferred contributions to the Savings Plan subject to limitations under applicable law.  Participant’s accounts are self-directed and the Company bears the costs of administering the Savings Plan.  The Company matches 100% of the first 3% of eligible compensation deferred by employees and 50% of the next 2%, subject to a maximum as provided by the Code.  The Company has elected to operate the Savings Plan under the applicable safe harbor provisions of the Code, whereby among other things, the Company must make contributions for all participating employees and all matches contributed by the Company immediately vest 100%.  For the three months ended September 30, 2018 and 2017, the Company recognized expenses for matching contributions of $89,000 and $87,500, respectively, and $282,000 and $262,500 for the nine months ended September 30, 2018 and 2017, respectively.

XML

Fair Value of Financial Instruments

9 Months Ended

Sep. 30, 2018

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial Instruments

A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.  The three levels of valuation hierarchy are defined as follows:

Level 1 — Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2 — Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

Level 3 — Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

The following describes the valuation methodologies used for the Company’s financial instruments measured at fair value on a recurring basis, as well as the general classification of such instruments pursuant to the valuation hierarchy.

Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as Collateral

The fair value of U.S. Treasury securities obtained as collateral and the associated obligation to return securities obtained as collateral are based upon prices obtained from a third-party pricing service, which are indicative of market activity.  Securities obtained as collateral are classified as Level 1 in the fair value hierarchy.

MBS and CRT Securities

The Company determines the fair value of its Agency MBS based upon prices obtained from third-party pricing services, which are indicative of market activity, and repurchase agreement counterparties.

For Agency MBS, the valuation methodology of the Company’s third-party pricing services incorporate commonly used market pricing methods, trading activity observed in the marketplace and other data inputs.  The methodology also considers the underlying characteristics of each security, which are also observable inputs, including: collateral vintage, coupon, maturity date, loan age, reset date, collateral type, periodic and life cap, geography, and prepayment speeds.  Management analyzes pricing data received from third-party pricing services and compares it to other indications of fair value including data received from repurchase agreement counterparties and its own observations of trading activity observed in the marketplace.

In determining the fair value of the Company’s Non-Agency MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services and brokers as well as dialogue with market participants.  In valuing Non-Agency MBS, the Company understands that pricing services use observable inputs that include, in addition to trading activity observed in the marketplace, loan delinquency data, credit enhancement levels and vintage, which are taken into account to assign pricing factors such as spread and prepayment assumptions.  For tranches of Legacy Non-Agency MBS that are cross-collateralized, performance of all collateral groups involved in the tranche are considered.  The Company collects and considers current market intelligence on all major markets, including benchmark security evaluations and bid-lists from various sources, when available.

The Company’s Legacy Non-Agency MBS, RPL/NPL MBS and CRT securities are valued using various market data points as described above, which management considers directly or indirectly observable parameters.  Accordingly, these securities are classified as Level 2 in the fair value hierarchy.

Term Notes Backed by MSR Related Collateral

The Company’s valuation process for term notes backed by MSR related collateral considers a number of factors, including a comparable bond analysis performed by a third-party pricing service which involves determining a pricing spread at issuance of the term note. The pricing spread is used at each subsequent valuation date to determine an implied yield to maturity of the term note, which is used to derive an indicative market value for the security. This indicative market value is further reviewed by the Company and may be adjusted to ensure it reflects a realistic exit price at the valuation date given the structural features of these securities. At September 30, 2018, the indicative implied yields used in the valuation of these securities ranged from 4.9% to 6.2%. The weighted average indicative yield to maturity was 5.62%. Other factors taken into consideration include indicative values provided by repurchase agreement counterparties, estimated changes in fair value of the related underlying MSR collateral and the financial performance of the ultimate parent or sponsoring entity of the issuer, which has provided a guarantee that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the related underlying MSR collateral be insufficient. As this process includes significant unobservable inputs, these securities are classified as Level 3 in the fair value hierarchy.

Residential Whole Loans, at Fair Value

The Company determines the fair value of its residential whole loans held at fair value after considering valuations obtained from a third-party that specializes in providing valuations of residential mortgage loans. The valuation approach applied generally depends on whether the loan is considered performing or non-performing at the date the valuation is performed. For performing loans, estimates of fair value are derived using a discounted cash flow approach, where estimates of cash flows are determined from the scheduled payments, adjusted using forecasted prepayment, default and loss given default rates. For non-performing loans, asset liquidation cash flows are derived based on the estimated time to liquidate the loan, expected costs and home price appreciation. Estimated cash flows for both performing and non-performing loans are discounted at yields considered appropriate to arrive at a reasonable exit price for the asset. Indications of loan value such as actual trades, bids, offers and generic market color may be used in determining the appropriate discount yield. The Company’s residential whole loans held at fair value are classified as Level 3 in the fair value hierarchy.

Swaps

All of the Company’s Swaps are cleared by a central clearing house. Valuations provided by the clearing house are used for purposes of determining the fair value of the Company’s Swaps. Such valuations obtained are tested with internally developed models that apply readily observable market parameters.  As the Company’s Swaps are subject to the clearing house’s margin requirements, no credit valuation adjustment was considered necessary in determining the fair value of such instruments.  Beginning in January 2017, variation margin payments on the Company’s cleared Swaps are treated as a legal settlement of the exposure under the Swap contract. Previously such payments were treated as collateral pledged against the exposure under the Swap contract. The effect of this change is to reduce what would have otherwise been reported as fair value of the Swap. Swaps are classified as Level 2 in the fair value hierarchy.

Changes to the valuation methodologies used with respect to the Company’s financial instruments are reviewed by management to ensure any such changes result in appropriate exit price valuations.  The Company will refine its valuation methodologies as markets and products develop and pricing methodologies evolve.  The methods described above may produce fair value estimates that may not be indicative of net realizable value or reflective of future fair values.  Furthermore, while the Company believes its valuation methods are appropriate and consistent with those used by market participants, the use of different methodologies, or assumptions, to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.  The Company uses inputs that are current as of the measurement date, which may include periods of market dislocation, during which price transparency may be reduced.  The Company reviews the classification of its financial instruments within the fair value hierarchy on a quarterly basis, and management may conclude that its financial instruments should be reclassified to a different level in the future.

The following tables present the Company’s financial instruments carried at fair value on a recurring basis as of September 30, 2018 and December 31, 2017, on the consolidated balance sheets by the valuation hierarchy, as previously described:

Fair Value at September 30, 2018

(In Thousands)	Level 1		Level 2		Level 3		Total
Assets:
Agency MBS	$	—	$	2,905,490	$	—	$	2,905,490
Non-Agency MBS	—		3,334,610		—		3,334,610
CRT securities	—		538,945		—		538,945
Term notes backed by MSR related collateral	—		—		505,195		505,195
Residential whole loans, at fair value	—		—		1,449,365		1,449,365
Securities obtained and pledged as collateral	—		—		—		—
Swaps	—		22,311		—		22,311
Total assets carried at fair value	$	—	$	6,801,356	$	1,954,560	$	8,755,916
Liabilities:
Obligation to return securities obtained as collateral	$	—	$	—	$	—	$	—
Total liabilities carried at fair value	$	—	$	—	$	—	$	—

Fair Value at December 31, 2017

(In Thousands)	Level 1		Level 2		Level 3		Total
Assets:
Agency MBS	$	—	$	2,824,681	$	—	$	2,824,681
Non-Agency MBS	—		3,533,966		—		3,533,966
CRT securities	—		664,403		—		664,403
Term notes backed by MSR related collateral	—		—		381,804		381,804
Residential whole loans, at fair value	—		—		1,325,115		1,325,115
Securities obtained and pledged as collateral	504,062		—		—		504,062
Swaps	—		679		—		679
Total assets carried at fair value	$	504,062	$	7,023,729	$	1,706,919	$	9,234,710
Liabilities:
Obligation to return securities obtained as collateral	$	504,062	$	—	$	—	$	504,062
Total liabilities carried at fair value	$	504,062	$	—	$	—	$	504,062

Changes in Level 3 Assets Measured at Fair Value on a Recurring Basis

The following table presents additional information for the three and nine months ended September 30, 2018 and 2017 about the Company’s Residential whole loans, at fair value, which are classified as Level 3 and measured at fair value on a recurring basis:

	Residential Whole Loans, at Fair Value (1)
	Three Months Ended September 30,						Nine Months Ended September 30,
(In Thousands)	2018			2017			2018			2017
Balance at beginning of period	$	1,468,540		$	744,072		$	1,325,115		$	814,682
Purchases and capitalized advances (2)	76,566			284,930			393,867			295,094
Changes in fair value recorded in Net gain on residential whole loans held at fair value	8,442			5,289			26,788			12,499
Collection of principal, net of liquidation gains/losses	(54,331		)	(17,670		)	(155,199		)	(53,366		)
Repurchases	(561		)	(257		)	(1,623		)	(1,013		)
Transfer to REO	(51,089		)	(33,214		)	(141,381		)	(84,746		)
Balance at end of period	$	1,447,567		$	983,150		$	1,447,567		$	983,150

(1) Excludes approximately $1.8 million and $120.4 million of residential whole loans held at fair value for which the closing of the purchase transaction had not occurred as of September 30, 2018 and 2017, respectively.

(2) Included in the activity presented for the three and nine months ended September 30, 2018 and 2017 are approximately $34.4 million and$92.7 million of loans the Company committed to purchase during the three months ended June 30, 2018 and year ended December 31, 2017, but for which the closing of the purchase transaction occurred during the three and nine months ended September 30, 2018 and 2017, respectively.

The following table presents additional information for the three and nine months ended September 30, 2018 and 2017 about the Company’s investments in term notes backed by MSR related collateral held at fair value, which are classified as Level 3 and measured at fair value on a recurring basis:

	Term Notes Backed by MSR Related Collateral
	Three Months Ended September 30,						Nine Months Ended September 30,
(In Thousands)	2018			2017			2018			2017 (1)
Balance at beginning of period	$	381,390		$	273,961		$	381,804		$	—
Purchases	290,042			161,000			439,392			311,000
Collection of principal	(166,120		)	(123,961		)	(316,120		)	(140,980		)
Changes in unrealized gain/losses	(117		)	563			119			563
Transfers from Level 2 to Level 3 (1)	—			—			—			140,980
Balance at end of period	$	505,195		$	311,563		$	505,195		$	311,563

(1) Investments in term notes backed by MSR related collateral were transferred from Level 2 to Level 3 during the nine months endedSeptember 30, 2017 as there had been very limited secondary market trading in these securities since issuance. Transfers between levels are deemed to take place on the first day of the reporting period in which the transfer has taken place.

The Company did not transfer any assets or liabilities from one level to another during the three and nine months ended September 30, 2018 and the three months endedSeptember 30, 2017.

Fair Value Methodology for Level 3 Financial Instruments

Residential Whole Loans, at Fair Value

The following tables present a summary of quantitative information about the significant unobservable inputs used in the fair value measurement of the Company’s residential whole loans held at fair value for which it has utilized Level 3 inputs to determine fair value as of September 30, 2018 and December 31, 2017:

	September 30, 2018
(Dollars in Thousands)	Fair Value (1)		Valuation Technique	Unobservable Input	Weighted Average (2)			Range
Residential whole loans, at fair value	$	693,874	Discounted cash flow	Discount rate	5.3		%	4.5-8.0%
				Prepayment rate	3.8		%	0.0-13.5%
				Default rate	2.7		%	0.0-31.0%
				Loss severity	13.0		%	0.0-100.0%
	$	683,566	Liquidation model	Discount rate	8.2		%	6.1-50.0%
				Annual change in home prices	3.3		%	(1.0)-11.8%
				Liquidation timeline (in years)	1.8			0.1-4.5
				Current value of underlying properties (3)	$	767		$2-$7,950
Total	$	1,377,440

	December 31, 2017
(Dollars in Thousands)	Fair Value (1)		Valuation Technique	Unobservable Input	Weighted Average (2)			Range
Residential whole loans, at fair value	$	358,871	Discounted cash flow	Discount rate	5.5		%	4.5-13.0%
				Prepayment rate	4.1		%	1.15-15.1%
				Default rate	2.9		%	0.0-6.5%
				Loss severity	13.8		%	0.0-100.0%
	$	592,940	Liquidation model	Discount rate	8.0		%	6.1-50.0%
				Annual change in home prices	2.5		%	(8.0)-8.8%
				Liquidation timeline (in years)	1.6			0.1-4.5
				Current value of underlying properties (3)	$	772		$0-$9,900
Total	$	951,811

(1) Excludes approximately $70.1 million and $373.3 million of loans for which management considers the purchase price continues to reflect the fair value of such loans at September 30, 2018 and December 31, 2017, respectively.

(2) Amounts are weighted based on the fair value of the underlying loan.

(3) The simple average value of the properties underlying residential whole loans held at fair value valued via a liquidation model was approximately$378,000 and $336,000 as of September 30, 2018 and December 31, 2017, respectively.

The following table presents the carrying values and estimated fair values of the Company’s financial instruments at September 30, 2018 and December 31, 2017:

	September 30, 2018				December 31, 2017
	Carrying Value		Estimated Fair Value		Carrying Value		Estimated Fair Value
(In Thousands)
Financial Assets:
Agency MBS	$	2,905,490	$	2,905,490	$	2,824,681	$	2,824,681
Non-Agency MBS	3,334,610		3,334,610		3,533,966		3,533,966
CRT securities	538,945		538,945		664,403		664,403
MSR related assets	565,272		565,272		492,080		493,026
Residential whole loans, at carrying value	2,471,567		2,549,927		908,516		988,688
Residential whole loans, at fair value	1,449,365		1,449,365		1,325,115		1,325,115
Securities obtained and pledged as collateral	—		—		504,062		504,062
Cash and cash equivalents	104,186		104,186		449,757		449,757
Restricted cash	6,489		6,489		13,307		13,307
Swaps	22,311		22,311		679		679
Financial Liabilities (1):
Repurchase agreements	7,278,270		7,289,006		6,614,701		6,623,255
Securitized debt	714,203		713,783		363,944		366,109
Obligation to return securities obtained as collateral	—		—		504,062		504,062
Senior Notes	96,805		100,791		96,773		103,729

(1) Carrying value of securitized debt, Senior Notes and certain repurchase agreements is net of associated debt issuance costs.

In addition to the methodologies used to determine the fair value of the Company’s financial assets and liabilities reported at fair value on a recurring basis discussed on pages 45-50, the following methods and assumptions were used by the Company in arriving at the fair value of the Company’s other financial instruments presented in the above table that are not reported at fair value on a recurring basis:

Residential Whole Loans, at Carrying Value:  The Company generally determines the fair value of its residential whole loans held at carrying value using the same approach applied for residential whole loans held at fair value. Given the short duration of the Company’s Rehabilitation loans, these investments are determined to have a carrying value which approximates fair value. The Company’s residential whole loans held at carrying value are classified as Level 3 in the fair value hierarchy.

Cash and Cash Equivalents and Restricted Cash:  Cash and cash equivalents and restricted cash are comprised of cash held in overnight money market investments and demand deposit accounts.  At September 30, 2018 and December 31, 2017, the Company’s money market funds were invested in securities issued by the U.S. Government or its agencies, instrumentalities, and sponsored entities, and repurchase agreements involving the securities described above.  Given the overnight term and assessed credit risk, the Company’s investments in money market funds are determined to have a fair value equal to their carrying value.

Corporate Loans: The Company determines the fair value of its Corporate loans after considering recent past and expected future loan performance, recent financial performance of the borrower and estimates of the current value of the underlying collateral, which includes certain MSRs and other assets of the borrower that are pledged to secure the borrowing. The Company’s investment in Corporate loans are classified as Level 3 in the fair value hierarchy.

Repurchase Agreements:  The fair value of repurchase agreements reflects the present value of the contractual cash flows discounted at market interest rates at the valuation date for repurchase agreements with a term equivalent to the remaining term to interest rate repricing, which may be at maturity.  Such interest rates are estimated based on LIBOR rates observed in the market.  The Company’s repurchase agreements are classified as Level 2 in the fair value hierarchy.

Securitized Debt:  In determining the fair value of securitized debt, management considers a number of observable market data points, including prices obtained from pricing services and brokers as well as dialogue with market participants. Accordingly, the Company’s securitized debt is classified as Level 2 in the fair value hierarchy.

Senior Notes:  The fair value of the Senior Notes is determined using the end of day market price quoted on the NYSE at the reporting date.  The Company’s Senior Notes are classified as Level 1 in the fair value hierarchy.

The Company holds REO at the lower of the current carrying amount or fair value less estimated selling costs. At September 30, 2018 and December 31, 2017, the Company’s REO had an aggregate carrying value of $223.1 million and $152.4 million, and an aggregate estimated fair value of $246.0 million and $175.8 million, respectively. The Company classifies fair value measurements of REO as Level 3 in the fair value hierarchy.

XML

Use of Special Purpose Entities and Variable Interest Entities

9 Months Ended

Sep. 30, 2018

Use of Special Purpose Entities and Variable Interest Entities

Use of Special Purpose Entities and Variable Interest Entities

Use of Special Purpose Entities and Variable Interest Entities

A Special Purpose Entity (“SPE”) is an entity designed to fulfill a specific limited need of the company that organized it.  SPEs are often used to facilitate transactions that involve securitizing financial assets or resecuritizing previously securitized financial assets.  The objective of such transactions may include obtaining non-recourse financing, obtaining liquidity or refinancing the underlying financial assets on improved terms.  Securitization involves transferring assets to a SPE to convert all or a portion of those assets into cash before they would have been realized in the normal course of business, through the SPE’s issuance of debt or equity instruments.  Investors in an SPE usually have recourse only to the assets in the SPE and, depending on the overall structure of the transaction, may benefit from various forms of credit enhancement such as over-collateralization in the form of excess assets in the SPE, priority with respect to receipt of cash flows relative to holders of other debt or equity instruments issued by the SPE, or a line of credit or other form of liquidity agreement that is designed with the objective of ensuring that investors receive principal and/or interest cash flow on the investment in accordance with the terms of their investment agreement. 

The Company has entered into several financing transactions that resulted in the Company consolidating as VIEs the SPEs that were created to facilitate these transactions. See Note 2(r) for a discussion of the accounting policies applied to the consolidation of VIEs and transfers of financial assets in connection with financing transactions.

The Company has engaged in loan securitizations and in prior years, MBS resecuritization transactions, primarily for the purpose of obtaining improved overall financing terms as well as non-recourse financing on a portion of its residential whole loan and Non-Agency MBS portfolios. Notwithstanding the Company’s participation in these transactions, the risks facing the Company are largely unchanged as the Company remains economically exposed to the first loss position on the underlying assets transferred to the VIEs.

Loan Securitization Transactions

In July 2018, as part of a loan securitization transaction, the Company sold residential whole loans with an aggregate unpaid principal balance of $347.7 million to an entity that the Company consolidates as a VIE. In connection with the transaction, third-party investors purchased $236.0 million face amount of senior bonds (“Senior Bonds”) with a coupon rate of 4.164%. As a result of this transaction, the Company acquired $101.7 million face amount of non-rated certificates issued by the securitization vehicle, and received $236.0 million in cash, excluding expenses, accrued interest, and underwriting fees.

In May 2018, as part of a loan securitization transaction, the Company sold residential whole loans with an aggregate unpaid principal balance of $319.1 million to an entity that the Company consolidates as a VIE. In connection with the transaction, third-party investors purchased $184.0 million face amount of Senior Bonds with a coupon rate of 3.875%. As a result of this transaction, the Company acquired $46.4 million face amount of non-rated certificates issued by the securitization vehicle, and received $184.0 million in cash, excluding expenses, accrued interest, and underwriting fees.

The following table summarizes the key details of the loan securitization transactions the Company has been involved in to date:

(Dollars in Thousands)	September 30, 2018				December 31, 2017
Aggregate unpaid principal balance of residential whole loans sold	$	1,290,029			$	620,924
Face amount of Senior Bonds issued by the VIE and purchased by third-party investors	$	802,817			$	382,847
Outstanding amount of Senior Bonds	$	714,203		(1)	$	363,944		(1)
Weighted average fixed rate for Senior Bonds issued	3.65		%	(2)	3.14		%	(2)
Face amount of Senior Support Certificates received by the Company (3)	$	275,174			$	127,001
Cash received	$	802,815			$	382,845

(1) Net of $4.1 million and $2.3 million of deferred financing costs at September 30, 2018 and December 31, 2017, respectively.

(2) At September 30, 2018 and December 31, 2017, $604.7 million and $233.7 million, respectively, of Senior Bonds sold in securitization transactions contained a contractual coupon step-up feature whereby the coupon increases by 300 basis points at 36 months from issuance if the bond is not redeemed before such date.

(3) Provides credit support to the Senior Bonds sold to third-party investors in the securitization transactions.

As of September 30, 2018 and December 31, 2017, as a result of the transactions described above, securitized loans with a carrying value of approximately $215.1 million and $183.2 million are included in “Residential whole loans, at carrying value,” securitized loans with a fair value of approximately $723.8 million and $289.3 million are included in “Residential whole loans, at fair value,” and REO with a carrying value approximately $61.0 million and $5.5 million are included in “Other assets” on the Company’s consolidated balance sheets, respectively. As of September 30, 2018 and December 31, 2017, the aggregate carrying value of Senior Bonds issued by consolidated VIEs was $714.2 million and $363.9 million, respectively.  These Senior Bonds are disclosed as “Securitized debt” and are included in Other liabilities on the Company’s consolidated balance sheets.  The holders of the securitized debt have no recourse to the general credit of the Company, but the Company does have the obligation, under certain circumstances to repurchase assets from the VIE upon the breach of certain representations and warranties with respect to the residential whole loans sold to the VIE.  In the absence of such a breach, the Company has no obligation to provide any other explicit or implicit support to any VIE.

The Company concluded that the entities created to facilitate the loan securitization transactions are VIEs.  The Company then completed an analysis of whether each VIE created to facilitate the securitization transactions should be consolidated by the Company, based on consideration of its involvement in each VIE, including the design and purpose of the SPE, and whether its involvement reflected a controlling financial interest that resulted in the Company being deemed the primary beneficiary of each VIE.  In determining whether the Company would be considered the primary beneficiary, the following factors were assessed:

• whether the Company has both the power to direct the activities that most significantly impact the economic performance of the VIE;  and

• whether the Company has a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE.

Based on its evaluation of the factors discussed above, including its involvement in the purpose and design of the entity, the Company determined that it was required to consolidate each VIE created to facilitate the loan securitization transactions.

Residential Whole Loans and REO (including Residential Whole Loans and REO transferred to consolidated VIEs)

Included on the Company’s consolidated balance sheets as of September 30, 2018 and December 31, 2017 are a total of $3.9 billion and $2.2 billion of residential whole loans, of which approximately $2.5 billion and $908.5 million are reported at carrying value and $1.4 billion and $1.3 billion are reported at fair value, respectively. In addition, at September 30, 2018 and December 31, 2017, the Company had REO with an aggregate carrying value of $223.1 million and $152.4 million, and an aggregate estimated fair value of $246.0 million and $175.8 million, respectively. The inclusion of these assets arises from the Company’s interests in certain trusts established to acquire the loans and entities established in connection with its loan securitization transactions. The Company has assessed that these entities are required to be consolidated. During the three and nine months ended September 30, 2018, the Company recognized interest income from residential whole loans reported at carrying value of approximately $29.5 million and $61.8 million, respectively. During the three and nine months ended September 30, 2017, the Company recognized interest income from residential whole loans reported at carrying value of approximately $9.0 million and $26.2 million, respectively. These amounts are included in Interest Income on the Company’s consolidated statements of operations. In addition, the Company recognized net gains on residential whole loans held at fair value during the three and nine months ended September 30, 2018 of approximately $34.9 million and $105.9 million, respectively. During the three and nine months ended September 30, 2017, the Company recognized net gains on residential whole loans held at fair value $18.7 million and $48.7 million, respectively. These amounts are included in Other Income, net on the Company’s consolidated statements of operations. (See Note 4)

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

Basis of Presentation and Consolidation

Basis of Presentation and Consolidation

The interim unaudited consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”).  Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been condensed or omitted according to these SEC rules and regulations.  Management believes that the disclosures included in these interim unaudited consolidated financial statements are adequate to make the information presented not misleading.  The accompanying unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.  In the opinion of management, all normal and recurring adjustments necessary to present fairly the financial condition of the Company at September 30, 2018 and results of operations for all periods presented have been made.  The results of operations for the three and nine months ended September 30, 2018 should not be construed as indicative of the results to be expected for the full year.

The accompanying consolidated financial statements of the Company have been prepared on the accrual basis of accounting in accordance with GAAP.  The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Although the Company’s estimates contemplate current conditions and how it expects them to change in the future, it is reasonably possible that actual conditions could differ from those estimates, which could materially impact the Company’s results of operations and its financial condition.  Management has made significant estimates in several areas, including other-than-temporary impairment (“OTTI”) on MBS (See Note 3), valuation of MBS, CRT securities and MSR related assets (See Notes 3 and 14), income recognition and valuation of residential whole loans (See Notes 4 and 14), valuation of derivative instruments (See Notes 5(c) and 14) and income recognition on certain Non-Agency MBS (defined below) purchased at a discount. (See Note 3)  In addition, estimates are used in the determination of taxable income used in the assessment of REIT compliance and contingent liabilities for related taxes, penalties and interest. (See Note 2(o))  Actual results could differ from those estimates.

The Company has one reportable segment as it manages its business and analyzes and reports its results of operations on the basis of one operating segment; investing, on a leveraged basis, in residential mortgage assets.

The consolidated financial statements of the Company include the accounts of all subsidiaries; all intercompany accounts and transactions have been eliminated. In addition, the Company consolidates entities established to facilitate transactions related to the acquisition and securitization of residential whole loans as well as MBS resecuritization transactions completed in prior years. Certain prior period amounts have been reclassified to conform to the current period presentation.

MBS and CRT Securities

MBS and CRT Securities

The Company has investments in residential MBS that are issued or guaranteed as to principal and/or interest by a federally chartered corporation, such as the Federal National Mortgage Association (“Fannie Mae”) or the Federal Home Loan Mortgage Corporation (“Freddie Mac”), or an agency of the U.S. Government, such as the Government National Mortgage Association (“Ginnie Mae”) (collectively, “Agency MBS”), and residential MBS that are not guaranteed by any agency of the U.S. Government or any federally chartered corporation (“Non-Agency MBS”). In addition, the Company has investments in CRT securities that are issued by Fannie Mae and Freddie Mac. The coupon payments on CRT securities are paid by Fannie Mae and Freddie Mac and the principal payments received are based on the performance of loans in a reference pool of previously securitized MBS. As the loans in the underlying reference pool are paid, the principal balance of the CRT securities is paid. As an investor in a CRT security, the Company may incur a loss if certain defined credit events occur, including, for certain CRT securities, if the loans in the reference pool experience delinquencies exceeding specified thresholds.

Designation

MBS that the Company generally intends to hold until maturity, but that it may sell from time to time as part of the overall management of its business, are designated as “available-for-sale” (“AFS”). Such MBS are carried at their fair value with unrealized gains and losses excluded from earnings (except when an OTTI is recognized, as discussed below) and reported in Accumulated other comprehensive income/(loss) (“AOCI”), a component of Stockholders’ Equity.

Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of AOCI to earnings as a realized gain or loss using the specific identification method.

The Company has elected the fair value option for certain of its Agency MBS that it does not intend to hold to maturity. These securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statements of operations.

The Company has elected the fair value option for its CRT securities as it considers this method of accounting to more appropriately reflect the risk sharing structure of these securities. Such securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statements of operations.

Revenue Recognition, Premium Amortization and Discount Accretion

Interest income on securities is accrued based on the outstanding principal balance and their contractual terms. Premiums and discounts associated with Agency MBS and Non-Agency MBS assessed as high credit quality at the time of purchase are amortized into interest income over the life of such securities using the effective yield method. Adjustments to premium amortization are made for actual prepayment activity.

Interest income on the Non-Agency MBS that were purchased at a discount to par value and/or are considered to be of less than high credit quality is recognized based on the security’s effective interest rate which is the security’s internal rate of return (“IRR”). The IRR is determined using management’s estimate of the projected cash flows for each security, which are based on the Company’s observation of current information and events and include assumptions related to fluctuations in interest rates, prepayment speeds and the timing and amount of credit losses. On at least a quarterly basis, the Company reviews and, if appropriate, makes adjustments to its cash flow projections based on input and analysis received from external sources, internal models, and its judgment about interest rates, prepayment rates, the timing and amount of credit losses, and other factors. Changes in cash flows from those originally projected, or from those estimated at the last evaluation, may result in a prospective change in the IRR/ interest income recognized on these securities or in the recognition of OTTIs.  (See Note 3)

Based on the projected cash flows from the Company’s Non-Agency MBS purchased at a discount to par value, a portion of the purchase discount may be designated as non-accretable purchase discount (“Credit Reserve”), which effectively mitigates the Company’s risk of loss on the mortgages collateralizing such MBS and is not expected to be accreted into interest income.  The amount designated as Credit Reserve may be adjusted over time, based on the actual performance of the security, its underlying collateral, actual and projected cash flow from such collateral, economic conditions and other factors.  If the performance of a security with a Credit Reserve is more favorable than forecasted, a portion of the amount designated as Credit Reserve may be reallocated to accretable discount and recognized into interest income over time.  Conversely, if the performance of a security with a Credit Reserve is less favorable than forecasted, the amount designated as Credit Reserve may be increased, or impairment charges and write-downs of such securities to a new cost basis could result.

Determination of Fair Value for MBS and CRT Securities

In determining the fair value of the Company’s MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity.  (See Note 14)

Impairments/OTTI

When the fair value of an AFS security is less than its amortized cost at the balance sheet date, the security is considered impaired.  The Company assesses its impaired securities on at least a quarterly basis and designates such impairments as either “temporary” or “other-than-temporary.”  If the Company intends to sell an impaired security, or it is more likely than not that it will be required to sell the impaired security before its anticipated recovery, then the Company must recognize an OTTI through charges to earnings equal to the entire difference between the investment’s amortized cost and its fair value at the balance sheet date.  If the Company does not expect to sell an other-than-temporarily impaired security, only the portion of the impairment related to credit losses is recognized through charges to earnings with the remainder recognized through AOCI on the consolidated balance sheets.  Impairments recognized through other comprehensive income/(loss) (“OCI”) do not impact earnings.  Following the recognition of an OTTI through earnings, a new cost basis is established for the security and may not be adjusted for subsequent recoveries in fair value through earnings.  However, OTTIs recognized through charges to earnings may be accreted back to the amortized cost basis of the security on a prospective basis through interest income.  The determination as to whether an OTTI exists and, if so, the amount of credit impairment recognized in earnings is subjective, as such determinations are based on factual information available at the time of assessment as well as the Company’s estimates of the future performance and cash flow projections.  As a result, the timing and amount of OTTIs constitute material estimates that are susceptible to significant change.  (See Note 3)

Non-Agency MBS that are assessed to be of less than high credit quality and on which impairments are recognized have experienced, or are expected to experience, credit-related adverse cash flow changes.  The Company’s estimate of cash flows for its Non-Agency MBS is based on its review of the underlying mortgage loans securing the MBS.  The Company considers information available about the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, year of origination, loan-to-value ratios (“LTVs”), geographic concentrations and dialogue with market participants.  As a result, significant judgment is used in the Company’s analysis to determine the expected cash flows for its Non-Agency MBS.  In determining the OTTI related to credit losses for securities that were purchased at significant discounts to par and/or are considered to be of less than high credit quality, the Company compares the present value of the remaining cash flows expected to be collected at the purchase date (or last date previously revised) against the present value of the cash flows expected to be collected at the current financial reporting date.  The discount rate used to calculate the present value of expected future cash flows is the current yield used for income recognition purposes.  Impairment assessment for Non-Agency MBS that were purchased at prices close to par and/or are otherwise considered to be of high credit quality involves comparing the present value of the remaining cash flows expected to be collected against the amortized cost of the security at the assessment date.  The discount rate used to calculate the present value of the expected future cash flows is based on the instrument’s IRR.

Balance Sheet Presentation

The Company’s MBS and CRT Securities pledged as collateral against repurchase agreements and Swaps are included on the consolidated balance sheets with the fair value of the securities pledged disclosed parenthetically.  Purchases and sales of securities are recorded on the trade date. 

MSR Related Assets

MSR Related Assets

The Company has investments in financial instruments whose cash flows are considered to be largely dependent on underlying MSRs that either directly or indirectly act as collateral for the investment. These financial instruments, which are referred to as MSR related assets, are discussed in more detail below. The Company’s MSR related assets pledged as collateral against repurchase agreements are included in the consolidated balance sheets with the amounts pledged disclosed parenthetically. Purchases and sales of MSR related assets are recorded on the trade date. (See Notes 3, 6, 7 and 14)

Term Notes Backed by MSR Related Collateral

The Company has invested in term notes that are issued by special purpose vehicles (“SPV”) that have acquired rights to receive cash flows representing the servicing fees and/or excess servicing spread associated with certain MSRs. The Company considers payment of principal and interest on these term notes to be largely dependent on the cash flows generated by the underlying MSRs as this impacts the cash flows available to the SPV that issued the term notes. Credit risk borne by the holders of the term notes is also mitigated by structural credit support in the form of over-collateralization. Credit support is also provided by a corporate guarantee from the ultimate parent or sponsor of the SPV that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the underlying MSRs be insufficient.

The Company’s term notes backed by MSR related collateral are reported at fair value on the Company’s consolidated balance sheets with unrealized gains and losses excluded from earnings and reported in AOCI. Interest income is recognized on an accrual basis on the Company’s consolidated statements of operations. The Company’s valuation process for such notes considers a number of factors, including a comparable bond analysis performed by a third-party pricing service which involves determining a pricing spread at issuance of the term note. The pricing spread is used at each subsequent valuation date to determine an implied yield to maturity of the term note, which is then used to derive an indicative market value for the security. This indicative market value is further reviewed by the Company and may be adjusted to ensure it reflects a realistic exit price at the valuation date given the structural features of these securities. Other factors taken into consideration include indicative values provided by repurchase agreement counterparties, estimated changes in fair value of the related underlying MSR collateral and the financial performance of the ultimate parent or sponsoring entity of the issuer, which has provided a guarantee that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the related underlying MSR collateral be insufficient.

Corporate Loans

The Company has made or participated in loans to provide financing to entities that originate residential mortgage loans and own the related MSRs. These corporate loans are generally secured by certain MSRs, as well as certain other unencumbered assets owned by the borrower.

Corporate loans are recorded on the Company’s consolidated balance sheets at the drawn amount, on which interest income is recognized on an accrual basis on the Company’s consolidated statements of operations. Commitment fees received on the undrawn amount are deferred and recognized as interest income over the remaining loan term at the time of draw. At the end of the commitment period, any remaining deferred commitment fees are recorded as Other Income on the Company’s consolidated statements of operations. The Company evaluates the recoverability of its corporate loans on a quarterly basis considering various factors, including the current status of the loan, changes in the fair value of the MSRs that secure the loan and the recent financial performance of the borrower.

Residential Whole Loans (including Residential Whole Loans transferred to consolidated VIEs)

Residential Whole Loans (including Residential Whole Loans transferred to consolidated VIEs)

Residential whole loans included in the Company’s consolidated balance sheets are primarily comprised of pools of fixed and adjustable rate residential mortgage loans acquired through consolidated trusts in secondary market transactions, with the majority at discounted purchase prices. The accounting model utilized by the Company is determined at the time each loan package is initially acquired and is generally based on the delinquency status of the majority of the underlying borrowers in the package at acquisition. The accounting model described below for purchased credit impaired loans that are held at carrying value is typically utilized by the Company for purchased credit impaired loans where the underlying borrower has a delinquency status of less than 60 days at the acquisition date. The Company may also purchase newly or recently originated loans that are performing as of the purchase date. Such loans are typically held at carrying value, but the accounting methods for income recognition and determination and measurement of any required loan loss reserves differ to those used for purchased credit impaired loans held at carrying value. The accounting model described below for residential whole loans held at fair value is typically utilized by the Company for loans where the underlying borrower has a delinquency status of 60 days or more at the acquisition date. The accounting model initially applied is not subsequently changed.

The Company’s residential whole loans pledged as collateral against repurchase agreements are included in the consolidated balance sheets with amounts pledged disclosed parenthetically.  Purchases and sales of residential whole loans are recorded on the trade date, with amounts recorded reflecting management’s current estimate of assets that will be acquired or disposed at the closing of the transaction. This estimate is subject to revision at the closing of the transaction, pending the outcome of due diligence performed prior to closing. Recorded amounts of residential whole loans for which the closing of the purchase transaction is yet to occur are not eligible to be pledged as collateral against any repurchase agreement financing until the closing of the purchase transaction. (See Notes 4, 6, 7, 14 and 15)

Residential Whole Loans at Carrying Value

Purchased Credit Impaired Loans

The Company has elected to account for these loans as credit impaired as they were acquired at discounted prices that reflect, in part, the impaired credit history of the borrower. Substantially all of these loans have previously experienced payment delinquencies and the amount owed may exceed the value of the property pledged as collateral. Consequently, these loans generally have a higher likelihood of default than newly originated mortgage loans with LTVs of 80% or less to creditworthy borrowers. The Company believes that amounts paid to acquire these loans represent fair market value at the date of acquisition. Loans considered credit impaired are initially recorded at the purchase price with no allowance for loan losses. Subsequent to acquisition, the recorded amount for these loans reflects the original investment amount, plus accretion of interest income, less principal and interest cash flows received. These loans are presented on the Company’s consolidated balance sheets at carrying value, which reflects the recorded amount reduced by any allowance for loan losses established subsequent to acquisition.

Under the application of the accounting model for purchased credit impaired loans, the Company may aggregate into pools loans acquired in the same fiscal quarter that are assessed as having similar risk characteristics. For each pool established, or on an individual loans basis for loans not aggregated into pools, the Company estimates at acquisition, and periodically on at least a quarterly basis, the principal and interest cash flows expected to be collected. The difference between the cash flows expected to be collected and the carrying amount of the loans is referred to as the “accretable yield.” This amount is accreted as interest income over the life of the loans using an effective interest rate (level yield) methodology. Interest income recorded each period reflects the amount of accretable yield recognized and not the coupon interest payments received on the underlying loans. The difference between contractually required principal and interest payments and the cash flows expected to be collected is referred to as the “non-accretable difference,” and includes estimates of both the effect of prepayments and expected credit losses over the life of the underlying loans.

A decrease in expected cash flows in subsequent periods may indicate impairment at the pool and/or individual loan level, thus requiring the establishment of an allowance for loan losses by a charge to the provision for loan losses. The allowance for loan losses generally represents the present value of cash flows expected at acquisition, adjusted for any increases due to changes in estimated cash flows, that are subsequently no longer expected to be received at the relevant measurement date. Under the accounting model applied to credit impaired loans, a significant increase in expected cash flows in subsequent periods first reduces any previously recognized allowance for loan losses and then will result in a recalculation in the amount of accretable yield. The adjustment of accretable yield due to a significant increase in expected cash flows is accounted for prospectively as a change in estimate and results in reclassification from nonaccretable difference to accretable yield.

Other Loans at Carrying Value

The Company also has investments in loans that are not considered to be credit impaired at purchase. To date such loans have included newly or previously originated performing loans that are primarily comprised of: (i) loans to finance (or refinance) one-to-four family residential properties and are not considered to meet the definition of a “Qualified Mortgage” in accordance with guidelines adopted by the Consumer Financial Protection Bureau (“Non-QM loans”), (ii) short-term business purpose loans collateralized by residential properties made to non-occupant borrowers who intend to rehabilitate and sell the property for a profit (“Rehabilitation loans” or “Fix and Flip loans”), (iii) loans to finance (or refinance) non-owner occupied one-to-four family residential properties that are rented to one or more tenants (“Single-family rental loans”), and (iv) previously originated loans secured by residential real estate that is generally owner occupied (“Seasoned performing loans”), (collectively “Other Loans at Carrying Value”). The Company’s Other Loans at Carrying Value are initially recorded at their purchase price. Interest income on Other Loans at Carrying Value purchased at par is accrued based on each loan’s current interest bearing balance and current interest rate, net of related servicing costs. Interest income on such loans purchased at a premium/discount to par is recorded each period based on the contractual coupon net of any premium or discount and related servicing costs, and adjusted for actual prepayment activity.

An allowance for loan losses is recorded when, based on current information and events, it is probable that the Company will be unable to collect all amounts due according to the existing contractual terms of the loan agreement. Any required loan loss allowance would typically be measured based on fair value of the collateral securing the loan and would reduce the carrying value of the loan with a corresponding charge to earnings. Significant judgments are required in determining any allowance for loan loss, including assumptions regarding the loan cash flows expected to be collected, the value of the underlying collateral and the ability of the Company to collect on any other forms of security, such as a personal guaranty provided either by the borrower or an affiliate of the borrower. Income recognition is suspended for loans at the earlier of the date at which payments become 90 days past due or when, in the opinion of management, a full recovery of income and principal becomes doubtful. When the ultimate collectability of the principal of an impaired loan is in doubt, all payments are applied to principal under the cost recovery method. When the ultimate collectability of the principal of an impaired loan is not in doubt, interest income is recorded under the cash basis method as interest payments are received. Interest accruals are resumed when the loan becomes contractually current and performance is demonstrated to be resumed. A loan is written off when it is no longer realizable and/or it is legally discharged.

Residential Whole Loans at Fair Value

Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at time of acquisition. For the majority of these loans, there is significant uncertainty associated with estimating the timing of and amount of cash flows that will be collected. Further, the cash flows ultimately collected may be dependent on the value of the property securing the loan. Consequently, the Company considers that accounting for these loans at fair value should result in a better reflection over time of the economic returns for the majority of these loans. The Company determines the fair value of its residential whole loans held at fair value after considering portfolio valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans and trading activity observed in the market place. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations.

Cash received reflecting coupon payments on residential whole loans held at fair value is not included in Interest Income, but rather is presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations. Cash outflows associated with loan-related advances made by the Company on behalf of the borrower are included in the basis of the loan and are reflected in Net gain on residential whole loans held at fair value.

Cash and Cash Equivalents

Cash and Cash Equivalents

Cash and cash equivalents include cash on deposit with financial institutions and investments in money market funds, all of which have original maturities of three months or less.  Cash and cash equivalents may also include cash pledged as collateral to the Company by its repurchase agreement counterparties as a result of reverse margin calls (i.e., margin calls made by the Company).  At September 30, 2018 and December 31, 2017, the Company had cash and cash equivalents of $104.2 million and $449.8 million, respectively.

Restricted Cash

Restricted Cash

Restricted cash represents the Company’s cash held by its counterparties in connection with certain of the Company’s repurchase agreements that is not available to the Company for general corporate purposes. Restricted cash may be applied against amounts due to repurchase agreement counterparties, or may be returned to the Company when the related collateral requirements are exceeded or at the maturity of the repurchase agreement.

Goodwill

Goodwill

At September 30, 2018 and December 31, 2017, the Company had goodwill of $7.2 million, which represents the unamortized portion of the excess of the fair value of its common stock issued over the fair value of net assets acquired in connection with its formation in 1998.  Goodwill is tested for impairment at least annually, or more frequently under certain circumstances, at the entity level.  Through September 30, 2018, the Company had not recognized any impairment against its goodwill. Goodwill is included in Other assets on the Company’s consolidated balance sheets.

Real Estate Owned (REO)

Real Estate Owned (“REO”)

REO represents real estate acquired by the Company, including through foreclosure, deed in lieu of foreclosure, or purchased in connection with the acquisition of residential whole loans. REO acquired through foreclosure or deed in lieu of foreclosure is initially recorded at fair value less estimated selling costs. REO acquired in connection with the acquisition of residential whole loans is initially recorded at its purchase price. Subsequent to acquisition, REO is reported, at each reporting date, at the lower of the current carrying amount or fair value less estimated selling costs and for presentation purposes is included in Other assets on the Company’s consolidated balance sheets. Changes in fair value that result in an adjustment to the reported amount of an REO property that has a fair value at or below its carrying amount are reported in Other Income, net on the Company’s consolidated statements of operations.

Depreciation

Depreciation

Leasehold Improvements and Other Depreciable Assets

Depreciation is computed on the straight-line method over the estimated useful life of the related assets or, in the case of leasehold improvements, over the shorter of the useful life or the lease term.  Furniture, fixtures, computers and related hardware have estimated useful lives ranging from five to eight years at the time of purchase.

Loan Securitization and Other Debt Issuance Costs

Loan Securitization and Other Debt Issuance Costs

Loan securitization related costs are costs associated with the issuance of beneficial interests by consolidated VIEs and incurred by the Company in connection with various financing transactions completed by the Company.  Other debt issuance and related costs include costs incurred by the Company in connection with issuing 8% Senior Notes due 2042 (“Senior Notes”) and certain other repurchase agreement financings. These costs may include underwriting, rating agency, legal, accounting and other fees.  Such costs, which reflect deferred charges, are included on the Company’s consolidated balance sheets as a direct deduction from the corresponding debt liability. These deferred charges are amortized as an adjustment to interest expense using the effective interest method. For Senior Notes and other repurchase agreement financings, such costs are amortized over the shorter of the period to the expected or stated legal maturity of the debt instruments. The Company periodically reviews the recoverability of these deferred costs and in the event an impairment charge is required, such amount will be included in Operating and Other Expense on the Company’s consolidated statements of operations.

Repurchase Agreements

Repurchase Agreements

The Company finances the holdings of a significant portion of its residential mortgage assets with repurchase agreements.  Under repurchase agreements, the Company sells securities to a lender and agrees to repurchase the same securities in the future for a price that is higher than the original sale price.  The difference between the sale price that the Company receives and the repurchase price that the Company pays represents interest paid to the lender.  Although legally structured as sale and repurchase transactions, the Company accounts for repurchase agreements as secured borrowings. Under its repurchase agreements, the Company pledges its securities as collateral to secure the borrowing, which is equal in value to a specified percentage of the fair value of the pledged collateral, while the Company retains beneficial ownership of the pledged collateral.  At the maturity of a repurchase financing, unless the repurchase financing is renewed with the same counterparty, the Company is required to repay the loan including any accrued interest and concurrently receives back its pledged collateral from the lender.  With the consent of the lender, the Company may renew a repurchase financing at the then prevailing financing terms.  Margin calls, whereby a lender requires that the Company pledge additional securities or cash as collateral to secure borrowings under its repurchase financing with such lender, are routinely experienced by the Company when the value of the MBS pledged as collateral declines as a result of principal amortization and prepayments or due to changes in market interest rates, spreads or other market conditions.  The Company also may make margin calls on counterparties when collateral values increase.

The Company’s repurchase financings typically have terms ranging from one month to six months at inception, but may also have longer or shorter terms.  Should a counterparty decide not to renew a repurchase financing at maturity, the Company must either refinance elsewhere or be in a position to satisfy the obligation.  If, during the term of a repurchase financing, a lender should default on its obligation, the Company might experience difficulty recovering its pledged assets which could result in an unsecured claim against the lender for the difference between the amount loaned to the Company plus interest due to the counterparty and the fair value of the collateral pledged by the Company to such lender, including accrued interest receivable or such collateral.  (See Notes 6, 7 and 14)

In addition to the repurchase agreement financing arrangements discussed above, as part of its financing strategy for Non-Agency MBS, the Company in prior periods entered into contemporaneous repurchase and reverse repurchase agreements with a single counterparty.  Under a typical reverse repurchase agreement, the Company buys securities from a borrower for cash and agrees to sell the same securities in the future for a price that is higher than the original purchase price.  The difference between the purchase price the Company originally paid and the sale price represents interest received from the borrower.  In contrast, the contemporaneous repurchase and reverse repurchase transactions effectively resulted in the Company pledging Non-Agency MBS as collateral to the counterparty in connection with the repurchase agreement financing and obtaining U.S. Treasury securities as collateral from the same counterparty in connection with the reverse repurchase agreement.  No net cash was exchanged between the Company and counterparty at the inception of the transactions.  Securities obtained and pledged as collateral are recorded in Other assets on the Company’s consolidated balance sheets.  Interest income is recorded on the reverse repurchase agreement and interest expense is recorded on the repurchase agreement on an accrual basis.   The Company’s liability to the counterparty in prior periods in connection with this financing arrangement is recorded in Other liabilities on the Company’s consolidated balance sheets and disclosed as “Obligation to return securities obtained as collateral, at fair value.”

Equity-Based Compensation

Equity-Based Compensation

Compensation expense for equity-based awards that are subject to vesting conditions, is recognized ratably over the vesting period of such awards, based upon the fair value of such awards at the grant date.  For certain awards granted prior to January 1, 2017, compensation expense recognized included the impact of estimated forfeitures, with any changes in estimated forfeiture rates accounted for as a change in estimate. Upon adoption of new accounting guidance that was effective for the Company on January 1, 2017, the Company made a policy election to account for forfeitures as they occur.

Beginning in 2014, the Company has made annual grants of restricted stock units (“RSUs”) certain of which cliff vest after a three-year period and others of which cliff vest after a three-year period, subject to the achievement of certain performance criteria based on a formula tied to the Company’s achievement of average total stockholder return during that three-year period, as well as the total shareholder return (“TSR”) of the Company relative to the TSR of a group of peer companies (over the three-year period) selected by the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) at the date of grant. The features in these awards related to the attainment of total stockholder return over a specified period constitute a “market condition” which impacts the amount of compensation expense recognized for these awards.  Specifically, the uncertainty regarding the achievement of the market condition was reflected in the grant date fair valuation of the RSUs, which is recognized as compensation expense over the relevant vesting period.  The amount of compensation expense recognized is not dependent on whether the market condition was or will be achieved.

The Company makes dividend equivalent payments in connection with certain of its equity-based awards.   A dividend equivalent is a right to receive a distribution equal to the dividend distributions that would be paid on a share of the Company’s common stock.  Dividend equivalents may be granted as a separate instrument or may be a right associated with the grant of another award (e.g., an RSU) under the Company’s Equity Compensation Plan (the “Equity Plan”), and they are paid in cash or other consideration at such times and in accordance with such rules, terms and conditions, as the Compensation Committee may determine in its discretion.  Payments pursuant to dividend equivalents are generally charged to Stockholders’ Equity to the extent that the attached equity awards are expected to vest.  Compensation expense is recognized for payments made for dividend equivalents to the extent that the attached equity awards (i) do not or are not expected to vest and (ii) grantees are not required to return payments of dividends or dividend equivalents to the Company. 

Earnings per Common Share (EPS)

Earnings per Common Share (“EPS”)

Basic EPS is computed using the two-class method, which includes the weighted-average number of shares of common stock outstanding during the period and an estimate of other securities that participate in dividends, such as the Company’s unvested restricted stock and RSUs that have non-forfeitable rights to dividends and dividend equivalents attached to/associated with RSUs and vested stock options to arrive at total common equivalent shares.  In applying the two-class method, earnings are allocated to both shares of common stock and estimated securities that participate in dividends based on their respective weighted-average shares outstanding for the period.  For the diluted EPS calculation, common equivalent shares are further adjusted for the effect of dilutive unexercised stock options and RSUs outstanding that are unvested and have dividends that are subject to forfeiture using the treasury stock method.  Under the treasury stock method, common equivalent shares are calculated assuming that all dilutive common stock equivalents are exercised and the proceeds, along with future compensation expenses associated with such instruments, are used to repurchase shares of the Company’s outstanding common stock at the average market price during the reported period. 

Comprehensive Income/(Loss)

Comprehensive Income/(Loss)

The Company’s comprehensive income/(loss) available to common stock and participating securities includes net income, the change in net unrealized gains/(losses) on its AFS securities and derivative hedging instruments, (to the extent that such changes are not recorded in earnings), adjusted by realized net gains/(losses) reclassified out of AOCI for sold AFS securities and is reduced by dividends declared on the Company’s preferred stock and issuance costs of redeemed preferred stock.

U.S. Federal Income Taxes

U.S. Federal Income Taxes

The Company has elected to be taxed as a REIT under the provisions of the Internal Revenue Code of 1986, as amended, (the “Code”) and the corresponding provisions of state law.  The Company expects to operate in a manner that will enable it to satisfy the various requirements to maintain its status as a REIT for federal income tax purposes. In order to maintain its status as a REIT, the Company must, among other things, distribute at least 90% of its REIT taxable income (excluding net long-term capital gains) to stockholders in the timeframe permitted by the Code.  As long as the Company maintains its status as a REIT, the Company will not be subject to regular federal income tax to the extent that it distributes 100% of its REIT taxable income (including net long-term capital gains) to its stockholders within the permitted timeframe.  Should this not occur, the Company would be subject to federal taxes at prevailing corporate tax rates on the difference between its REIT taxable income and the amounts deemed to be distributed for that tax year.  As the Company’s objective is to distribute 100% of its REIT taxable income to its stockholders within the permitted timeframe, no provision for current or deferred income taxes has been made in the accompanying consolidated financial statements.  Should the Company incur a liability for corporate income tax, such amounts would be recorded as REIT income tax expense on the Company’s consolidated statements of operations. Furthermore, if the Company fails to distribute during each calendar year, or by the end of January following the calendar year in the case of distributions with declaration and record dates falling in the last three months of the calendar year, at least the sum of (i) 85% its REIT ordinary income for such year, (ii) 95% of its REIT capital gain income for such year, and (iii) any undistributed taxable income from prior periods, the Company would be subject to a 4% nondeductible excise tax on the excess of the required distribution over the amounts actually distributed. To the extent that the Company incurs interest, penalties or related excise taxes in connection with its tax obligations, including as a result of its assessment of uncertain tax positions, such amounts will be included in Operating and Other Expense on the Company’s consolidated statements of operations.

In addition, the Company has elected to treat certain of its subsidiaries as a TRS. In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. Generally, a domestic TRS is subject to U.S. federal, state and local corporate income taxes. Since a portion of the Company’s business may be conducted through one or more TRS, its income earned by TRS may be subject to corporate income taxation. To maintain the Company’s REIT election, no more than 20% of the value of a REIT’s assets at the end of each calendar quarter may consist of stock or securities in TRS. For purposes of the determination of U.S. federal and state income taxes, the Company’s subsidiaries that elected to be treated as a TRS record current or deferred income taxes based on differences (both permanent and timing) between the determination of their taxable income and net income under GAAP. No deferred tax benefit was recorded by the Company for the nine months endedSeptember 30, 2018 and 2017, as a valuation allowance for the full amount of the associated deferred tax asset was recognized as its recovery is not considered more likely than not.

 Based on its analysis of any potential uncertain tax positions, the Company concluded that it does not have any material uncertain tax positions that meet the relevant recognition or measurement criteria as of September 30, 2018, December 31, 2017, or September 30, 2017. The Company filed its 2017 tax return prior to October 15, 2018. The Company’s tax returns for tax years 2015 through 2017 are open to examination.

Derivative Financial Instruments

Derivative Financial Instruments

The Company may use a variety of derivative instruments to economically hedge a portion of its exposure to market risks, including interest rate risk and prepayment risk. The objective of the Company’s risk management strategy is to reduce fluctuations in net book value over a range of interest rate scenarios. In particular, the Company attempts to mitigate the risk of the cost of its variable rate liabilities increasing during a period of rising interest rates. The Company’s derivative instruments are currently comprised of Swaps, the majority of which are designated as cash flow hedges against the interest rate risk associated with its borrowings.

Swaps

The Company documents its risk-management policies, including objectives and strategies, as they relate to its hedging activities and the relationship between the hedging instrument and the hedged liability for all Swaps designated as hedging transactions.  The Company assesses, both at inception of a hedge and on a quarterly basis thereafter, whether or not the hedge is “highly effective.”

Swaps are carried on the Company’s consolidated balance sheets at fair value, in Other assets, if their fair value is positive, or in Other liabilities, if their fair value is negative.  Beginning in January 2017, variation margin payments on the Company’s Swaps that have been novated to a clearing house are treated as a legal settlement of the exposure under the Swap contract. Previously such payments were treated as collateral pledged against the exposure under the Swap contract. The effect of this change is to reduce what would have otherwise been reported as fair value of the Swap. All of the Company’s Swaps have been novated to a central clearing house. Changes in the fair value of the Company’s Swaps designated in hedging transactions are recorded in OCI provided that the hedge remains effective.  Changes in fair value for any ineffective amount of a Swap are recognized in earnings.  The Company has not recognized any change in the value of its existing Swaps designated as hedges through earnings as a result of hedge ineffectiveness. Periodic payments accrued in connection with Swaps designated as hedges are included in interest expense, and are treated as an operating cash flow.

The Company discontinues hedge accounting on a prospective basis and recognizes changes in fair value through earnings when: (i) it is determined that the derivative is no longer effective in offsetting cash flows of a hedged item (including forecasted transactions); (ii) it is no longer probable that the forecasted transaction will occur; or (iii) it is determined that designating the derivative as a hedge is no longer appropriate. (See Notes 5(c), 7 and 14)

Changes in the fair value of the Company’s Swaps not designated in hedging transactions are recorded in Other income, net on the Company’s consolidated statement of operations.

Fair Value Measurements and the Fair Value Option for Financial Assets and Financial Liabilities

Fair Value Measurements and the Fair Value Option for Financial Assets and Financial Liabilities

The Company’s presentation of fair value for its financial assets and liabilities is determined within a framework that stipulates that the fair value of a financial asset or liability is an exchange price in an orderly transaction between market participants to sell the asset or transfer the liability in the market in which the reporting entity would transact for the asset or liability, that is, the principal or most advantageous market for the asset or liability.  The transaction to sell the asset or transfer the liability is a hypothetical transaction at the measurement date, considered from the perspective of a market participant that holds the asset or owes the liability.  This definition of fair value focuses on exit price and prioritizes the use of market-based inputs over entity-specific inputs when determining fair value.  In addition, the framework for measuring fair value establishes a three-level hierarchy for fair value measurements based upon the observability of inputs to the valuation of an asset or liability as of the measurement date. 

In addition to the financial instruments that it is required to report at fair value, the Company has elected the fair value option for certain of its residential whole loans, Agency MBS and CRT securities at time of acquisition. Subsequent changes in the fair value of these financial instruments are reported in Other income, net, in the Company’s consolidated statements of operations. A decision to elect the fair value option for an eligible financial instrument, which may be made on an instrument by instrument basis, is irrevocable.

Variable Interest Entities

Variable Interest Entities

An entity is referred to as a VIE if it meets at least one of the following criteria:  (i) the entity has equity that is insufficient to permit the entity to finance its activities without additional subordinated financial support of other parties; or (ii) as a group, the holders of the equity investment at risk lack (a) the power to direct the activities of an entity that most significantly impact the entity’s economic performance; (b) the obligation to absorb the expected losses; or (c) the right to receive the expected residual returns; or (iii) have disproportional voting rights and the entity’s activities are conducted on behalf of the investor that has disproportionately few voting rights.

The Company consolidates a VIE when it has both the power to direct the activities that most significantly impact the economic performance of the VIE and a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE.   The Company is required to reconsider its evaluation of whether to consolidate a VIE each reporting period, based upon changes in the facts and circumstances pertaining to the VIE.

The Company has entered into several financing transactions which resulted in the Company consolidating the VIEs that were created to facilitate these transactions.  In determining the accounting treatment to be applied to these transactions, the Company concluded that the entities used to facilitate these transactions were VIEs and that they should be consolidated.  If the Company had determined that consolidation was not required, it would have then assessed whether the transfers of the underlying assets would qualify as sale or should be accounted for as secured financings under GAAP. (See Note 15)

The Company also includes on its consolidated balance sheets certain financial assets and liabilities that are acquired/issued by trusts and/or other special purpose entities that have been evaluated as being required to be consolidated by the Company under the applicable accounting guidance.

Offering Costs Related to Issuance and Redemption of Preferred Stock

Offering Costs Related to Issuance and Redemption of Preferred Stock

Offering costs related to issuance of preferred stock are recorded as a reduction in Additional paid-in capital, a component of Stockholders’ Equity, at the time such preferred stock is issued. On redemption of preferred stock, any excess of the fair value of the consideration transferred to the holders of the preferred stock over the carrying amount of the preferred stock in the Company’s consolidated balance sheets is included in the determination of Net Income Available to Common Stock and Participating Securities in the calculation of EPS.

New Accounting Standards and Interpretations

New Accounting Standards and Interpretations

Accounting Standards Adopted in 2018

Compensation - Stock Compensation - Scope of Modification Accounting

In May 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-09, Scope of Modification Accounting (“ASU 2017-09”). The amendments in ASU 2017-09 provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. Pursuant to this ASU, an entity should account for the effects of a modification unless all of the following are met: (1) the fair value (or calculated value or intrinsic value, if such an alternative measurement method is used) of the modified award is the same as the fair value (or calculated value or intrinsic value, if such an alternative measurement method is used) of the original award immediately before the original award is modified; (2) the vesting conditions of the modified award are the same as the vesting conditions of the original award immediately before the original award is modified; and (3) the classification of the modified award as an equity instrument or a liability instrument is the same as the classification of the original award immediately before the original award date is modified. The Company adopted ASU 2017-09 on January 1, 2018 and its adoption did not have an impact on its financial position or financial statement disclosures.

Statement of Cash Flows - Restricted Cash

In November 2016, the FASB issued ASU 2016-18, Restricted Cash (“ASU 2016-18”). ASU 2016-18 clarifies how entities should present restricted cash and restricted cash equivalents in the statement of cash flows with the objective of reducing the existing diversity in practice. The amendments in ASU 2016-18 require restricted cash and restricted cash equivalents to be included with cash and cash equivalents when reconciling the beginning-of-period and end-of period total amounts shown on the statement of cash flows. The Company adopted ASU 2016-18 on January 1, 2018 and its adoption did not have a significant impact on its financial position or financial statement disclosures.

Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments

In August 2016, the FASB issued ASU 2016-15, Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”). The amendments in ASU 2016-15 provide guidance for eight specific cash flow classification issues, certain cash receipts and cash payments on the statement of cash flows with the objective of reducing the existing diversity in practice. The Company adopted ASU 2016-15 on January 1, 2018 and its adoption did not have a significant impact on its financial position or financial statement disclosures.

Financial Instruments - Overall - Recognition and Measurement of Financial Assets and Financial Liabilities

In January 2016, the FASB issued ASU 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”). The amendments in this ASU affect all entities that hold financial assets or owe financial liabilities, and address certain aspects of recognition, measurement, presentation, and disclosure of financial instruments.  The classification and measurement guidance of investments in debt securities and loans are not affected by the amendments in this ASU. ASU 2016-01 was effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017.  The Company’s adoption of this ASU on January 1, 2018 did not have a significant impact on the Company’s financial position or financial statement disclosures as the classification and measurement of its investments in debt securities and loans were not affected by the amendments in this ASU.

Revenue from Contracts with Customers

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”).  The ASU requires an entity to recognize revenue in an amount that reflects the consideration to which it expects to be entitled for the transfer of promised goods or services to customers.  ASU 2014-09 replaced most existing revenue recognition guidance in GAAP when it became effective. The Company adopted this ASU on January 1, 2018 and its adoption did not have a material impact on the Company’s financial position or financial statement disclosures as the majority of the Company’s revenues are generated by financial instruments that are explicitly scoped out of this ASU. On adoption of the new standard on January 1, 2018, the Company recorded a transition adjustment, under the modified retrospective approach, of approximately $295,000 to the opening balance of retained earnings in order to reflect the recognition of a gain on sale of REO that was previously deferred under the prior accounting guidance.

XML

MBS, CRT Securities and MSR Related Assets (Tables)

9 Months Ended

Sep. 30, 2018

Investments, Debt and Equity Securities [Abstract]

Schedule of information about MBS and CRT Securities

The following tables present certain information about the Company’s MBS and CRT securities at September 30, 2018 and December 31, 2017:

September 30, 2018

(In Thousands)	Principal/ Current Face		Purchase Premiums		Accretable Purchase Discounts			Discount Designated as Credit Reserve and  OTTI (1)			Amortized Cost (2)		Fair Value		Gross Unrealized Gains		Gross Unrealized Losses			Net Unrealized Gain/(Loss)
Agency MBS: (3)
Fannie Mae	$	1,851,447	$	70,882	$	(29	)	$	—		$	1,922,300	$	1,896,739	$	14,650	$	(40,211	)	$	(25,561	)
Freddie Mac	987,833		40,183		—			—			1,028,453		1,003,583		1,027		(25,897		)	(24,870		)
Ginnie Mae	5,028		92		—			—			5,120		5,168		48		—			48
Total Agency MBS	2,844,308		111,157		(29		)	—			2,955,873		2,905,490		15,725		(66,108		)	(50,383		)
Non-Agency MBS:
Expected to Recover Par (4)(5)	1,343,835		41		(23,835		)	—			1,320,041		1,343,272		25,146		(1,915		)	23,231
Expected to Recover Less than Par (4)	2,165,454		—		(167,910		)	(531,757		)	1,465,787		1,991,338		525,770		(219		)	525,551
Total Non-Agency MBS (6)	3,509,289		41		(191,745		)	(531,757		)	2,785,828		3,334,610		550,916		(2,134		)	548,782
Total MBS	6,353,597		111,198		(191,774		)	(531,757		)	5,741,701		6,240,100		566,641		(68,242		)	498,399
CRT securities (7)	495,018		9,936		(178		)	—			504,776		538,945		34,173		(4		)	34,169
Total MBS and CRT securities	$	6,848,615	$	121,134	$	(191,952	)	$	(531,757	)	$	6,246,477	$	6,779,045	$	600,814	$	(68,246	)	$	532,568

December 31, 2017

(In Thousands)	Principal/ Current Face		Purchase Premiums		Accretable Purchase Discounts			Discount Designated as Credit Reserve and  OTTI (1)			Amortized Cost (2)		Fair Value		Gross Unrealized Gains		Gross Unrealized Losses			Net Unrealized Gain/(Loss)
Agency MBS: (3)
Fannie Mae	$	2,170,974	$	82,271	$	(40	)	$	—		$	2,253,205	$	2,246,600	$	21,736	$	(28,341	)	$	(6,605	)
Freddie Mac	561,346		21,683		—			—			584,920		571,748		1,624		(14,796		)	(13,172		)
Ginnie Mae	6,142		112		—			—			6,254		6,333		79		—			79
Total Agency MBS	2,738,462		104,066		(40		)	—			2,844,379		2,824,681		23,439		(43,137		)	(19,698		)
Non-Agency MBS:
Expected to Recover Par (4)(5)	1,128,808		50		(22,737		)	—			1,106,121		1,132,205		26,518		(434		)	26,084
Expected to Recover Less than Par (4)	2,589,935		—		(192,588		)	(593,227		)	1,804,120		2,401,761		597,660		(19		)	597,641
Total Non-Agency MBS (6)	3,718,743		50		(215,325		)	(593,227		)	2,910,241		3,533,966		624,178		(453		)	623,725
Total MBS	6,457,205		104,116		(215,365		)	(593,227		)	5,754,620		6,358,647		647,617		(43,590		)	604,027
CRT securities (7)	602,799		8,887		(3,550		)	—			608,136		664,403		56,290		(23		)	56,267
Total MBS and CRT securities	$	7,060,004	$	113,003	$	(218,915	)	$	(593,227	)	$	6,362,756	$	7,023,050	$	703,907	$	(43,613	)	$	660,294

(1) Discount designated as Credit Reserve and amounts related to OTTI are generally not expected to be accreted into interest income.  Amounts disclosed at September 30, 2018 reflect Credit Reserve of $519.6 million and OTTI of $12.2 million.  Amounts disclosed at December 31, 2017 reflect Credit Reserve of $579.0 million and OTTI of $14.2 million.

(2) Includes principal payments receivable of $438,000 and $1.9 million at September 30, 2018 and December 31, 2017, respectively, which are not included in the Principal/Current Face.

(3) Amounts disclosed at September 30, 2018 include Agency MBS with a fair value of $746.7 million for which the fair value option has been elected. Such securities had no unrealized gains and gross unrealized losses of approximately $5.5 million at September 30, 2018. The Company did not have any Agency MBS for which the fair value option had been elected at December 31, 2017.

(4) Based on management’s current estimates of future principal cash flows expected to be received.

(5) Includes RPL/NPL MBS, which at September 30, 2018 had a $1.2 billion Principal/Current face, $1.2 billion amortized cost and $1.2 billion fair value. At December 31, 2017, RPL/NPL MBS had a $922.0 million Principal/Current face, $920.1 million amortized cost and $923.1 millionfair value.

(6) At September 30, 2018 and December 31, 2017, the Company expected to recover approximately 85% and 84% of the then-current face amount of Non-Agency MBS, respectively.

(7) Amounts disclosed at September 30, 2018 includes CRT securities with a fair value of $538.9 million for which the fair value option has been elected. Such securities had gross unrealized gains of approximately $34.2 million and gross unrealized losses of approximately $4,000 at September 30, 2018. Amounts disclosed at December 31, 2017 includes CRT securities with a fair value of $528.9 million for which the fair value option has been elected. Such securities had gross unrealized gains of approximately $40.5 million and gross unrealized losses of approximately $23,000 at December 31, 2017.

Schedule of information about MBS and CRT Securities that were in an unrealized loss position

The following table presents information about the Company’s MBS and CRT securities that were in an unrealized loss position at September 30, 2018:

Unrealized Loss Position For:

	Less than 12 Months					12 Months or more					Total
	Fair Value		Unrealized Losses		Number of Securities	Fair Value		Unrealized Losses		Number of Securities	Fair Value		Unrealized Losses
(Dollars in Thousands)
Agency MBS: (1)
Fannie Mae	$	438,980	$	4,293	105	$	838,566	$	35,918	251	$	1,277,546	$	40,211
Freddie Mac	668,566		6,020		37	298,083		19,877		103	966,649		25,897
Total Agency MBS	1,107,546		10,313		142	1,136,649		55,795		354	2,244,195		66,108
Non-Agency MBS:
Expected to Recover Par (2)	435,011		1,849		15	3,877		66		7	438,888		1,915
Expected to Recover Less than Par (2)	44,630		219		6	—		—		—	44,630		219
Total Non-Agency MBS	479,641		2,068		21	3,877		66		7	483,518		2,134
Total MBS	1,587,187		12,381		163	1,140,526		55,861		361	2,727,713		68,242
CRT securities (3)	15,754		4		4	—		—		—	15,754		4
Total MBS and CRT securities	$	1,602,941	$	12,385	167	$	1,140,526	$	55,861	361	$	2,743,467	$	68,246

(1) Amounts disclosed at September 30, 2018 include Agency MBS with a fair value of $746.7 million on which the fair value option has been elected. Such securities had unrealized losses of $5.5 million at September 30, 2018. 

(2) Based on management’s current estimates of future principal cash flows expected to be received.

(3) Amounts disclosed at September 30, 2018 represent CRT securities on which the fair value option has been elected.

Schedule of composition of OTTI charges recorded

The following table presents the composition of OTTI charges recorded by the Company for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,				Nine Months Ended   September 30,
(In Thousands)	2018		2017		2018		2017
Total OTTI losses	$	—	$	—	$	—	$	(63	)
OTTI reclassified from OCI	—		—		—		(969		)
OTTI recognized in earnings	$	—	$	—	$	—	$	(1,032	)

Schedule of changes in credit loss component of OTTI

The following table presents a roll-forward of the credit loss component of OTTI on the Company’s Non-Agency MBS for which a non-credit component of OTTI was previously recognized in OCI.  Changes in the credit loss component of OTTI are presented based upon whether the current period is the first time OTTI was recorded on a security or a subsequent OTTI charge was recorded.

	Three Months Ended   September 30,		Nine Months Ended   September 30,
(In Thousands)	2018		2018
Credit loss component of OTTI at beginning of period	$	38,337	$	38,337
Additions for credit related OTTI not previously recognized	—		—
Subsequent additional credit related OTTI recorded	—		—
Credit loss component of OTTI at end of period	$	38,337	$	38,337

Schedule of changes in the components of the purchase discount on Non-Agency MBS

The following tables present the changes in the components of the Company’s purchase discount on its Non-Agency MBS between purchase discount designated as Credit Reserve and OTTI and accretable purchase discount for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30, 2018						Three Months Ended   September 30, 2017
(In Thousands)	Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)			Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)
Balance at beginning of period	$	(553,596	)	$	(202,248	)	$	(626,498	)	$	(257,967	)
Impact of RMBS Issuer Settlement (2)	—			(2,734		)	—			—
Accretion of discount	—			20,115			—			18,621
Realized credit losses	12,042			—			13,982			—
Purchases	(1,975		)	1,368			—			(1,929		)
Sales	1,552			1,974			4,620			11,244
Transfers/release of credit reserve	10,220			(10,220		)	14,762			(14,762		)
Balance at end of period	$	(531,757	)	$	(191,745	)	$	(593,134	)	$	(244,793	)

	Nine Months Ended   September 30, 2018						Nine Months Ended   September 30, 2017
(In Thousands)	Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)			Discount Designated as Credit Reserve and OTTI			Accretable Discount (1)
Balance at beginning of period	$	(593,227	)	$	(215,325	)	$	(694,241	)	$	(278,191	)
Impact of RMBS Issuer Settlement (2)(3)	—			(14,822		)	—			—
Accretion of discount	—			54,860			—			60,461
Realized credit losses	31,443			—			39,445			—
Purchases	(2,510		)	1,856			(484		)	(3,449		)
Sales	7,144			7,079			29,398			10,166
Net impairment losses recognized in earnings	—			—			(1,032		)	—
Transfers/release of credit reserve	25,393			(25,393		)	33,780			(33,780		)
Balance at end of period	$	(531,757	)	$	(191,745	)	$	(593,134	)	$	(244,793	)

(1) Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security.

(2) Includes the impact of approximately $2.7 million of cash proceeds (a one-time payment) received by the Company during the three and nine months ended September 30, 2018 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by Lehman Brothers Holdings Inc.

(3) Includes the impact of approximately $12.1 million of cash proceeds (a one-time payment) received by the Company during the nine months ended September 30, 2018 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by JP Morgan Chase & Co. and affiliated entities.

Schedule of impact of AFS on AOCI

The following table presents the impact of the Company’s AFS securities on its AOCI for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended September 30,						Nine Months Ended September 30,
(In Thousands)	2018			2017			2018			2017
AOCI from AFS securities:
Unrealized gain on AFS securities at beginning of period	$	548,551		$	668,223		$	620,648		$	620,403
Unrealized loss on Agency MBS, net	(9,177		)	(3,032		)	(27,507		)	(22,241		)
Unrealized (loss)/gain on Non-Agency MBS, net	(25,101		)	10,020			(62,743		)	93,429
Reclassification adjustment for MBS sales included in net income	(9,455		)	(14,935		)	(25,580		)	(30,283		)
Reclassification adjustment for OTTI included in net income	—			—			—			(1,032		)
Change in AOCI from AFS securities	(43,733		)	(7,947		)	(115,830		)	39,873
Balance at end of period	$	504,818		$	660,276		$	504,818		$	660,276

Schedule of interest income on MBS, CRT Securities and MSR Related Assets

The following table presents the components of interest income on the Company’s MBS, CRT securities and MSR related assets for the three and nine months ended September 30, 2018 and 2017: 

	Three Months Ended September 30,						Nine Months Ended September 30,
(In Thousands)	2018			2017			2018			2017
Agency MBS
Coupon interest	$	21,549		$	23,473		$	62,546		$	74,589
Effective yield adjustment (1)	(7,217		)	(7,940		)	(19,751		)	(24,575		)
Interest income	$	14,332		$	15,533		$	42,795		$	50,014
Legacy Non-Agency MBS
Coupon interest	$	27,026		$	30,688		$	83,791		$	97,796
Effective yield adjustment (2)(3)	18,984			18,005			53,648			59,033
Interest income	$	46,010		$	48,693		$	137,439		$	156,829
RPL/NPL MBS
Coupon interest	$	11,526		$	13,947		$	31,167		$	54,475
Effective yield adjustment (1)(4)	1,131			612			1,206			1,424
Interest income	$	12,657		$	14,559		$	32,373		$	55,899
CRT securities
Coupon interest	$	7,257		$	7,868		$	23,484		$	19,712
Effective yield adjustment (2)	491			808			2,455			3,186
Interest income	$	7,748		$	8,676		$	25,939		$	22,898
MSR related assets
Coupon interest	$	6,407		$	7,117		$	19,005		$	17,621
Effective yield adjustment (1)	—			77			1,244			212
Interest income	$	6,407		$	7,194		$	20,249		$	17,833

(1)  Includes amortization of premium paid net of accretion of purchase discount.  For Agency MBS, RPL/NPL MBS and the corporate loan secured by MSRs, interest income is recorded at an effective yield, which reflects net premium amortization/accretion based on actual prepayment activity.

(2) The effective yield adjustment is the difference between the net income calculated using the net yield, which is based on management’s estimates of the amount and timing of future cash flows, less the current coupon yield.

(3) Includes accretion income recognized due to the impact of redemptions of certain securities that had been previously been purchased at a discount of $2.3 million during the three months ended September 30, 2018 and $2.3 million and $1.7 million during the nine months ended September 30, 2018 and 2017, respectively.

(4) Includes accretion income recognized due to the impact of redemptions of certain securities that had been previously been purchased at a discount of $1.1 million and $575,000 during the three months ended September 30, 2018 and 2017, respectively and $1.2 million during each of the nine months ended September 30, 2018 and 2017, respectively.

XML

Residential Whole Loans (Tables)

9 Months Ended

Sep. 30, 2018

Receivables [Abstract]

Residential Whole Loans, at Carrying Value

The following table presents the components of the Company’s Residential whole loans, at carrying value at September 30, 2018 and December 31, 2017:

(Dollars In Thousands)	September 30, 2018		December 31, 2017
Purchased credit impaired loans	$	825,614	$	790,879
Other loans at carrying value:
Non-QM loans	989,818		55,612
Rehabilitation loans	329,301		56,706
Single-family rental loans	79,699		5,319
Seasoned performing loans	247,135		—
Total other loans at carrying value	$	1,645,953	$	117,637
Total Residential whole loans, at carrying value	$	2,471,567	$	908,516
Number of loans	9,900		4,800

Financing Receivable Credit Quality Indicators

The following table presents additional information regarding the Company’s Residential whole loans, at carrying value at September 30, 2018:

September 30, 2018

	Carrying Value		Unpaid Principal Balance (“UPB”)		Weighted Average Coupon (1)		Weighted Average Term to Maturity (Months)	Weighted Average LTV Ratio (2)		Aging by UPB
												Past Due Days
(Dollars In Thousands)										Current		30-59		60-89		90+
Purchased credit impaired loans	$	825,614	$	1,034,890	4.36	%	304	87	%	N/A		N/A		N/A		N/A
Other loans at carrying value:(3)
Non-QM loans	989,818		956,162		6.18		358	66		$	944,564	$	8,564	$	1,865	$	1,169
Rehabilitation loans	329,301		329,301		7.51		9	65		309,951		12,836		3,620		2,894
Single-family rental loans	79,699		79,563		5.84		355	68		78,172		870		—		521
Seasoned performing loans	240,362		260,770		4.05		194	49		239,025		20,373		635		737
Residential whole loans, at carrying value, total or weighted average	$	2,464,794	$	2,660,686	5.46	%	278

(1) Weighted average is calculated based on the interest bearing principal balance of each loan within the related category. For loans acquired with servicing rights released by the seller, interest rates included in the calculation do not reflect loan servicing fees. For loans acquired with servicing rights retained by the seller, interest rates included in the calculation are net of servicing fees.

(2) LTV represents the ratio of the total unpaid principal balance of the loan, to the estimated value of the collateral securing the related loan. For Rehabilitation loans, the LTV generally represents the ratio of the maximum unpaid principal balance of the loan, including unfunded commitments, to the estimated after repaired value of the collateral securing the related loan. For certain Rehabilitation loans, an after repaired valuation is not obtained during loan underwriting. For these loans, the LTV represents the ratio of the current unpaid principal balance of the loan, to the “as is” estimated value of the collateral securing the related loan.

(3) Excluded from the table above are approximately $6.8 million of other loans held at carrying value for which the closing of the purchase transaction had not occurred as of September 30, 2018.

Schedule of Activity in Allowance for Loan Losses, Residential Whole Loans

The following table presents the activity in the Company’s allowance for loan losses on its purchased credit impaired loans held at carrying value for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,					Nine Months Ended   September 30,
(In Thousands)	2018		2017			2018		2017
Balance at the beginning of period	$	297	$	375		$	330	$	990
Provisions/(reversal of provisions) for loan losses	164		(57		)	131		(672		)
Balance at the end of period	$	461	$	318		$	461	$	318

Certain Loans Acquired in Transfer Not Accounted for as Debt Securities Acquired During Period

The following table presents information regarding the estimates of the contractually required payments, the cash flows expected to be collected, and the estimated fair value of the purchased credit impaired loans held at carrying value acquired by the Company for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended  September 30, (1)						Nine Months Ended  September 30, (1)
(In Thousands)	2018			2017			2018			2017
Contractually required principal and interest	$	154,911		$	185,234		$	154,911		$	185,234
Contractual cash flows not expected to be collected (non-accretable yield)	(15,378		)	(33,448		)	(15,378		)	(33,448		)
Expected cash flows to be collected	139,533			151,786			139,533			151,786
Interest component of expected cash flows (accretable yield)	(41,947		)	(53,916		)	(41,947		)	(53,916		)
Fair value at the date of acquisition	$	97,586		$	97,870		$	97,586		$	97,870

(1) Included in the activity presented for the three and nine months ended September 30, 2018 and 2017 are approximately $54.9 million and $97.9 million of purchase credit impaired loans held at carrying value the Company committed to purchase during the three months endedJune 30, 2018 and 2017, but for which the closing of the purchase transaction occurred during the three months endedSeptember 30, 2018 and 2017, respectively.

Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Accretable Yield Movement

The following table presents accretable yield activity for the Company’s purchased credit impaired loans held at carrying value for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended September 30, (1)						Nine Months Ended September 30, (1)
(In Thousands)	2018			2017			2018			2017
Balance at beginning of period	$	401,075		$	318,125		$	421,872		$	334,379
Additions	41,947			53,916			41,947			53,916
Accretion	(11,198		)	(9,026		)	(33,139		)	(26,219		)
Liquidations and other	(8,378		)	—			(23,388		)	—
Reclassifications (to)/from non-accretable difference, net	9,694			303			25,848			1,242
Balance at end of period	$	433,140		$	363,318		$	433,140		$	363,318

(1) Included in the activity presented for the three and nine months ended September 30, 2018 and 2017 are approximately $54.9 million and $97.9 million of purchase credit impaired loans held at carrying value the Company committed to purchase during the three months endedJune 30, 2018 and 2017, but for which the closing of the purchase transaction occurred during the three months endedSeptember 30, 2018 and 2017, respectively.

Residential Whole Loans, Fair Value

The following table presents information regarding the Company’s residential whole loans held at fair value at September 30, 2018 and December 31, 2017:

(Dollars in Thousands)	September 30, 2018 (1)			December 31, 2017
Less than 60 Days Past Due:
Outstanding principal balance	$	585,024		$	488,600
Aggregate fair value	$	544,890		$	446,616
Weighted Average LTV Ratio (2)	76.17		%	74.98		%
Number of loans	2,775			2,323
60 Days to 89 Days Past Due:
Outstanding principal balance	$	70,018		$	45,955
Aggregate fair value	$	62,043		$	37,927
Weighted Average LTV Ratio (2)	77.62		%	89.25		%
Number of loans	319			207
90 Days or More Past Due:
Outstanding principal balance	$	972,488		$	1,027,818
Aggregate fair value	$	840,634		$	840,572
Weighted Average LTV Ratio (2)	89.48		%	94.50		%
Number of loans	3,416			3,984
Total Residential whole loans, at fair value	$	1,447,567		$	1,325,115

(1) Excluded from the table above are approximately $1.8 million of residential whole loans held at fair value for which the closing of the purchase transaction had not occurred as of September 30, 2018.

(2) LTV represents the ratio of the total unpaid principal balance of the loan, to the estimated value of the collateral securing the related loan. Excluded from the calculation of weighted average LTV are certain low value loans secured by vacant lots, for which the LTV ratio is not meaningful.

Residential Whole Loans, Fair Value, Component of Net gain on residential whole loans

The following table presents the components of Net gain on residential whole loans held at fair value for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,				Nine Months Ended   September 30,
(In Thousands)	2018		2017		2018		2017
Coupon payments and other income received (1)	$	17,634	$	9,824	$	52,034	$	27,971
Net unrealized gains	8,442		5,289		26,788		12,499
Net gain on payoff/liquidation of loans	3,251		1,456		10,203		3,076
Net gain on transfers to REO	5,615		2,110		16,858		5,114
Total	$	34,942	$	18,679	$	105,883	$	48,660

(1) Primarily includes coupon interest payments received upon the liquidation of previously delinquent mortgage loans, recurring coupon interest payments received on mortgage loans that are contractually current, and cash payments received from private mortgage insurance on liquidated loans.

XML

Other Assets (Tables)

9 Months Ended

Sep. 30, 2018

Other Assets [Abstract]

Schedule of other assets

The following table presents the components of the Company’s Other assets at September 30, 2018 and December 31, 2017:

(In Thousands)	September 30, 2018		December 31, 2017
Securities obtained and pledged as collateral, at fair value	$	—	$	504,062
REO	223,105		152,356
MBS and loan related receivables	101,578		54,640
Swaps, at fair value	22,311		679
Goodwill	7,189		7,189
Other	51,886		23,983
Total Other Assets	$	406,069	$	742,909

Schedule of activity for real estate owned

The following table presents the activity in the Company’s REO for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,						Nine Months Ended September 30,
(In Thousands)	2018			2017			2018			2017
Balance at beginning of period	$	192,162		$	104,443		$	152,356		$	80,503
Adjustments to record at lower of cost or fair value	(4,056		)	(3,129		)	(11,592		)	(7,306		)
Transfer from residential whole loans (1)	58,051			38,944			161,572			97,388
Purchases and capital improvements	4,897			15,342			10,179			17,224
Disposals	(27,949		)	(17,621		)	(89,410		)	(49,830		)
Balance at end of period	$	223,105		$	137,979		$	223,105		$	137,979

(1)  Includes net gain recorded on transfer of approximately $5.8 million and $2.8 million, for the three months ended September 30, 2018 and 2017, respectively; and approximately $17.0 million and $5.3 million for the nine months ended September 30, 2018 and 2017, respectively.

Schedule of derivative instruments and balance sheet location

The following table presents the fair value of the Company’s derivative instruments and their balance sheet location at September 30, 2018 and December 31, 2017:

			September 30, 2018				December 31, 2017
Derivative Instrument (1)	Designation	Balance Sheet Location	Notional Amount		Fair Value		Notional Amount		Fair Value
(In Thousands)
Swaps	Hedging	Other assets	$	2,122,000	$	18,650	$	750,000	$	679
Swaps	Hedging	Other liabilities	$	—	$	—	$	1,800,000	$	—
Swaps	Non-Hedging	Other assets	$	515,000	$	3,661	$	—	$	—

(1) Represents Swaps executed bilaterally with a counterparty in the over-the-counter market but then novated to a central clearing house, whereby the central clearing house becomes the counterparty to both of the original counterparties.

Schedule of assets pledged as collateral against derivative contracts

The following table presents the assets pledged as collateral against the Company’s Swap contracts at September 30, 2018 and December 31, 2017:

(In Thousands)	September 30, 2018		December 31, 2017
Agency MBS, at fair value	$	2,877	$	21,756
Restricted cash	—		6,405
Total assets pledged against Swaps	$	2,877	$	28,161

Schedule of information about swaps

The following table presents information about the Company’s Swaps at September 30, 2018 and December 31, 2017:

	September 30, 2018						December 31, 2017
	Notional Amount		Weighted Average Fixed-Pay Interest Rate		Weighted Average Variable Interest Rate (2)		Notional Amount		Weighted Average Fixed-Pay Interest Rate		Weighted Average Variable Interest Rate (2)
Maturity (1)
(Dollars in Thousands)
Within 30 days	$	—	—	%	—	%	$	—	—	%	—	%
Over 30 days to 3 months	—		—		—		—		—		—
Over 3 months to 6 months	100,000		1.71		2.21		50,000		1.45		1.56
Over 6 months to 12 months	100,000		1.71		2.21		500,000		1.50		1.46
Over 12 months to 24 months	1,630,000		2.27		2.20		200,000		1.71		1.54
Over 24 months to 36 months	322,000		2.34		2.17		1,500,000		2.22		1.51
Over 36 months to 48 months	—		—		—		200,000		2.20		1.53
Over 48 months to 60 months	355,000		2.85		2.28		—		—		—
Over 60 months to 72 months	—		—		—		100,000		2.75		1.50
Over 72 months to 84 months	—		—		—		—		—		—
Over 84 months	130,000		2.94		2.32		—		—		—
Total Swaps	$	2,637,000	2.35	%	2.21	%	$	2,550,000	2.04	%	1.50	%

(1)  Each maturity category reflects contractual amortization and/or maturity of notional amounts.

(2)  Reflects the benchmark variable rate due from the counterparty at the date presented, which rate adjusts monthly or quarterly based on one-month or three-month LIBOR, respectively.

Schedule of interest expense and the weighted average interest rate paid and received on swaps

The following table presents the net impact of the Company’s derivative hedging instruments on its interest expense and the weighted average interest rate paid and received for such Swaps for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,						Nine Months Ended   September 30,
(Dollars in Thousands)	2018			2017			2018			2017
Interest expense attributable to Swaps	$	547		$	5,310		$	4,187		$	19,606
Weighted average Swap rate paid	2.19		%	2.04		%	2.09		%	1.96		%
Weighted average Swap rate received	2.09		%	1.23		%	1.86		%	1.00		%

Schedule of impact of hedging instruments on AOCI

The following table presents the impact of the Company’s derivative hedging instruments on its AOCI for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,					Nine Months Ended   September 30,
(In Thousands)	2018		2017			2018			2017
AOCI from derivative hedging instruments:
Balance at beginning of period	$	16,160	$	(35,841	)	$	(11,424	)	$	(46,721	)
Net gain on Swaps	5,390		5,791			32,974			16,671
Balance at end of period	$	21,550	$	(30,050	)	$	21,550		$	(30,050	)

XML

Repurchase Agreements (Tables)

9 Months Ended

Sep. 30, 2018

Disclosure of Repurchase Agreements [Abstract]

Schedule of Company's borrowings under repurchase agreements and associated assets pledged as collateral

The following table presents information with respect to the Company’s borrowings under repurchase agreements and associated assets pledged as collateral at September 30, 2018 and December 31, 2017:

(Dollars in Thousands)	September 30, 2018			December 31, 2017
Repurchase agreement borrowings secured by Agency MBS	$	2,584,097		$	2,501,340
Fair value of Agency MBS pledged as collateral under repurchase agreements	$	2,792,396		$	2,705,754
Weighted average haircut on Agency MBS (1)	4.48		%	4.65		%
Repurchase agreement borrowings secured by Legacy Non-Agency MBS	$	1,592,067		$	1,256,033
Fair value of Legacy Non-Agency MBS pledged as collateral under repurchase agreements	$	2,075,540		$	1,652,983
Weighted average haircut on Legacy Non-Agency MBS (1)	21.70		%	21.87		%
Repurchase agreement borrowings secured by RPL/NPL MBS	$	913,249		$	567,140
Fair value of RPL/NPL MBS pledged as collateral under repurchase agreements	$	1,161,568		$	726,540
Weighted average haircut on RPL/NPL MBS (1)	21.22		%	22.05		%
Repurchase agreements secured by U.S. Treasuries	$	—		$	470,334
Fair value of U.S. Treasuries pledged as collateral under repurchase agreements	$	—		$	472,095
Weighted average haircut on U.S. Treasuries (1)	—		%	1.47		%
Repurchase agreements secured by CRT securities	$	405,168		$	459,058
Fair value of CRT securities pledged as collateral under repurchase agreements	$	504,931		$	595,900
Weighted average haircut on CRT securities (1)	19.73		%	22.16		%
Repurchase agreements secured by MSR related assets	$	435,762		$	317,255
Fair value of MSR related assets pledged as collateral under repurchase agreements	$	565,272		$	482,158
Weighted average haircut on MSR related assets (1)	22.56		%	33.19		%
Repurchase agreements secured by residential whole loans (2)	$	1,347,946		$	1,043,747
Fair value of residential whole loans pledged as collateral under repurchase agreements (3)	$	1,888,445		$	1,474,704
Weighted average haircut on residential whole loans (1)	21.93		%	26.10		%

(1) Haircut represents the percentage amount by which the collateral value is contractually required to exceed the loan amount.

(2) Excludes $19,000 and $206,000 of unamortized debt issuance costs at September 30, 2018 and December 31, 2017, respectively.

(3) At September 30, 2018 includes Non-Agency MBS with an aggregate fair value of $27.0 million obtained in connection with the Company’s loan securitization transactions that are eliminated in consolidation.

Schedule of repricing information about borrowings under repurchase agreements

The following table presents repricing information about the Company’s borrowings under repurchase agreements, which does not reflect the impact of associated derivative hedging instruments, at September 30, 2018 and December 31, 2017:

	September 30, 2018				December 31, 2017
	Balance		Weighted Average Interest Rate		Balance		Weighted Average Interest Rate
Time Until Interest Rate Reset
(Dollars in Thousands)
Within 30 days	$	6,985,487	3.01	%	$	6,161,008	2.39	%
Over 30 days to 3 months	29,501		2.48		453,899		2.76
Over 3 months to 12 months	263,301		3.09		—		—
Total repurchase agreements	7,278,289		3.01	%	6,614,907		2.42	%
Less debt issuance costs	19				206
Total repurchase agreements less debt   issuance costs	$	7,278,270			$	6,614,701

Schedule of contractual maturity information about repurchase agreements

The following table presents contractual maturity information about the Company’s borrowings under repurchase agreements, all of which are accounted for as secured borrowings, at September 30, 2018, and does not reflect the impact of derivative contracts that hedge such repurchase agreements:

	September 30, 2018
Contractual Maturity	Overnight			Within 30 Days			Over 30 Days to 3 Months			Over 3 Months to 12 Months			Over 12 months			Total
(Dollars in Thousands)
Agency MBS	$	—		$	2,570,990		$	13,107		$	—		$	—		$	2,584,097
Legacy Non-Agency MBS	—			1,544,995			47,072			—			—			1,592,067
RPL/NPL MBS	—			887,087			26,162			—			—			913,249
CRT securities	—			399,064			6,104			—			—			405,168
MSR related assets	—			342,704			93,058			—			—			435,762
Residential whole loans	—			267,129			376,936			703,881			—			1,347,946
Total (1)	$	—		$	6,011,969		$	562,439		$	703,881		$	—		$	7,278,289
Weighted Average Interest Rate	—		%	2.85		%	3.73		%	3.80		%	—		%	3.01		%
Gross amount of recognized liabilities for repurchase agreements in Note 8																$	7,278,289
Amounts related to repurchase agreements not included in offsetting disclosure in Note 8																$	—

(1) Excludes $19,000 of unamortized debt issuance costs at September 30, 2018.

Schedule of information about counterparty for repurchase agreements for which the entity had greater than 5% of stockholders' equity at risk

The following table presents information with respect to each counterparty under repurchase agreements for which the Company had greater than 5% of stockholders’ equity at risk in the aggregate at September 30, 2018:

	September 30, 2018
	Counterparty Rating (1)	Amount  at Risk (2)		Weighted  Average Months  to Maturity for Repurchase Agreements	Percent of Stockholders’ Equity
Counterparty
(Dollars in Thousands)
Barclay's Bank	BBB/Aa3/A	$	346,185	4	9.8	%
Goldman Sachs (3)	BBB+/A3/A	305,862		1	8.6
Wells Fargo (4)	A+/Aa2/AA-	252,651		5	7.1
RBC (5)	AA-/Aa2/AA	243,731		1	6.9

(1) As rated at September 30, 2018 by S&P, Moody’s and Fitch, Inc., respectively.  The counterparty rating presented is the lowest published for these entities.

(2) The amount at risk reflects the difference between (a) the amount loaned to the Company through repurchase agreements, including interest payable, and (b) the cash and the fair value of the securities pledged by the Company as collateral, including accrued interest receivable on such securities.

(3) Includes $171.3 million at risk with Goldman Sachs Bank USA and $134.6 million at risk with Goldman Sachs Lending Partners.

(4) Includes $241.0 million at risk with Wells Fargo Bank, NA and $11.7 million at risk with Wells Fargo Securities LLC.

(5) Includes $237.6 million at risk with RBC Barbados and $6.1 million at risk with RBC New York. Counterparty ratings are not published for RBC Barbados and RBS Capital Market LLC.

XML

Collateral Positions (Tables)

9 Months Ended

Sep. 30, 2018

Collateral Positions

Schedule of fair value of collateral pledged and collateral held

The following table summarizes the fair value of the Company’s collateral positions, which includes collateral pledged and collateral held, with respect to its borrowings under repurchase agreements, reverse repurchase agreements and derivative hedging instruments at September 30, 2018 and December 31, 2017: 

	September 30, 2018				December 31, 2017
(In Thousands)	Assets Pledged		Collateral Held		Assets Pledged		Collateral Held
Derivative Hedging Instruments:
Agency MBS	$	2,877	$	—	$	21,756	$	—
Cash (1)	—		—		6,405		—
	2,877		—		28,161		—
Repurchase Agreement Borrowings:
Agency MBS	2,792,396		—		2,705,754		—
Legacy Non-Agency MBS (2)	2,075,540		—		1,652,983		—
RPL/NPL MBS	1,161,568		—		726,540		—
U.S. Treasury securities	—		—		472,095		—
CRT securities	504,931		—		595,900		—
MSR related assets	565,272		—		482,158		—
Residential whole loans (3)	1,888,445		—		1,474,704		—
Cash (1)	6,489		—		6,902		—
	8,994,641		—		8,117,036		—
Reverse Repurchase Agreements:
U.S. Treasury securities	—		—		—		504,062
	—		—		—		504,062
Total	$	8,997,518	$	—	$	8,145,197	$	504,062

(1)  Cash pledged as collateral is reported as Restricted cash on the Company’s consolidated balance sheets.

(2)  In addition, at December 31, 2017$688.1 million of Legacy Non-Agency MBS were pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty.

(3) At September 30, 2018 includes Non-Agency MBS with an aggregate fair value of $27.0 million obtained in connection with the Company’s loan securitization transactions that are eliminated in consolidation.

Schedule of additional information about assets Pledged as collateral pursuant to borrowings under repurchase agreements and Derivative Hedging Contracts

The following table presents detailed information about the Company’s assets pledged as collateral pursuant to its borrowings under repurchase agreements and derivative hedging instruments at September 30, 2018:

	September 30, 2018
	Assets Pledged Under Repurchase  Agreements						Assets Pledged Against Derivative Hedging Instruments						Total Fair Value of Assets Pledged and Accrued Interest
(In Thousands)	Fair Value		Amortized Cost		Accrued  Interest on Pledged  Assets		Fair Value/  Carrying  Value		Amortized Cost		Accrued Interest on  Pledged  Assets
Agency MBS	$	2,792,396	$	2,842,022	$	8,527	$	2,877	$	3,036	$	7	$	2,803,807
Legacy Non-Agency MBS	2,075,540		1,548,906		8,531		—		—		—		2,084,071
RPL/NPL MBS	1,161,568		1,162,829		984		—		—		—		1,162,552
CRT securities	504,931		472,217		436		—		—		—		505,367
MSR related assets	565,272		564,350		644		—		—		—		565,916
Residential whole loans (1)(2)	1,888,445		1,861,387		8,485		—		—		—		1,896,930
Cash (3)	6,489		6,489		—		—		—		—		6,489
Total	$	8,994,641	$	8,458,200	$	27,607	$	2,877	$	3,036	$	7	$	9,025,132

(1) Includes residential whole loans held at carrying value with an aggregate fair value of $1.2 billion and aggregate amortized cost of $1.1 billion and residential whole loans held at fair value with an aggregate fair value and amortized cost of $685.1 million.

(2) Includes Non-Agency MBS with an aggregate fair value and amortized cost of $27.0 million obtained in connection with the Company’s loan securitization transactions that are eliminated in consolidation.

(3) Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets.

XML

Offsetting Assets and Liabilities (Tables)

9 Months Ended

Sep. 30, 2018

Offsetting [Abstract]

Schedule of information about certain assets that are subject to master netting arrangements (or similar agreements)

The following tables present information about certain assets and liabilities that are subject to master netting arrangements (or similar agreements) and may potentially be offset on the Company’s consolidated balance sheets at September 30, 2018 and December 31, 2017:

Offsetting of Financial Assets and Derivative Assets

	Gross Amounts of Recognized Assets		Gross Amounts Offset in the Consolidated Balance Sheets		Net Amounts of Assets Presented in the Consolidated Balance Sheets		Gross Amounts Not Offset in  the Consolidated Balance Sheets					Net Amount
(In Thousands)							Financial Instruments			Cash  Collateral  Received
September 30, 2018
Swaps, at fair value	$	22,311	$	—	$	22,311	$	(22,311	)	$	—	$	—
Total	$	22,311	$	—	$	22,311	$	(22,311	)	$	—	$	—
December 31, 2017
Swaps, at fair value	$	679	$	—	$	679	$	(679	)	$	—	$	—
Total	$	679	$	—	$	679	$	(679	)	$	—	$	—

Schedule of information about certain liabilities that are subject to master netting arrangements (or similar agreements)

Offsetting of Financial Liabilities and Derivative Liabilities

	Gross Amounts of Recognized Liabilities		Gross Amounts Offset in the Consolidated Balance Sheets		Net Amounts of Liabilities Presented in the Consolidated Balance Sheets		Gross Amounts Not Offset in the  Consolidated Balance Sheets						Net Amount
(In Thousands)							Financial  Instruments (1)			Cash  Collateral  Pledged (1)
September 30, 2018
Swaps, at fair value (2)	$	—	$	—	$	—	$	—		$	—		$	—
Repurchase agreements (3)(4)	7,278,289		—		7,278,289		(7,271,800		)	(6,489		)	—
Total	$	7,278,289	$	—	$	7,278,289	$	(7,271,800	)	$	(6,489	)	$	—
December 31, 2017
Swaps, at fair value (2)	$	—	$	—	$	—	$	—		$	—		$	—
Repurchase agreements (3)(4)	6,614,907		—		6,614,907		(6,608,005		)	(6,902		)	—
Total	$	6,614,907	$	—	$	6,614,907	$	(6,608,005	)	$	(6,902	)	$	—

(1) Amounts disclosed in the Financial Instruments column of the above table represent collateral pledged that is available to be offset against liability balances associated with repurchase agreements.  Amounts disclosed in the Cash Collateral Pledged column of the above table represent amounts pledged as collateral against repurchase agreements.

(2) The fair value of securities pledged against the Company’s Swaps was $2.9 million and $21.8 million at September 30, 2018 and December 31, 2017, respectively. Beginning in January 2017, variation margin payments on the Company’s cleared Swaps are treated as a legal settlement of the exposure under the Swap contract. Previously such payments were treated as collateral pledged against the exposure under the Swap contract. The effect of this change is to reduce what would have otherwise been reported as fair value of the Swap.

(3) The fair value of financial instruments pledged against the Company’s repurchase agreements was $9.0 billion and $8.1 billion at September 30, 2018 and December 31, 2017, respectively.

(4) Excludes $19,000 and $206,000 of unamortized debt issuance costs at September 30, 2018 and December 31, 2017, respectively.

XML

Other Liabilities (Tables)

9 Months Ended

Sep. 30, 2018

Other Liabilities [Abstract]

Other Liabilities

The following table presents the components of the Company’s Other liabilities at September 30, 2018 and December 31, 2017:

(In Thousands)	September 30, 2018		December 31, 2017
Securitized debt (1)	$	714,203	$	363,944
Obligation to return securities held as collateral, at fair value	—		504,062
Senior Notes	96,805		96,773
Dividends and dividend equivalents payable	90,136		79,771
Accrued interest payable	11,630		12,263
Payable for unsettled MBS and residential whole loans purchases	10,888		—
Accrued expenses and other	27,821		21,584
Total Other Liabilities	$	951,483	$	1,078,397

(1) Securitized debt represents third-party liabilities of consolidated VIEs and excludes liabilities of the VIEs acquired by the Company that are eliminated in consolidation. The third-party beneficial interest holders in the VIEs have no recourse to the general credit of the Company. (See Notes 10 and 15 for further discussion.)

XML

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2018

Stockholders' Equity Note [Abstract]

Schedule of preferred stock dividend declaration and payment

The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2018 through September 30, 2018:

Declaration Date	Record Date	Payment Date	Dividend Per Share
August 20, 2018	September 7, 2018	September 28, 2018	$	0.46875
May 17, 2018	June 4, 2018	June 29, 2018	0.46875
February 20, 2018	March 2, 2018	March 30, 2018	0.46875

Schedule of cash dividends declared on common stock

The following table presents cash dividends declared by the Company on its common stock from January 1, 2018 through September 30, 2018:

Declaration Date (1)	Record Date	Payment Date	Dividend Per Share
September 13, 2018	October 1, 2018	October 31, 2018	$	0.20	(1)
June 7, 2018	June 29, 2018	July 31, 2018	0.20
March 7, 2018	March 29, 2018	April 30, 2018	0.20

(1)  At September 30, 2018, the Company had accrued dividends and dividend equivalents payable of $90.1 million related to the common stock dividend declared on September 13, 2018

Schedule of sale of stock

The table below presents information with respect to shares of the Company’s common stock issued through public offerings during the nine months ended September 30, 2018 and the year ended December 31, 2017.

Share Issue Date	Shares Issued		Gross Proceeds Per Share		Gross Proceeds
(In Thousands, Except Per Share Amounts)
August 7, 2018	50,875	(1)	$	7.78	$	395,807	(1)
May 10, 2017	23,000		7.85		180,550		(2)

(1) Includes approximately 875,000 shares issued on September 5, 2018 pursuant to the exercise of the underwriters’ option to purchase additional shares. The Company incurred approximately $6.5 million of underwriting discounts and related expenses in connection with this equity offering.

(2) The Company incurred approximately $2.3 million of underwriting discounts and related expenses in connection with this equity offering.

Schedule of changes in balances of each component of the entity's AOCI

The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2018:

	Three Months Ended   September 30, 2018								Nine Months Ended   September 30, 2018
(In Thousands)	Net Unrealized Gain/(Loss) on AFS Securities			Net  (Loss)/Gain on Swaps		Total AOCI			Net Unrealized Gain/(Loss) on AFS Securities			Net  (Loss)/Gain on Swaps			Total AOCI
Balance at beginning of period	$	548,551		$	16,160	$	564,711		$	620,648		$	(11,424	)	$	609,224
OCI before reclassifications	(34,278		)	5,390		(28,888		)	(90,250		)	32,974			(57,276		)
Amounts reclassified from AOCI (1)	(9,455		)	—		(9,455		)	(25,580		)	—			(25,580		)
Net OCI during the period (2)	(43,733		)	5,390		(38,343		)	(115,830		)	32,974			(82,856		)
Balance at end of period	$	504,818		$	21,550	$	526,368		$	504,818		$	21,550		$	526,368

(1)  See separate table below for details about these reclassifications.

(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).

The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2017:

	Three Months Ended   September 30, 2017									Nine Months Ended   September 30, 2017
(In Thousands)	Net Unrealized Gain/(Loss) on AFS Securities			Net  (Loss)/Gain on Swaps			Total AOCI			Net Unrealized Gain/(Loss) on AFS Securities			Net  (Loss)/Gain on Swaps			Total AOCI
Balance at beginning of period	$	668,223		$	(35,841	)	$	632,382		$	620,403		$	(46,721	)	$	573,682
OCI before reclassifications	6,988			5,791			12,779			71,188			16,671			87,859
Amounts reclassified from AOCI (1)	(14,935		)	—			(14,935		)	(31,315		)	—			(31,315		)
Net OCI during the period (2)	(7,947		)	5,791			(2,156		)	39,873			16,671			56,544
Balance at end of period	$	660,276		$	(30,050	)	$	630,226		$	660,276		$	(30,050	)	$	630,226

(1)  See separate table below for details about these reclassifications.

(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).

Information about the significant amounts reclassified out of the entity's AOCI

The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and nine months ended September 30, 2018:

	Three Months Ended   September 30, 2018			Nine Months Ended   September 30, 2018
Details about AOCI Components	Amounts Reclassified from AOCI						Affected Line Item in the Statement Where Net Income is Presented
(In Thousands)
AFS Securities:
Realized gain on sale of securities	$	(9,455	)	$	(25,580	)	Net gain on sales of investment securities
Total AFS Securities	$	(9,455	)	$	(25,580	)
Total reclassifications for period	$	(9,455	)	$	(25,580	)

The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and nine months ended September 30, 2017:

	Three Months Ended   September 30, 2017			Nine Months Ended   September 30, 2017
Details about AOCI Components	Amounts Reclassified from AOCI						Affected Line Item in the Statement Where Net Income is Presented
(In Thousands)
AFS Securities:
Realized gain on sale of securities	$	(14,935	)	$	(30,283	)	Net gain on sales of investment securities
OTTI recognized in earnings	—			(1,032		)	Net impairment losses recognized in earnings
Total AFS Securities	$	(14,935	)	$	(31,315	)
Total reclassifications for period	$	(14,935	)	$	(31,315	)

XML

EPS Calculation (Tables)

9 Months Ended

Sep. 30, 2018

Earnings Per Share [Abstract]

Schedule of reconciliation of the earnings and shares used in calculating basic and diluted EPS

The following table presents a reconciliation of the earnings and shares used in calculating basic and diluted EPS for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,						Nine Months Ended   September 30,
(In Thousands, Except Per Share Amounts)	2018			2017			2018			2017
Numerator:
Net income	$	87,132		$	63,805		$	240,922		$	221,799
Dividends declared on preferred stock	(3,750		)	(3,750		)	(11,250		)	(11,250		)
Dividends, dividend equivalents and undistributed earnings allocated to participating securities	(472		)	(409		)	(1,393		)	(1,299		)
Net income to common stockholders - basic and diluted	$	82,910		$	59,646		$	228,279		$	209,250
Denominator:
Weighted average common shares for basic and diluted earnings per share (1)	428,713			396,698			408,614			385,282
Basic and diluted earnings per share	$	0.19		$	0.15		$	0.56		$	0.54

(1) At September 30, 2018, the Company had approximately 2.2 million equity instruments outstanding that were not included in the calculation of diluted EPS for the three and nine months ended September 30, 2018, as their inclusion would have been anti-dilutive.  These equity instruments reflect RSUs (based on current estimate of expected share settlement amount) with a weighted average grant date fair value of $6.72. These equity instruments may have a dilutive impact on future EPS.

XML

Equity Compensation, Employment Agreements and Other Benefit Plans (Tables)

9 Months Ended

Sep. 30, 2018

Compensation Related Costs [Abstract]

Schedule of expenses related to equity-based compensation

The following table presents the Company’s expenses related to its equity-based compensation instruments for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,				Nine Months Ended   September 30,
(In Thousands)	2018		2017		2018		2017
RSUs	$	1,082	$	1,836	$	3,891	$	5,194
Restricted shares of common stock	—		74		—		175
Total	$	1,082	$	1,910	$	3,891	$	5,369

Schedule of expenses related to deferred compensation plans

The following table presents the Company’s expenses related to its Deferred Plans for the three and nine months ended September 30, 2018 and 2017:

	Three Months Ended   September 30,					Nine Months Ended   September 30,
(In Thousands)	2018			2017		2018		2017
Non-employee directors	$	(22	)	$	125	$	—	$	339
Total	$	(22	)	$	125	$	—	$	339

Schedule of aggregate income deferred by participants and associated liability under deferred compensation plans

The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through September 30, 2018 and December 31, 2017 that had not been distributed and the Company’s associated liability for such deferrals at September 30, 2018 and December 31, 2017:

	September 30, 2018				December 31, 2017
(In Thousands)	Undistributed Income Deferred (1)		Liability Under Deferred Plans		Undistributed Income Deferred (1)		Liability Under Deferred Plans
Non-employee directors	$	2,100	$	2,420	$	1,688	$	2,056
Total	$	2,100	$	2,420	$	1,688	$	2,056

(1)  Represents the cumulative amounts that were deferred by participants through September 30, 2018 and December 31, 2017, which had not been distributed through such respective date.

XML

Fair Value of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2018

Fair Value Disclosures [Abstract]

Schedule of fair value measurement inputs and valuation techniques

The following tables present a summary of quantitative information about the significant unobservable inputs used in the fair value measurement of the Company’s residential whole loans held at fair value for which it has utilized Level 3 inputs to determine fair value as of September 30, 2018 and December 31, 2017:

	September 30, 2018
(Dollars in Thousands)	Fair Value (1)		Valuation Technique	Unobservable Input	Weighted Average (2)			Range
Residential whole loans, at fair value	$	693,874	Discounted cash flow	Discount rate	5.3		%	4.5-8.0%
				Prepayment rate	3.8		%	0.0-13.5%
				Default rate	2.7		%	0.0-31.0%
				Loss severity	13.0		%	0.0-100.0%
	$	683,566	Liquidation model	Discount rate	8.2		%	6.1-50.0%
				Annual change in home prices	3.3		%	(1.0)-11.8%
				Liquidation timeline (in years)	1.8			0.1-4.5
				Current value of underlying properties (3)	$	767		$2-$7,950
Total	$	1,377,440

	December 31, 2017
(Dollars in Thousands)	Fair Value (1)		Valuation Technique	Unobservable Input	Weighted Average (2)			Range
Residential whole loans, at fair value	$	358,871	Discounted cash flow	Discount rate	5.5		%	4.5-13.0%
				Prepayment rate	4.1		%	1.15-15.1%
				Default rate	2.9		%	0.0-6.5%
				Loss severity	13.8		%	0.0-100.0%
	$	592,940	Liquidation model	Discount rate	8.0		%	6.1-50.0%
				Annual change in home prices	2.5		%	(8.0)-8.8%
				Liquidation timeline (in years)	1.6			0.1-4.5
				Current value of underlying properties (3)	$	772		$0-$9,900
Total	$	951,811

(1) Excludes approximately $70.1 million and $373.3 million of loans for which management considers the purchase price continues to reflect the fair value of such loans at September 30, 2018 and December 31, 2017, respectively.

(2) Amounts are weighted based on the fair value of the underlying loan.

(3) The simple average value of the properties underlying residential whole loans held at fair value valued via a liquidation model was approximately$378,000 and $336,000 as of September 30, 2018 and December 31, 2017, respectively.

The following tables present the Company’s financial instruments carried at fair value on a recurring basis as of September 30, 2018 and December 31, 2017, on the consolidated balance sheets by the valuation hierarchy, as previously described:

Fair Value at September 30, 2018

(In Thousands)	Level 1		Level 2		Level 3		Total
Assets:
Agency MBS	$	—	$	2,905,490	$	—	$	2,905,490
Non-Agency MBS	—		3,334,610		—		3,334,610
CRT securities	—		538,945		—		538,945
Term notes backed by MSR related collateral	—		—		505,195		505,195
Residential whole loans, at fair value	—		—		1,449,365		1,449,365
Securities obtained and pledged as collateral	—		—		—		—
Swaps	—		22,311		—		22,311
Total assets carried at fair value	$	—	$	6,801,356	$	1,954,560	$	8,755,916
Liabilities:
Obligation to return securities obtained as collateral	$	—	$	—	$	—	$	—
Total liabilities carried at fair value	$	—	$	—	$	—	$	—

Fair Value at December 31, 2017

(In Thousands)	Level 1		Level 2		Level 3		Total
Assets:
Agency MBS	$	—	$	2,824,681	$	—	$	2,824,681
Non-Agency MBS	—		3,533,966		—		3,533,966
CRT securities	—		664,403		—		664,403
Term notes backed by MSR related collateral	—		—		381,804		381,804
Residential whole loans, at fair value	—		—		1,325,115		1,325,115
Securities obtained and pledged as collateral	504,062		—		—		504,062
Swaps	—		679		—		679
Total assets carried at fair value	$	504,062	$	7,023,729	$	1,706,919	$	9,234,710
Liabilities:
Obligation to return securities obtained as collateral	$	504,062	$	—	$	—	$	504,062
Total liabilities carried at fair value	$	504,062	$	—	$	—	$	504,062

Schedule of significant unobservable inputs used in fair value measurement of residential whole loans

The following table presents additional information for the three and nine months ended September 30, 2018 and 2017 about the Company’s Residential whole loans, at fair value, which are classified as Level 3 and measured at fair value on a recurring basis:

	Residential Whole Loans, at Fair Value (1)
	Three Months Ended September 30,						Nine Months Ended September 30,
(In Thousands)	2018			2017			2018			2017
Balance at beginning of period	$	1,468,540		$	744,072		$	1,325,115		$	814,682
Purchases and capitalized advances (2)	76,566			284,930			393,867			295,094
Changes in fair value recorded in Net gain on residential whole loans held at fair value	8,442			5,289			26,788			12,499
Collection of principal, net of liquidation gains/losses	(54,331		)	(17,670		)	(155,199		)	(53,366		)
Repurchases	(561		)	(257		)	(1,623		)	(1,013		)
Transfer to REO	(51,089		)	(33,214		)	(141,381		)	(84,746		)
Balance at end of period	$	1,447,567		$	983,150		$	1,447,567		$	983,150

(1) Excludes approximately $1.8 million and $120.4 million of residential whole loans held at fair value for which the closing of the purchase transaction had not occurred as of September 30, 2018 and 2017, respectively.

(2) Included in the activity presented for the three and nine months ended September 30, 2018 and 2017 are approximately $34.4 million and$92.7 million of loans the Company committed to purchase during the three months ended June 30, 2018 and year ended December 31, 2017, but for which the closing of the purchase transaction occurred during the three and nine months ended September 30, 2018 and 2017, respectively.

The following table presents additional information for the three and nine months ended September 30, 2018 and 2017 about the Company’s investments in term notes backed by MSR related collateral held at fair value, which are classified as Level 3 and measured at fair value on a recurring basis:

	Term Notes Backed by MSR Related Collateral
	Three Months Ended September 30,						Nine Months Ended September 30,
(In Thousands)	2018			2017			2018			2017 (1)
Balance at beginning of period	$	381,390		$	273,961		$	381,804		$	—
Purchases	290,042			161,000			439,392			311,000
Collection of principal	(166,120		)	(123,961		)	(316,120		)	(140,980		)
Changes in unrealized gain/losses	(117		)	563			119			563
Transfers from Level 2 to Level 3 (1)	—			—			—			140,980
Balance at end of period	$	505,195		$	311,563		$	505,195		$	311,563

(1) Investments in term notes backed by MSR related collateral were transferred from Level 2 to Level 3 during the nine months endedSeptember 30, 2017 as there had been very limited secondary market trading in these securities since issuance. Transfers between levels are deemed to take place on the first day of the reporting period in which the transfer has taken place.

Schedule of carrying value and fair value of financial instruments

The following table presents the carrying values and estimated fair values of the Company’s financial instruments at September 30, 2018 and December 31, 2017:

	September 30, 2018				December 31, 2017
	Carrying Value		Estimated Fair Value		Carrying Value		Estimated Fair Value
(In Thousands)
Financial Assets:
Agency MBS	$	2,905,490	$	2,905,490	$	2,824,681	$	2,824,681
Non-Agency MBS	3,334,610		3,334,610		3,533,966		3,533,966
CRT securities	538,945		538,945		664,403		664,403
MSR related assets	565,272		565,272		492,080		493,026
Residential whole loans, at carrying value	2,471,567		2,549,927		908,516		988,688
Residential whole loans, at fair value	1,449,365		1,449,365		1,325,115		1,325,115
Securities obtained and pledged as collateral	—		—		504,062		504,062
Cash and cash equivalents	104,186		104,186		449,757		449,757
Restricted cash	6,489		6,489		13,307		13,307
Swaps	22,311		22,311		679		679
Financial Liabilities (1):
Repurchase agreements	7,278,270		7,289,006		6,614,701		6,623,255
Securitized debt	714,203		713,783		363,944		366,109
Obligation to return securities obtained as collateral	—		—		504,062		504,062
Senior Notes	96,805		100,791		96,773		103,729

(1) Carrying value of securitized debt, Senior Notes and certain repurchase agreements is net of associated debt issuance costs.

XML

Use of Special Purpose Entities and Variable Interest Entities (Tables)

9 Months Ended

Sep. 30, 2018

Use of Special Purpose Entities and Variable Interest Entities

Summary of key details related to securitization transactions

The following table summarizes the key details of the loan securitization transactions the Company has been involved in to date:

(Dollars in Thousands)	September 30, 2018				December 31, 2017
Aggregate unpaid principal balance of residential whole loans sold	$	1,290,029			$	620,924
Face amount of Senior Bonds issued by the VIE and purchased by third-party investors	$	802,817			$	382,847
Outstanding amount of Senior Bonds	$	714,203		(1)	$	363,944		(1)
Weighted average fixed rate for Senior Bonds issued	3.65		%	(2)	3.14		%	(2)
Face amount of Senior Support Certificates received by the Company (3)	$	275,174			$	127,001
Cash received	$	802,815			$	382,845

(1) Net of $4.1 million and $2.3 million of deferred financing costs at September 30, 2018 and December 31, 2017, respectively.

(2) At September 30, 2018 and December 31, 2017, $604.7 million and $233.7 million, respectively, of Senior Bonds sold in securitization transactions contained a contractual coupon step-up feature whereby the coupon increases by 300 basis points at 36 months from issuance if the bond is not redeemed before such date.

(3) Provides credit support to the Senior Bonds sold to third-party investors in the securitization transactions.

XML

Summary of Significant Accounting Policies (Details)	9 Months Ended
	Sep. 30, 2018 USD ($) segment	Mar. 31, 2018 USD ($)	Dec. 31, 2016 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of reportable segments | segment	1
Number of operating segments | segment	1
Corporate Loan
Accounts, Notes, Loans and Financing Receivable [Line Items]
Commitment to lend | $	$ 100,000,000		$ 130,000,000
Amount drawn | $	$ 60,100,000	$ 124,200,000

XML

Summary of Significant Accounting Policies (Residential Whole Loans) (Details)	9 Months Ended
	Sep. 30, 2018
Accounting Policies [Abstract]
Number of days considered to classify loans delinquent	60 days
Weighted Average LTV Ratio	80.00%

XML

Summary of Significant Accounting Policies (Cash and Cash Equivalents) (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Accounting Policies [Abstract]
Cash and cash equivalents	$ 104,186	$ 449,757
Overnight money market funds	71,100	354,000
Restricted cash	$ 6,489	$ 13,307

XML

Summary of Significant Accounting Policies (Goodwill) (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Accounting Policies [Abstract]
Goodwill	$ 7,189	$ 7,189

XML

Summary of Significant Accounting Policies (Depreciation) (Details) - Furniture, fixtures, computers and related hardwares	9 Months Ended
	Sep. 30, 2018
Low end of range
Estimated useful life of long-lived assets
Estimated useful life	5 years
High end of range
Estimated useful life of long-lived assets
Estimated useful life	8 years

XML

Summary of Significant Accounting Policies (Repurchase Agreements) (Details)	9 Months Ended
	Sep. 30, 2018
Accounting Policies [Abstract]
Repurchase financing period, low end of range	1 month
Repurchase financing period, high end of range	6 months

XML

Summary of Significant Accounting Policies (Equity Based Compensation) (Details) - RSUs	51 Months Ended
	Mar. 31, 2018
Share based compensation
Vesting period of restricted share units (RSUs)	3 years
Period for measuring market condition of award	3 years

XML

Summary of Significant Accounting Policies (Income Tax) (Details) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Accounting Policies [Abstract]
Percentage of annual REIT taxable income distributed to stockholders	100.00%
REIT income tax expense	$ 0
Deferred income tax expense (benefit)	$ 0	$ 0

XML

Summary of Significant Accounting Policies (Accounting Standards Adopted in 2018) (Details) $ in Thousands	Jan. 01, 2018 USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect adjustment on adoption of new accounting standard for revenue recognition	$ 295
Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect adjustment on adoption of new accounting standard for revenue recognition	295
Retained Earnings | Accounting Standards Update 2014-09
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect adjustment on adoption of new accounting standard for revenue recognition	$ 295

XML

MBS, CRT Securities and MSR Related Assets (Narrative) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Debt Securities, Available-for-sale [Line Items]
Minimum term of fixed rate mortgages underlying MBS			15 years
Maximum term of fixed rate mortgages underlying MBS			30 years
Available-for-sale, unrealized loss position, accumulated loss	$ 68,246,000		$ 68,246,000
Reclassification adjustment for OTTI included in net income	0	$ 0	0	$ (1,032,000)
Agency MBS
Debt Securities, Available-for-sale [Line Items]
Available-for-sale, unrealized loss position, accumulated loss	66,108,000		66,108,000
Non-Agency MBS
Debt Securities, Available-for-sale [Line Items]
Available-for-sale, unrealized loss position, accumulated loss	$ 2,134,000		$ 2,134,000
Minimum | RPL/NPL MBS
Debt Securities, Available-for-sale [Line Items]
Debt instrument, basis spread on variable rate			3.00%
Debt instrument, coupon step-up period			36 months
Maximum | RPL/NPL MBS
Debt Securities, Available-for-sale [Line Items]
Debt instrument, basis spread on variable rate			4.00%
Debt instrument, coupon step-up period			48 months

XML

MBS, CRT Securities and MSR Related Assets (MBS and CRT Securities) (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face	$ 6,848,615		$ 7,060,004
Purchase Premiums	121,134		113,003
Accretable Purchase Discounts	(191,952)		(218,915)
Discount Designated as Credit Reserve and OTTI	(531,757)		(593,227)
Amortized Cost	6,246,477		6,362,756
Fair Value	6,779,045		7,023,050
Gross Unrealized Gains	600,814		703,907
Gross Unrealized Losses	68,246		43,613
Net Unrealized Gain/(Loss)	532,568		660,294
Principal payments receivable	438		1,900
Agency MBS
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face	2,844,308		2,738,462
Purchase Premiums	111,157		104,066
Accretable Purchase Discounts	(29)		(40)
Discount Designated as Credit Reserve and OTTI	0		0
Amortized Cost	2,955,873		2,844,379
Fair Value	2,905,490		2,824,681
Gross Unrealized Gains	15,725		23,439
Gross Unrealized Losses	66,108		43,137
Net Unrealized Gain/(Loss)	(50,383)		(19,698)
Agency MBS | Fannie Mae
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face	1,851,447		2,170,974
Purchase Premiums	70,882		82,271
Accretable Purchase Discounts	(29)		(40)
Discount Designated as Credit Reserve and OTTI	0		0
Amortized Cost	1,922,300		2,253,205
Fair Value	1,896,739		2,246,600
Gross Unrealized Gains	14,650		21,736
Gross Unrealized Losses	40,211		28,341
Net Unrealized Gain/(Loss)	(25,561)		(6,605)
Agency MBS | Freddie Mac
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face	987,833		561,346
Purchase Premiums	40,183		21,683
Accretable Purchase Discounts	0		0
Discount Designated as Credit Reserve and OTTI	0		0
Amortized Cost	1,028,453		584,920
Fair Value	1,003,583		571,748
Gross Unrealized Gains	1,027		1,624
Gross Unrealized Losses	25,897		14,796
Net Unrealized Gain/(Loss)	(24,870)		(13,172)
Agency MBS | Ginnie Mae
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face	5,028		6,142
Purchase Premiums	92		112
Accretable Purchase Discounts	0		0
Discount Designated as Credit Reserve and OTTI	0		0
Amortized Cost	5,120		6,254
Fair Value	5,168		6,333
Gross Unrealized Gains	48		79
Gross Unrealized Losses	0		0
Net Unrealized Gain/(Loss)	48		79
Non-Agency MBS
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face	3,509,289		3,718,743
Purchase Premiums	41		50
Accretable Purchase Discounts	(191,745)		(215,325)
Discount Designated as Credit Reserve and OTTI	(531,757)		(593,227)
Amortized Cost	2,785,828		2,910,241
Fair Value	3,334,610		3,533,966
Gross Unrealized Gains	550,916		624,178
Gross Unrealized Losses	2,134		453
Net Unrealized Gain/(Loss)	548,782		623,725
Credit reserve	519,600	$ 579,000
OTTI	12,200		14,200
Non-Agency MBS | Expected to Recover Par
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face	1,343,835		1,128,808
Purchase Premiums	41		50
Accretable Purchase Discounts	(23,835)		(22,737)
Discount Designated as Credit Reserve and OTTI	0		0
Amortized Cost	1,320,041		1,106,121
Fair Value	1,343,272		1,132,205
Gross Unrealized Gains	25,146		26,518
Gross Unrealized Losses	1,915		434
Net Unrealized Gain/(Loss)	23,231		26,084
Non-Agency MBS | Expected to Recover Less Than Par
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face	2,165,454		2,589,935
Purchase Premiums	0		0
Accretable Purchase Discounts	(167,910)		(192,588)
Discount Designated as Credit Reserve and OTTI	(531,757)		(593,227)
Amortized Cost	1,465,787		1,804,120
Fair Value	1,991,338		2,401,761
Gross Unrealized Gains	525,770		597,660
Gross Unrealized Losses	219		19
Net Unrealized Gain/(Loss)	$ 525,551		$ 597,641
Percentage of current face amount of Non-Agency MBS to be recovered	85.00%		84.00%
Total MBS
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face	$ 6,353,597		$ 6,457,205
Purchase Premiums	111,198		104,116
Accretable Purchase Discounts	(191,774)		(215,365)
Discount Designated as Credit Reserve and OTTI	(531,757)		(593,227)
Amortized Cost	5,741,701		5,754,620
Fair Value	6,240,100		6,358,647
Gross Unrealized Gains	566,641		647,617
Gross Unrealized Losses	68,242		43,590
Net Unrealized Gain/(Loss)	498,399		604,027
CRT securities
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face	495,018		602,799
Purchase Premiums	9,936		8,887
Accretable Purchase Discounts	(178)		(3,550)
Discount Designated as Credit Reserve and OTTI	0		0
Amortized Cost	504,776		608,136
Fair Value	538,945		664,403
Gross Unrealized Gains	34,173		56,290
Gross Unrealized Losses	4		23
Net Unrealized Gain/(Loss)	34,169		56,267
RPL/NPL MBS
Debt Securities, Available-for-sale [Line Items]
Principal/ Current Face	1,200,000		922,000
Amortized Cost	1,200,000		920,100
Fair Value	1,200,000		923,100
Agency MBS, Fair Value Option
Debt Securities, Available-for-sale [Line Items]
Fair Value	746,700
Gross Unrealized Gains	0
Gross Unrealized Losses	5,500
Debt Securities, Fair Value Option	746,700
CRT, Fair Value Option
Debt Securities, Available-for-sale [Line Items]
Fair Value	538,900
Gross Unrealized Gains	34,200		40,500
Gross Unrealized Losses	$ 4		23
Debt Securities, Fair Value Option			$ 528,900

XML

MBS, CRT Securities and MSR Related Assets (Sale of MBS) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Non-Agency MBS
Debt Securities, Available-for-sale [Line Items]
Proceeds from sale of MBS categorized as available-for-sale	$ 24.3	$ 44.5	$ 43.7	$ 83.1
Gains on sales of MBS	3.4	$ 14.9	12.2	$ 30.8
Agency MBS
Debt Securities, Available-for-sale [Line Items]
Proceeds from sale of MBS categorized as available-for-sale			75.3
Gains on sales of MBS			(3.8)
CRT securities
Debt Securities, Available-for-sale [Line Items]
Proceeds from sale of MBS categorized as available-for-sale	118.9		222.9
Gains on sales of MBS	$ 13.0		$ 24.2

XML

MBS, CRT Securities and MSR Related Assets (Unrealized Losses) (Details) $ in Thousands	Sep. 30, 2018 USD ($) security	Dec. 31, 2017 USD ($)
Fair Value
Less than 12 Months	$ 1,602,941
12 Months or more	1,140,526
Total	2,743,467
Unrealized Losses
Less than 12 Months	12,385
12 Months or more	55,861
Total	$ 68,246
Number of Securities
Less than 12 months (in security) | security	167
12 months or more (in security) | security	361
Available-for-sale securities	$ 6,779,045	$ 7,023,050
Gross Unrealized Losses	68,246	43,613
Agency MBS
Fair Value
Less than 12 Months	1,107,546
12 Months or more	1,136,649
Total	2,244,195
Unrealized Losses
Less than 12 Months	10,313
12 Months or more	55,795
Total	$ 66,108
Number of Securities
Less than 12 months (in security) | security	142
12 months or more (in security) | security	354
Available-for-sale securities	$ 2,905,490	2,824,681
Gross Unrealized Losses	66,108	43,137
Agency MBS | Fannie Mae
Fair Value
Less than 12 Months	438,980
12 Months or more	838,566
Total	1,277,546
Unrealized Losses
Less than 12 Months	4,293
12 Months or more	35,918
Total	$ 40,211
Number of Securities
Less than 12 months (in security) | security	105
12 months or more (in security) | security	251
Available-for-sale securities	$ 1,896,739	2,246,600
Gross Unrealized Losses	40,211	28,341
Agency MBS | Freddie Mac
Fair Value
Less than 12 Months	668,566
12 Months or more	298,083
Total	966,649
Unrealized Losses
Less than 12 Months	6,020
12 Months or more	19,877
Total	$ 25,897
Number of Securities
Less than 12 months (in security) | security	37
12 months or more (in security) | security	103
Available-for-sale securities	$ 1,003,583	571,748
Gross Unrealized Losses	25,897	14,796
Non-Agency MBS
Fair Value
Less than 12 Months	479,641
12 Months or more	3,877
Total	483,518
Unrealized Losses
Less than 12 Months	2,068
12 Months or more	66
Total	$ 2,134
Number of Securities
Less than 12 months (in security) | security	21
12 months or more (in security) | security	7
Available-for-sale securities	$ 3,334,610	3,533,966
Gross Unrealized Losses	2,134	453
Non-Agency MBS | Expected to Recover Par
Fair Value
Less than 12 Months	435,011
12 Months or more	3,877
Total	438,888
Unrealized Losses
Less than 12 Months	1,849
12 Months or more	66
Total	$ 1,915
Number of Securities
Less than 12 months (in security) | security	15
12 months or more (in security) | security	7
Available-for-sale securities	$ 1,343,272	1,132,205
Gross Unrealized Losses	1,915	434
Non-Agency MBS | Expected to Recover Less Than Par
Fair Value
Less than 12 Months	44,630
12 Months or more	0
Total	44,630
Unrealized Losses
Less than 12 Months	219
12 Months or more	0
Total	$ 219
Number of Securities
Less than 12 months (in security) | security	6
12 months or more (in security) | security	0
Available-for-sale securities	$ 1,991,338	2,401,761
Gross Unrealized Losses	219	19
Total MBS
Fair Value
Less than 12 Months	1,587,187
12 Months or more	1,140,526
Total	2,727,713
Unrealized Losses
Less than 12 Months	12,381
12 Months or more	55,861
Total	$ 68,242
Number of Securities
Less than 12 months (in security) | security	163
12 months or more (in security) | security	361
Available-for-sale securities	$ 6,240,100	6,358,647
Gross Unrealized Losses	68,242	43,590
CRT securities
Fair Value
Less than 12 Months	15,754
12 Months or more	0
Total	15,754
Unrealized Losses
Less than 12 Months	4
12 Months or more	0
Total	$ 4
Number of Securities
Less than 12 months (in security) | security	4
12 months or more (in security) | security	0
Available-for-sale securities	$ 538,945	664,403
Gross Unrealized Losses	4	$ 23
Agency MBS, Fair Value Option
Number of Securities
Available-for-sale securities	746,700
Gross Unrealized Losses	$ 5,500

XML

MBS, CRT Securities and MSR Related Assets (Composition of OTTI Charges) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Investments, Debt and Equity Securities [Abstract]
Total OTTI losses	$ 0	$ 0	$ 0	$ (63)
OTTI reclassified from OCI	0	0	0	(969)
OTTI recognized in earnings	$ 0	$ 0	$ 0	$ (1,032)

XML

MBS, CRT Securities and MSR Related Assets (Credit Loss Component of OTTI) (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2018
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Roll Forward]
Credit loss component of OTTI at beginning of period	$ 38,337	$ 38,337
Additions for credit related OTTI not previously recognized	0	0
Subsequent additional credit related OTTI recorded	0	0
Credit loss component of OTTI at end of period	$ 38,337	$ 38,337

XML

MBS, CRT Securities and MSR Related Assets (Purchase Discounts) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Changes in the components of the purchase discount on Non-Agency MBS
Realized credit losses	$ 0	$ 0	$ 0	$ 1,032
Discount Designated as Credit Reserve and OTTI | Non-Agency MBS
Changes in the components of the purchase discount on Non-Agency MBS
Balance at beginning of period	(553,596)	(626,498)	(593,227)	(694,241)
Impact of RMBS Issuer Settlement	0	0	0	0
Accretion of discount	0	0	0	0
Realized credit losses	12,042	13,982	31,443	39,445
Purchases	(1,975)	0	(2,510)	(484)
Sales	1,552	4,620	7,144	29,398
Net impairment losses recognized in earnings			0	(1,032)
Transfers/release of credit reserve	10,220	14,762	25,393	33,780
Balance at end of period	(531,757)	(593,134)	(531,757)	(593,134)
Accretable Discount | Non-Agency MBS
Changes in the components of the purchase discount on Non-Agency MBS
Balance at beginning of period	(202,248)	(257,967)	(215,325)	(278,191)
Impact of RMBS Issuer Settlement	(2,734)	0	(14,822)	0
Accretion of discount	20,115	18,621	54,860	60,461
Realized credit losses	0	0	0	0
Purchases	1,368	(1,929)	1,856	(3,449)
Sales	1,974	11,244	7,079	10,166
Net impairment losses recognized in earnings			0	0
Transfers/release of credit reserve	(10,220)	(14,762)	(25,393)	(33,780)
Balance at end of period	(191,745)	$ (244,793)	(191,745)	$ (244,793)
Jp Morgan Chase
Changes in the components of the purchase discount on Non-Agency MBS
Proceeds from Legal Settlements			$ 12,100
Lehman Brothers
Changes in the components of the purchase discount on Non-Agency MBS
Proceeds from Legal Settlements	$ 2,700

XML

MBS, CRT Securities and MSR Related Assets (Impact of AFS Securities on AOCI) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
AOCI from AFS Securities:
Unrealized gain on AFS securities at beginning of period	$ 548,551,000	$ 668,223,000	$ 620,648,000	$ 620,403,000
Reclassification adjustment for MBS sales included in net income	(9,455,000)	(14,935,000)	(25,580,000)	(30,283,000)
Reclassification adjustment for OTTI included in net income	0	0	0	(1,032,000)
Change in AOCI from AFS securities	(43,733,000)	(7,947,000)	(115,830,000)	39,873,000
Balance at end of period	504,818,000	660,276,000	504,818,000	660,276,000
Agency MBS
AOCI from AFS Securities:
Unrealized (loss)/gain on AFS securities, net	(9,177,000)	(3,032,000)	(27,507,000)	(22,241,000)
Non-Agency MBS
AOCI from AFS Securities:
Unrealized (loss)/gain on AFS securities, net	$ (25,101,000)	$ 10,020,000	$ (62,743,000)	$ 93,429,000

XML

MBS, CRT Securities and MSR Related Assets (MSR Related Assets - Narrative) (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017	Mar. 31, 2018	Dec. 31, 2016
Term notes backed by MSR related collateral
Debt Securities, Available-for-sale [Line Items]
Term notes backed by MSR related collateral	$ 505,195,000		$ 505,195,000		$ 381,804,000
Amortized costs	504,300,000		504,300,000		381,000,000
Gross unrealized gains	922,000		$ 922,000		$ 804,000
Weighted average yield			5.15%		5.80%
Weighted average to maturity			4 years 6 months 18 days		3 years 5 months 4 days
Corporate Loan
Debt Securities, Available-for-sale [Line Items]
Commitment to lend	100,000,000		$ 100,000,000				$ 130,000,000
Amount drawn	$ 60,100,000		$ 60,100,000			$ 124,200,000
Interest coupon rate	5.64%		5.64%
Debt term			1 year 10 months 24 days
Commitment period on undrawn amount	1 year 10 months 24 days
Interest income	$ 138,000	$ 2,100,000	$ 3,800,000	$ 5,700,000
Discount accretion	0	$ 76,000	$ 1,300,000	$ 212,000
Commitment fee income	$ 136,000
Minimum | Corporate Loan
Debt Securities, Available-for-sale [Line Items]
Commitment fee on undrawn amount	0.25%		0.25%
Maximum | Corporate Loan
Debt Securities, Available-for-sale [Line Items]
Commitment fee on undrawn amount	1.00%		1.00%

XML

MBS, CRT Securities and MSR Related Assets (Interest Income) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Agency MBS
Debt Securities, Available-for-sale [Line Items]
Coupon interest	$ 21,549,000	$ 23,473,000	$ 62,546,000	$ 74,589,000
Effective yield adjustment	(7,217,000)	(7,940,000)	(19,751,000)	(24,575,000)
Interest income	14,332,000	15,533,000	42,795,000	50,014,000
Legacy Non-Agency MBS
Debt Securities, Available-for-sale [Line Items]
Coupon interest	27,026,000	30,688,000	83,791,000	97,796,000
Effective yield adjustment	18,984,000	18,005,000	53,648,000	59,033,000
Interest income	46,010,000	48,693,000	137,439,000	156,829,000
Accretion Income	2,300,000		2,300,000	1,700,000
RPL/NPL MBS
Debt Securities, Available-for-sale [Line Items]
Coupon interest	11,526,000	13,947,000	31,167,000	54,475,000
Effective yield adjustment	1,131,000	612,000	1,206,000	1,424,000
Interest income	12,657,000	14,559,000	32,373,000	55,899,000
Accretion Income	1,100,000	575,000	1,200,000	1,200,000
CRT securities
Debt Securities, Available-for-sale [Line Items]
Coupon interest	7,257,000	7,868,000	23,484,000	19,712,000
Effective yield adjustment	491,000	808,000	2,455,000	3,186,000
Interest income	7,748,000	8,676,000	25,939,000	22,898,000
MSR related assets
Debt Securities, Available-for-sale [Line Items]
Coupon interest	6,407,000	7,117,000	19,005,000	17,621,000
Effective yield adjustment	0	77,000	1,244,000	212,000
Interest income	$ 6,407,000	$ 7,194,000	$ 20,249,000	$ 17,833,000

XML

Residential Whole Loans (Narrative) (Details) - USD ($) $ in Billions	Sep. 30, 2018	Dec. 31, 2017
Receivables [Abstract]
Total residential whole loans	$ 3.9	$ 2.2

XML

Residential Whole Loans (Residential Whole Loans, at Carrying Value) (Details) $ in Thousands		Sep. 30, 2018 USD ($) loan	Dec. 31, 2017 USD ($) loan
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Residential whole loans, at carrying value	[1]	$ 2,471,567	$ 908,516
Number of loans | loan		9,900	4,800
Purchased credit impaired loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Purchased credit impaired loans		$ 825,614	$ 790,879
Non-QM loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other loans at carrying value		989,818	55,612
Rehabilitation loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other loans at carrying value		329,301	56,706
Single-family rental loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other loans at carrying value		79,699	5,319
Seasoned performing loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other loans at carrying value		247,135	0
Total other loans at carrying value
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other loans at carrying value		$ 1,645,953	$ 117,637

[1] Includes approximately $215.1 million and $183.2 million of Residential whole loans, at carrying value and $723.8 million and $289.3 million of Residential whole loans, at fair value transferred to consolidated variable interest entities (“VIEs”) at September 30, 2018 and December 31, 2017, respectively. Such assets can be used only to settle the obligations of the VIEs.

XML

Residential Whole Loans (Residential Whole Loans, at Carrying Value - Additional Information) (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Accounts, Notes, Loans and Financing Receivable [Line Items]
Residential whole loans, at carrying value, total or weighted average	$ 2,464,794
Unpaid Principal Balance (“UPB”)	$ 2,660,686
Weighted Average Coupon	5.46%
Weighted Average Term to Maturity (Months)	278 months
Weighted Average LTV Ratio	80.00%
Other loans held at carrying value excluded	$ 8,600
Purchased credit impaired loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Purchased credit impaired loans	825,614	$ 790,879
Unpaid Principal Balance (“UPB”)	$ 1,034,890
Weighted Average Coupon	4.36%
Weighted Average Term to Maturity (Months)	304 months
Weighted Average LTV Ratio	87.00%
Non-QM loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other loans at carrying value	$ 989,818	55,612
Unpaid Principal Balance (“UPB”)	$ 956,162
Weighted Average Coupon	6.18%
Weighted Average Term to Maturity (Months)	358 months
Weighted Average LTV Ratio	66.00%
Rehabilitation loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other loans at carrying value	$ 329,301	56,706
Unpaid Principal Balance (“UPB”)	$ 329,301
Weighted Average Coupon	7.51%
Weighted Average Term to Maturity (Months)	9 months
Weighted Average LTV Ratio	65.00%
Single-family rental loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other loans at carrying value	$ 79,699	5,319
Unpaid Principal Balance (“UPB”)	$ 79,563
Weighted Average Coupon	5.84%
Weighted Average Term to Maturity (Months)	355 months
Weighted Average LTV Ratio	68.00%
Seasoned performing loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other loans at carrying value	$ 247,135	$ 0
Seasoned performing loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other loans at carrying value	240,362
Unpaid Principal Balance (“UPB”)	$ 260,770
Weighted Average Coupon	4.05%
Weighted Average Term to Maturity (Months)	194 months
Weighted Average LTV Ratio	49.00%
Other residential whole loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other loans held at carrying value excluded	$ 6,800
Current | Non-QM loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance (“UPB”)	944,564
Current | Rehabilitation loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance (“UPB”)	309,951
Current | Single-family rental loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance (“UPB”)	78,172
Current | Seasoned performing loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance (“UPB”)	239,025
30-59 | Non-QM loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance (“UPB”)	8,564
30-59 | Rehabilitation loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance (“UPB”)	12,836
30-59 | Single-family rental loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance (“UPB”)	870
30-59 | Seasoned performing loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance (“UPB”)	20,373
60-89 | Non-QM loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance (“UPB”)	1,865
60-89 | Rehabilitation loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance (“UPB”)	3,620
60-89 | Single-family rental loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance (“UPB”)	0
60-89 | Seasoned performing loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance (“UPB”)	$ 635
90 or more
Accounts, Notes, Loans and Financing Receivable [Line Items]
Weighted Average LTV Ratio	89.48%	94.50%
90 or more | Non-QM loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance (“UPB”)	$ 1,169
90 or more | Rehabilitation loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance (“UPB”)	2,894
90 or more | Single-family rental loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance (“UPB”)	521
90 or more | Seasoned performing loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Unpaid Principal Balance (“UPB”)	$ 737

XML

Residential Whole Loans (Purchased Credit Impaired Loans - Narrative) (Details) - Purchased credit impaired loans - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Jun. 30, 2018	Dec. 31, 2017	Jun. 30, 2017	Dec. 31, 2016
Financing Receivable, Impaired [Line Items]
Allowance for loan losses	$ 461	$ 318	$ 461	$ 318	$ 297	$ 330	$ 375	$ 990
Provisions/(reversal of provisions) for loan losses	$ 164	$ (57)	$ 131	$ (672)

XML

Residential Whole Loans (Provision for Loan Losses) (Details) - Purchased credit impaired loans - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Allowance for Loan and Lease Losses [Roll Forward]
Balance at the beginning of period	$ 297	$ 375	$ 330	$ 990
Provisions/(reversal of provisions) for loan losses	164	(57)	131	(672)
Balance at the end of period	$ 461	$ 318	$ 461	$ 318

XML

Residential Whole Loans (Carrying Value) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Investments, Debt and Equity Securities [Abstract]
Contractually required principal and interest	$ 154,911	$ 185,234	$ 154,911	$ 185,234
Contractual cash flows not expected to be collected (non-accretable yield)	(15,378)	(33,448)	(15,378)	(33,448)
Expected cash flows to be collected	139,533	151,786	139,533	151,786
Interest component of expected cash flows (accretable yield)	(41,947)	(53,916)	(41,947)	(53,916)
Fair value at the date of acquisition	97,586	97,870	97,586	97,870
Purchase credit impaired loans transaction closed in current period which were purchased in prior periods	$ 54,900	$ 97,900	$ 54,900	$ 97,900

XML

Residential Whole Loans (Carrying Value Accretable Yield Rollforward) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Residential Whole Loans Accretable Yield [Roll Forward]
Balance at beginning of period	$ 401,075	$ 318,125	$ 421,872	$ 334,379
Additions	41,947	53,916	41,947	53,916
Accretion	(11,198)	(9,026)	(33,139)	(26,219)
Liquidations and other	(8,378)	0	(23,388)	0
Reclassifications (to)/from non-accretable difference, net	9,694	303	25,848	1,242
Balance at end of period	433,140	363,318	433,140	363,318
Purchase credit impaired loans transaction closed in current period which were purchased in prior periods	$ 54,900	$ 97,900	$ 54,900	$ 97,900

XML

Residential Whole Loans (Other Loans at Carrying Value) (Details) $ in Millions	Sep. 30, 2018 USD ($) loan
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of other loans at carrying value | loan	10
Unpaid balance of other loans	$ 5.3
Total outstanding principal balance of all of the Company’s Other Loans at Carrying Value	0.30%
Rehabilitation loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Commitment to lend, unfunded	$ 43.9

XML

Residential Whole Loans (Fair Value) (Details) $ in Thousands		9 Months Ended	12 Months Ended
		Sep. 30, 2018 USD ($) loan	Dec. 31, 2017 USD ($) loan	Sep. 30, 2017 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Weighted Average LTV Ratio		80.00%
Total Residential whole loans, at fair value	[1]	$ 1,447,567	$ 1,325,115
Less than 60 Days Past Due:
Accounts, Notes, Loans and Financing Receivable [Line Items]
Outstanding principal balance		585,024	488,600
Aggregate fair value		$ 544,890	$ 446,616
Weighted Average LTV Ratio		76.17%	74.98%
Number of loans | loan		2,775	2,323
60 Days to 89 Days Past Due:
Accounts, Notes, Loans and Financing Receivable [Line Items]
Outstanding principal balance		$ 70,018	$ 45,955
Aggregate fair value		$ 62,043	$ 37,927
Weighted Average LTV Ratio		77.62%	89.25%
Number of loans | loan		319	207
90 Days or More Past Due:
Accounts, Notes, Loans and Financing Receivable [Line Items]
Outstanding principal balance		$ 972,488	$ 1,027,818
Aggregate fair value		$ 840,634	$ 840,572
Weighted Average LTV Ratio		89.48%	94.50%
Number of loans | loan		3,416	3,984
Residential whole loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Excluded amount, unsettled purchases, residential whole loans, at fair value		$ 1,800		$ 120,400

[1] Includes approximately $215.1 million and $183.2 million of Residential whole loans, at carrying value and $723.8 million and $289.3 million of Residential whole loans, at fair value transferred to consolidated variable interest entities (“VIEs”) at September 30, 2018 and December 31, 2017, respectively. Such assets can be used only to settle the obligations of the VIEs.

XML

Residential Whole Loans (Fair Value Components of Net Income) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Receivables [Abstract]
Coupon payments and other income received	$ 17,634	$ 9,824	$ 52,034	$ 27,971
Net unrealized gains	8,442	5,289	26,788	12,499
Net gain on payoff/liquidation of loans	3,251	1,456	10,203	3,076
Net gain on transfers to REO	5,615	2,110	16,858	5,114
Total	$ 34,942	$ 18,679	$ 105,883	$ 48,660

XML

Other Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Jun. 30, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Dec. 31, 2016
Other Assets [Abstract]
Securities obtained and pledged as collateral, at fair value	$ 0		$ 504,062
REO	223,105	$ 192,162	152,356	$ 137,979	$ 104,443	$ 80,503
MBS and loan related receivables	101,578		54,640
Swaps, at fair value	22,311		679
Goodwill	7,189		7,189
Other	51,886		23,983
Total Other Assets	$ 406,069		$ 742,909

XML

Other Assets (Real Estate Owned) (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018 USD ($) property	Sep. 30, 2017 USD ($) property	Sep. 30, 2018 USD ($) property	Sep. 30, 2017 USD ($) property	Jun. 30, 2018 USD ($)	Dec. 31, 2017 USD ($) property	Jun. 30, 2017 USD ($)	Dec. 31, 2016 USD ($)
Real Estate Properties [Line Items]
Number of real estate owned properties | property	979		979			709
Real estate owned	$ 223,105	$ 137,979	$ 223,105	$ 137,979	$ 192,162	$ 152,356	$ 104,443	$ 80,503
Number of real estate properties reclassified to REO during period | property	240	174	795	521
Mortgage loans reclassified to REO	$ 58,051	$ 38,944	$ 161,572	$ 97,388
Residential Whole Loans acquired through foreclosure ordered in lieu	$ 214,400		$ 214,400
Number of REO properties sold during period | property	157	139	537	368
Proceeds from sale of real estate owned	$ 29,900	$ 18,400	$ 96,000	$ 53,000
Gains/(losses) on sales of real estate owned	2,000	805	6,582	2,844
Adjustments to record at lower of cost or fair value	4,056	3,129	11,592	7,306
Estimated Fair Value
Real Estate Properties [Line Items]
Mortgage loans reclassified to REO	58,100	$ 38,900	161,600	$ 97,400
Mortgage loans in process of foreclosure	720,100		720,100
Carrying Value
Real Estate Properties [Line Items]
Mortgage loans in process of foreclosure	$ 48,700		$ 48,700

XML

Other Assets (Real Estate Owned - Activity) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Real Estate Owned [Roll Forward]
Balance at beginning of period	$ 192,162	$ 104,443	$ 152,356	$ 80,503
Adjustments to record at lower of cost or fair value	(4,056)	(3,129)	(11,592)	(7,306)
Transfer from residential whole loans	58,051	38,944	161,572	97,388
Purchases and capital improvements	4,897	15,342	10,179	17,224
Disposals	(27,949)	(17,621)	(89,410)	(49,830)
Balance at end of period	223,105	137,979	223,105	137,979
Gain recorded on transfer from residential whole loans to real estate owned	$ 5,800	$ 2,800	$ 17,000	$ 5,300

XML

Other Assets (Derivative Instruments - Balance Sheet Location) (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Derivative Instruments
Derivative assets, fair value	$ 22,311	$ 679
Swap | Hedging | Assets
Derivative Instruments
Notional amount of derivative assets	2,122,000	750,000
Derivative assets, fair value	18,650	679
Swap | Hedging | Other liabilities
Derivative Instruments
Notional amount of derivative liabilities	0	1,800,000
Derivative liabilities, at fair value	0	0
Swap | Non-Hedging | Assets
Derivative Instruments
Notional amount of derivative assets	515,000	0
Derivative assets, fair value	$ 3,661	$ 0

XML

Other Assets (Derivative Instruments) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Derivative [Line Items]
Assets pledged	$ 8,997,518		$ 8,997,518		$ 8,145,197
Interest expense attributable to Swaps	58,878	$ 49,275	161,242	$ 148,646
AOCI from derivative hedging instruments:
Balance at beginning of period	16,160	(35,841)	(11,424)	(46,721)
Net gain on Swaps	5,390	5,791	32,974	16,671
Balance at end of period	21,550	(30,050)	21,550	(30,050)
Interest Rate Contract
Derivative [Line Items]
Assets pledged	2,877		2,877		28,161
Interest Rate Contract | Agency MBS, at fair value
Derivative [Line Items]
Assets pledged	2,877		2,877		21,756
Interest Rate Contract | Restricted cash
Derivative [Line Items]
Assets pledged	0		0		6,405
Swaps, at fair value
Derivative [Line Items]
Aggregate notional amount of derivatives	$ 2,637,000		$ 2,637,000		$ 2,550,000
Weighted average fixed-pay rate	2.35%		2.35%		2.04%
Weighted Average Variable Interest Rate	2.21%		2.21%		1.50%
Interest expense attributable to Swaps	$ 547	$ 5,310	$ 4,187	$ 19,606
Weighted average Swap rate paid	2.19%	2.04%	2.09%	1.96%
Weighted average Swap rate received	2.09%	1.23%	1.86%	1.00%
Swaps, at fair value | Within 30 days
Derivative [Line Items]
Aggregate notional amount of derivatives	$ 0		$ 0		$ 0
Weighted average fixed-pay rate	0.00%		0.00%		0.00%
Weighted Average Variable Interest Rate	0.00%		0.00%		0.00%
Swaps, at fair value | Over 30 days to 3 months
Derivative [Line Items]
Aggregate notional amount of derivatives	$ 0		$ 0		$ 0
Weighted average fixed-pay rate	0.00%		0.00%		0.00%
Weighted Average Variable Interest Rate	0.00%		0.00%		0.00%
Swaps, at fair value | Over 3 months to 6 months
Derivative [Line Items]
Aggregate notional amount of derivatives	$ 100,000		$ 100,000		$ 50,000
Weighted average fixed-pay rate	1.71%		1.71%		1.45%
Weighted Average Variable Interest Rate	2.21%		2.21%		1.56%
Swaps, at fair value | Over 6 months to 12 months
Derivative [Line Items]
Aggregate notional amount of derivatives	$ 100,000		$ 100,000		$ 500,000
Weighted average fixed-pay rate	1.71%		1.71%		1.50%
Weighted Average Variable Interest Rate	2.21%		2.21%		1.46%
Swaps, at fair value | Over 12 months to 24 months
Derivative [Line Items]
Aggregate notional amount of derivatives	$ 1,630,000		$ 1,630,000		$ 200,000
Weighted average fixed-pay rate	2.27%		2.27%		1.71%
Weighted Average Variable Interest Rate	2.20%		2.20%		1.54%
Swaps, at fair value | Over 24 months to 36 months
Derivative [Line Items]
Aggregate notional amount of derivatives	$ 322,000		$ 322,000		$ 1,500,000
Weighted average fixed-pay rate	2.34%		2.34%		2.22%
Weighted Average Variable Interest Rate	2.17%		2.17%		1.51%
Swaps, at fair value | Over 36 months to 48 months
Derivative [Line Items]
Aggregate notional amount of derivatives	$ 0		$ 0		$ 200,000
Weighted average fixed-pay rate	0.00%		0.00%		2.20%
Weighted Average Variable Interest Rate	0.00%		0.00%		1.53%
Swaps, at fair value | Over 48 months to 60 months
Derivative [Line Items]
Aggregate notional amount of derivatives	$ 355,000		$ 355,000		$ 0
Weighted average fixed-pay rate	2.85%		2.85%		0.00%
Weighted Average Variable Interest Rate	2.28%		2.28%		0.00%
Swaps, at fair value | Over 60 months to 72 months
Derivative [Line Items]
Aggregate notional amount of derivatives	$ 0		$ 0		$ 100,000
Weighted average fixed-pay rate	0.00%		0.00%		2.75%
Weighted Average Variable Interest Rate	0.00%		0.00%		1.50%
Swaps, at fair value | Over 72 months to 84 months
Derivative [Line Items]
Aggregate notional amount of derivatives	$ 0		$ 0		$ 0
Weighted average fixed-pay rate	0.00%		0.00%		0.00%
Weighted Average Variable Interest Rate	0.00%		0.00%		0.00%
Swaps, at fair value | Over 84 months
Derivative [Line Items]
Aggregate notional amount of derivatives	$ 130,000		$ 130,000		$ 0
Weighted average fixed-pay rate	2.94%		2.94%		0.00%
Weighted Average Variable Interest Rate	2.32%		2.32%		0.00%
Swaps, at fair value | Hedging
Derivative [Line Items]
Aggregate notional amount of derivatives	$ 2,600,000		$ 2,600,000
Average maturity term of swaps			32 months
Swaps, at fair value | Minimum | LIBOR
Derivative [Line Items]
Derivative, variable interest rate, term			1 month
Swaps, at fair value | Maximum | Hedging
Derivative [Line Items]
Maximum maturity term of swaps			121 months
Swaps, at fair value | Maximum | LIBOR
Derivative [Line Items]
Derivative, variable interest rate, term			3 months
Swap | Non-Hedging
Derivative [Line Items]
Gain on derivatives	$ 4,000		$ 4,400

XML

Repurchase Agreements (Borrowings Under Repurchase Agreement And Associated Assets Pledged as Collateral) (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Assets Sold under Agreements to Repurchase [Line Items]
Balance of repurchase agreements	$ 7,278,270	$ 6,614,701
Unamortized debt issuance expense	19	206
Agency MBS
Assets Sold under Agreements to Repurchase [Line Items]
Balance of repurchase agreements	2,584,097	2,501,340
Fair value of securities pledged as collateral under repurchase agreements	$ 2,792,396	$ 2,705,754
Weighted average haircut (percent)	4.48%	4.65%
Non-Agency MBS
Assets Sold under Agreements to Repurchase [Line Items]
Balance of repurchase agreements	$ 1,592,067	$ 1,256,033
Fair value of securities pledged as collateral under repurchase agreements	$ 2,075,540	$ 1,652,983
Weighted average haircut (percent)	21.70%	21.87%
RPL/NPL MBS
Assets Sold under Agreements to Repurchase [Line Items]
Balance of repurchase agreements	$ 913,249	$ 567,140
Fair value of securities pledged as collateral under repurchase agreements	$ 1,161,568	$ 726,540
Weighted average haircut (percent)	21.22%	22.05%
U.S. Treasury securities
Assets Sold under Agreements to Repurchase [Line Items]
Balance of repurchase agreements	$ 0	$ 470,334
Fair value of securities pledged as collateral under repurchase agreements	$ 0	$ 472,095
Weighted average haircut (percent)	0.00%	1.47%
CRT securities
Assets Sold under Agreements to Repurchase [Line Items]
Balance of repurchase agreements	$ 405,168	$ 459,058
Fair value of securities pledged as collateral under repurchase agreements	$ 504,931	$ 595,900
Weighted average haircut (percent)	19.73%	22.16%
MSR related assets
Assets Sold under Agreements to Repurchase [Line Items]
Balance of repurchase agreements	$ 435,762	$ 317,255
Fair value of securities pledged as collateral under repurchase agreements	$ 565,272	$ 482,158
Weighted average haircut (percent)	22.56%	33.19%
Residential whole loans
Assets Sold under Agreements to Repurchase [Line Items]
Balance of repurchase agreements	$ 1,347,946	$ 1,043,747
Fair value of securities pledged as collateral under repurchase agreements	$ 1,888,445	$ 1,474,704
Weighted average haircut (percent)	21.93%	26.10%
Repurchase Agreement Borrowings
Assets Sold under Agreements to Repurchase [Line Items]
Weighted average remaining term-to-interest rate reset of borrowings under repurchase agreements, days	25 days	16 days
Effective repricing period, months	11 months	11 months
Balance of repurchase agreements	$ 7,278,289	$ 6,614,907
Unamortized debt issuance expense	19	$ 206
Loan Securitization
Assets Sold under Agreements to Repurchase [Line Items]
Fair value of securities pledged as collateral under repurchase agreements	$ 27,000

XML

Repurchase Agreements (Borrowings Under Repurchase Agreement) (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	$ 7,278,270	$ 6,614,701
Less debt issuance costs	19	206
Amounts related to repurchase agreements not included in offsetting disclosure in Note 8	0
Repurchase Agreement Borrowings
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	$ 7,278,289	$ 6,614,907
Weighted Average Interest Rate	3.01%	2.42%
Less debt issuance costs	$ 19	$ 206
Total repurchase agreements less debt issuance costs	7,278,270	6,614,701
Repurchase Agreement Borrowings | Overnight
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	$ 0
Weighted Average Interest Rate	0.00%
Repurchase Agreement Borrowings | Within 30 Days
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	$ 6,011,969
Weighted Average Interest Rate	2.85%
Repurchase Agreement Borrowings | Over 30 Days to 3 Months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	$ 562,439
Weighted Average Interest Rate	3.73%
Repurchase Agreement Borrowings | Over 3 Months to 12 Months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	$ 703,881
Weighted Average Interest Rate	3.80%
Repurchase Agreement Borrowings | Over 12 months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	$ 0
Weighted Average Interest Rate	0.00%
Repurchase Agreement Borrowings | Within 30 days
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	$ 6,985,487	$ 6,161,008
Weighted Average Interest Rate	3.01%	2.39%
Repurchase Agreement Borrowings | Over 30 days to 3 months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	$ 29,501	$ 453,899
Weighted Average Interest Rate	2.48%	2.76%
Repurchase Agreement Borrowings | Over 3 months to 12 months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	$ 263,301	$ 0
Weighted Average Interest Rate	3.09%	0.00%
Agency MBS
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	$ 2,584,097	$ 2,501,340
Agency MBS | Overnight
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	0
Agency MBS | Within 30 Days
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	2,570,990
Agency MBS | Over 30 Days to 3 Months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	13,107
Agency MBS | Over 3 Months to 12 Months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	0
Agency MBS | Over 12 months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	0
Legacy Non-Agency MBS
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	1,592,067	1,256,033
Legacy Non-Agency MBS | Overnight
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	0
Legacy Non-Agency MBS | Within 30 Days
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	1,544,995
Legacy Non-Agency MBS | Over 30 Days to 3 Months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	47,072
Legacy Non-Agency MBS | Over 3 Months to 12 Months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	0
Legacy Non-Agency MBS | Over 12 months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	0
RPL/NPL MBS
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	913,249	567,140
RPL/NPL MBS | Overnight
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	0
RPL/NPL MBS | Within 30 Days
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	887,087
RPL/NPL MBS | Over 30 Days to 3 Months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	26,162
RPL/NPL MBS | Over 3 Months to 12 Months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	0
RPL/NPL MBS | Over 12 months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	0
CRT securities
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	405,168	459,058
CRT securities | Overnight
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	0
CRT securities | Within 30 Days
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	399,064
CRT securities | Over 30 Days to 3 Months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	6,104
CRT securities | Over 3 Months to 12 Months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	0
CRT securities | Over 12 months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	0
MSR related assets
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	435,762	317,255
MSR related assets | Overnight
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	0
MSR related assets | Within 30 Days
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	342,704
MSR related assets | Over 30 Days to 3 Months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	93,058
MSR related assets | Over 3 Months to 12 Months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	0
MSR related assets | Over 12 months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	0
Residential whole loans
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	1,347,946	$ 1,043,747
Residential whole loans | Overnight
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	0
Residential whole loans | Within 30 Days
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	267,129
Residential whole loans | Over 30 Days to 3 Months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	376,936
Residential whole loans | Over 3 Months to 12 Months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	703,881
Residential whole loans | Over 12 months
Debt Securities, Available-for-sale [Line Items]
Balance of repurchase agreements	$ 0

XML

Repurchase Agreements (Counterparty for Repurchase Agreement) (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2018 USD ($) counterparty	Dec. 31, 2017 counterparty
Repurchase agreements counterparty risk
Number of counterparties | counterparty	28	31
Threshold of stockholders' equity at risk with single counterparty to repurchase agreements or linked transactions (greater than) (percent)	5.00%
Barclay's Bank
Repurchase agreements counterparty risk
Amount at Risk	$ 346,185
Weighted Average Months to Maturity for Repurchase Agreements	4 months
Percent of Stockholders’ Equity	9.80%
Goldman Sachs
Repurchase agreements counterparty risk
Amount at Risk	$ 305,862
Weighted Average Months to Maturity for Repurchase Agreements	1 month
Percent of Stockholders’ Equity	8.60%
Goldman Sachs Bank USA
Repurchase agreements counterparty risk
Amount at Risk	$ 171,300
Goldman Sachs Lending Partners
Repurchase agreements counterparty risk
Amount at Risk	134,600
Wells Fargo
Repurchase agreements counterparty risk
Amount at Risk	$ 252,651
Weighted Average Months to Maturity for Repurchase Agreements	5 months
Percent of Stockholders’ Equity	7.10%
Wells Fargo Bank, NA
Repurchase agreements counterparty risk
Amount at Risk	$ 241,000
Wells Fargo Securities LLC
Repurchase agreements counterparty risk
Amount at Risk	11,700
RBC
Repurchase agreements counterparty risk
Amount at Risk	$ 243,731
Weighted Average Months to Maturity for Repurchase Agreements	1 month
Percent of Stockholders’ Equity	6.90%
RBC Barbados
Repurchase agreements counterparty risk
Amount at Risk	$ 237,600
RBC New York
Repurchase agreements counterparty risk
Amount at Risk	$ 6,100

XML

Repurchase Agreements (Undrawn Financing Commitment) (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Debt Instrument [Line Items]
Repurchase agreements	$ 7,278,270	$ 6,614,701
MSR Asset Financing
Debt Instrument [Line Items]
Repurchase agreement, borrowing commitment	$ 75,000
MSR Asset Financing | Minimum
Debt Instrument [Line Items]
Commitment fee	0.125%
MSR Asset Financing | Maximum
Debt Instrument [Line Items]
Commitment fee	0.50%
MSR related assets
Debt Instrument [Line Items]
Repurchase agreements	$ 435,762	$ 317,255
MSR related assets | Corporate Loan
Debt Instrument [Line Items]
Repurchase agreements	$ 45,100

XML

Collateral Positions (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Collateral Positions
Assets Pledged	$ 8,997,518	$ 8,145,197
Collateral Held	0	504,062
Derivative Hedging Instruments
Collateral Positions
Assets Pledged	2,877	28,161
Collateral Held	0	0
Derivative Hedging Instruments | Agency MBS
Collateral Positions
Assets Pledged	2,877	21,756
Collateral Held	0	0
Derivative Hedging Instruments | Cash
Collateral Positions
Assets Pledged	0	6,405
Collateral Held	0	0
Repurchase Agreement Borrowings
Collateral Positions
Assets Pledged	8,994,641	8,117,036
Collateral Held	0	0
Repurchase Agreement Borrowings | Agency MBS
Collateral Positions
Assets Pledged	2,792,396	2,705,754
Collateral Held	0	0
Repurchase Agreement Borrowings | Legacy Non-Agency MBS
Collateral Positions
Assets Pledged	2,075,540	1,652,983
Collateral Held	0	0
Non-Agency MBS pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty		688,100
Repurchase Agreement Borrowings | RPL/NPL MBS
Collateral Positions
Assets Pledged	1,161,568	726,540
Collateral Held	0	0
Repurchase Agreement Borrowings | U.S. Treasury securities
Collateral Positions
Assets Pledged	0	472,095
Collateral Held	0	0
Repurchase Agreement Borrowings | CRT securities
Collateral Positions
Assets Pledged	504,931	595,900
Collateral Held	0	0
Repurchase Agreement Borrowings | MSR related assets
Collateral Positions
Assets Pledged	565,272	482,158
Collateral Held	0	0
Repurchase Agreement Borrowings | Residential whole loans
Collateral Positions
Assets Pledged	1,888,445	1,474,704
Collateral Held	0	0
Repurchase Agreement Borrowings | Cash
Collateral Positions
Assets Pledged	6,489	6,902
Collateral Held	0	0
Reverse Repurchase Agreements
Collateral Positions
Assets Pledged	0	0
Collateral Held	0	504,062
Reverse Repurchase Agreements | U.S. Treasury securities
Collateral Positions
Assets Pledged	0	0
Collateral Held	0	$ 504,062
Loan Securitization
Collateral Positions
Fair value of securities pledged as collateral under repurchase agreements	$ 27,000

XML

Collateral Positions (Details 2) $ in Thousands	Sep. 30, 2018 USD ($)
Collateral Positions
Total Fair Value of Assets Pledged and Accrued Interest	$ 9,025,132
Agency MBS
Collateral Positions
Total Fair Value of Assets Pledged and Accrued Interest	2,803,807
Legacy Non-Agency MBS
Collateral Positions
Total Fair Value of Assets Pledged and Accrued Interest	2,084,071
RPL/NPL MBS
Collateral Positions
Total Fair Value of Assets Pledged and Accrued Interest	1,162,552
CRT securities
Collateral Positions
Total Fair Value of Assets Pledged and Accrued Interest	505,367
MSR related assets
Collateral Positions
Total Fair Value of Assets Pledged and Accrued Interest	565,916
Residential whole loans
Collateral Positions
Total Fair Value of Assets Pledged and Accrued Interest	1,896,930
Cash
Collateral Positions
Total Fair Value of Assets Pledged and Accrued Interest	6,489
Repurchase Agreements and Other Advances
Collateral Positions
Fair Value	8,994,641
Amortized Cost	8,458,200
Accrued Interest on Pledged Assets	27,607
Repurchase Agreements and Other Advances | Agency MBS
Collateral Positions
Fair Value	2,792,396
Amortized Cost	2,842,022
Accrued Interest on Pledged Assets	8,527
Repurchase Agreements and Other Advances | Legacy Non-Agency MBS
Collateral Positions
Fair Value	2,075,540
Amortized Cost	1,548,906
Accrued Interest on Pledged Assets	8,531
Repurchase Agreements and Other Advances | RPL/NPL MBS
Collateral Positions
Fair Value	1,161,568
Amortized Cost	1,162,829
Accrued Interest on Pledged Assets	984
Repurchase Agreements and Other Advances | CRT securities
Collateral Positions
Fair Value	504,931
Amortized Cost	472,217
Accrued Interest on Pledged Assets	436
Repurchase Agreements and Other Advances | MSR related assets
Collateral Positions
Fair Value	565,272
Amortized Cost	564,350
Accrued Interest on Pledged Assets	644
Repurchase Agreements and Other Advances | Residential whole loans
Collateral Positions
Fair Value	1,888,445
Amortized Cost	1,861,387
Accrued Interest on Pledged Assets	8,485
Repurchase Agreements and Other Advances | Cash
Collateral Positions
Fair Value	6,489
Amortized Cost	6,489
Accrued Interest on Pledged Assets	0
Repurchase Agreements and Other Advances | Residential Loans At Fair Value
Collateral Positions
Fair Value	1,200,000
Amortized Cost	1,100,000
Total Fair Value of Assets Pledged and Accrued Interest	685,100
Derivative Hedging Instruments
Collateral Positions
Fair Value	2,877
Amortized Cost	3,036
Accrued Interest on Pledged Assets	7
Derivative Hedging Instruments | Agency MBS
Collateral Positions
Fair Value	2,877
Amortized Cost	3,036
Accrued Interest on Pledged Assets	7
Derivative Hedging Instruments | Legacy Non-Agency MBS
Collateral Positions
Fair Value	0
Amortized Cost	0
Accrued Interest on Pledged Assets	0
Derivative Hedging Instruments | RPL/NPL MBS
Collateral Positions
Fair Value	0
Amortized Cost	0
Accrued Interest on Pledged Assets	0
Derivative Hedging Instruments | CRT securities
Collateral Positions
Fair Value	0
Amortized Cost	0
Accrued Interest on Pledged Assets	0
Derivative Hedging Instruments | MSR related assets
Collateral Positions
Fair Value	0
Amortized Cost	0
Accrued Interest on Pledged Assets	0
Derivative Hedging Instruments | Residential whole loans
Collateral Positions
Fair Value	0
Amortized Cost	0
Accrued Interest on Pledged Assets	0
Derivative Hedging Instruments | Cash
Collateral Positions
Fair Value	0
Amortized Cost	0
Accrued Interest on Pledged Assets	0
Loan Securitization
Collateral Positions
Amortized Cost	27,000
Fair value of securities pledged as collateral under repurchase agreements	$ 27,000

XML

Offsetting Assets and Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Swaps, at fair value
Gross Amounts of Recognized Assets	$ 22,311	$ 679
Gross Amounts Offset in the Consolidated Balance Sheets	0	0
Net Amounts of Assets Presented in the Consolidated Balance Sheets	22,311	679
Gross Amounts Not Offset in the Consolidated Balance Sheets
Financial Instruments	(22,311)	(679)
Cash Collateral Received	0	0
Net Amount	0	0
Swaps, at fair value
Gross Amounts of Recognized Liabilities	0	0
Gross Amounts Offset in the Consolidated Balance Sheets	0	0
Net Amounts of Liabilities Presented in the Consolidated Balance Sheets	0	0
Gross Amounts Not Offset in the Consolidated Balance Sheets
Financial Instruments	0	0
Cash Collateral Pledged	0	0
Net Amount	0	0
Repurchase agreements
Gross Amounts of Recognized Liabilities	7,278,289	6,614,907
Gross Amounts Offset in the Consolidated Balance Sheets	0	0
Net Amounts of Liabilities Presented in the Consolidated Balance Sheets	7,278,289	6,614,907
Gross Amounts Not Offset in the Consolidated Balance Sheets
Financial Instruments	(7,271,800)	(6,608,005)
Cash Collateral Pledged	(6,489)	(6,902)
Net Amount	0	0
Total
Gross Amounts of Recognized Liabilities	7,278,289	6,614,907
Gross Amounts Offset in the Consolidated Balance Sheets	0	0
Net Amounts of Liabilities Presented in the Consolidated Balance Sheets	7,278,289	6,614,907
Gross Amounts Not Offset in the Consolidated Balance Sheet
Financial Instruments	(7,271,800)	(6,608,005)
Cash Collateral Pledged	(6,489)	(6,902)
Net Amount	0	0
Additional disclosures
Fair value of securities pledged against the swaps	2,900	21,800
Fair value of financial instruments pledged against the repurchase agreements and other advances	9,000,000	8,100,000
Unamortized debt issuance expense	19	206
Swaps, at fair value
Swaps, at fair value
Gross Amounts of Recognized Assets	22,311	679
Gross Amounts Offset in the Consolidated Balance Sheets	0	0
Net Amounts of Assets Presented in the Consolidated Balance Sheets	22,311	679
Gross Amounts Not Offset in the Consolidated Balance Sheets
Financial Instruments	(22,311)	(679)
Cash Collateral Received	0	0
Net Amount	$ 0	$ 0

XML

Other Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017	Sep. 30, 2017
Other Liabilities [Abstract]
Securitized debt	$ 714,203	$ 363,944
Obligation to return securities held as collateral, at fair value	0	504,062
Senior Notes	96,805	96,773
Dividends and dividend equivalents payable	90,136	79,771	$ 79,605
Accrued interest payable	11,630	12,263
Payable for unsettled MBS and residential whole loans purchases	10,888	0
Accrued expenses and other	27,821	21,584
Total Other Liabilities	$ 951,483	$ 1,078,397

XML

Other Liabilities (Senior Notes) (Details) - Senior Notes - USD ($)		9 Months Ended
	Apr. 11, 2012	Sep. 30, 2018
Debt Instrument [Line Items]
Proceeds from issuance of debt	$ 100,000,000.0
Proceed from senior notes net of offering expenses and underwriting discount	$ 96,600,000
Stated interest rate		8.00%
Effective interest rate		8.31%
Redemption price as percentage of principal amount		100.00%

XML

Commitments and Contingencies (Lease Commitments) (Details)	9 Months Ended
	Sep. 30, 2018 USD ($) lease
Lease Commitments
Number of operating leases | lease	2
Corporate headquarters
Lease Commitments
Irrevocable standby letter of credit provided to landlord	$ 785,000
Corporate headquarters | High end of range
Lease Commitments
Aggregate annual lease payments	2,500,000
Off-site back-up facility | High end of range
Lease Commitments
Aggregate annual lease payments	$ 32,000

XML

Commitments and Contingencies (Corporate Loans) (Details) - Corporate Loan - USD ($)	Sep. 30, 2018	Mar. 31, 2018	Dec. 31, 2016
Other Commitments [Line Items]
Commitment to lend	$ 100,000,000		$ 130,000,000
Amount drawn	$ 60,100,000	$ 124,200,000

XML

Commitments and Contingencies (MBS Purchase Commitments) (Details) $ in Millions	Sep. 30, 2018 USD ($)
Non-Agency MBS
Other Commitments [Line Items]
Other commitment	$ 2.3

XML

Commitments and Contingencies (Residential Whole Loan Purchase Commitments) (Details) - USD ($) $ in Millions	Sep. 30, 2018	Sep. 30, 2017
Other Commitments [Line Items]
Other loans held at carrying value excluded	$ 8.6
Other residential whole loans
Other Commitments [Line Items]
Other loans held at carrying value excluded	6.8
Residential whole loans
Other Commitments [Line Items]
Excluded amount, unsettled purchases, residential whole loans, at fair value	$ 1.8	$ 120.4

XML

Commitments and Contingencies (Rehabilitation Loan Commitments) (Details) $ in Millions	Sep. 30, 2018 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Unfunded commitment for rehabilitation loans	$ 43.9

XML

Stockholders' Equity (Narrative) (Details) $ / shares in Units, $ in Thousands								3 Months Ended		9 Months Ended		12 Months Ended	181 Months Ended
	Sep. 13, 2018 $ / shares	Aug. 20, 2018 $ / shares	Jun. 07, 2018 $ / shares	May 17, 2018 $ / shares	Mar. 07, 2018 $ / shares	Feb. 20, 2018 $ / shares	Apr. 15, 2013 $ / shares shares	Sep. 30, 2018 USD ($) $ / shares shares	Sep. 30, 2017 USD ($) $ / shares	Sep. 30, 2018 USD ($) director quarter $ / shares shares	Sep. 30, 2017 USD ($) $ / shares	Dec. 31, 2017 USD ($) $ / shares shares	Sep. 30, 2018 USD ($) $ / shares shares	Sep. 16, 2016 shares	Dec. 31, 2013 shares	Aug. 31, 2005 shares
Stockholders' Equity
Preferred stock, shares issued								8,000,000		8,000,000		8,000,000	8,000,000
Preferred stock, par value (in dollars per share) | $ / shares								$ 0.01		$ 0.01		$ 0.01	$ 0.01
Preferred stock, dividend rate (as a percent)										7.50%		7.50%
Maximum quarters without dividends to get voting rights, in quarters | quarter										6
Common stock, cash dividends declared (in dollars per share) | $ / shares	$ 0.20		$ 0.20		$ 0.20			$ 0.20	$ 0.20	$ 0.60	$ 0.60
Dividends and dividend equivalents declared and unpaid | $								$ 90,136	$ 79,605	$ 90,136	$ 79,605	$ 79,771	$ 90,136
Aggregate number of shares of common stock authorized (in shares)								886,950,000		886,950,000		886,950,000	886,950,000
Number of shares authorized to be repurchased under the Repurchase Program (in shares)															10,000,000.0	4,000,000.0
Repurchase of shares of common stock (in shares)										0
Number of remaining shares authorized to be repurchased under the Repurchase Program (in shares)								6,616,355		6,616,355			6,616,355
DRSPP
Stockholders' Equity
Aggregate number of shares of common stock authorized (in shares)														15,000,000
Shares of common stock authorized and available for issuance (in shares)								11,900,000		11,900,000			11,900,000
Common shares issued through DRSPP (in shares)								64,731		302,264			33,978,241
Net proceeds from shares issued through DRSPP | $								$ 519		$ 2,200			$ 283,700
Series B
Stockholders' Equity
Dividend declared per share, preferred stock (in dollars per share) | $ / shares		$ 0.46875		$ 0.46875		$ 0.46875
Preferred Stock | Series B
Stockholders' Equity
Preferred stock, shares issued							8,000,000.0
Preferred stock, par value (in dollars per share) | $ / shares							$ 0.01
Preferred stock, liquidation preference (in dollars per share) | $ / shares							$ 25.00	$ 25.00		$ 25.00		$ 25	$ 25.00
Preferred stock, dividend rate (as a percent)							7.50%			7.50%		7.50%
Preferred stock, redemption price (in dollars per share) | $ / shares							$ 25.00
Number of additional directors that can be elected by preferred stock holders | director										2
Minimum percentage of preferred shareholders required for approval (percent)							66.67%

XML

Stockholders' Equity (Public Offering of Common Stock) (Details) - USD ($) $ / shares in Units, $ in Thousands			9 Months Ended		12 Months Ended
	Sep. 05, 2018	May 10, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Subsidiary, Sale of Stock [Line Items]
Issuance costs			$ 350	$ 412
Public Offering
Subsidiary, Sale of Stock [Line Items]
Shares issues (in shares)	875,000
Shares Issued			50,875,000		23,000,000
Gross Proceeds Per Share (USD per share)			$ 7.78		$ 7.85
Gross Proceeds			$ 395,807		$ 180,550
Issuance costs	$ 6,500	$ 2,300

XML

Stockholders' Equity (Accumulated Other Comprehensive Income/(Loss)) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Components of accumulated other comprehensive income/(loss)
OCI before reclassifications	$ (28,888)		$ (57,276)
Amounts reclassified from AOCI	(9,455)	$ (14,935)	(25,580)	$ (31,315)
Net OCI during the period	(38,343)	(2,156)	(82,856)	56,544
Total AOCI
Components of accumulated other comprehensive income/(loss)
Balance at beginning of period	564,711	632,382	609,224	573,682
OCI before reclassifications		12,779		87,859
Amounts reclassified from AOCI		(14,935)		(31,315)
Net OCI during the period		(2,156)		56,544
Balance at end of period	526,368	630,226	526,368	630,226
Net Unrealized Gain/(Loss) on AFS Securities
Components of accumulated other comprehensive income/(loss)
Balance at beginning of period	548,551	668,223	620,648	620,403
OCI before reclassifications	(34,278)	6,988	(90,250)	71,188
Amounts reclassified from AOCI	(9,455)	(14,935)	(25,580)	(31,315)
Net OCI during the period	(43,733)	(7,947)	(115,830)	39,873
Balance at end of period	504,818	660,276	504,818	660,276
Net (Loss)/Gain on Swaps
Components of accumulated other comprehensive income/(loss)
Balance at beginning of period	16,160	(35,841)	(11,424)	(46,721)
OCI before reclassifications	5,390	5,791	32,974	16,671
Amounts reclassified from AOCI	0	0	0	0
Net OCI during the period	5,390	5,791	32,974	16,671
Balance at end of period	$ 21,550	$ (30,050)	$ 21,550	$ (30,050)

XML

Stockholders' Equity (Amounts Reclassified out of AOCI) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Amounts Reclassified from AOCI
Realized gain on sale of securities	$ 16,415	$ 14,933	$ 32,661	$ 30,530
Net Income Available to Common Stock and Participating Securities	83,382	60,055	229,672	210,549
Total reclassifications for period	(9,455)	(14,935)	(25,580)	(31,315)
Accumulated Other Comprehensive Income/(Loss)
Unrealized losses recorded in AOCI on securities for which Other-than-temporary impairments had been recognized in earnings in prior periods	0		0		$ 0
Amounts Reclassified from AOCI | Accumulated Net Investment Gain (Loss) Including Portion Attributable to Noncontrolling Interest
Amounts Reclassified from AOCI
Realized gain on sale of securities	(9,455)	(14,935)	(25,580)	(30,283)
OTTI recognized in earnings		0		(1,032)
Net Income Available to Common Stock and Participating Securities	$ (9,455)	$ (14,935)	$ (25,580)	$ (31,315)

XML

EPS Calculation (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Numerator:
Net income	$ 87,132	$ 63,805	$ 240,922	$ 221,799
Dividends declared on preferred stock	(3,750)	(3,750)	(11,250)	(11,250)
Dividends, dividend equivalents and undistributed earnings allocated to participating securities	(472)	(409)	(1,393)	(1,299)
Net income to common stockholders - basic and diluted	$ 82,910	$ 59,646	$ 228,279	$ 209,250
Denominator:
Weighted average common shares for basic and diluted earnings per share (in shares)	428,713	396,698	408,614	385,282
Basic and diluted earnings per share (in dollars per share)	$ 0.19	$ 0.15	$ 0.56	$ 0.54
Anti-dilutive securities excluded from diluted earnings per share calculations (in shares)	2,300		2,200
RSUs
Denominator:
Weighted average grant date fair value (in dollars per share)	$ 6.72		$ 6.72

XML

Equity Compensation, Employment Agreements and Other Benefit Plans (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Share based compensation
Maximum shares authorized for grant	12,000,000.0		12,000,000.0
Shares available for grant (in shares)	5,700,000		5,700,000
RSUs
Share based compensation
Awards granted (in shares)	0	0	843,802	898,945
Forfeitures (in shares)			20,000	0
Unrecognized compensation cost	$ 6.2		$ 6.2		$ 4.1
Period for recognizing unrecognized compensation cost			1 year 9 months 29 days
Restricted shares of common stock
Share based compensation
Awards granted (in shares)			0	0
Share-based awards outstanding (in shares)	0		0
Equity Compensation Plan
Share based compensation
Maximum number of common shares that can be granted to participant in any one year			1,500,000.0
Period during which a participant can be awarded the maximum number of shares allowable under the Plan			1 year
Maximum percentage of common shares that can be owned or deemed to be owned by a participant (more than)			9.80%

XML

Equity Compensation, Employment Agreements and Other Benefit Plans (Allocated Expense) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Share based compensation
Allocated expense	$ 1,082	$ 1,910	$ 3,891	$ 5,369
RSUs
Share based compensation
Allocated expense	1,082	1,836	3,891	5,194
Restricted shares of common stock
Share based compensation
Allocated expense	$ 0	$ 74	$ 0	$ 175

XML

Equity Compensation, Employment Agreements and Other Benefit Plans (Details 2) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018 USD ($) officer	Sep. 30, 2017 USD ($)	Sep. 30, 2018 USD ($) officer	Sep. 30, 2017 USD ($)	Dec. 31, 2017 USD ($)
Deferred Compensation Activity
Number of officers having employment agreements with the company | officer	4		4
Deferred Compensation Plans
Deferred Compensation Activity
Deferrable compensation by the employee, maximum			100.00%
Non-employee directors	$ (22)	$ 125	$ 0	$ 339
Undistributed Income Deferred	2,100		2,100		$ 1,688
Liability Under Deferred Plans	2,420		2,420		2,056
Deferred Compensation Plans | Non-employee directors
Deferred Compensation Activity
Non-employee directors	(22)	125	0	339
Undistributed Income Deferred	2,100		2,100		1,688
Liability Under Deferred Plans	2,420		$ 2,420		$ 2,056
Savings Plan
Deferred Compensation Activity
Employer contribution percentage on first 3 percent of eligible compensation deferred by employees (percent)			100.00%
Percentage of eligible compensation deferred by employees qualifying for 100 percent matching contribution (percent)			3.00%
Employer contribution percentage on next 2 percent of eligible compensation deferred by employees (percent)			50.00%
Percentage of eligible compensation deferred by employees qualifying for 50 percent matching contribution (percent)			2.00%
Percentage of employer matching contributions that vest immediately (percent)			100.00%
Expenses for matching contributions	$ 89	$ 88	$ 282	$ 263

XML

Fair Value of Financial Instruments (Narrative) (Details) $ in Thousands	Sep. 30, 2018 USD ($)	Jun. 30, 2018 USD ($)	Dec. 31, 2017 USD ($)	Sep. 30, 2017 USD ($)	Jun. 30, 2017 USD ($)	Dec. 31, 2016 USD ($)
Carrying value and estimated fair value of financial instruments
Real estate owned	$ 223,105	$ 192,162	$ 152,356	$ 137,979	$ 104,443	$ 80,503
Other real estate, fair value	$ 246,000		$ 175,800
Expected Dividend Rate | Minimum | Term notes backed by MSR related collateral
Carrying value and estimated fair value of financial instruments
Measurement input	0.049
Expected Dividend Rate | Maximum | Term notes backed by MSR related collateral
Carrying value and estimated fair value of financial instruments
Measurement input	0.062
Discount rate | Term notes backed by MSR related collateral
Carrying value and estimated fair value of financial instruments
Measurement input	0.0562

XML

Fair Value of Financial Instruments (Fair Value Hierarchy) (Details) - USD ($)		Sep. 30, 2018	Dec. 31, 2017
Assets:
Available-for-sale securities		$ 6,779,045,000	$ 7,023,050,000
Residential whole loans, at fair value	[1]	1,449,365,000	1,325,115,000
Securities obtained and pledged as collateral		0	504,062,000
Swaps		22,311,000	679,000
Total assets carried at fair value		8,755,916,000	9,234,710,000
Liabilities:
Obligation to return securities obtained as collateral		0	504,062,000
Total liabilities carried at fair value		0	504,062,000
Agency MBS
Assets:
Available-for-sale securities		2,905,490,000	2,824,681,000
Non-Agency MBS
Assets:
Available-for-sale securities		3,334,610,000	3,533,966,000
CRT securities
Assets:
Available-for-sale securities		538,945,000	664,403,000
Term notes backed by MSR related collateral
Assets:
Term notes backed by MSR related collateral		505,195,000	381,804,000
Residential whole loans
Assets:
Residential whole loans, at fair value		1,449,365,000	1,325,115,000
Level 1
Assets:
Securities obtained and pledged as collateral		0	504,062,000
Swaps		0	0
Total assets carried at fair value		0	504,062,000
Liabilities:
Obligation to return securities obtained as collateral		0	504,062,000
Total liabilities carried at fair value		0	504,062,000
Level 1 | Agency MBS
Assets:
Available-for-sale securities		0	0
Level 1 | Non-Agency MBS
Assets:
Available-for-sale securities		0	0
Level 1 | CRT securities
Assets:
Available-for-sale securities		0	0
Level 1 | Term notes backed by MSR related collateral
Assets:
Term notes backed by MSR related collateral		0	0
Level 1 | Residential whole loans
Assets:
Residential whole loans, at fair value		0	0
Level 2
Components of financial instruments carried at fair value
Credit valuation adjustment to derivative liabilities		0
Credit valuation adjustment to derivative assets		0
Assets:
Securities obtained and pledged as collateral		0	0
Swaps		22,311,000	679,000
Total assets carried at fair value		6,801,356,000	7,023,729,000
Liabilities:
Obligation to return securities obtained as collateral		0	0
Total liabilities carried at fair value		0	0
Level 2 | Agency MBS
Assets:
Available-for-sale securities		2,905,490,000	2,824,681,000
Level 2 | Non-Agency MBS
Assets:
Available-for-sale securities		3,334,610,000	3,533,966,000
Level 2 | CRT securities
Assets:
Available-for-sale securities		538,945,000	664,403,000
Level 2 | Term notes backed by MSR related collateral
Assets:
Term notes backed by MSR related collateral		0	0
Level 2 | Residential whole loans
Assets:
Residential whole loans, at fair value		0	0
Level 3
Assets:
Securities obtained and pledged as collateral		0	0
Swaps		0	0
Total assets carried at fair value		1,954,560,000	1,706,919,000
Liabilities:
Obligation to return securities obtained as collateral		0	0
Total liabilities carried at fair value		0	0
Level 3 | Agency MBS
Assets:
Available-for-sale securities		0	0
Level 3 | Non-Agency MBS
Assets:
Available-for-sale securities		0	0
Level 3 | CRT securities
Assets:
Available-for-sale securities		0	0
Level 3 | Term notes backed by MSR related collateral
Assets:
Term notes backed by MSR related collateral		505,195,000	381,804,000
Level 3 | Residential whole loans
Assets:
Residential whole loans, at fair value		$ 1,449,365,000	$ 1,325,115,000

[1] Includes approximately $215.1 million and $183.2 million of Residential whole loans, at carrying value and $723.8 million and $289.3 million of Residential whole loans, at fair value transferred to consolidated variable interest entities (“VIEs”) at September 30, 2018 and December 31, 2017, respectively. Such assets can be used only to settle the obligations of the VIEs.

XML

Fair Value of Financial Instruments (Level 3 Assets) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Purchase credit impaired loans transaction closed in current period which were purchased in prior periods	$ 54,900	$ 97,900	$ 54,900	$ 97,900
Residential Whole Loans, at Fair Value (1)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Purchase credit impaired loans transaction closed in current period which were purchased in prior periods	34,400	92,700	34,400	92,700
Recurring basis | Level 3 | Residential Whole Loans, at Fair Value (1)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of period	1,468,540	744,072	1,325,115	814,682
Purchases and capitalized advances	76,566	284,930	393,867	295,094
Changes in fair value recorded in Net gain on residential whole loans held at fair value	8,442	5,289	26,788	12,499
Collection of principal, net of liquidation gains/losses	(54,331)	(17,670)	(155,199)	(53,366)
Repurchases	(561)	(257)	(1,623)	(1,013)
Transfer to REO	(51,089)	(33,214)	(141,381)	(84,746)
Balance at end of period	1,447,567	983,150	1,447,567	983,150
Recurring basis | Level 3 | Term Notes Backed by MSR Related Collateral
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of period	381,390	273,961	381,804	0
Purchases and capitalized advances	290,042	161,000	439,392	311,000
Collection of principal, net of liquidation gains/losses	(166,120)	(123,961)	(316,120)	(140,980)
Changes in unrealized gain/losses	(117)	563	119	563
Transfers from Level 2 to Level 3 (1)	0	0	0	140,980
Balance at end of period	505,195	311,563	505,195	311,563
Residential whole loans
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Excluded amount, unsettled purchases, residential whole loans, at fair value	$ 1,800	$ 120,400	$ 1,800	$ 120,400

XML

Fair Value of Financial Instruments (Fair Value Methodology) (Details) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2018 USD ($)	Dec. 31, 2017 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Residential whole loans, at fair value	$ 1,377,440	$ 951,811
Purchases excluded from level 2 fair value	70,100	373,300
Discounted cash flow
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Residential whole loans, at fair value	693,874	358,871
Liquidation model
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Residential whole loans, at fair value	683,566	592,940
Simple average amount	$ 378	$ 336
Residential whole loans | Level 3 | Liquidation model | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Annual change in home prices	(1.00%)	(8.00%)
Liquidation timeline (in years)	1 month 6 days	1 month 6 days
Current value of underlying properties	$ 2	$ 0
Residential whole loans | Level 3 | Liquidation model | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Annual change in home prices	11.80%	8.80%
Liquidation timeline (in years)	4 years 6 months	4 years 6 months
Current value of underlying properties	$ 7,950	$ 9,900
Discount rate | Residential whole loans | Level 3 | Discounted cash flow | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.045	0.045
Discount rate | Residential whole loans | Level 3 | Discounted cash flow | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.080	0.130
Discount rate | Residential whole loans | Level 3 | Discounted cash flow | Weighted Average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.053	0.055
Discount rate | Residential whole loans | Level 3 | Liquidation model | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.061	0.061
Discount rate | Residential whole loans | Level 3 | Liquidation model | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.500	0.500
Discount rate | Residential whole loans | Level 3 | Liquidation model | Weighted Average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.082	0.080
Prepayment rate | Residential whole loans | Level 3 | Discounted cash flow | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.000	0.0115
Prepayment rate | Residential whole loans | Level 3 | Discounted cash flow | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.135	0.151
Prepayment rate | Residential whole loans | Level 3 | Discounted cash flow | Weighted Average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.038	0.041
Prepayment rate | Residential whole loans | Level 3 | Liquidation model | Weighted Average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.033	0.025
Default rate | Residential whole loans | Level 3 | Discounted cash flow | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.000	0.000
Default rate | Residential whole loans | Level 3 | Discounted cash flow | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.310	0.065
Default rate | Residential whole loans | Level 3 | Discounted cash flow | Weighted Average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.027	0.029
Default rate | Residential whole loans | Level 3 | Liquidation model | Weighted Average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liquidation timeline (in years)	1 year 9 months 18 days	1 year 7 months 6 days
Loss severity | Residential whole loans | Level 3 | Discounted cash flow | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.000	0.000
Loss severity | Residential whole loans | Level 3 | Discounted cash flow | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	1.000	1.000
Loss severity | Residential whole loans | Level 3 | Discounted cash flow | Weighted Average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.130	0.138
Loss severity | Residential whole loans | Level 3 | Liquidation model | Weighted Average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Current value of underlying properties	$ 767	$ 772

XML

Fair Value of Financial Instruments (Carrying Value vs Fair Value) (Details) - USD ($) $ in Thousands		Sep. 30, 2018	Dec. 31, 2017
Carrying value and estimated fair value of financial instruments
Other real estate, fair value		$ 246,000	$ 175,800
Financial Assets:
Available-for-sale securities		6,779,045	7,023,050
MSR related assets		565,272	492,080
Residential whole loans, at carrying value	[1]	2,471,567	908,516
Residential whole loans, at fair value	[1]	1,449,365	1,325,115
Securities obtained and pledged as collateral		0	504,062
Restricted cash		6,489	13,307
Swaps		22,311	679
Financial Liabilities (1):
Repurchase agreements		7,278,270	6,614,701
Securitized debt		714,203	363,944
Obligation to return securities obtained as collateral		0	504,062
Senior Notes		96,805	96,773
Carrying Value
Financial Assets:
MSR related assets		565,272	492,080
Securities obtained and pledged as collateral		0	504,062
Cash and cash equivalents		104,186	449,757
Restricted cash		6,489	13,307
Swaps		22,311	679
Financial Liabilities (1):
Repurchase agreements		7,278,270	6,614,701
Securitized debt		714,203	363,944
Obligation to return securities obtained as collateral		0	504,062
Senior Notes		96,805	96,773
Estimated Fair Value
Financial Assets:
MSR related assets		565,272	493,026
Securities obtained and pledged as collateral		0	504,062
Cash and cash equivalents		104,186	449,757
Restricted cash		6,489	13,307
Swaps		22,311	679
Financial Liabilities (1):
Repurchase agreements		7,289,006	6,623,255
Securitized debt		713,783	366,109
Obligation to return securities obtained as collateral		0	504,062
Senior Notes		100,791	103,729
Agency MBS
Financial Assets:
Available-for-sale securities		2,905,490	2,824,681
Financial Liabilities (1):
Repurchase agreements		2,584,097	2,501,340
Agency MBS | Carrying Value
Financial Assets:
Available-for-sale securities		2,905,490	2,824,681
Agency MBS | Estimated Fair Value
Financial Assets:
Available-for-sale securities		2,905,490	2,824,681
Non-Agency MBS
Financial Assets:
Available-for-sale securities		3,334,610	3,533,966
Financial Liabilities (1):
Repurchase agreements		1,592,067	1,256,033
Non-Agency MBS | Carrying Value
Financial Assets:
Available-for-sale securities		3,334,610	3,533,966
Non-Agency MBS | Estimated Fair Value
Financial Assets:
Available-for-sale securities		3,334,610	3,533,966
CRT securities
Financial Assets:
Available-for-sale securities		538,945	664,403
Financial Liabilities (1):
Repurchase agreements		405,168	459,058
CRT securities | Carrying Value
Financial Assets:
Available-for-sale securities		538,945	664,403
CRT securities | Estimated Fair Value
Financial Assets:
Available-for-sale securities		538,945	664,403
Residential whole loans
Financial Assets:
Residential whole loans, at fair value		1,449,365	1,325,115
Financial Liabilities (1):
Repurchase agreements		1,347,946	1,043,747
Residential whole loans | Carrying Value
Financial Assets:
Residential whole loans, at carrying value		2,471,567	908,516
Residential whole loans, at fair value		1,449,365	1,325,115
Residential whole loans | Estimated Fair Value
Financial Assets:
Residential whole loans, at carrying value		2,549,927	988,688
Residential whole loans, at fair value		$ 1,449,365	$ 1,325,115

[1] Includes approximately $215.1 million and $183.2 million of Residential whole loans, at carrying value and $723.8 million and $289.3 million of Residential whole loans, at fair value transferred to consolidated variable interest entities (“VIEs”) at September 30, 2018 and December 31, 2017, respectively. Such assets can be used only to settle the obligations of the VIEs.

XML

Use of Special Purpose Entities and Variable Interest Entities (Loan Securitization Transaction) (Details) - USD ($)	1 Months Ended		9 Months Ended	12 Months Ended
	Jul. 31, 2018	May 31, 2018	Sep. 30, 2018	Dec. 31, 2017	Jul. 30, 2018
Variable Interest Entity [Line Items]
Outstanding amount of Senior Bonds			$ 96,805,000	$ 96,773,000
Asset-backed Securities, Securitized Loans and Receivables
Variable Interest Entity [Line Items]
Aggregate fair value		$ 319,100,000	$ 1,290,029,000	$ 620,924,000	$ 347,700,000
Weighted average interest rate			3.65%	3.14%
Cash received			$ 802,815,000	$ 382,845,000
Outstanding amount of Senior Bonds			714,203,000	363,944,000
Debt issuance cost			4,100,000	2,300,000
Senior Notes | Asset-backed Securities, Securitized Loans and Receivables
Variable Interest Entity [Line Items]
Principal amount of Securitized debt			802,817,000	382,847,000
Proceeds from Senior bond sold with Step up feature			604,700,000	$ 233,700,000
Debt instrument, basis spread on variable rate				300.00%
Debt instrument, coupon step-up period				36 months
Rated and Non-Rated Certificates | Asset-backed Securities, Securitized Loans and Receivables
Variable Interest Entity [Line Items]
Principal amount of Securitized debt			$ 275,174,000	$ 127,001,000
Trust, Ownership in Residential Whole Loans | Asset-backed Securities, Securitized Loans and Receivables
Variable Interest Entity [Line Items]
Cash received	$ 236,000,000	184,000,000
Trust, Ownership in Residential Whole Loans | Senior Notes | Asset-backed Securities, Securitized Loans and Receivables
Variable Interest Entity [Line Items]
Principal amount of Securitized debt		$ 183,970,000			$ 236,000,000
Weighted average interest rate		3.875%			4.164%
Trust, Ownership in Residential Whole Loans | Non Rated Certificates | Asset-backed Securities, Securitized Loans and Receivables
Variable Interest Entity [Line Items]
Principal amount of Securitized debt		$ 46,400,000			$ 101,700,000

XML

Use of Special Purpose Entities and Variable Interest Entities (Narrative) (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Jun. 30, 2018	Dec. 31, 2017	Jun. 30, 2017	Dec. 31, 2016
Variable Interest Entity [Line Items]
Residential whole loans, at fair value	[1]	$ 1,449,365		$ 1,449,365			$ 1,325,115
Securitized debt		714,203		714,203			363,944
Total residential whole loans		3,900,000		3,900,000			2,200,000
Residential whole loans, at carrying value	[1]	2,471,567		2,471,567			908,516
Real estate owned		223,105	$ 137,979	223,105	$ 137,979	$ 192,162	152,356	$ 104,443	$ 80,503
Other real estate, fair value		246,000		246,000			175,800
Residential whole loans held at carrying value		29,524	9,026	61,788	26,219
Net gain on residential whole loans held at fair value		34,942	$ 18,679	105,883	$ 48,660
Asset-backed Securities, Securitized Loans and Receivables
Variable Interest Entity [Line Items]
Purchased credit impaired loans		215,100		215,100			183,200
Residential whole loans, at fair value		723,800		723,800			289,300
Securitized debt		714,200		714,200			363,900
Other Assets | Asset-backed Securities, Securitized Loans and Receivables
Variable Interest Entity [Line Items]
Real estate owned at fair value		$ 61,000		$ 61,000			$ 5,500

[1] Includes approximately $215.1 million and $183.2 million of Residential whole loans, at carrying value and $723.8 million and $289.3 million of Residential whole loans, at fair value transferred to consolidated variable interest entities (“VIEs”) at September 30, 2018 and December 31, 2017, respectively. Such assets can be used only to settle the obligations of the VIEs.